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Abstract
Polyhydroxybutyrate (PHB) is a biodegradable polymer produced by many microorganisms
when they find themselves limited in an essential nutrient such as nitrogen or phosphorus but in
the presence of an abundant carbon source. PHB and other related polymers are of interest
because they have valuable properties as elastomers and thermoplastics, and are
environmentally-friendly plastics than can potentially replace oil-based polymers. Bacteria
package PHB as insoluble granules within the cell, maintaining the amorphous nature of the
polymer, which is necessary for its degradation and reutilization when the environment becomes
more conducive to growth and division. We are interested in understanding how the bacteria
synthesize PHB and how they package it in such a way as to maintain its amorphous (rather than
crystalline) nature. Examination of PHB biosynthesis has primarily been carried out in Ralstonia
eutropha, which accumulates PHB to 80% of its cell dry weight (cdw) under the appropriate
growth conditions. However most organisms do not accumulate PHB to such extremes, thus we
have focused our efforts on understanding whether what we have learned about PHB
biosynthesis in R. eutropha is true for organisms that accumulate far less PHB. To that end we
have studied PHB accumulation in Caulobacter crescentus. Under conditions of nitrogen
limitation but with abundant glucose available, C. crescentus accumulates PHB to ~12% of its
cdw. We have quantitatively examined the levels of the PHB synthase, the major granule-
associated protein PhaP and PHB per cell to gain an understanding of PHB biosynthesis in C.
crescentus. We have furthermore isolated and characterized the PHB synthase and PhaP, and
studied their roles in polymer formation in vitro. Our results have led to a model for granule
formation in C. crescentus and suggest that many aspects of the model for granule formation
developed based on studies in R. eutropha are true for organisms that accumulate PHB to much
lower levels.
Thesis Supervisor: JoAnne Stubbe
Title: Novartis Professor of Chemistry and Professor of Biology
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Introduction
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1 Introduction
1.1 General relevance of PHAs
1.1.1 Relevance to biodegradable plastics
Polyhydroxyalkanoates (PHAs) are polyoxoesters synthesized by most microorganisms
when they are exposed to environments limited in a nutrient such as nitrogen, phosphorus, etc.,
but with an abundant carbon source (sugar or fatty acid) (1, 2). As the polymers are synthesized
from soluble CoA monomers, they undergo a phase transition and are deposited as insoluble
inclusions, or granules, within the cytoplasm (Figure 1. 1A). When the environment is once again
conducive to growth and division, the bacteria break down the polymer and use the energy and
monomeric precursors for biosynthetic pathways.
A) B)
R H 0 -SCoA R 0
R"I'k-  YSCoA 0 y
m =0 to 2 n = 100 to 30,000
R = H, CH3, C2H5  : ThermoplasticsWhen m = 1
R = C3H7 - C9H19  Elastomers
Figure 1.1 General structure and properties of PHAs. A) Transmission electron micrograph
of Ralstonia eutropha filled with cytoplasmic granules (1). B) General scheme of polymerization
and properties of PHAs depending on monomeric precursors.
PHAs are of general interest because they are biodegradable polymers from renewable
sources. Depending on the structure of the monomeric precursors they can have properties of
thermoplastics (R = H, CH3 , C2H5) and elastomers (R = C3H7 - C13H27) (Figure 1.1 B) (3, 4). Oil-
based polymers have enjoyed widespread use in the last century owing to their diverse properties
and durability. Unfortunately they are not biodegradable, and in 2010, world-wide manufactured
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plastic waste exceeded 31 million tons, 14 million tons of which was generated in the US alone
(5). This waste accumulates both in landfills and in the ocean (6). Thus PHAs are an attractive
alternative to environmentally unfriendly oil-based polymers. The commercial development and
distribution of PHAs has been undertaken by a number of companies, including Metabolix Inc.
(Cambridge, MA), and Proctor and Gamble (Cincinnati, OH). One challenge facing these
companies is the engineering of recombinant systems such as bacteria and plants for efficient
production of PHAs with varied properties. Unfortunately this process is far from optimal in
terms of the levels of PHA accumulated (e.g. <15% cell dry weight, cdw, in plants) and
production and polymer extraction costs (6, 7). Understanding PHA production at a fundamental
level, by studying the mechanism of polymerization and the means by which the bacteria store
and utilize PHAs, contributes to the goal of producing PHAs in an economically viable fashion.
1.1.2 Relevance to non-template driven biological polymerizations
PHA biosynthesis is also interesting from a fundamental point of view since it is a
paradigm for non-template-driven polymerization reactions. A great deal is known about
template-driven biological polymerizations, including the biosynthesis of DNA, RNA and
proteins. In contrast relatively little is known about the mechanisms of initiation, elongation and
termination of non-template-driven polymerizations (2), for example, the synthesis of starch
from ADP-glucose (8), glycogen from UDP-glucose (9), polyphosphate from ATP (10) and
poly-y-glutamate from glutamate (11). These processes all use soluble monomeric precursors
that undergo a phase change to insoluble material as they are polymerized. The insoluble
polymer is then deposited inside the cell as granules or inclusions.
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1.2 Widespread occurrence of PHA biosynthesis in microorganisms
A wide variety of microorganisms synthesize PHAs, the most common of which is
polyhydroxybutyrate (PHB). PHB was first identified in and isolated from Bacillus sp. in 1926
by Lemoigne (12). Macrae and Wilkinson later identified specific growth conditions under
which B. cereus and B. megaterium accumulated and degraded PHB, and they demonstrated that
it was accumulated after logarithmic growth in the stationary phase (13). They also concluded, as
a result of their experiments, that PHB served as intracellular carbon and energy storage. PHA
accumulation has since been documented in numerous bacteria, including cyanobacteria,
thermophiles, proteobacteria, and Gram-positive bacteria, as well as in archaea. Table 1.1
summarizes some of the organisms in which PHA accumulation has been studied. It is by no
means exhaustive and is intended to give a sense of the range in extent of accumulation of PHAs.
In almost all cases, the bacteria in Table 1.1 were cultured in conditions that maximize PHA
production.
Table 1.1 Extent of PHA accumulation in various bacteria and archaea.
PHA content
Organism (% cdw) Carbon source Reference
Gram-positive bacteria
Bacillus subtilis DSM10 33.5 Acetate and 3-hydroxybutyrate (14)
Bacillus cereus DSM31 41.4 Acetate and 3-hydroxybutyrate (14)
Micrococcus sp. 35-40 Sucrose (15)
Nocardia carollina 2.4 Glucose (16)
Streptomyces 1-10 Glucose (17)
Cyanobacteria
Gloeothece sp. PCC6909 6-9 Acetate (18)
Spirulina 2.5 Acetate (19)
Synechocystis PCC6803 4.1 CO 2 (20)
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Thermophiles
Chelatococcus sp. MW10
Synechococcus sp. MA19
Thermus thermophilus
Proteobacteria
Azotobacter vinelandii
Caulobacter crescentus
Ectothiorhodospira
shaposhnikovii
Enterobacter aerogenes
Methylobacterium
Paracoccus denitrificans
Pseudomonas stutzeri
Ralstonia eutropha
Rhizobium
Archaea
Haloarcula hispanica
Haloarculajaponica
Haloferax mediterranei
Halopiger aswanensis
70
20
35-40
75
10-20
1
7.3
30
24
7
80
25-45
2.4
0.5
17
34
Glucose
CO 2
Gluconate, octanoate
Glucose
Glucose
Bicarbonate
Glucose
Methanol, valerate
n-pentanol
Glucose
Fructose
Mannitol
Glucose
Glucose
Glucose
Acetate/butyrate
PHB production by the soil bacterium Ralstonia eutropha has been extensively studied.
Under conditions of nitrogen limitation with fructose as a carbon source, R. eutropha can
accumulate polymer up to 80% of its cdw (1, 2, 30). Of the organisms whose PHA accumulation
has been studied, R. eutropha is on the high end of accumulation. While this is interesting from
the point of view of producing biodegradable polymers for commercial distribution, it is unlikely
that organisms accumulate PHAs to such high levels in the natural environment. In contrast,
Caulobacter crescentus - the focus of much of the research presented in this thesis - is on the
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(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(27)
(1, 2, 30)
(31)
(32)
(33)
(34)
(35)
lower end of PHA accumulation and accumulates considerably less PHB than R. eutropha. Thus
C. crescentus, with our extensive knowledge of this organism's biochemistry and genetics,
provides a good model for studying PHA biosynthesis.
1.3 Proteins involved in PHB biosynthesis
1.3.1 Overview of players
This section presents an overview of the protein players in PHB biosynthesis in R.
eutropha and C. crescentus. The proteins, and the various manners in which they were identified
and characterized, will be discussed more thoroughly in the following sections. R. eutropha
produces PHB via the proteins encoded by the phaCAB operon (36, 37). This operon encodes
three proteins: PhaA is a thiolase that catalyzes the condensation of two molecules of acetyl CoA
to acetoacetyl CoA (Figure 1.2); PhaB is an NADPH-dependent reductase that reduces
acetoacetyl CoA to 3-(R)-hydroxybutyryl CoA (HBCoA); and PhaC catalyzes the polymerization
of HBCoA monomeric units to generate PHB.
o -SCoA 0 0 NADPH NADP* OH 0 -SCoA = 0
2 SCoA SCoA SCoA ot- atPhaA PhaB PhaC n
Acetyl-CoA Acetoacetyl-CoA HBCoA PHB
n= 103 - 104
Figure 1.2 Biosynthetic pathway for PHB production.
Several additional gene products are involved in PHB biosynthesis in R. eutropha (Figure
1.3A). PhaP1 is the major granule associated phasin protein and its gene is located 58 kbp
upstream of phaCAB (38, 39). phaR encodes the transcription factor PhaR, which negatively
regulates the expression of phaP] and autoregulates its own production, and is located
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immediately downstream of phaCAB (40). The genes that encode several intracellular PHB
depolymerases, collectively called PhaZs, are dispersed throughout the genome (39).
A)
H16_1381 H16_1437 H16_1438 H16_1439 H16_1440
phaPi phaC phaA phaB phaR
1.50 Mbp 1.55 Mbp
B)
CC_0250 CC_0509 CC_0510 CC_0511 CC_1380 CC_2160
S- // - :1-- // -Z- // -<~
phaZ phaR phaA phaB phaC phaP
0.25 Mbp 0.54 Mbp 1.56 Mbp 2.54 Mbp
Figure 1.3 Organization of PHB biosynthetic genes in A) Ralstonia eutropha and B)
Caulobacter crescentus. R. eutropha has multiple and redundant putative phasins (PhaPs) and
depolymerases (PhaZs). The position of the major phasin, phaP1, in the R. eutropha genome is
shown. Thus far we have only identified a single depolymerase (phaZ) and a single phasin
(phaP) in C. crescentus.
The research presented in this thesis focuses primarily on the PHB biosynthetic system in
C. crescentus. In contrast to R. eutropha, it appears that C. crescentus has a simpler set of PHB
biosynthesis proteins. The genes encoding these proteins are annotated based on homology of the
protein products to known PHB biosynthetic proteins. Sequence annotation indicates that the
organization of the PHB biosynthetic genes in C. crescentus differs from that in R. eutropha in
terms of the organization of the genes within the genome and the number of putative PHB
biosynthetic proteins (Figure 1.3B). Although phaA and phaB in C. crescentus are colocalized in
the genome as in R. eutropha, phaR is immediately upstream but transcribed in the opposite
direction (41). phaZ is 300 kbp upstream of phaAB, and phaC and phaP are located -1 Mbp and
-2 Mbp downstream of phaAB, respectively. The putative PhaR has 29% identity with PhaR
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from R. eutropha. The putative PhaZ has 47% identity with PhaZal from R. eutropha.
Sequencing of the R. eutropha genome has thus far revealed six additional PhaP 1 homologs that
colocalize with PHB granules, but their expression levels are much lower than that of PhaP 1 (42-
44). R. eutropha also contains a homolog of PhaC, encoded byphaC2, that shares 33% sequence
identity with PhaC, but it is not expressed even when phaC is deleted (45). Preliminary analysis
by sequence gazing does not reveal additional phasins in the C. crescentus genome, nor have we
thus far been able to conclusively identify PhaZ homologs other than that annotated in the
genome.
1.3.2 PHA synthases (PhaCs)
1.3.2.1 Overview of synthases
PHA synthases, or PhaCs, are divided into classes I through IV based on their substrate
specificities, subunit composition and quaternary structure. Class I and III synthases are short
chain polymerases (R = CH 3, CH2CH3, Figure 1.1B) and generate PHB from HBCoA or
copolymers of HBCoA and 3-(R)-hydroxyvaleryl CoA (HVCoA) (46). Class I synthases are
composed of a single subunit, PhaC, that is typically ~65 kDa. Class III synthases are composed
of two 40 kDa subunits, the synthase PhaC and PhaE, a protein of unknown function. Ralstonia
eutropha and Allochromatium vinosum produce the prototypes for the class I and III synthases,
respectively. Class II synthases consist of a single subunit PhaC, -60 kDa, and polymerize long
chain 3-hydroxyalkanoates derived from fatty acids, where R = C3H7 to C14 H2 9 (47).
Pseudomonas aeruginosa expresses the prototypical class II synthase. Class IV synthases also
accept HBCoA and HVCoA as substrates, but have a subunit composition and quatemary
structure distinct from the class I and III synthases. They consist of two subunits, PhaC and
PhaR (distinct from the transcription factor PhaR discussed below) that are 40 kDa and 20 kDa,
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respectively. Members of the genus Bacillus produce the prototype of the class IV sythases (48).
The vast majority of our mechanistic understanding of PHB polymerization comes from studies
carried out on the class I synthase from R. eutropha and the class III synthase from A. vinosum.
These studies will be summarized as a backdrop to the motivation of the studies on C.
crescentus.
To study the mechanism of polymerization, a rapid and reproducible assay is required.
Two different assays for PhaC have been developed (49). The first uses 5,5'-dithiobis-(2-
nitrobenzoic acid) (DTNB) to measure the release of the product CoA as an indicator of the
addition of each new hydroxybutyryl (HB) unit to the growing polymer. The free thiol of CoA
reacts with DTNB to liberate the 2-nitro-5-thiobenzoate anion (TNB), which has a X at 412
nm (c = 13,600 M- cm-1). Assays are typically carried out in a discontinuous fashion, as TNB~
has been shown to inhibit PhaC activity (50). This assay is the most reliable way to measure
activity. A drawback of this assay, however, is that it does not directly measure polymerization,
as CoA release may be the result of hydrolysis of substrate as well as polymerization. This
becomes an issue when considering the activity of mutant PhaCs and the polymerization of
unnatural substrates. A second assay uses [3- 3H]-HBCoA and directly measures the products of
the polymerization. The reaction is quenched and the [3H]-(HB). products are extracted into
chloroform and analyzed by scintillation counting (49). However, the extraction efficiency of the
products into chloroform is dependent on their length, and efficiency drops off as the length
increases. The DTNB assay is thus more efficient and reliable to study PhaC activity.
Class I synthases. The class I synthases are coded for by a single gene, phaC. phaC from
R. eutropha was first cloned and characterized in 1989 by Peoples and Sinskey (37). Successful
overexpression, purification and characterization of the synthase, PhaCRe, was reported in 1994
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by the Sinskey lab in collaboration with our lab (49). Initial efforts to purify PhaC were thwarted
by its propensity to "stick" to the chromatography resin and glassware. Addition of the non-ionic
detergent hecameg (Figure 1.4) at levels substantially below its critical micelle concentration
(cmc) overcame this issue for reasons that are still not well understood. In the presence of
hecameg, PhaCRe was readily purified to homogeneity. Almost all experiments with PhaCRe
described subsequently included hecameg.
0
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Figure 1.4 Structure of the non-ionic detergent hecameg (methyl-6-0-(N-heptylcarbamoyl).
The specific activity of early preparations of PhaCRe varied between 8 and 40 U/mg
(where a unit, U, of activity is one pimol of substrate consumed per min) (46, 49). The
discrepancy between measurements was attributed to the presence of high-molecular-weight
(Mw) aggregates of PhaCRe. Once the aggregates were removed by size exclusion
chromatography (SEC), the specific activity plateaued at 40 U/mg. PhaCRe purified as an N-
terminally hexahistidine-tagged construct has a specific activity is ~40 U/mg at 30 'C (46, 51).
Removal of the tag does not change the specific activity (46). The enzyme exhibits a lag phase in
CoA release that is dependent on enzyme concentration (Figure 1.5A). Goodwin and coworkers
have measured a Km of 110 pM for PhaCRe in the presence of 70% fructose, which they claim
eliminates the lag phase. In our hands, however, the experiments could not be reproduced (46).
Furthermore they monitored the disappearance of the absorbance of the thioester of HBCoA at
236 nm as an indicator for polymerization. Given that the absorption of the adenine moiety of
CoA at 260 nm is strong and extends into the 236 nm region, their assay is not very sensitive.
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Very recently, Ushimaru and coworkers demonstrated that addition of the detergent Triton X-
100 at concentrations well below its cmc to assays of PhaCRe eliminated the lag phase and
allowed them to measure a Km for HBCoA of 321 pM (52).
The lag phase in CoA release has many possible explanations. One possibility considered
was that PhaCRe exists in two conformational states, only one of which is active, and that a
necessity for conversion between the inactive and active states causes the lag phase. SEC
revealed that PhaCRe existed as a monomeric form in equilibrium with a dimeric form, and the
equilibrium shifts toward dimer upon acylation with artificial substrates, as described below (49).
A second possibility considered was that the lag phase in PhaCRe activity could be in part due to
omission of a suitable primer. Lag phases have been observed in activity assays of glycogen
synthase and rubber polymerase when the appropriate primer units are omitted (53-55). The
origin of the lag phase is discussed in further detail below.
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Figure 1.5 Kinetics of class I and class III synthases. A) CoA release from the class I synthase
PhaCRe shows a variable lag phase followed by a linear phase. Specific activity of PhaCRe is
determined from the linear phase. Adapted from reference (56). B) CoA release from the class III
synthase PhaECA, shows a burst phase followed by a slower phase. Specific activity of PhaECAV
is measured from the burst phase. Adapted from reference (50).
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Class III synthases. Class III synthases are composed of two subunits, PhaC and PhaE.
PhaC is the synthase whereas PhaE is of unknown function and is not homologous to any protein
in the database. The class III synthase from A. vinosum, PhaECAV, was first purified
recombinantly from E. coli in 1994 by Steinbichel and coworkers (57). PhaE was shown to be
essential for optimal activity and the active synthase contains PhaE and PhaC in a 1:1 ratio (50).
In contrast to PhaCRe, PhaECAv is well-behaved in solution, despite immunogold labeling
experiments and transmission electron microscopy (TEM) evidence suggesting that it too is
associated with the surface of PHB granules in vivo (57). PhaECAv is kinetically distinct from
PhaCRe and has a rapid phase in CoA release, followed by a slower phase (Figure 1.5B). At 30
'C, the specific activity of PhaECAV, which is determined from the burst phase, is 140 U/mg (50).
The Km for HBCoA, again measured from the rate of the burst phase, is 0.13 mM (46). By size
exclusion chromatography the enzyme is a mixture of dimers and tetramers of PhaEC (58).
1.3.2.2 Sequence alignments and threading models of PHA synthases
Threading models for structure prediction of PhaCs. Early mechanistic thinking was
guided by analysis of residues conserved among the available sequences of synthases and by
comparison with the sequences and structure of lipases. Lipases catalyze the hydrolysis of fatty
acyl groups from triacylglycerides (TAG) and as such function at lipid-water interfaces.
Similarly, PhaCs are thought to function at the interface of the cytosol and the PHA granule
surface. Lipases belong to the a/p-hydrolase family and contain the conserved catalytic residues
Ser/(Asp/Glu)/His within the a/P hydrolase domain (59-61). The Ser participates in covalent
catalysis and is found within a lipase box motif (G-X-S-X-G), and the His deprotonates the Ser
to activate it for covalent catalysis. The role of the conserved Asp/Glu is not well understood, as
its deletion has little effect on catalytic activity in the case of lipases. SteinbUchel and coworkers
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noted in 1992 that PhaCs also contain a lipase box motif in which the active site Ser in lipases is
replaced with a conserved Cys (62). The mechanistic significance of this was not known at the
time.
Subsequently, our lab demonstrated by sequence alignment that PhaCAV has a 45 amino
acid stretch with 42% homology to the a/P hydrolase domain of Pseudomonas lipase containing
the active site (49, 63). The essential Ser and His in lipases align with the conserved Cys (C149)
located within the lipase box and with a conserved His (H33 1) in PhaCAv. These residues were
shown by mutagenesis to be essential to activity (63). Furthermore, while two conserved Asp
residues were identified, only one (D302) was important to catalysis, as demonstrated by
mutagenesis (63). Together these observations indicated an important role for these residues that
must be taken into account in a mechanistic model. The alignment of PhaCAv with lipase also
suggested that PhaCAv was a member of the a/P hydrolase domain family and would therefore
likely be structurally similar to lipases within this domain. Using the X-ray structure of
Pseudomonas lipase as a template, a threading model was generated to predict the structure of
the a/p-hydrolase fold domain of PhaCAV, as well as the relative locations of the conserved Cys,
Asp and His residues (63). The model suggested that the active site nucleophile C149 sits in a
sharp elbow turn between a p-strand and an a-helix, as is the case with the Ser nucleophile of
lipases. H33 1 is predicted to be located on an adjacent loop, and D302A was predicted to be near
the core of the structure in which C149 sits, though no precise distance could be given. The
localization of these three residues within the core structure of the modeled synthase further
underscored their mechanistic importance. Alignments of class I synthase sequences reveal the
corresponding conserved Cys, Asp and His residues, and suggest that the class I enzymes are
also members of the a/0 hydrolase fold family. A threading model of PhaCRe was also generated
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using lipase from Burkholderia glumae as a template, predicting the same relative positions of
the active site residues (64). The numbering of the Cys/Asp/His in PhaCRe, PhaECAv, and PhaC
from C. crescentus (PhaCcc) is given in Table 1.2.
Table 1.2 Numbering of active site residues in PhaCRe and PhaECAV and PhaCcc.
Class I - PhaCRe Class III - PhaECAv Class I - PhaCcc
C319 C149 C406
D480 D302 D562
H508 H331 H590
Current analysis of available PhaC sequences. In the decade since the alignments above
were done, hundreds of PhaC sequences have been deposited in the database. As of 2012, an
alignment of 72 class I synthases selected from a variety of genera and species reveals a total of
39 absolutely conserved residues, including the Cys, Asp, and His residues discussed above.
These residues are indicated in the sequence of PhaCRe in Figure 1.6. The active site Cys is the
only conserved Cys residue. Five conserved Pro and nine conserved Gly residues likely play
important structural roles. Furthermore, six Asp, three Ser, three Asn, and five Trp residues are
absolutely conserved.
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matgkgaaastqegksqpfkvtpgpfdpatwlewsrqwqgtegnghaaasgipgldalagvkiapaql
gdiqqrymkdf salwqamaegkaeatgplhdrrfagdawrtnlpyrfaaafyllnaralteladavea
daktrqrirfaisqwvdamspanflatnpeaqrlliesggeslragvrnmmedltrgkisqtdesafe
vgrnvavtegavvfeneyfqllqykpltdkvharpllmvppcinkyyildlqpesslvrhvveqghtv
f lvswrnpdasmagstwddyiehaairaievardisgqdkinvlgfcvggtivstalavlaargehpa
asvtllttlldfadtgildvfvdeghvqlreatlgggagapcallrglelantfsflrpndlvwnyvv
dnylkgntpvpfdllfwngdatnlpgpwycwylrhtylqnelkvpgkltvcgvpvdlasidvptyiyg
sredhivpwtaayastallanklrfvlgasghiagvinppaknkrshwtndalpespqqwlagaiehh
gswwpdwtawlagqagakraapanygnaryraiepapgryvkaka
Figure 1.6 Absolutely conserved amino acids in class I synthases. The sequence given is of
PhaCRe. Residues highlighted in red are absolutely conserved in a sequence alignment of 72 class
I synthases. The catalytic Cys, Asp and His residues are additionally underlined.
An alignment of 35 class III PhaCs reveals that, including the active site Cys, Asp and
His, there are a total of 14 absolutely conserved residues. These residues are indicated in the
primary sequence of PhaCAv in Figure 1.7. Among these residues are D84 and S90, which were
recognized over a decade ago as absolutely conserved among the then reported sequences of
class III synthases (50). D84N and S90A mutants were constructed and had activities that were
3% and 0.75% that of wt, respectively, suggesting they are important, but not essential, to
activity (Jia and Stubbe, unpublished results). There are two conserved Pro and four conserved
Gly residues, two of which are contained within the lipase box. Finally there are two conserved
Trp and one conserved Asn residue.
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mfpidirpdkltqemldysrklgqgmenllnaeaidtgvspkqavysedklvlyrydrpegapeaqpv
pllivyalvnrpymtdiqedrstikgllatgqdvylidwgypdqgdraltlddyingyidrcvdylre
ahgvdkvnllgicqggaf slmysalhpdkvrnlvtmvtpvdfktpdnllsawvqnvdidlavdtmgni
pgellnwtflslkpfsltgqkyvnmvdllddpdkvknflrmekwifdspdqagetfrqfikdfyqnng
f lnggvvlggqevdlkditcpvlnifalqdhlvppdasralkgltsspdytelafpgghligiyvsgka
qkevtpaigkwlner
Figure 1.7 Absolutely conserved amino acids in class III synthases. The sequence given is of
PhaCAv. Residues highlighted in red are absolutely conserved in a sequence alignment of 35 class
III synthases. The catalytic Cys, Asp and His residues are additionally underlined.
Several programs are available online that attempt to predict the secondary and tertiary
structure of proteins based on the primary sequence. These programs rely on sequence homology
of proteins of unknown structure with those of known 3-dimensional structure as well as motifs
common to particular known protein folds. Given the vast increase in the number of 3D
structures of proteins since the original threading models were generated, it is worth
investigating what information an updated threading model might provide. The C-terminal
domain of PhaCRe (encompassing residues 230-558, PhaCRe230-558) and the entire PhaCAv
sequence were submitted to the online programs Phyre2 (65) and SPARKS-X (66). The C-
terminal domain of PhaCRe was selected because it contains the active site residues Cys/Asp/His
and the a/P hydrolase domain. The top hit for PhaCRe230-558 and the second hit for PhaCAV were
models generated using the template with protein databank ID 2RAU. 2RAU is a 40 kDa
putative lipase in the archaea species Sulfolobus solfotaricus, whose structure was solved to 1.85
A resolution by the Joint Center for Structural Genomics. Its structure has not been published in
an accompanying paper. Interestingly, a BLAST search of the sequence of 2RAU against
available protein sequences in the database retrieves entries annotated as putative class III PHA
synthases in Acinetobacter, among other organisms. Closer examination of the sequences of
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these putative synthases reveals that the active site Cys of the typical PHB synthase is replaced
by a Ser and that there is no phaE homolog adjacent to the gene sequence in the genome.
However, alignment of the putative PhaC from Acinetobacter baumanii (PhaCAb) with PhaCAv
reveals that the Ser of PhaCAb aligns with C149 of PhaCAv. Furthermore an Asp and His in
PhaCAb align with D302 and H331 in PhaCAv. The two synthases share 24% sequence identity.
Thus, it is unclear whether these sequences are unusual PhaCs or lipases. However, these
observations led us to believe that 2RAU might serve as a good template for threading models of
PhaCs.
The overall folds of the models are shown in Figure 1.8. Loops (in green) are included to
give a sense of what percentage of the structure cannot be assigned a secondary structure. The
backbones of the models overlay in the regions that have defined secondary structure. In both
models, the core of the structure is an a/P hydrolase domain consisting of a P-sheet (composed of
six to eight P-strands) surrounded by four a-helices. An additional domain composed of three to
four short a-helices is also modeled (above the a/P hydrolase domains in Figure 1.8), but does
not contain the active site residues and is primarily loops.
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A) B)
Figure 1.8 Overall structure of models generated for A) PhaCAV and B) PhaCRe230-558 using
the program SPARKS-X. The active site Cys, Asp and His are indicated with a black circle.
In both models, the essential Cys (C149/319) involved in covalent catalysis is located on
a sharp turn between a P-strand and an a-helix, just as the early threading models predicted.
D302/477 and H331/508 are also located on different loops between a P-strand and an a-helix. In
both, models the Cys/Asp/His residues of the active site form a triangle with His in the middle.
In the model of PhaCA, C149 is 3.6 A from H331, and D302 is 3.9 A from H331 (Figure 1.9A).
In the model of PhaCRe230-558, C319 is 3.7 A from H508, and H508 is 4 A from D477 (Figure
1.9B).
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A) B)
Figure 1.9 Structure models of A) PhaCAV and B) PhaCR1230-558 to indicate the relative
locations of the active site residues. The structures are rotated ~90' relative to the structures in
Figure 1.8. The active site residues are indicated in green.
The active site in both models lies at the back of a pocket with two channels connecting it
to the surface. In the structure of 2RAU, a PEG molecule from the crystallization buffer occupies
this site. When the structure of 2RAU is aligned with either synthase, this PEG molecule fits into
the synthase active site. Figure 1.10 shows a surface rendering of both structures with PEG
molecule docked into the active site to provide a sense of depth. The two views are rotated ~90'
from one another and show the two entrances to the active site. The observation of two channels
into the active site is intriguing given the presumed necessity for a PHB synthase to have both an
entrance to the active site for incoming HBCoA monomers and an exit from the active site for
extrusion of growing polymer. However, as this is both a model and representative of a static
structure, conformational changes that reshape the putative active site (e.g., upon substrate
binding) cannot be ruled out. In the model of PhaCRe23O-558, D477 sits at the edge of one of the
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entrances into the active site. In the model of PhaCAv, D302 is obscured from the surface by an
unstructured loop.
A) B)
C) D)
Figure 1.10 Surface rendering of PhaCAV and PhaCRe230-5 5 8. A) and B) are PhaCAV rotated 90
with respect to one another. C149 is shown in orange, D302 is shown in red and H331 is shown
in blue. The absolutely conserved residues are cyan. C) and D) are PhaCRe230-558 rotated 900 with
respect to one another. C319 is shown in orange, D480 is shown in red and H508 is shown in
blue. The absolutely conserved residues are cyan. The PEG molecule (green) is shown docked in
the active sites of both structures.
54
C)D
Figure 1.11 Positions of absolutely conserved residues in class I and class III PhaCs. Active
site residues are shown in green, and additional absolutely conserved residues are shown in cyan.
A) PhaCA, and B) PhaCRe230-558, with active site residues in front. C) PhaCAv and D) PhaCRe230-
558 rotated 180* with respect to A and B. The absolutely conserved residues D84 and S90 (in
PhaCAv) and D254 and S260 (in PhaCRe) are indicated in a black circle.
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Figures 1.11 A and B show the predicted positions of the absolutely conserved residues
(cyan) in class I and III synthases, in addition to the active site residues (green). In PhaCAv, the
absolutely conserved residues D84 and S90, discussed above, are located on the opposite side of
the protein to the active site, 14.9 A and 20.7 A away from C149, respectively. These two
residues are the two most likely candidates, among the conserved residues, for involvement in
termination, reinitiation or loading of substrate, as discussed in subsequent sections. From the
models, it is difficult to say whether D84 and S90 are involved, as conformational changes may
change their positions relative to the active site. Interestingly, when the two models are overlaid,
D84 and S90 in PhaCAv overlay with the absolutely conserved residues D254 and S260 in
PhaCRe230-558. This observation further suggests that these residues might have an as yet
unresolved role in catalysis.
In PhaCRe230-558, five of the six absolutely conserved Asp residues are included in the
modeled portion of the protein. D351 and D428 both sit at one entrance to the active site. The
three conserved Ser residues in the model are located 15-20 A from C319. As expected, the
conserved Pro residues are located immediately before or after secondary structural elements.
Another conserved residue, A510, is modeled in an a-helix following the active site H508.
Taguchi et al. have proposed that A510 is involved in substrate recognition (67). They first
examined a conserved residue, Q418, in PhaCl from Pseudomonas sp. 61-3, and demonstrated
via directed evolution that its mutation to Leu allowed the synthase to incorporate 36 mol%
lactyl CoA into a copolymer of HB and lactyl units (67). The wt enzyme, in comparison,
polymerizes long-chain 3-hydroxyalkanoates. The authors hypothesized that Q481 plays a role in
substrate specificity in PhaC1 from Pseudomonas. A510 in PhaCRe aligns with Q481 in PhaC1;
thus, the authors investigated the role of A510 in PhaCRe- PhaCRe does not normally accept
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lactyl-CoA as a substrate (46), but mutation of A5 10 to several different amino acids resulted in
a variety of mutant synthases that incorporated lactyl CoA into copolymers of HB an lactyl
monomers in varying mol% (68). The position of A510 near the active site of PhaCRe in the
threading model is consistent with their observations that it plays a role in substrate recognition.
1.3.2.3 Working model for the mechanism ofpolymerization
Figure 1.12 illustrates two of several possible mechanistic models that could account for
the roles of Cys, Asp and His in polymerization. We currently favor the model presented in
Figure 1.12B. The evidence that supports this model will be discussed in the following sections.
The model proposes that synthases act as a dimer of PhaCs (in the case of class I) or PhaECs (in
the case of class III). In both models, the essential Cys residue participates in covalent catalysis
with the growing PHB chain. The essential His deprotonates Cys to generate the active thiolate
nucleophile, which then attacks the thioester of HBCoA, liberating -SCoA and forming an HB-
PhaC thioester. At this point, the two mechanisms diverge. In the mechanism shown in Figure
1.12A, the second HBCoA is loaded to the active site Cys of the other PhaC monomer. The
catalytically important Asp acts as a general base to deprotonate the hydroxyl group of the
second HBCoA, which attacks the HB-PhaC thioester of the first PhaC monomer. The growing
chain is transferred to the second PhaC and the elongation process continues. The active site is
therefore formed at the interface of the dimer of PhaCs. This mechanism predicts that the
growing PHB chain is always covalently attached to the enzyme and that there are no non-
covalent intermediates. The second mechanism, presented in Figure 1.12B, proposes that only
one PhaC active site in the dimer participates in polymerization. After the first HBCoA unit is
loaded onto the active site Cys, a second HBCoA monomer binds non-covalently to the same
active site. Asp serves as the general base catalyst to deprotonate the hydroxyl group, which then
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attacks the HB-PhaC thioester, temporarily releasing the growing chain from the enzyme. The
enzyme rapidly reacylates to continue polymerization. This mechanism predicts that only a
single active site Cys of the PhaC dimer is required for catalysis, and that polymerization
involves covalent as well as non-covalent intermediates.
In light of the threading models presented above, it seems unlikely that the active site
could be formed at the interface of two monomers, given that the active site residues are
relatively buried. The active sites of lipases are also buried, and furthermore the lipases thus far
characterized are all monomeric (69, 70). Thus, the available information we have from structure
modeling efforts and analogy to lipases seems to indicate that the mechanism shown in Figure
1.12A is unlikely to be correct.
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Figure 1.12 Models for the mechanisms of initiation and elongation. The mechanism
involves conserved C/D/H residues. We currently favor model B, which proceeds via both
covalent and non-covalent intermediates. Adapted from reference (71).
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1.3.2.4 Evidence for covalent catalysis and efforts to study the initiation process
Priming studies with PhaCRe. In the original purification of recombinant PhaCRe,
Gerngross and coworkers identified C319 by mutagenesis as essential for activity (49). In an
effort to identify covalent intermediates at early stages in polymerization, they incubated PhaCRe
with 10-100 equivalents of [3- 3H]-HBCoA and examined the products by sucrose density
gradient ultracentrifugation. Fractions throughout the gradient were analyzed for radioactivity by
scintillation counting. The radioactivity was associated entirely with a fraction that migrated as
large polymer, even when HBCoA was present in small excess over synthase (49). Furthermore,
only a small amount of synthase was associated with the large polymer, while the majority
remained unmodified. These results suggested that the rate of initiation was much slower than
the rate of polymerization, resulting in non-uniform loading of the synthase. This approach
would therefore not facilitate identification of early intermediates in polymerization; thus,
alternative approaches were necessary to obtain evidence for covalent catalysis.
Studies of non-template-dependent polymerization reactions have suggested that often
"primers" made from the monomeric building blocks of the polymer are involved in the initiation
process (2). The use of artificial primers to uniformly load PhaCs allowed for the investigation of
early steps in polymerization as well as the identification of covalent intermediates. A series of
(HB)nCoA (n = 2-4) primers and a saturated trimer of HBCoA (sTCoA) (Figure 1.13) were
synthesized and examined for their potential to prime PhaCRe (51). Incubation of these oligomers
with PhaCRe in the absence of HBCoA provided several key insights into the mechanism of
polymerization. When PhaCRe was incubated with (HB) 3CoA and sTCoA, the quaternary
structure shifted from predominantly monomer to predominantly dimer. Furthermore, the length
of the lag phase of CoA release decreased, and the specific activity increased. The data together
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led to a model in which a requirement for priming and formation of the PhaCRe dimer was a
cause of the lag phase in CoA release (51). Incubation of PhaCRe with [3H]-sTCoA revealed that
only the dimer fraction contained radiolabel, and that the stoichiometry was one label per dimer
of PhaC. These results suggested that the dimer was the predominant active form of the synthase
and that one dimer of PhaCs makes a single PHB chain. However, assays of the monomer
fraction isolated by SEC reveal that it has the same specific activity as the dimer (51, 58).
Finally, trypsin digest of PhaCRe reacted with [3H]-sTCoA revealed three peptides containing the
radiolabel. These peptides were sequenced by N-terminal degradation and all three contained
C319, providing the first evidence for covalent catalysis by the active site Cys (72). Subsequent
studies further examined priming of PhaCRe with sTCoA (72). Incubation of PhaCRe with sTCoA
resulted in a burst of CoA release equal to 0.5 equivalents of CoA per monomer of PhaC. This
result was consistent with the above experiments that demonstrated that each dimer was labeled
with one [3H]-sT and further confirmed that a dimer of PhaCs synthesizes a single PHB chain.
Importantly, the radiolabel of [3H]-sTCoA can be chased into polymer when HBCoA is added to
the reaction mixture, demonstrating the chemical competence of sTCoA (51, 72).
0 0 OH n=1:(HB)2 CoA
COAS U ?,,' =n = 2: (HB) 3CoACoAS n =3:(HB)4CoA
0 0? ? R R = H: sTCoA
CoAS O O R = 
3H: [3H]-sTCoA
Figure 1.13 Structures of (HB)3CoA (R = OH) and sTCoA (R = H or 3H).
Because PhaCRe is non-uniformly loaded in vitro, efforts were made to find a protein
factor that might serve the function in vivo that artificial primers serve in vitro, that is, uniformly
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loading the synthase and in the case of PhaCRe, decreasing or eliminating the lag phase in activity
(58). However, recent results from our lab suggest non-uniform loading occurs in vivo as well.
Incorporation of a Strep2-tagged synthase gene in place of the wt gene under the endogenous
promoter in the R. eutropha genome allowed PhaCRe to be isolated by affinity chromatography
(73). It was hoped that rapid isolation of the synthase might allow copurification of a protein
factor involved in initiating polymerization, but no factor was found. However, a portion of the
Strep2-tagged synthase as isolated was associated with high M, PHB, while the remainder was
unmodified. The PHB-complexed PhaCRe exhibited no lag phase and had a higher specific
activity than the recombinant PhaCRe. These results suggest that PHB can function as the primer,
that PhaCRe is non-uniformly loaded in vivo, and that priming is responsible in part for
elimination of the lag phase (73).
Priming studies with PhaEC,. While PhaECAv is kinetically distinct from PhaCRe, in
vitro studies with PhaECAv primed with sTCoA have highlighted the mechanistic similarities
between the two synthases. SDS-PAGE and autoradiography analysis of the products of
PhaECAv reacted with 5 and 50 equiv. [1-1 4 C]-HBCoA revealed that a few molecules of PhaECAv
generate large polymer, while the majority of the synthase remains unmodified. Thus, as is the
case with PhaCRe, the rate of initiation of polymerization by PhaECAv is also much slower than
the rate of elongation (74, 75). Incubation of PhaECAv with sTCoA results in a burst of CoA
release corresponding to 0.5 equivalents per PhaEC, again suggesting that a dimer of PhaECs
makes a single PHB chain (63). Trypsin digest of synthase following incubation with [3H]-
sTCoA revealed three radiolabeled peptides. The M, of the peptides was determined by
electrospray ionization mass spectrometry (ESI-MS) and they were sequenced MS/MS methods,
revealing that C149 was covalently attached to sT, confirming its role in covalent catalysis (50).
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Surprisingly, peptides containing C149 labeled with sT elongated by one and two additional HB
units were also identified. An explanation for this observation is that sTCoA stored for extended
periods of time undergoes slow hydrolysis, and the sTCoA stock therefore contained small
amounts of HBCoA. The enzyme was thus serendipitously caught in the act of elongation,
providing the most convincing evidence for the involvement of C149 in covalent catalysis (50).
Priming studies with PhaC from Aeromonas caviae. Recently Doi and coworkers
demonstrated in vitro that HBCoA can act as a primer for the class I PhaC from Aeromonas
caviae (PhaCAc) and that PhaCAc can be uniformly loaded (76). These observations are
potentially interesting because this is the first report of a wt PhaC that appears to be uniformly
loaded with substrate alone (i.e. without artificial primers). The authors used matrix assisted laser
dissorption ionization, time-of-flight (MALDI-TOF) spectrometry, SEC and dynamic light
scattering (DLS) to monitor the polymerization reaction and the oligomeric state of PhaCAc-
MALDI-TOF demonstrated that when PhaCAc was reacted with 60 equivalents of HBCoA, the
unmodified protein peak disappeared concomitant with appearance of a peak of higher m/z,
suggesting all of the synthase is modified with oligomer/polymer. It should be noted that a caveat
to using mass spectrometry methods to monitor polymerization reactions is that the ionization
efficiencies of the various species are not well understood and may differ depending on
oligomer/polymer length. Furthermore, in the figures in their paper, the m/z values of the peaks
are illegible, and there is no discussion about whether the m/z values of the various peaks are
consistent with PhaCAc modified with PHB chains of various lengths. The authors further
demonstrated by SEC and DLS that reaction with HBCoA shifts the equilibrium from
predominantly monomeric to dimeric PhaCAc (76). Again with the amount of detail provided for
their DLS experiments, it is difficult to critically evaluate their data. The authors conclude that a
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dimer of PhaCAc is the favored form during catalysis, consistent with our observations that the
dimer form of PhaCRe and dimer/tetramer forms of PhaECAv are active for polymerization.
However, a more careful and thorough investigation of priming PhaCAc with HBCoA is
necessary to determine whether this synthase is interesting.
1.3.2.5 Evidence for roles of His and Asp in initiation and elongation
The artificial primer sTCoA was also used to investigate of the role of the conserved His
and Asp residues in initiation and elongation in both PhaCRe and PhaECAv. When H508 of
PhaCRe was mutated to Gln, incubation with sTCoA resulted in no CoA release, suggesting that
His functions to deprotonate the Cys involved in catalysis (72). When D480 was mutated to Asn,
slow CoA release was observed upon incubation with sTCoA, suggesting that this residue does
not play a role in activating C319 for covalent catalysis. Similar experiments were carried out
with PhaECAv. When H331 was mutated to Gln, no CoA release was observed upon incubation
with sTCoA (63). Interestingly, when D302 of PhaECAv was mutated to Asn, acylation with
sTCoA revealed a burst of 0.5 equivalents of CoA per PhaC, and no additional CoA release over
120 min (63). This result demonstrated that D302 is not involved in acylation of Cys with
sTCoA and suggested that the acylated mutant synthase was stable to hydrolysis. In contrast,
following the initial burst of CoA release from priming wt PhaECAv with sTCoA, CoA release
continues at a substantially slower rate, resulting in the production of the sT acid. This result was
interpreted to suggest that D302 functions as a general base catalyst to activate water for
hydrolysis of the acylated enzyme, and further that its role in polymerization is to deprotonate
the hydroxyl group of HBCoA for ester formation.
The mutant D302A-PhaECAv was used to study elongation in vitro. The mutation to Ala
slows the rate of elongation to make it more comparable to the rate of initiation. D302A-
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PhaECAV has a specific activity that is 0.012% that of wt. In vitro reactions between D302A-
PhaECAv and 5-300 equivalents of [1- 4 C]-HBCoA allowed for the detection for the first time of
(HB). intermediates covalently bound to PhaCAv by Western blot analysis using antibodies to
PhaECAv and autoradiography of the dried gel (74). Trypsin digest of D302A-PhaECAv reacted
with 50 equiv. HBCoA followed by ESI-MS analysis of the peptides revealed that C149 was
modified with HBj, where n = 3-10. Evidently, mutation of D302 to A allowed for more uniform
loading and elongation, supporting the role for D302 in elongation.
1.3.2.6 Evidence for covalent and non-covalent intermediates in elongation
Efforts to form heterodimers to support or eliminate the mechanism in Figure 1. 12A. A
central question was to distinguish between the mechanisms shown in Figure 1. 12A and B. One
key distinction is that the mechanism in Figure 1.12A requires the participation of the active site
Cys residues from both subunits in polymerization, whereas the mechanism in Figure 1.12B
requires a Cys from a single subunit only. In this second model, only one of the two monomers
would be active. Zhang and coworkers attempted to reconstitute heterodimers of PhaCRe with
one wt subunit and one catalytically inactive C319A mutant subunit (77). In their experiments,
the specific activity of wt-PhaCRe was first measured. It was then combined in a stoichiometric
ratio of 1:1 with C319A-PhaCRe under dilute conditions, which the authors believe promotes
dissociation of the synthase entirely into monomers. Solid fructose was then dissolved in the
solution for a final concentration of 70% w/v, which the authors claim shifts the equilibrium in
favor of dimerization. Their analysis, which we have presented below, is somewhat convoluted.
Statistically, the monomers should reform heterodimers in a ratio of 1:2:1 of wt-wt-PhaCRe to wt-
C319A-PhaCRe to C319A-C319A-PhaCRe. That is, 50% of the wt PhaCRe would reassociate with
other wt subunits, whereas the other 50% would associate with C319A subunits. As such, the
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specific activity of wt-PhaCRe (measured originally based only on the amount of wt-PhaCRe
present in the assay mixture) should either decrease by 50% (if heterodimers are catalytically
inactive) or stay the same (if heterodimers are catalytically active). In their experiments, the
authors measured a decrease in specific activity of wt-PhaCRe of 50% upon reconstitution of wt-
C319A-PhaCRe heterodimers, which they interpreted to suggest that heterodimers are
catalytically inactive. They therefore conclude that Cys from each subunit of the dimer is
required for polymerization (as in the mechanism in Figure 1.12A).
In principle this is the ideal experiment to address whether one Cys or two is necessary
for activity. However Zhang and coworkers failed to consider the complicated equilibria of
monomer-dimer interconversion (77). A best estimation from the information available in their
paper is that their "dilute" conditions that promote monomerization are 3 iM PhaC. We have
estimated the monomer/dimer equilibrium to have a KD of less than 4 piM. Furthermore, in our
hands fructose decreased the specific activity of PhaCRe, inconsistent with the findings on which
Zhang and coworkers based their studies (1, 58). Therefore, the conclusions from their studies in
our minds remain unresolved.
Efforts to trap non-covalent intermediates. A second distinction between the two
mechanisms is that the mechanism in Figure 1.12A predicts only covalent intermediates, whereas
the mechanism in Figure 1.12B predicts that transient non-covalent intermediates form during
polymerization. Three sets of experiments suggest that the mechanism of elongation proceeds
through non-covalent intermediates as outlined in Figure 1.12B. The first set of experiments was
in vitro polymerization reactions carried out using PhaECAv and the artificial substrate HB-N-
acetylcysteamine (HB-NAC), which revealed that the synthase could polymerize HB-NAC (78).
The kcat for this reaction was 0.65 s-f, compared to 65 s-1 with HBCoA (46). The Km of HB-NAC
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was 8.6 mM, 60-fold higher than for HBCoA. The HB-NAC was entirely consumed in the
reaction and the polymer generated was -75 kDa in M., compared to -1,000 kDa for polymer
generated from HBCoA. One possible interpretation for the lower M, resulting from HB-NAC
polymerization is that the reaction proceeds through non-covalent intermediates [(HB).NAC] as
in Figure 1.12B (78). The partitioning between reacylation of the active site Cys and dissociation
in these experiments is, in principle, governed only by the KDs of the NAC vs. CoA moieties
(which are reflected in their Kms). Thus dissociation of (HB)rNAC would occur more readily
than (HB).CoA and potentially at a lower M,. An alternative interpretation of these results is
that they are suggestive of a model of chain termination by thiolysis. This proposal will be
explored below in the section dealing with mechanisms of termination.
In the second set of experiments, the C149S-PhaEC mutant of PhaECAV was used to
detect non-covalent intermediates [(HB).CoA]. Efforts to detect non-covalent intermediates with
wt PhaECAv by rapid mixing of sT-PhaECAv with [1-1 4C]-HBCoA followed by quenching with
acid revealed that all of the radioactivity remained associated with the protein, that is, there were
no detectable non-covalent intermediates. A failure to detect non-covalent intermediates does not
rule out the mechanism in Figure 1.12B, however, because the rate of reacylation of the wt
synthase following addition of an HB unit may be too fast to allow detection. Therefore, it was
proposed that the mutant C149S-PhaECAv might allow detection of putative non-covalent
intermediates due to a reduced rate of reacylation. The relative rates of reacylation in the wt and
C149S enzymes were estimated by measuring the rates of acylation with [3 H]-sTCoA. As
expected, the rate of reacylation of C149S-PhaECAv was 170-fold slower than for wt (0.035 s-1
vs. 5 s'i). Chemical quench experiments from 1-15 min of C149S-PhaECA with [1-1 4C]-HBCoA
allowed detection for the first time of the non-covalent intermediates (HB),CoA, where n = 2 and
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3 (71). When the reaction was carried out for 60 min, 50% of the radioactivity was present in
(HB) 2CoA, indicating that it is a major species formed in the reaction. These results provide
evidence to support the mechanism in Figure 1.12B. It should be noted, however, that because
the first experiments rely on the use of a substrate analog (HB-NAC) and the second set of
experiments relies on a mutant synthase, the relevance of these results to the wt enzyme
mechanism remains to be established conclusively.
Reaction of sT-C149S-PhaECAv suggests the enzyme is capable of catalyzing reactions
in addition to polymerization. Very recently, chain elongation experiments with PhaCRe and
PhaECAv primed with sTCoA have given unusual results that could be interpreted to suggest the
presence of a loading site separate from the active site Cys (Li and Stubbe, unpublished results).
For these experiments, an HBCoA analog, HBCH2CoA, was synthesized in which the S atom of
the thioester was replaced with a methylene group (Figure 1.14).
O OH
CoA HBCH2CoA
CoA 0 3  [
CoA [3H]-sTCH2CoA
O 0 0, a 3 H
CoA dK K K ~ ~ K[ 3H]-sT4CH2CoA
Figure 1.14 Structures of the substrate analog HBCH 2CoA and non-covalent intermediates
[3H]-sTCH 2CoA and [3H]-sT 4CH 2CoA.
This analog was designed to function as a chain terminator that would allow the detection
of non-covalent intermediates as seen with the C149S-PhaECA, mutant above. When PhaECAV
was primed with [3H]-sTCoA 'and then reacted with HBCH 2CoA, the major resulting
intermediate was [3H]-sTCH 2CoA rather than the expected chain elongation product [3H]-
sT4CH2CoA (Figure 1.14). A similar result was seen when an identical experiment was carried
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out with wt PhaCRe. Quantitation of the radioactivity in these experiments is summarized in
Table 1.3 and revealed the major product is [3H]-sTCH 2CoA.
Table 1.3 Distribution of radioactivity among covalent and non-covalent intermediates
from reactions of wt [3H]-sT- PhaECA, or wt PhaCRe and HBCH2CoA.
[3H]- ['H]- [3H]-labeled
Enzyme [HBCH2CoA] sTCH2CoA sT 4CH 2CoA acids Protein pellet
Wt [3H]-sT- 200 p.M 23% 0% 23% 50%
PhaCRe
Wt [3H]-sT- 5.5 mM 44% 0% 29% 24%
PhaCRe
Wt [3H]-sT- 490 p.M 16% 6% 31% 37%
PhaECAv
Wt [3H]-sT- 10 mM 33% 6% 32% 22%
PhaECAv
Similar experiments with C149S-PhaECAv demonstrated that the same phenomenon is
observed when HBCoA is used instead of HBCH2CoA, and with primers other than sTCoA.
Thus, the unusual results are neither primer specific nor specific to HBCH 2CoA. Furthermore,
while priming of C149S-PhaECAv with sTCoA results in CoA release as detected by DTNB
assay (suggesting loading of the entire sT chain onto S149), ESI-MS of the protein immediately
following the priming process revealed that the enzyme was acylated with sD, rather than sT.
This result was interpreted to suggest that the sT chain may be first loaded to a site distinct from
S149, followed by transfer of the sD chain to S149 where polymerization then occurs. This
alternative loading site could be either S149 of the other PhaC subunit, or a different amino acid
residue, such as another conserved Ser. HB-C149S-PhaECAv is not detected by ESI-MS, likely
due to its rapid hydrolysis following chain transfer. One model to explain these results is shown
in Figure 1.15. The relevance of this model to the normal reaction mechanism is as yet unclear.
Furthermore, the positions of the conserved residues relative to the active site on the threading
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model of PhaCAv reveal no obvious candidates for a loading site. In the threading model of
PhaCRe, three absolutely conserved residues near the active site include T323, D351 and D428;
however, there are no conserved Ser or Cys residues in the vicinity. The results are nonetheless
interesting and reveal that synthases are capable of catalyzing unusual chemistry that requires
further examination.
KS1 49
CoA
LX O
S149
X OH rapid hydrolysis -
o 3 H
S149 HB acid S149
0 0 0 0 0 3H
CoA CoA o O
Figure 1.15 Proposed model to explain the unusual phenomenon observed in reactions
between sT-PhaCs and the chain terminator HBCH2CoA. X indicates a nucleophile (either
C149 of the second PhaC subunit, or another nucleophilic amino acid). S can be either C149 or
S149, in the case of the C149S mutant.
70
1.3.2.7 Experiments investigating the mechanisms of termination and reinitiation
The role of the synthase in termination and investigations into the nature of a putative
chain transfer agent. PhaCs generate high M. PHBs that are remarkably monodisperse, raising
the question of how PHB M, is sensed and what controls termination and reinitiation. Early
experiments by Gerngross and coworkers suggested that PHB Mv is a property dictated by the
synthase itself, rather than by HBCoA concentration (79). They demonstrated that low
concentrations of PhaCRe in in vitro polymerization reactions resulted in higher Mv PHB than at
higher concentrations. Furthermore, increasing the concentration of HBCoA from 0.9-8.9 mM
did not affect the M, of PHB, nor did terminating the reaction prior to complete substrate
consumption.
In another study, our lab carried out in vitro studies with PhaECAV to investigate how the
synthase might catalyze termination and reinitiation. PhaECAv was incubated with 70,000
equivalents of HBCoA and the reaction was monitored as a function of time by Western blot
using antibodies to PhaECAv (75). These experiments revealed that PhaCAv gradually disappears
from its monomeric position on the gel as the reaction progressed, until a PHB chain of 1.8 MDa
was synthesized (as judged by separate DTNB assays), after which PhaCAv reappears at its
monomeric position. This suggests that PhaCAv is able to terminate and release the completed
PHB chain. When a similar reaction was investigated at lower substrate to enzyme ratios, a time-
dependent phenomenon was observed by SDS-PAGE and autoradiography: when PhaECAv was
incubated with [1-1 4C]-HBCoA for extended periods of time, a species thought to be PhaECAV
labeled with 40-100 [14C]-HB units converted to PhaECAv labeled with 3-10 [14C]-HB units (75).
These results suggested that PhaECAv catalyzed termination by hydrolysis of the PHB chain at a
position removed from the active site Cys, leaving a primed synthase. The primed synthase is
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likely PhaC that is covalently attached to an HB oligomer that is 3-10 HB units long. Hydrolysis
could either occur by activation of a water molecule by an amino acid residue such as a
conserved Asp, or by chain transfer directly to a nucleophilic residue followed by hydrolysis.
Other in vivo studies have suggested that the chain transfer agent may be a compound
containing a hydroxyl group. In fermentations of R. eutropha under PHB accumulation
conditions, the addition of compounds such as polyethylene glycol (80), glycerol (81) and 1,2-
propanediol (81) resulted in PHB of a lower Mv than when the compounds were omitted.
Furthermore, isolation and characterization of the PHB by NMR revealed that the alcohols were
covalently attached to the carboxy terminus of the PHB chains (81, 82). These observations lead
the authors to conclude that the alcohols served as more efficient chain transfer agents than a
putative endogenous chain transfer agent, which they propose could be hydroxybutyrate. It
should be noted that hydroxybutyrate as a chain transfer agent is pure speculation on the part of
the authors, as this would be difficult to determine in vivo. An alternative explanation for the
observations with alcohol chain terminators is that these compounds interact with the PHB
granules themselves (rather than with the synthase active site) to catalyze transesterification.
Thus, the evidence for alcohols serving as chain transfer agents is inconclusive. Finally, the
results presented earlier in which PhaCRe was reacted with the substrate analog HB-NAC could
also be interpreted as suggesting a mechanism for termination (78). In those experiments, the
observation that the PHB chains terminated in NAC could be explained by one of two models. In
the first model, discussed above, the chain could dissociate from the active site instead of
reacylating the enzyme. Alternatively, the enzyme could reacylate with the growing chain, and
the CoA liberated from the addition of the last HB unit could reattack either at the thioester of
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the acylated enzyme or at an oxoester within the PHB chain. This latter mechanism would
account for the observations of primed synthase following termination, as discussed above.
The role of PhaP in PHB chain termination. Finally, in vivo studies of R. eutropha grown
in both rich TSB medium and nitrogen-limited PHBhigh medium have examined the ratio of
molecules of PHB to molecules of PhaCRe by quantitation of PHB amounts, GPC analysis of
PHB M, and Western blots of PhaCRe levels. These experiments demonstrated that PhaC is
constitutively expressed in R. eutropha, and there are as many as 60-100 PHB chains per PhaC,
depending on the growth condition (56, 83). This suggests that there are multiple reinitiation
events per PhaC, that is, each PhaC makes several PHB chains. Recent studies carried out by our
lab suggest that in vivo the ratio of PhaP 1 to PhaCRe is responsible for determining the M, of
PHB. In a AphaR strain of R. eutropha, which overexpresses PhaP 1, the ratio of PhaP 1 to PhaCRe
is higher than in wt, and the PHB M, is lower, possibly due to increased chain termination
events (56).
Working modelfor termination. Together these studies suggest a model whereby PhaC
itself catalyzes termination, but PhaP "triggers" (by an unknown mechanism) the termination
event. Termination by PhaC may be catalyzed by direct transfer of the PHB chain to a
nucleophilic residue such as an Asp on the PhaC, followed by hydrolysis. Alternatively,
termination may be catalyzed by hydrolysis via general base catalysis by PhaC on a water
molecule or chain transfer to CoA or a hydroxyl-containing molecule, such as hydroxybutyrate.
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1.3.3 Phasins and regulation of phasin expression in R. eutropha
1.3.3.1 PhaP, PhaP2-7 and PhaM
Phasins are the predominant granule-associated proteins and have been identified in
numerous organisms by analysis of their genomes and by their association with isolated PHB
granules (84). Phasins are typically 13-25 kDa in M, but have very little sequence conservation
between organisms, in contrast to other proteins involved in PHB biosynthesis. The most well
studied phasin is PhaPi, which is the major phasin in R. eutropha and can constitute up to 5% of
the total cellular protein content in times of maximum PHB accumulation. PhaP1 was first
identified associated with purified granules by SteinbUchel and coworkers in 1995 (38). Studies
carried out in R. eutropha have provided much of the basis of our understanding of the role of
phasins in PHB accumulation. TEM using gold-labeled PhaP1 antibodies demonstrated the in
vivo association of PhaPi with the surface of granules (38). Under nitrogen-limiting conditions,
wt R. eutropha contains 5-15 granules that are 700-800 nm in diameter (Figure 1.16A) (85).
Deletion of phaP] of R. eutropha results in a strain that accumulated ~2-fold less PHB
than the wt strain and the PHB was contained in a single, irregularly shaped granule (Figure
1.16B) (38, 86). Overexpression of PhaP 1, on the other hand, results in the production of many
smaller granules relative to wt (38, 87). These results led to the early proposal that PhaPl
controls the size and number of PHB granules and also prevents fusion of granules to control the
surface area to volume ratio (38). However our recent cryoelectron tomography (cryoET)
experiments investigating granule biogenesis in R. eutropha grown in medium promoting
accumulation of PHB to 80% cdw suggests that in fact the granules are constantly fusing, thus
PhaPI may only function to prevent excessive fusion (85).
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A ± C ~ -
Figure 1.16 TEM of A) wt R. eutropha, B) AphaPl and C) AphaR, PhaP1 overexpression.
Figure adapted from reference (1).
Additional evidence for the role of PhaP 1 in controlling the number and size of granules
was provided by in vitro studies of synthesis of PHB granules by PhaECAv monitored by
scanning electron microscopy (88). These studies demonstrated that addition of PhaPi from R.
eutropha resulted in the synthesis of many smaller granules compared to those synthesized in the
absence of PhaPl. From the information provided, we estimate that the concentrations used in
their assays were 10 nM PhaECAv and 250 nM PhaPl. Additionally, Horowitz and Sanders
demonstrated by solid-state NMR spectroscopy that PHB in granules in vivo is amorphous rather
than crystalline (89). They proposed that an amphipathic species such as a granule-associated
protein could bind the surface to prevent coalescence of smaller granules into larger ones, which
otherwise would promote nucleation events that would result in crystalline polymer. Thus, it has
been suggested that phasins play a role in preventing crystallization of PHB. Crystallization
prevents reutilization of PHB by intracellular depolymerases, which act only on amorphous PHB
(as discussed below).
Subsequent to the discovery of PhaP1, several additional phasins were identified in R.
eutropha (39). Genome scanning studies carried out by Patter and coworkers identified three
additional phasins based on 40-50% homology to PhaP 1, which they called PhaP2, 3 and 4 (42).
They demonstrated the granule association of PhaP3 and PhaP4 by 2D PAGE of PHB granules.
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PhaP2 was shown to bind crystalline PHB granules in vitro, though this is tenuous evidence that
PhaP2 is a phasin. The authors did not quantitate expression levels, but PhaP3 and 4 are present
on the granules at much lower levels than PhaPl. Finally, in a mutant strain of R. eutropha in
which the phaP1 promoter is disrupted (but which still expresses low levels of PhaP1), the
authors demonstrated an apparent increase in the amount of PhaP3 associated with isolated
granules, as judged by Coomassie-stained SDS-PAGE (42). Construction of the individual
deletion strains of phaP2, phaP3 or phaP4 had no discernible effect on growth, PHB
accumulation or granule size and number.
In efforts to find new players in PHB biosynthesis in R. eutropha, Pfeiffer and coworkers
screened for protein-protein interactions using PhaCRe and PhaPs 1-4 as bait in two-hybrid
assays, and in this way discovered a fifth phasin, PhaP5, that interacted with PhaP2 (43).
Deletion of phaP5 revealed that it is also not essential for PHB accumulation. And finally
Pfeiffer and coworkers found PhaP6 and PhaP7 by examining the R. eutropha genome for
proteins containing the "phasin 2 motif," which is a stretch of sequence enriched in hydrophobic
residues (44). They demonstrated that enhanced yellow fluorescent protein (eYFP) fusion
constructs with PhaP 1-7 colocalized with PHB granules during PHB production but were diffuse
in the cytoplasm in the absence of PHB. Each of these fusion constructs was under the regulation
of the phaCAB operon promoter, so their actual expression levels in these experiments likely
varied greatly from their native expression levels. Deletion of phaP6 or phaP7 had no
discernible effect on PHB accumulation. Thus, while PhaP2-7 may be granule-associated, their
roles (if any) in PHB biosynthesis are not well understood.
One additional granule-associated protein, PhaM, was recently identified by Jendrossek
and coworkers by two-hybrid assay using PhaCRe and PhaP5 as bait. Independently, Cho et al. in
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our lab found PhaM associated with PHB granules in R. eutropha (73, 90). Studies by the
Jendrossek lab demonstrated that deletion of phaM results in a strain in which PHB granules are
unevenly segregated between daughter cells during division. PhaM contains a Histone-like
domain, rich in Ala, Lys and Pro, and non-specifically binds DNA in vitro, thus Jendrossek et al.
suggested that PhaM functions to anchor PHB granules to the nucleoid to promote even
distribution between daughter cells during division (90, 91). Interestingly, isolation of Strep2-
tagged PhaCRe by Cho et al. revealed not only high M, PHB and PhaP 1 associated with the
synthase, but also DNA and PhaM, consistent with the role proposed by Jendrossek and
coworkers (73).
1.3.3.2 Structure of PhaP1 and interaction with PhaCRe
There is currently no X-ray structure available for any phasin protein. Small angle X-ray
scattering studies predicted that PhaPl is a flat, triangular homotrimer with a side length and
height of 80 ± 3 and 26 ± 1 A, respectively (92). In the same study, the authors attempted to
identify a particular sequence within PhaP1 that is responsible for binding to PHB. A variety of
truncations of PhaP 1 were fused to GFP and their PHB binding capacity assayed by fluorescence
and co-precipitation with PHB granules in vitro. These studies failed to identify a particular
portion of the PhaP1 sequence responsible for binding PHB granules. There is also no direct
evidence for interactions between PhaCRe and PhaPI in vivo or in vitro. Jendrossek and
coworkers used two-hybrid screens to identify interaction partners with PhaCRe, but PhaPI was
not among the proteins identified (43, 90). Furthermore, pull-down studies in our lab confirm
that PhaCRe and PhaP1 do not associate in vitro, though PhaP1 increases the length of the lag
phase and decreases the specific activity of PhaCRe (56).
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1.3.3.3 Expression levels of PhaP1 in R. eutropha
PHB accumulation in R. eutropha has been studied by our lab primarily in two growth
conditions: the nutrient rich medium tryptic soy broth (TSB) and the nitrogen-limited medium
supplemented with fructose, PHBhigh (83, 86, 93, 94). In TSB, R. eutropha transiently
accumulates PHB to a maximum of 25% cdw after 4 h, then declines to <5% cdw (Figure
1.17A). In PHBhigh, R. eutropha accumulates PHB from a minimum of 5% to a maximum of
80% of the cdw (Figure 1.17B). We have thus far not identified growth conditions in which R.
eutropha contains less than ~5% PHB cdw.
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Figure 1.17 PHB content of R. eutropha grown in A) TSB medium and B) PHBhigh medium.
A is adapted from (94). B is adapted from (56).
Analysis of PhaP 1 expression levels using antibodies and Western blots carried out in R.
eutropha grown in these media has provided additional insight into the function of PhaPl.
Studies from our lab demonstrated that PhaP1 expression is correlated with PHB accumulation
and is dependent on the expression of an active PhaCRe (86, 95). Western blots of PhaPl levels
and GPC analysis of the M, of PHB allowed a quantitative examination of PhaP1 and PHB
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levels. In R. eutropha grown 4 h in TSB medium there are one or two PhaPs per PHB chain (83).
After 24 h growth in PHBhigh medium, the molar ratio of PHB to PhaP is -2 (He and Stubbe,
unpublished data). These observations inspired a more thorough investigation of the PHB to
PhaP 1 ratio in PHBHigh medium, which found that this ratio remained between 1-2 throughout
growth (56).
1.3.3.4 Regulation of PhaP1 expression by PhaR
PhaP expression is thought to be coupled to PHB biosynthesis by the transcription factor
PhaR. The working model for regulation by PhaR is given in Figure 1.18. In this model PhaR
represses PhaP expression until PHB is produced by the constitutively active PhaC. PHB is
proposed to bind PhaR to allow PhaP expression. This model was proposed on the basis of
observations made in Paracoccus denitrificans and R. eutropha, which are discussed below.
PhaC
HBCoA
PhaR phaP phaP PhaP
PHB
Figure 1.18 Working model for regulation of phaP expression by PhaR. PhaR is also thought
to regulate its own expression by a manner similar to that illustrated for PhaP. Adapted from
reference (2).
Studies of PhaR from P. denitrificans by Maehara and coworkers provided the first
insight into the regulation of phasin expression (96). P. denitrificans produces PHB via the
protein products of the phaZCPR operon. Maehara et al. noted that phaR encoded a protein of
unknown function that was conserved in R. eutropha, Allochromatium vinosum, Rhizobium
meliloti and Thiocystis violacea. They demonstrated by gel mobility shift assays that PhaR bound
the intergenic regions of phaC-phaP and phaP-phaR in the phaZCPR operon. It should be noted
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however, that gel mobility shift experiments are inherently difficult to conduct, as the association
2+of transcription factors to DNA is particularly sensitive to the concentration of Mg . In fact,
Maehara and coworkers omitted Mg 2 all together from some of their gel shift assays. To
examine the effect of PhaR on phaP expression, they established a cell free protein expression
system in E coli harboring phaP on a plasmid, and demonstrated that addition of PhaR repressed
expression of phaP. Addition of PHB to the cell-free expression system derepressed the
transcription of phaP (97). However, as the amount of PHB added to the expression system was
increased, PhaP expression decreased, which is inconsistent with the model in Figure 1.18. The
authors explained this unexpected result by suggesting that proteins involved in transcription and
translation were non-specifically binding to the added PHB, thus decreasing PhaP expression in a
manner un-related to PhaR regulation. This underscores the caution that must be taken in over-
interpreting the in vitro association of proteins to granules, as well as the necessity for in vivo
studies, such as those described subsequently. Maehara and coworkers were able to demonstrate
the presence of PhaR on native PHB granules, isolated by sucrose density gradient
ultracentrifugation, by Western blot analysis using antibodies to PhaR. PhaR was also present in
the soluble cell fraction of cell lysates (97). Again, however, many proteins non-specifically
adhere to PHB granules due to their hydrophobic nature.
R. eutropha contains a homolog to P. denitrificans phaR just 0.45 kb downstream of the
phaCAB locus. Our lab has carried out in vivo studies in R. eutropha, which have contributed
several observations about the roles of PhaR and PhaPI in PHB biosynthesis. Deletion of phaR
resulted in reduction of PHB accumulation to ~70% the level of the wt strain. Furthermore,
PhaP1 expression was uncoupled from PHB accumulation such that PhaP1 levels were
constitutively high and not correlated with the amount of PHB in the cell (40). PhaPI expression
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was constitutive even in a AphaRAphaC double mutant incapable of accumulating any PHB. A
AphaPlAphaR mutant strain exhibited a more severe defect in PHB accumulation than the
Aphap] mutant strain, thus PhaR may play additional roles in PHB accumulation aside from
regulation of PhaP 1 expression, including but not limited to, regulating its own expression (40).
Collectively, the studies described in this section support the working model shown in
Figure 1.18. However, as there are no precedents for such a model of regulation in other non-
template driven biological polymerizations, the mechanisms of regulation of PHB biosynthesis
require additional study. Furthermore, the mechanisms of regulation of PHB biosynthesis may
turn out to be organism specific.
1.3.4 PHA depolymerases
The final major players in PHB biosynthesis are the PHB depolymerases, collectively
called PhaZs. There are two kinds of depolymerases, namely the extracellular and intracellular
depolymerases. Extracellular depolymerases degrade crystalline PHB, which is found in the
environment as a result of its release by dead bacteria or as biodegradable commercial goods.
Intracellular depolymerases are structurally distinct from extracellular depolymerases and act on
amorphous PHB, which is found inside the cell. Intracellular depolymerases are responsible for,
among other likely functions, the mobilization of PHB granules inside the cell when the
environment is conducive for growth and division (i.e. a limiting nutrient is restored).
Characterization of intracellular PHB depolymerases requires a good assay for activity in
vitro, which as yet is not available. One issue is that depolymerases only act on amorphous PHB
as it is found in vivo. Native granules isolated from the organism cannot be used as substrate for
in vitro assays because intracellular PhaZs co-purify during isolation. Thus artificial, amorphous
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granules prepared from crystalline PHB using detergents (98), short HB, oligomers (n = 2-4) or
p-nitrophenyl esters are used as substrates. In assays that use HBn oligomers are substrates,
hydroxybutyrate (HB) dehydrogenase is used to measure release of HB. However, release of HB
is a few steps removed from the first events of depolymerase activity, the release of HBn
oligomers, and is catalyzed by oligomer hydrolases included in assay mixtures. Due to these
issues, depolymerases are typically identified by homology to known depolymerases and
characterized primarily by in vivo genetic experiments.
R. eutropha has at least six intracellular depolymerases, which have been identified by
genetic screening methods. The first intracellular depolymerase, now called PhaZal, was
identified by shotgun gene cloning by Saito and coworkers (99). They purified PhaZal from
recombinant . coli for preparation of antibodies, and demonstrated by Western blot analysis that
PhaZal was associated with PHB granules in vivo. A null mutant was still capable of degrading
PHB, leading the authors to propose that R. eutropha contained multiple depolymerases.
Artificial granules were synthesized and used to characterize the in vitro activity of PhaZal,
which was found to release primarily HB oligomers as product with a specific activity of ~1
tmol/min/mg (100). Studies from our lab identified two additional intracellular depolymerases,
PhaZa2 and PhaZa3, based on ~30% sequence identity with PhaZal. The PHB accumulation and
utilization phenotypes of a series of single, double and triple mutant strains of phaZa], phaZa2
and phaZa3 were examined (AphaZal, AphaZa2, AphaZa3, AphaZal2, AphaZal3, AphaZa23,
and AphaZa]23) (101). These results demonstrated that PhaZal and PhaZa2 were sufficient to
account for PHB degradation during growth on rich medium and PHB utilization medium, but
did not identify a role for PhaZa3. Saito and coworkers identified two HB oligomer hydrolases,
PhaZb and PhaZc, as well as a fourth intracellular depolymerase, PhaZd (100, 102, 103). PhaZb,
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PhaZc, and PhaZd were present in both the cytosolic cell fraction and associated with PHB
granules, and individual deletion of any one resulted in higher levels of PHB during
accumulation and degradation. These results were interpreted to suggest that these enzymes play
a role in PHB utilization.
Several studies under different growth conditions have examined the expression levels of
the various depolymerases and oligomer hydrolases in order to gain insight into their roles in
PHB biosynthesis and homeostasis. mRNA profiling and Western blot analysis indicates that
PhaZal is constitutively expressed in both nutrient rich and nitrogen-limited media (93). PhaZa2
and PhaZd protein levels increase during PHB accumulation, then decrease during PHA
utilization (83, 93, 100). Differential expression patterns suggest the various depolymerases have
different roles in PHB biosynthesis that are still not well understood. How their activity is
regulated to prevent futile cycling, that is, simultaneous synthesis and degradation of PHB, is
also unclear. Jendrossek and coworkers demonstrated that native granules isolated from R.
eutropha can catalyze the formation of HBCoA when exogenous CoA is supplied (104). PhaZal
incubated with artificial granules and CoA also catalyzed the formation of HBCoA, thus the
authors suggested that PhaZal catalyzes thiolysis rather than hydrolysis to break down PHB.
This is an attractive proposal as it explains how cells can avoid futile cycling when PhaC and
PhaZs are expressed simultaneously.
1.4 Working model for granule formation
1.4.1 Size, composition and properties of PHB granules
A model that describes the process of granule formation must take into account several
properties of the granules. First, soluble monomeric precursors are converted into large insoluble
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polymers, which are packaged in granules, via a process that does not expose the cell to the toxic
effects of exposed hydrophobic polymer chains. At early stages in granule formation in R.
eutropha (when the cells contain 5-10% PHB cdw), the granules are small, typically ~100 nm in
diameter (85). As PHB levels increase, granules fuse and the resulting granules have diameters
of 600-700 nm (85). Second, the PHB in the granules is amorphous (89). How crystallization of
PHB, which readily occurs when granules are isolated from bacteria, is prevented during granule
formation must be accounted for.
Finally, a suitable model for granule formation must account for the composition of the
granule surface. To study the composition of granules, Griebel and coworkers developed a
density gradient centrifugation method to isolate PHB granules from Bacillus megaterium that
minimally disrupted the granule structure (105). They determined that the granules were
composed of 97-98% PHB, 2% protein and 0.5% lipid by mass. They demonstrated that the
isolated granules catalyzed the polymerization of [14 C]-HBCoA into polymer, suggesting that the
PHB synthase was associated with the granule surface. Western blot analysis and TEM using
gold-labeled antibodies have demonstrated that several proteins are associated with the surface of
the granules. As discussed above, PhaP 1 is the predominant granule-associated protein in R.
eutropha, and it covers 20-30% of the granule surface during growth in PHBhigh medium (38, 56,
85, 92). PhaC, PhaZs and PhaR are present in much lower levels (87, 99, 106). As discussed
above, various studies from our lab have demonstrated that in mature granules in R. eutropha,
there are 1-2 PHB chains per PhaP 1 (56, 83).
The role that lipids play in the surface structure of PHB granules has been controversial.
Isolation of granules, even by "gentle" methods such as ultracentrifugation, can potentially result
in the non-specific association of hydrophobic species such as membrane proteins and lipids.
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Mayer and Hoppert used TEM to examine the surface of PHB granules in ultrathin sections of R.
eutropha (107). They identified a boundary layer with a thickness of 3-4 nm, consistent with a
lipid monolayer. Atomic force microscopy (AFM) studies of the surface of PHB granules
isolated from lysed R. eutropha suggested the presence of a protein-based network layer,
proposed to be composed of PhaP1, surrounding the PHB granules. The network layer is in turn
covered by a smooth outer layer of unknown composition (108). It is important to note that both
of these techniques are rather perturbative. In the case of TEM, samples must be dehydrated,
stained and embedded in plastic. In the case of the AFM studies, the cells were lysed and the
granules were dried on the sample stage. Furthermore, tips used in AFM can cause sample
deformation. Recently our lab in collaboration with the Jensen lab examined the granule surface
using cryoET (85). Sample preparation for cryoET is mild: the cells are flash frozen in liquid
ethane, and following imaging, remain viable when thawed. By this method we have
demonstrated that the granules are surrounded by a discontinuous, "patchy" layer, inconsistent
with the observations by both TEM and AFM.
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1.4.2 Previous models to describe granule formation
Three models have been proposed in the literature to describe granule formation in vivo.
The models described in this section are summarized in Figure 1.19.
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Figure 1.19 Models for granule formation. A) Micelle model. B) Membrane budding model.
C) Scaffolding model. Adapted from (56).
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Micelle model (Figure 1. 19A). The micelle model was the earliest model proposed to
describe granule formation. The model proposes that granules are formed by random aggregation
of granule-nucleating species consisting of short PHB chains, covalently linked to PhaCs and
non-covalently associated with PhaP, into micelle structures. As the chains elongate by addition
of more HB units, the phase transition from soluble short PHB oligomers to insoluble polymer
occurs. As discussed above, various experiments suggest that initiation of polymerization is
much slower than elongation both in vitro and in vivo (49, 75). This observation seems at odds
with a simple micelle model as one would expect that if only a small fraction of PhaCs were
synthesizing polymer rapidly, there would not be sufficient time for small PHB chains to
aggregate into micelles. Furthermore, analysis of PHB by GPC in R. eutropha grown in PHBhigh
reveals that the M, is high even when the cells contain very little PHB (56).
Membrane budding model (Figure 1. 19B). An alternative model, the membrane budding
model, was proposed by our lab and was based on eukaryotic lipid body biosynthesis (1, 2). This
model could account for the presence of lipids on the surface of the granules. In this model, PhaP
and PhaC are associated with the inner leaflet of the plasma membrane and the growing PHB
chains are extruded into the membrane. The chains aggregate and form a granule, which
eventually buds off of the membrane. In this model the phase transition occurs in the membrane
and the granule is at least partially coated in a monolayer of membrane-derived lipids. A variant
of this model specifies that the granules bud from the membrane at the cell poles and the sites of
future poles based upon fluorescence imaging studies (43, 109). A specific prediction of the
membrane budding model is that lipid biosynthesis is upregulated during PHB accumulation to
account for the loss of lipid from the membrane. However recent microarray data from the
Sinskey lab suggest that the biosynthesis of the major membrane lipids in R. eutropha,
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phosphatidylethanolamine and phosphatidylglycerol/cardiolipin, is downregulated under
conditions that promote PHB accumulation (110). These findings are inconsistent with a
membrane budding model.
Scaffolding model (Figure 1. 19C). A third model, the scaffolding model, was also
proposed by our lab on the basis of TEM time course studies of R. eutropha grown in PHBhigh.
The images reveal a dark-stained feature along the center axis of the cell. Clustered around this
"mediation element" are several tiny (~100 nm in diameter) granules (Figure 1.20A) (94). PhaP
and PhaC are associated with the scaffold, which was proposed at the time to be composed of
DNA, protein or both. The scaffold serves to locally concentrate the PhaC and PhaP to allow for
granule nucleation and growth. As the granules grow larger the mediation element is no longer
observed, either due to its degradation, or because larger PHB granules obscure it (Figure
1.20D). This model predicts that the granule surface is composed of PhaP and PhaC with no
phospholipid component.
A
B
D
Figure 1.20 TEM of R. eutropha showing the dark-stained feature, or "mediation element."
The cells were grown in nitrogen limited PHBp medium for A) 2.5 h, B) 5 h, C) 9 h and D) 24 h.
Scale bar is 0.5 pm. Adapted from reference (94).
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1.4.3 Current working model for granule formation: the modified micelle model
Our recent cryoET data and biochemical studies of PhaCRe isolated for the first time from
R. eutropha have led us to favor a variation of the micelle model shown in Figure 1.1 9A, which
we call the modified micelle model. This model is diagrammed in Figure 1.21. The primary
difference between this model and the original micelle model is that the nucleating species is
composed of a dimer of PhaC covalently attached to a PHB chain with several (4-9) PhaPs also
associated. This initial "nucleating species" is soluble, which may be due to its high PhaP/PHB
ratio. The nucleating species grow as more PHB is synthesized, with PhaC catalyzing
termination and reinitiation of new PHB chains. As the nucleating species grow larger and fuse,
the ratio of PHB/PhaP reaches 1-2. During growth and fusion of the nucleating species, the phase
transition occurs, and the mature granules become insoluble. PhaR, PhaZs and other granule
associated proteins attach to the mature granules. The following paragraphs discuss the evidence
supporting the modified micelle model.
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Figure 1.21 Modified micelle model. This model differs from the original micelle model
primarily in the composition of the nucleating species. In the modified micelle model, this
species contains a PhaC dimer, several PhaPs and full length PHB. Several nucleating species
fuse and each completed PHB chain remains associated with a PhaP after termination. As the
species fuse the soluble-to-insoluble phase transition occurs and other granule-associated
proteins bind. Adapted from reference (56).
Evidence for the nucleating species comes from work by our lab in collaboration with the
Sinskey lab, which reported the first isolation of PhaCRe from the native organism (73). A
Strep2-tagged phaC was incorporated into the R. eutropha genome in place of the wt phaC gene.
The cells were then grown in TSB medium that promotes the transient accumulation of PHB to a
maximum of -15% PHB cdw after 4 h growth (Figure 1.17A). The affinity-tagged synthase was
isolated at the 4 h time point. While the original goal of this experiment was to identify a protein
factor responsible for modulating the rates of initiation and elongation such that they are more
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evenly matched, no factor was found. Instead, a soluble species containing high M, PHB, PhaC
and PhaP1 was unexpectedly isolated. This is the nucleating species proposed in Figure 1.21 and
accounted for 17% of the total PHB in the cells (73). Analysis of the M, of PHB in the soluble
and insoluble fractions confirmed that the soluble species is full-length, ~300 kDa under these
growth conditions. Western blots of PhaPI and PhaC levels and analysis of PHB content in the
soluble species revealed that the nucleating species contained 1-3 PhaC molecules, 4-9 PhaP1
molecules, and one PHB chain (73). The model proposes that the nucleating species fuse as
reinitiation events occur and the ratio of PhaP to PHB approaches 1, as observed in the whole
cell analysis described in previous sections. The fact that PhaR or other known granule-
associated species did not co-purify with the nucleating species suggest that these proteins bind
the mature granules. A complication of these experiments that must be considered is that in the
engineered strain of PhaCRe, StrepIl-PhaC was 30-fold overexpressed relative to PhaC in the wt
strain, in spite of being under control of the endogenous promoter. Furthermore, in wt R.
eutropha the PHB M, is -1,000 kDa, vs. 300 kDa in the engineered strain.
CryoET experiments carried out by our lab in collaboration with the Jensen lab support a
model in which PHB granules initiate and remain cytoplasmic throughout formation, consistent
with the modified micelle model (85). The distribution within the cytoplasm shows no bias
towards localization near the membrane, which argues against a membrane budding model. A
membrane budding model would also suggest at least partial coverage of the granule surface
with lipids. As discussed above, investigation of the surface of the PHB granules in the cryoET
tomographs revealed that the surface was discontinuous, or "patchy." The patches on the surface
layer were of low contrast and only -2 nm thick, too thin to be a lipid mono- or bilayer. In
contrast, membranes observed in the tomographs are high contrast and continuous (85). CryoET
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experiments also revealed the propensity of the granules to fuse as PHB synthesis continues, as
evidenced by non-spherical granules that resembled two granules of different radii that had just
fused.
While our TEM studies, which led to the scaffolding model for granule formation, did not
identify the composition of dark-stained feature, cryoET studies suggested that it is nucleoid. An
interesting result of the studies above was the finding that DNA was also associated with the
nucleating species. In addition to PhaC and PhaP1, PhaM also co-purified with the nucleating
species (73). PhaM was subsequently identified by Jendrossek and coworkers and its role
characterized as discussed above (90). The proposed function of PhaM is to anchor PhaC to the
nucleoid to promote even segregation of PHB granules between daughter cells during division
(90, 91, 111). These findings could be integrated into the modified micelle model to reconcile the
present studies with previous studies suggesting the presence of a scaffold. Granule self-
assembly from the nucleating species is cytoplasmic and may occur associated with nucleoid as a
scaffold.
Together these data convincingly support the modified micelle model for granule
formation in R. eutropha as shown in Figure 1.21. However, our experiments have been
primarily restricted to R. eutropha, and as discussed above, growth conditions have not yet been
identified in which the cells contain <5% PHB cdw (94). In order to look at granule formation in
cells containing <5% PHB cdw and to investigate the universality of the mechanism of granule
formation, we have investigated PHB biosynthesis in C. crescentus, which is described in detail
in Chapter 3 of this thesis.
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1.5 Lifestyle of Caulobacter crescentus
1.5.1 Early isolations and descriptions of Caulobacter crescentus
This thesis presents studies focused on characterizing the PHB biosynthetic apparatus in
Caulobacter crescentus, an oligotrophic, Gram-negative aquatic bacterium that is well-adapted
to living in nutrient-poor environments. Some of the first reported strains belonging to the genus
Caulobacter were isolated from tap water (111). The first description of the genus Caulobacter
was published in 1935 by Henrici and Johnson, who isolated bacteria attached to a microscope
slide that had been submerged in lake water (112). After extensive rinsing the bacteria remained
attached. The authors described the cell morphology as curved with rounded ends, and having a
long slender stalk protruding from one end of the cell, with what they designated holdfast
material at its distal end. This holdfast material appeared to anchor the cell to the surface of the
microscope slide.
Subsequent studies unraveled the dimorphic lifestyle of Caulobacters, specifically that of
Caulobacter crescentus. The stalked cell described in 1935 is one of two cell forms that C.
crescentus adopts. Each round of cell division produces a sessile stalked cell and a motile
flagellated cell, called a swarmer cell (Figure 1.22) (113-115). The stalked cell is capable of
DNA replication and immediately begins a new round of cell division. The swarmer cell,
however, cannot initiate DNA replication and remains for a period of time (the length of which is
dependent in part on nutrient availability) in the swarmer stage before differentiating into a
stalked cell. As such, C. crescentus has been widely studied in the last several decades as a
model for differentiation and cell cycle regulation (113, 114).
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Figure 1.22 Lifecycle of C. crescentus. The motile swarmer cell remains for a certain period of
time in the GI phase before differentiating into a sessile stalked cell. The stalked cell is capable
of DNA replication and immediately begins a round of cell division. Each stalked cell produces
one stalked cell and one swarmer cell which begin the cycle anew. GI, lag phase before DNA
replication. S, period of new DNA synthesis. CS, cell separation. Adapted from reference (114).
1.5.2 Adaptations to living in nutrient poor environments
As mentioned above, early isolates of the genus Caulobacter were obtained from dilute
aquatic environments, tap water and even distilled laboratory water (111, 115). Enrichment of
Caulobacters could be achieved by allowing extended growth that resulted in depletion of the
medium to nutrient levels that cannot support most strains of bacteria. The remaining viable
bacteria that did propagate were typically members of the genus Caulobacter. Several strains of
Caulobacter were initially isolated, characterized and propagated. Of these strains, Caulobacter
crescentus CB15 became the predominant laboratory strain, characterized by its ability to be
synchronized owing to the different densities of stalked and swarmer cells that allowed their
separation by centrifugation (115). After propagation of CB15 in the laboratory, the strain
94
CSGI
spontaneously mutated and lost the ability to be synchronized. The mutation causing this
behavior was never identified. However, through careful propagation of individual colonies of C.
crescentus CB 15, a mutant that was still synchronizable was once again identified. This strain,
now called Caulobacter crescentus NA1000, is the predominant laboratory strain of C.
crescentus studied today, and is the focus of the studies presented in this thesis.
One of the hallmarks of C. crescentus is its ability to thrive under low-nutrient
conditions, such as those that promote accumulation of PHAs. This adaptation is achieved in part
by its dimorphic lifestyle. Each round of cell division produces one sessile cell and one swarmer
cell. The swarmer cells have the ability to disperse and find new nutrient sources. They can then
differentiate into stalked cells and enter another round of division. Having one motile daughter
cell that disperses from the sessile daughter cell eliminates competition for resources between
successive generations and therefore allows greater propagation of the species in otherwise low-
nutrient environments.
A second adaptation to nutrient-limited conditions is the stalk, which is an extension of
the inner membrane, peptidoglycan and outer membrane of the cell. There are numerous theories
as to what role the stalk might play. One hypothesis is that the stalk increases the buoyancy of
the cell and keeps the cells near the air-water interface in aquatic environments, essential for an
obligate aerobe such as C. crescentus (115). Under conditions of phosphate limitation, the stalk
elongates to 10 times its ordinary length. Stalks serve to anchor the cell to a surface, so stalk
elongation at times of nutrient limitation would allow the cell to extend farther beyond the
surface. This extension would reduce competition between C. crescentus and a nascent biofilm
also associated with the same surface, for example. The validity of these theories is rather
difficult to assess experimentally. However, the role of the stalk in phosphate uptake has been
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studied experimentally by electron microscopy (116, 117). Elongation of the stalk under
phosphate limitation also serves to increase the surface area to volume ratio of the cytoplasm for
enhanced nutrient uptake. Brun and coworkers carried out 2D gel electrophoresis of the proteins
of the stalk of C. crescentus cells grown 3-5 days on minimal medium until phosphate was
limiting (118). They found that the stalk was devoid of cytoplasmic proteins and enriched in
periplasmic and outer membrane proteins. The proteins were identified and many were involved
in cell motility and secretion, and inorganic ion uptake and metabolism. These findings are
compatible with the hypothesis that the stalk is involved in nutrient uptake.
The sequencing of the C. crescentus genome allowed a more thorough genetic analysis of
the mechanisms of adaptation to a low-nutrient environment (41). E. coli and Vibrio cholera
have OmpF-type outer membrane porin proteins that allow for the passive diffusion of
hydrophilic molecules across the outer membrane. C. crescentus in contrast does not have
OmpF-type porins, and instead has 67 TonB-dependent outer membrane channel proteins. The
members of the TonB-dependent channel family catalyze energy-dependent transport of
substrates across the outer membrane. C. crescentus has more TonB-dependent channels than
any other sequenced organism. Pseudomonas aeruginosa contains 34 TonB-dependent channels,
which is the next highest number after C. crescentus. Most organisms contain only ~10 of these
channels. Substrates of TonB-dependent channels include ferric ions complexed to siderophores,
heme, cobalamin, maltodextrins, etc. (119-121). These nutrients are actively pumped by the
channels across the outer membrane using the electrochemical potential of the cytoplasmic
membrane (122). TonB-dependent channels have high affinity for their substrates, and in fact the
energy input is used for release of tightly-bound substrate. Once the nutrients are pumped across
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the outer membrane, they passively diffuse into the cytoplasm via lower-affinity cytoplasmic
membrane transporters.
In addition to mechanisms for enhancing the uptake of nutrients in the environment, the
C. crescentus genome contains a proportionally large number of genes related to sensing and
responding to environmental cues including nutrient availability. Approximately 2.5% of the
nearly 4,000 genes in the C. crescentus genome are dedicated to swarmer cell motility and
nutrient sensing. These include several genes whose predicted products are involved in
chemotaxis, 16 chemoreceptors, and genes involved in flagellar assembly or movement (41). All
of these adaptations make C. crescentus well-suited for thriving in low-nutrient environments
such as those that promote PHB accumulation.
1.5.3 Previous studies of PHB production in C. crescentus
Compared to R. eutropha, little is known about PHB accumulation in C. crescentus.
Early descriptions of C. crescentus, such as those reported by Poindexter, noted that TEM
analysis revealed white inclusions consistent with PHB granules in cells grown in 0.2% peptone,
0.1% yeast extract supplemented with MgSO 4 and CaCl 2 (PYE medium) (115). As discussed
above, phosphate limitation results in elongation of the stalk. Phosphate limitation is also known
to induce PHB accumulation, and thus researchers investigating stalk elongation by various
microscopy methods also observed PHB granules (115, 118, 123). Some examples of the
micrographs are provided in Figure 1.23.
PHB granules of ~100 nm in diameter have also been observed in cryoET experiments
carried out by the Jensen lab focused on examining filament bundles in C. crescentus in log
phase cells grown in M2 salts supplemented with glucose. An example of these PHB granules is
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shown in Figure 1.23C, revealing that the granules are adjacent to but not associated with the cell
membrane. In one image, the granule appeared to be associated with a filament bundle in this
picture, hence our interest in using this organism to study the scaffolding model. Closer
examination by Dr. Morgan Beeby in the Jensen group revealed this is not the case.
Figure 1.23 Sample micrographs of C. crescentus grown in various media in which PHB
granules have been observed. A) Thin section TEM of C. crescentus grown in PYE medium,
PG, PHB granule; PMS, polar membrane structure. Adapted from reference (115). B) Thin
section TEM of C. crescentus grown in PYE medium. P, PHB granule; cb, cross-band in wall of
stalk; S, stalk. Adapted from reference (123) C). CryoET of C. crescentus grown in M2 minimal
salts supplemented with glucose IM, internal membrane; PG, peptidoglycan; OM, outer
membrane; SL, S-layer; St, stalk; Rib, ribosome; GF, gold filament; Phb, PHB granule. Adapted
from reference (124). D) Whole cell TEM C. crescentus grown in PYE medium, adapted from
reference (123).
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In an effort to broaden understanding of PHB production in various bacteria, Qi and
Rehm examined the ability of C. crescentus to accumulate PHB in cells grown in PYE medium
with CaCl 2 omitted, supplemented with 1% glucose as a carbon source (25). The rationale for
their selection of growth medium was likely based on the observation by Poindexter that PHB
accumulation decreases with increasing Ca 2 availability (117). Presumably these conditions
were selected because Ca2+ is thought to facilitate phosphate uptake; thus, limitation of Ca in
the growth medium might indirectly result in phosphate limitation. The authors reported a time
course study over 100 h in which they recorded the growth and the extent of PHB accumulation.
After 40 h the cells accumulated a maximum of 18% PHB cdw. At this time, they isolated the
PHB and measured a M, of -550 kDa with a polydispersity of 1.6. They also performed a
preliminary characterization of the PHB synthase of C. crescentus.
C. crescentus contains a class I PhaC, which is annotated as a 65 kDa synthase in the
database. However, Qi and coworkers examined the gene sequence upstream of phaC and
identified an alternative start codon. This protein product would have a M, of 73 kDa, 8 kDa
larger than the 65 kDa typical of class I synthases. Excluding the predicted 8 kDa N-terminal
region in PhaC, PhaC from C. crescentus has 37% sequence identity with PhaCRe, leading the
authors to hypothesize that antibodies raised against PhaCRe would cross-react with PhaC in C.
crescentus. SDS-PAGE of crude cell extracts from C. crescentus were blotted and analyzed with
PhaCRe antibodies, revealing a band that migrated at -75 kDa, higher than the PhaCRe standard
(Figure 1.24). The authors also demonstrated that the 73 kDa synthase can be expressed
recombinantly and is active in crude extracts of E coli (25). Since this initial report there have
been no additional reports characterizing PHB accumulation in C. crescentus or the unusual class
I synthase.
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Figure 1.24 Western blot analysis of PhaC from C. crescentus and PhaCRe using antibodies
to PhaCRe. M, Mw markers. Lane 1, crude extract of R. eutropha H16 harboring a plasmid
containing phaC from C. crescentus. Lane 2, crude extract of E coli harboring a plasmid
containing phaC from C. crescentus. Lane 3, crude extracts of wt C. crescentus. Lane 4, PhaCRe
standard. Adapted from reference (25).
1.6 Preview of future chapters
The majority of the studies in this thesis are focused on characterization of the PHB
biosynthetic apparatus in C. crescentus, which is an attractive system to study because it is
genetically tractable and conditions for its growth have been well established (115). Furthermore,
C. crescentus has served as a model for studying bacterial two-component signaling systems
such as those used to sense and respond to nutrient levels in the environment (125, 126).
Chapter 2 presents the cloning and characterization of the class I synthase from C.
crescentus. We were initially interested in PhaCcc as a promising candidate for crystallization. In
contrast to PhaCRe, PhaCcc is extremely soluble and well-behaved in solution. Although we were
unable to crystallize PhaCc,, characterization of the synthase in vitro has given us some insight
into PHB biosynthesis in C. crescentus and mechanisms of polymerization by PhaCs. PhaCcc is a
73 kDa protein containing an unusual N-terminal domain, enriched in Ala, Pro and Lys residues,
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which has no homology to other proteins in the database. The truncated PhaCcc originally
annotated in the genome was also isolated with the N-terminal domain removed, and has a
specific activity that is 50-fold lower than that of the full length synthase. C. crescentus contains
a 15 kDa phasin, PhaP, which we have also characterized. In vitro assays containing PhaCc, and
PhaP reveal that the inclusion of PhaP enhances the turnover of HBCoA and increases the
specific activity of PhaCc,. We propose a model for in vitro granule assembly in which PhaP
helps to package the growing granule in such a way as to prevent its collapse onto PhaCcc, which
would hinder turnover. Priming studies using sTCoA in combination with size exclusion
chromatography suggest that a dimer of PhaCcc synthesizes two PHB chains, which is distinct
from PhaCRe and PhaECAV. These studies also unexpectedly reveal that PhaCcc is capable of
catalyzing thiolysis of a PHB chain, which may give insight into a mechanism of termination that
leaves the synthase primed with a single HB unit.
Chapter 3 presents characterization of PHB biogenesis in C. crescentus grown in M2
minimal medium that is limited in nitrogen and supplemented with 1% glucose as the sole
carbon source (PHBP medium). Whereas R. eutropha grown in nitrogen-limited medium
accumulates upwards of 80% PHB cdw, C. crescentus accumulates considerably less, only -10%
PHB cdw. These two organisms represent opposite ends of the spectrum of PHA accumulation
among the organisms thus far studied. Maximizing PHA accumulation is attractive from a
commercial point of view, but it is unlikely that organisms in their natural environments produce
PHB to the extent that R. eutropha does in the laboratory. Many important observations
regarding the roles of PhaC, PhaP 1 and PhaZs in PHB biogenesis have been made in R.
eutropha. Our studies in C. crescentus address the question of which of the observations made in
R. eutropha are more general aspects of PHB accumulating organisms.
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Isolation of PHB granules from C. crescentus grown in PHBP medium allowed the
identification of granule-associated proteins including PhaP, a putative PhaR and a PhaZ
homolog. Antibodies were generated to PhaP and PhaC, which were expressed and purified as
described in Chapter 2. At the earliest time points in PHB accumulation, -10% of the PHB in the
cells is in the soluble fraction, and this PHB is full length compared to the M, of PHB
throughout growth. Western blot analysis of PhaP, PhaC and PHB levels during PHB granule
initiation and accumulation revealed that PhaP increases concomitant with PHB, that the
molecular ratio is 1-2 PHB chains per PhaP, and that PhaC is constitutively expressed throughout
growth. A AphaP deletion strain was constructed to further examine the role of PhaP. This strain
was shown to accumulate only 1% PHB cdw under the same growth conditions as the wt strain.
PhaC is initially expressed at the same levels as in wt, but as the cells continue to grow, PhaC is
degraded. The M, and PDI of PHB in the wt strain and the two mutant strains AphaP and AphaR
(in which PhaP is overexpressed) are the same, suggesting that PhaC alone controls termination.
From our findings we propose a model for granule formation in C. crescentus in which the
nucleating granule species contains soluble full-length PHB, PhaC and -1 PhaP chain per PHB.
As PHB accumulates, these species fuse and granules continue to grow. PhaC catalyzes
termination, and a PhaP remains associated with each terminated chain to maintain its
amorphous state and package it into the growing granule. A newly synthesized PhaP molecule
replaces the one lost to the terminated chain, maintaining the ratio of 1-2 PHB chains per PhaP.
This model is similar to what we have proposed in R. eutropha as well, with a few minor
differences.
Chapter 4 summarizes our efforts to crystallize a PHB synthase that were done in
collaboration with the Allen lab at Boston University. As yet, no X-ray structure is available for
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a PHA synthase of any class. Thus, our early efforts were focused on cloning several synthases
from different organisms in the hopes that one would be more amenable to crystallization.
Several crystallization conditions were also identified and pursued for a truncated construct of
PhaECAv that was originally cloned, purified and crystallized by Dr. Paul Hubbard in the
Drennan lab. However we were unable to obtain crystals that diffracted higher than 4.5 A.
Furthermore, conditions were identified in which PhaCccAN could be crystallized in a form that
diffracted to 2 A; however, crystal growth took upwards of one year and could not be
reproduced. Finally, Chapter 5 presents additional experiments, including preliminary efforts to
examine the structure of a truncated construct of the class III synthase PhaECAv by electron
microscopy, TEM studies of the distribution of PHB granules at early time points between
stalked and swarmer cells, in vitro studies of the truncated PhaCccAN construct, and efforts to
prepare and characterize mutant heterodimers of PhaCcc.
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2. Characterization of the class I PHB synthase from Caulobacter crescentus
2.1 Introduction
Class I and class III PHA synthases catalyze the polymerization of (R)-3-hydroxybutyryl
CoA (HBCoA) to make polyhydroxybutyrate (PHB) (1, 2). The class I synthases are composed
of a single subunit PhaC, that is typically 65 kDa in molecular weight (M,), and are typified by
the synthase from Ralstonia eutropha (PhaCRe). The class III synthases are composed of two
subunits, PhaC and PhaE, both ~40 kDa in M., and are typified by PhaEC from Allochromatium
vinosum (PhaECAV). In the class III enzymes, PhaC is the synthase whereas PhaE is of unknown
function but is essential for activity. The class I and III synthases appear to share a common
mechanism for polymerization (3-5). As discussed in Chapter 1, polymerization occurs via
covalent catalysis at an active site Cys (C319 in PhaCRe and C149 in PhaECAv), and involves the
participation of a conserved His residue (H508 in PhaCRe and H331 in PhaECAv), which
deprotonates Cys to generate the active thiolate (3, 5, 6).
The two mechanistic models shown in Figure 2.1 have been the primary working models
for polymerization by class I and III synthases in the last decade. A number of observations with
both PhaCRe and PhaECAv have led to the development of these two models. First, PhaCRe is a
mixture of monomers and dimers in solution, and PhaECAV is a mixture of dimers and tetramers
of PhaEC in solution. Use of the artificial primer sTCoA, which is a terminally saturated
(HB) 3CoA analog (Figure 2.2), demonstrated that incubation of both synthases with sTCoA
results in acylation with sT at a stoichiometry of one per dimer (3-5). Thus, in both models a
dimer of synthases is proposed to generate a single PHB chain. The model in Figure 2.1A was
proposed based on analogy to fatty acid synthases (7) and involves the participation of two
thiols. These two thiols are proposed to be the active site Cys residues of each monomer; thus,
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the active site is formed at the interface of the monomers. Polymerization involves attack by the
active site Cys of one monomer on HBCoA, to release CoA. A second HBCoA unit is then
loaded onto the Cys residue of the other monomer. A conserved Asp residue (D480 in PhaCRe,
D302 in PhaECAv) is proposed to deprotonate the 3-OH of one HB unit, which attacks the HB-
PhaC thioester on the other subunit resulting in transfer of the growing chain to a single subunit.
A third HBCoA unit is then loaded onto the "empty" subunit, and polymerization continues. In
the model shown in Figure 2.1B, which is based on the model proposed for some type III
polyketide synthases (8), the second HBCoA monomer non-covalently binds and ester bond
formation occurs by attack at the enzyme-HB thioester to temporarily release the growing chain
from the enzyme. Cys then rapidly reattacks the growing chain, releasing the second CoA. A
major distinction between the models in Figure 2.lA and B is that the former predicts no non-
covalent intermediates, whereas the latter predicts the involvement of transient non-covalent
intermediates. The evidence for the various aspects of the models as well as attempts to
distinguish between the two will be described below.
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Figure 2.1 Working model for the mechanism of polymerization by PhaCs. A) Mechanistic
model based on analogy to fatty acid synthase involving the participating of two Cys residues. B)
Mechanistic model based on analogy to some type III polyketide synthases, involving the
participation of a single Cys residue.
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Studies of the mechanisms of initiation, elongation and termination of PHB
polymerization have proved challenging due to a number of peculiarities associated with PhaCRe
and PhaECAV- In the present work, we report the isolation and characterization of a class I
synthase from Caulobacter crescentus, PhaCc,. We were initially interested in PhaCcc as a
candidate for crystallography (Chapter 4), as currently no structure for a PHA synthase has been
solved. However, initial purifications revealed that PhaCcc was well-behaved in solution,
prompting us to explore whether it could provide insight into the mechanism of polymerization
that have previously been difficult to study in PhaECAv and PhaCRe.
0 0 OH n=1:(HB)2CoA
CoAS O n = 2: (HB)3CoA
n n=3:(HB)4CoA
O O 0 R R = H: sTCoA
CoAS Oi' O R = 3H: [3H]-sTCoA
O OH
CoA HBCH 2CoA
O 0 0 3 HH
CoA [3 H]-sTCH 2CoA
CoA"U i" oi' ol _ 0 3 [3 H]-sT4CH2CoA
Figure 2.2 Structures of synthetic primers, substrate analogs
discussed in this Chapter.
and non-covalent products
Studies of the initiation of polymerization have been carried out primarily in vitro on
recombinant synthases. Early attempts to purify overexpressed PhaCRe failed because it non-
specifically bound the chromatography resin and glassware. It was not until the non-ionic
detergent hecameg was found to bind to a hydrophobic surface of PhaCRe and prevent non-
specific binding that our lab in collaboration with the Sinskey lab reported the first successful
purification of PhaCRe (6). Analysis of CoA release to monitor polymer formation revealed a lag
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phase that is variable and dependent on concentration of the synthase. Lag phases in activity can
have many possible causes. For example, lag phases have been observed in glycogen synthase
when the appropriate initiating primer unit is omitted (9). Thus, artificial primers, short
oligomers of HBCoA (HBnCoA, where n = 2-4) and sTCoA (Figure 2.2), were investigated for
their effect on the lag phase of PhaCRe- Incubation with these molecules resulted in acylation of
the active site Cys, which in turn shifted the monomer/dimer equilibrium of PhaCRe towards the
dimeric form. In addition, the length of the lag phase of CoA release decreased and the specific
activity, measured by the linear part of CoA released subsequent to the lag phase, increased (3).
This observation suggests that a requirement for priming is at least in part responsible for the
observed lag phase, but also raises the question as to what is the relevant primer in vivo.
Several studies have addressed the identity of the native primer. Self-priming with
HBCoA cannot be studied directly because for both PhaCRe and PhaECAv, the rate of initiation of
polymerization is much slower than the rate of elongation. As a consequence, even in the
presence of just a few equivalents of HBCoA, a few molecules of PhaC make high Mw polymer
whereas the remainder of the PhaC is unmodified (6, 10, 11). Recently, Doi and coworkers
reported the characterization of the class I synthase from Aeromonas caviae, PhaCAc (12). They
incubated PhaCAc with just five equiv. HBCoA and demonstrated by size exclusion
chromatography (SEC) that, upon incubation with HBCoA, PhaCAc shifted from predominantly
monomeric to predominantly dimeric. There was no apparent loss of material due to
precipitation, though the fraction of aggregated material (that eluted in the void volume)
increased. These results suggested that PhaCAc was uniformly self-priming with HBCoA alone,
and that priming shifted the equilibrium towards dimeric PhaC. This result is potentially very
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interesting; unfortunately the overall characterization of the enzyme is very poor, thus a more
careful examination of priming of PhaCAC is necessary.
Kudo and coworkers have alternatively proposed that the TCA cycle intermediate
succinyl CoA serves as the primer (13). They extracted PHB from R. eutropha and partially
hydrolyzed it in a suspension of chloroform and aqueous HCl into fragments were small enough
(800-2500 Da) for end-group analysis by NMR and electrospray ionization mass spectrometry
(ESI-MS). From their analysis, they conclude that a fraction of the hydrolytic fragments
contained a succinyl group at one end. They propose these fragments represent the end of the
polymer synthesized first, and that succinyl CoA is the starter unit. However, attempts in our
group to prime PhaCRe by incubation with succinyl CoA did not result in CoA release (Cho and
Stubbe, unpublished), though it should be noted that succinyl CoA readily forms succinic
anhydride in solution. Thus the nature of the priming unit in PHB biosynthesis remains unclear.
The issue of the slow rate of initiation presents a challenge for studying elongation, as
synthase cannot be uniformly loaded in order to study the early steps in polymer elongation. A
key mechanistic question initially was to distinguish between the two mechanisms in Figure 2.1
by trapping the putative non-covalent intermediates in Figure 2.1B. To look for non-covalent
intermediates, wt PhaECAV was acylated with sTCoA then incubated with HBCoA (14). The
reaction was quenched in acid at various time points, the precipitated protein was removed by
centrifugation, and the supernatant was examined by HPLC. No non-covalent intermediates
could be trapped with wt PhaECAv. However, our inability to observe non-covalent intermediates
could mean either that the mechanism in Figure 2.1 B is incorrect, or that non-covalent
intermediates do form, but the rate of reacylation is too fast to be able to capture them. Thus
these experiments failed to distinguish between the two mechanisms. We have recently reported
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the trapping of the non-covalent intermediates (HB)2CoA and (HB)3CoA from the reaction of the
mutant C149S-PhaECAv with HBCoA (14). Mutation of the active site Cys to Ser slowed the rate
of reacylation -150-fold and allowed observation for the first time of non-covalent intermediates
of polymerization. However, the caveat remains that mutation of the active site Cys could alter
the mechanism of elongation, thus the relevance to the wt mechanism is not unequivocally
established.
Efforts have also been made to trap non-covalent intermediates by first priming wt
PhaCRe and PhaECAv with [3H]-sTCoA, then reacting the primed synthase with the chain
terminator HBCH2CoA (Figure 2.2). In principle, if polymerization occurs via the mechanism in
Figure 2.1 B, then HBCH 2CoA would bind the primed enzyme and attack the [3H]-sT-PhaC
thioester, resulting in the formation of [3H]-sT4CH 2CoA (Figure 2.2). Unexpectedly, the major
product of the reaction is [3H]-sTCH2CoA, though a small amount of [3H]-sT4CH 2CoA is formed
as well. A similar phenomenon was observed when the primers (HB)2CoA and (HB) 3CoA were
used in place of sTCoA. While these observations suggest that polymerization occurs via non-
covalent intermediates (with the caveat that artificial primers were necessary to observe them), it
also raises the issue of unusual, and potentially off-pathway, chemistry taking place in the
reaction between PhaCs and artificial primers. A model that could explain the results involves
the loading of [3H]-sT first onto an amino acid distinct from the active site Cys, followed by
transfer of a saturated dimer unit ([3H]-sD) to the active site Cys. HBCH2CoA could then bind
the active site and attack [3H]-sD-PhaC to produce the observed product [3 H]-sTCH2CoA.
Whether there is a loading site and the relevance of such a site to the wt enzyme is not clear.
These unusual results further underscore the necessity for caution when using substrate analogs
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such as artificial primers, but reveal that PhaCs are capable of catalyzing chemistry in addition to
the polymerization reaction.
In addition to the chemistry of elongation, the process involves physical steps of
packaging of the polymer as the phase transition from soluble to insoluble occurs. Granule
assembly in vivo involves several proteins in addition to the synthase that become associated
with the granule surface as PHB accumulates. Of these, the most predominant are the phasins
(PhaPs), which are low M, proteins that are thought to play a role in determining granule size
and number (15-17). Several studies have suggested that phasins play an important role in
granule assembly. In vitro, granules can assemble from synthase and HBCoA alone. However
Steinbtichel and coworkers demonstrated by phase contrast as well as scanning electron
microscopy that granules synthesized in vitro by PhaECAv are smaller when PhaPi from R.
eutropha is included (18). Their images are convincing and suggest that phasins influence the
process of elongation and granule packing. However, from the level of detail provided in the
paper the mole ratio of PhaECAv to PhaP1 cannot be determined. Assays of PhaCRe in the
presence of increasing equivalents of PhaPI (the major phasin in R. eutropha) reveal that PhaP1
increases the length of the lag phase and decreases the specific activity of the enzyme without
changing the M, of the PHB produced. These results were interpreted to suggest that PhaP1
slows the rate of polymerization in order to allow for folding of the nascent PHB chain (19).
Finally, when a PHB chain has reached a certain M., the chain must be terminated in
order to free the PhaC active site for additional polymerization. It has long been known that
termination and reinitiation occur in vivo (20). Recently we have shown in R. eutropha that the
ratio of PHB chains to PhaCRe increases -15-fold, from 6 to 87, as the amount of PHB in the
cells increases from 5% to 80% cdw, suggesting that there are many termination and reinitiation
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events per synthase during PHB accumulation (19). PhaCs are thought to catalyze termination,
and several species have been proposed to serve as chain transfer agents, including
hydroxybutyrate (21), CoA (22) and a nucleophilic water molecule (11, 20, 23). The idea that
hydroxybutyrate may function in termination comes from the observation that including
compounds such as polyethylene glycol (24), glycerol (21) and 1,2-propanediol (21) in
fermentations of R. eutropha resulted in PHB of a lower M, than when these compounds were
omitted. Furthermore, the polymer was isolated and characterized by NMR, revealing that the
alcohols were attached to the carboxy terminus of the PHB chains, and suggesting that they
served as more efficient chain transfer agent than the natural agent, which may be water or
hydroxybutyrate. However, an alternative explanation for the observed decrease in M, is that the
alcohols undergo transesterification with the PHB after it is synthesized, rather than specifically
interacting with the PhaC active site during polymerization. Thus, the significance of these
observations is unclear.
Alternatively, CoA could catalyze termination. Our lab has demonstrated that polymer
produced from the substrate analog HB-N-acetylcysteamine (HB-NAC) terminates in NAC (25).
One possible interpretation of this observation is that in the natural system, CoA serves as the
chain transfer agent; however, this has not been demonstrated with HBCoA. Our lab has also
previously demonstrated that the synthase catalyzes termination to leave an HBn (where n = 3-
10) primer unit attached to PhaC (11, 26). Thus, a plausible model for termination involves the
PhaC either activating a water molecule and catalyzing hydrolysis of the PHB chain or
catalyzing thiolysis by CoA liberated during the addition of the final HB unit. Finally, the Mw of
PHB produced by the R. eutropha mutant strains AphaP] and AphaR (in which PhaP1 is
overexpressed) is lower than that in wt, and in AphaP] the PDI is higher. These results suggest
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that while PhaCRe catalyzes termination, the ratio of PhaP1 to PhaC somehow influences
termination in R. eutropha, thereby determining the M, and PDI of the PHB (19).
Studies of the mechanisms of initiation, elongation and termination carried out with
PhaECA, and PhaCRe have provided a good deal of insight into PHB biosynthesis. However there
have been several challenges associated with studying these enzymes, as described above. In this
Chapter, we present the isolation and characterization of the class I synthase PhaCcc in order to
gain additional insight into the mechanism of polymerization. PhaCc, was originally cloned and
purified as a candidate for crystallography studies. In contrast to PhaCRe, PhaCcc was found to be
soluble and well-behaved in solution, supporting our efforts to pursue crystallization but also
prompting us to investigate whether mechanistic studies could further shed light on our
understanding of the polymerization process.
Our studies demonstrate that like PhaCRe and PhaECAv, the rate of initiation by PhaCcc is
much slower than the rate of elongation. Priming PhaCcc with sTCoA uniformly loads the
synthase, but the rate of hydrolysis of the acylated enzyme appears to be rapid and consequently
large polymer is still produced. We have also isolated the phasin PhaP, which we identified in
studies presented in Chapter 3, and demonstrate that it plays a role in interacting with the
growing PHB chain, likely to facilitate in vitro granule formation. Finally, studies with the
artificial primer sTCoA have revealed additional unusual chemistry suggesting that PhaCcc can
catalyze thiolysis with CoA. These results may provide insight into a possible mechanism for
termination by thiolysis via CoA at an internal ester bond leaving PhaCcc primed with an HB
unit.
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2.2 Materials and Methods
2.2.1 Materials
All chemicals were obtained at the highest purity available from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified. (R/S)-[1-"C]-HBCoA was obtained from American
Radiolabeled Chemicals, Inc. and diluted with (R)-HBCoA synthesized by Dr. Ping Li following
the method of Yuan et al. (27). The compounds sTCoA and [3H]-sTCoA were synthesized by Dr.
Ping Li according to the method of Jia et al. (4). Oligonucleotide primers used in this study were
obtained from Integrated DNA Technologies (Coralville, IA) and are listed in Table 2.1.
Restriction enzymes were purchased from New England Biolabs (Beverly, MA), GoTaq DNA
polymerase was purchased from Promega (Fitchburg, WI), and PfuII Turbo and Pfx polymerases
were purchased from Stratagene (La Jolla, CA). The plasmids used in this study are listed in
Table 2.2. Scintillation fluid was obtained from Perkin Ellmer.
2.2.2 Construction of expression vectors encoding N-terminally tagged PhaCces
Genomic DNA was isolated from 1 mL of saturated overnight C. crescentus culture
grown in PYE using the GenElute Bacterial Genomic Kit (Sigma-Aldrich, St. Louis, MO)
according to the manufacturer's protocol for Gram-negative bacteria.
For the construction of pRBhis6phaCAN and pRBhis6phaC, phaCAN and phaC were
amplified from -200 ng of genomic DNA using PfuII Turbo polymerase. For phaCAN, the
primers phaCANfw/phaCANrev were used to insert a 5' BamHI restriction site and a 3' NheI
restriction site. For phaC, the primers phaCfw/phaCrev were used to insert a BamHI restriction
site at the 5' end of phaC and an NheI restriction site at the 3' end of phaC. An annealing
temperature of 55 C and an extension temperature of 72 'C for 1 min were used for both
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reactions. The amplified products phaCAN and phaC were digested with BamHI and NheI, then
ligated into pET28a (Novagen) digested with the same enzymes at an insert to vector ratio of 5:1.
The ligation reactions were transformed into E. coli XL10 Gold cells, and colonies were
screened by colony PCR using GoTaq polymerase and the primers phaCANfw/phaCANrev or
phaCfw/phaCrev for pRBhis6phaCAN and pRBhis6phaC, respectively. For each plasmid, one
colony containing insert was sent for sequencing at MIT Biopolymers Laboratory.
Table 2.1 Primers used in Chapter 2.
Name Sequencea
phaCANfw 5' - GATATAGCTAGCGTCGAGACCCTCTCGGCGAAT - 3'
phaCANrev 5'- GATATAGGATCCTCAGGGTTGTGACTTTACCAGCAC - 3'
phaCfw 5' - GATATAGCTAGCATGGCCACGGCGAA - 3'
phaCrev 5' - GATATAGGATCCTCAGGGTTGTGACTTTACCAGCAC - 3'
phaPfw 5' - GATATACATATGGCCGCGGCCGAAAACCTGAAGACCAC - 3'
phaPrev 5' - GATATAAAGCTTTTAGCGGGCGGCCTGGAACTTTTCGAC - 3'
phaC406Afw 5' - GCGTCAACACCGTAGGCTACGCCATCGGCGGCACCCTG
CT - 3'
phaC406Arev 5' - AGCAGGGTGCCGCCGATGGCGTAGCCTACGGTGTTGAC
GC - 3'
phaC406Sfw 5' - CCGTAGGCTACTCCATCGGCGGCACCC - 3'
phaC406Srev 5' - GGGTGCCGCCGATGGAGTAGCCTACGG - 3'
phaCD562Nfw 5' - GTGCAGTCCTCGAAGGACAACCACATCGCG - 3'
phaCD562Nrev 5' - CGCGATGTGGTTGTCCTTCGAGGACTGCAC - 3'
phaCH590Qfw 5' - CCATGGCCGGTTCGGGTCAGATCGCGGGCGTGATCAACC - 3'
phaCH590Qrev 5' - GGTTGATCACGCCCGCGATCTGACCCGAACCGGCCATGG- 3'
aRestriction sites and mutated codons are underlined.
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Table 2.2 Plasmids used in Chapter 2.
Plasmid Description Reference
pRBphaCcc phaCcc inserted into pET28a between NheI and This work
BamHI restriction sites; encodes N-terminal His6 -
tag and the linker SSGLVPRGSHMAS
containing a thrombin site (underlined).
pRBphaCcc-C406A Same as pRBphaCcc, with point mutation C406A This work
pRBphaCcc-C406S Same as pRBphaCcc, with point mutation C406S This work
pRBphaCcc-D562N Same as pRBphaCcc, with point mutation D562N This work
pRBphaCcc-H590Q Same as pRBphaCcc, with point mutation H590Q This work
pRBphaCccAN phaCccAN inserted into pET28a between NheI This work
and BamHI restriction sites; encodes N-terminal
His 6-tag and the linker SSGLVPRGSHMAS
containing a thrombin site (underlined).
pRBphaP phaP inserted into pET28a between NdeI and This work
HindIll restriction sites; encodes N-terminal His6 -
tag and the linker SSGLVPRGSH containing a
thrombin site (underlined).
2.2.3 Expression and purification of PhaCcs
PhaCccAN and PhaCcc were expressed in E coli BL21(DE3) cells (Stratagene) from
plasmids pRBphaCccAN and pRBphaCcc, respectively. Cultures (2 L LB supplemented with 50
ptg/mL kanamycin [Km] in 6 L flasks) were inoculated with 5 mL saturated overnight LB
cultures and grown at 37 'C to OD 60 0 = 0.6. The cultures were then cooled rapidly on ice to -18
'C and induced with 0.4 mM isopropyl s-D- 1 -thiogalactopyranoside (IPTG). The cells were
grown an additional 3-4 h at 18 'C, then harvested by centrifugation at 3,500 xg for 10 min.
Cells were flash frozen in liquid nitrogen and stored at -80 'C until use. A typical yield was 2 g
wet cell paste per L.
All purification steps were carried out at 4 'C. PhaCccAN and PhaCcc were purified by
identical methods. In the purification of PhaCcc, all steps included 1 tablet of protease inhibitor
cocktail (Roche) per 50 mL of buffer. Cells were resuspended in 3-5 mL/g of wet cell paste in
lysis buffer containing: 50 mM NaH 2PO 4, 300 mM NaCl, 10 mM imidazole, pH 8.0. The cells
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were lysed by two passes through a French pressure cell at 14,000 psi. The insoluble cell debris
was removed by centrifugation at 17,000 xg for 20 min. The soluble fraction was equilibrated
with 1 mL of Ni-NTA resin (Qiagen) per 5 mL of soluble extract for 30 min by gentle stirring.
The slurry was loaded into a column and the resin allowed to settle, then the flowthrough was
collected. The column was washed with 20 column volumes (cv) of lysis buffer followed by 10
cv of lysis buffer with 50 mM imidazole. PhaCcc and PhaCccAN were eluted by batch elution
with lysis buffer with 250 mM imidazole. For PhaCcc, the elution fractions containing protein
were combined and concentrated to -200-300 pM (-10-20 mg/mL). PhaCcc was then exchanged
into 20 mM Hepes pH 7.5, 200 mM NaCl, and stored at 4 *C or flash frozen and stored at -80 *C.
PhaCccAN was concentrated to 0.5-1 mM (-30-60 mg/mL), flash frozen in liquid nitrogen and
stored at -80 'C. Typical yields for PhaCcc and PhaCccAN were 3 mg and 10 mg per g of cells,
and had specific activities of 50 and 1 U/mg, respectively.
2.2.4 Protein quantitation
Protein concentration was determined by A2 80 (F = 103,270 M~1 cm-1 for PhaCccAN; e =
103,630 M-1 cm~1 for PhaCcc; , = 8,250 M-1 cm~1 for PhaP) or Bradford assay using BSA as a
standard (28). The extinction coefficients were determined using the Peptide Property Calculator
from Northwestern University (http://www.basic.northwestern.edu/biotools/proteincalc.html) and the
concentrations determined using the calculated values were consistent with concentrations
determined using the Bradford assay. For heterogeneous mixtures of proteins, total concentration
was determined by Bradford assay.
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2.2.5 Enzyme assays
All assays are carried out at 30 0C. A typical assay contained in a final volume of 170 pL:
20 mM Hepes pH 7.5, 20 mM NaCl, 1 mM HBCoA and 500 nM PhaCccAN, 25 nM PhaCc, or
50-100 iM PhaCcc mutant (PhaCcc-C406A, -C406S, -D562N, or -H590Q). The reaction was
initiated by addition of enzyme. At various time points, 20 pL aliquots were withdrawn and
quenched in 50 pL ice-cold 10% trichloroacetic acid (TCA). The samples were centrifuged 5 min
at 14,000 xg to remove precipitated protein, and 68 pL was removed and added to 262 pL of
0.25 mM 5,5'-dithiobis-(2-nitrobenzoic acid (DTNB) in 0.5 M KH2 PO4 , pH 7.8. The reactions
were incubated for 5 min and A412 of each sample was measured. Specific activity was calculated
from the rate of the first linear phase and is given in U/mg, where one unit is one pimol substrate
consumed per min. Data were fit to a sigmoidal function using Equation 2.1.
Equation 2.1 y = x-
To determine the kinetic parameters for HBCoA, the concentration of HBCoA was varied
from 0.05 to 6 mM with 50 nM PhaCcc. The data were fit to the Michaelis-Menten equation,
equation 2.2, and the Hill equation, Equation 2.3
Equation 2.2 v = Vmax[S]
KM+[S]
Equation 2.3 V Vmax [ 1Kn+ [S]n
2.2.6 Stability of purified PhaCc, upon storage at 4 C and -80 'C
The specific activity of freshly-purified PhaCcc was compared to PhaCcc stored for one
week at 4 C in 20 mM Hepes pH 7.5, 200 mM NaCl with and without 20% glycerol or for one
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week at -80 C in 20 mM Hepes pH 7.5, 200 mM NaCl with and without 20% glycerol. The
activity was measured as described above.
2.2.7 Construction of active site mutants of PhaCc,
The mutants PhaCcc-C406S, -D562N and -H590Q were generated from the template
pRBhis6phaC using the primers phaCC406Sfw/phaCC406Srev, phaCD562Nfw/phaCD562Nrev
and phaCH590Qfw/phaCH59OQrev, respectively (Table 2.1). The reactions contained 50 ng
pRBhis6phaC as template and 1 p.M of each primer and PfuII Turbo polymerase, and were
carried out using an annealing temperature of 55 'C for 30 s and an extension temperature of 68
'C for 7 min. All sequences and mutations were confirmed by sequencing at MIT Biopolymers
Laboratory.
Attempts to generate the active site C406A mutant synthase by conventional mutagenesis
methods were unsuccessful. Therefore, this mutant was generated by the primer overlap
extension method (29). This method is briefly outlined in Figure 2.3. The PCR products
described below are named following the scheme in Figure 2.3. For the construction of
pRBhis6phaC-C406A, the 5' region of phaC was amplified using GoTaq polymerase and the
primers phaCfw and phaCC406Arev (product his6AB), and the 3' region was amplified using
GoTaq polymerase and the primers phaCC406Afw and phaCrev (product his6CD) (Table 2.1).
An annealing temperature of 55 'C and extension temperature of 72 C for 1 min were used.
phaCfw introduced an NheI restriction site at the 5' end of his6AB and phaCrev introduced a
BamHI restriction site at the 3' end of his6CD.
The amplified PCR products were purified and the relative concentrations estimated by
densitometry analysis by ethidium bromide staining in a 1% agarose gel. Based on this analysis,
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products his6AB and his6CD were combined in a 1:1 ratio. These products then served as the
templates for a second set of PCR reactions. his6AB and his6CD were amplified using GoTaq
polymerase and the primers phaCfw and phaCrev. This PCR reaction "stitched" together the two
template pieces, producing the products his6AD corresponding to his6-phaC-C406A. his6-phaC-
C406A was subcloned into pCR2.1 TOPO by the manufacturer's protocol, then excised using the
appropriate restriction enzymes. Using T4 DNA ligase, his6-phaC-C406A was then ligated into
pET28a (Novagen) between the NheI and BamHI restriction sites.
The resulting plasmid, pRBhis6phaC-C406A was sequenced at MIT Biopolymers
Laboratory and found to contain a single base pair insertion at the site of the mutation. Therefore
a final round of mutagenesis using PfuII polymerase and the primers phaCC406Afw and
phaCC406Afw was carried out to remove the insertion using an annealing temperature of 55 C
and an extension temperature of 68 C. The sequence was confirmed by sequencing at the MIT
Biopolymers Laboratory.
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Figure 2.3 Schematic of primer overlap extension method of mutagenesis adapted from
(29). Site-directed mutagenesis is accomplished using primers b and c, which contain the
mutation (*), and primers a and d, which anneal to the 5' and 3' ends of the gene, respectively.
The first PCR reaction produces fragments AB and CD. PCR products AB and CD, which
overlap at the site of the mutation, are then used as template for the second PCR reaction. AB
and CD hybridize at the site of the mutation and PCR using primers a and d generates the full
length product AD.
2.2.8 Determination of the quaternary structure of PhaCc, by size exclusion
chromatography (SEC)
PhaCcc (100 pL, 1-100 pM) and PhaCccAN (1-50 pM) were injected onto a Superdex
200 10/300 GL analytical column (M, range = 10,000-600,000 Da, GE Healthcare, Piscataway,
NJ) attached to an Akta Purifier FPLC (GE Healthcare, Piscataway, NJ) at 4 'C. The eluent was
20 mM Hepes pH 7.5, 200 mM NaCl and the flow rate was 0.25 mL/min. A280 and A260 were
monitored. Retention volumes (times) were compared with the retention volumes (times) of M,
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standards (GE Healthcare): thyroglobulin (M, = 669 kDa, retention volume, time = 8.5 mL, 34
min); ferritin (440 KDa, 10.0 mL, 40 min); aldolase (158 kDa, 12.3 mL, 49.2 min); conalbumin
(75 kDa, 13.9 mL, 55.6 min); ovalbumin (44 kDa, 58.8 min). The void volume of the column
(7.22 mL, 28.9 min) was measured by injecting 100 ptL of a 1 mg/mL solution of Blue Dextran
(GE Healthcare). To prepare the standard curve, the partition coefficient (Kay) of each sample
was calculated using Equation 2.4.
Equation 2.4 Kav = e-Vo
Vc- VO
Ve is the retention volume measured for a given standard, Vo is the void volume, and V, is the
column bed volume (24 mL). A plot of Kay vs. logM, was prepared from the Ka, values of the
standards generating the standard curve and the M, determined using this curve.
To measure the recovery of PhaCc, from the column, the protein peak was collected and
concentrated to -3 mL using a Centricon YM30 spin concentrator with a molecular weight cutoff
of 30,000 Da (Millipore, Billerica, MA).
2.2.9 Stoichiometry of acylation and rate of hydrolysis of acylated PhaCcc generated from
sTCoA
The stoichiometry of acylation of PhaCcc was measured using the DTNB assay to
monitor CoA release. The reaction was carried out at 30 *C and contained in a final volume of
110 ptL: 20 mM Hepes pH 7.5, 20 mM NaCl, 50 pM PhaCc, and 500 p.M sTCoA. At various
time points, 20 p.L aliquots were withdrawn and quenched in 50 p.L ice cold 10% TCA. The
samples were analyzed by the discontinuous DTNB assay described above at time points from 10
s to 5 min.
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2.2.10 Stability of [3H]-sT-PhaCcc by Sephadex G50 chromatography
2.2.10.1 Separation in 20 mMHepes, pH 7.5, 200 mMNaCl.
In a final volume of 75 pL at 30 'C, the reaction contained: 50 pM PhaCc, (3.75 nmol)
and 500 pM [3H]-sTCoA (specific activity 1900 cpm/nmol) in 20 mM Hepes pH 7.5, 200 mM
NaCl. The reaction was initiated by addition of enzyme and then immediately loaded onto a 10
mL Sephadex G50 column (7 mm x 300 mm). The column was eluted with 20 mM Hepes pH
7.5, 200 mM NaCl at 0.6 mL/min. The eluent was collected in 25 x 80 IL fractions, 70 x 40 ptL
fractions, then 95 x 80 p.L fractions in 96-well plates. The A2 80 and A260 of each fraction was
measured and then the fractions were added to 900 iL H20 and 9 mL scintillation fluid. Each
well was washed with an additional 120 l H20, and added to the mix.
2.2.10.2 Separation in 20 mM KH2PO4, pH 4.5, 2 M urea
The reaction was carried out at 30 'C. In a final volume of 50 l, the reaction contained:
50 pM PhaCcc (2.5 nmol) and 500 ptM [3H]-sTCoA (specific activity 1300 cpm/nmol) in 20 mM
Hepes pH 7.5, 200 mM NaCl. The reaction was initiated by addition of enzyme and was
immediately loaded onto a 10 mL Sephadex G50 column (7 mm x 300 mm) and eluted with 20
mM KH2PO4 pH 4.5, 2 M urea at 0.3 mL/min. The eluent was collected in 160 x 100 tL
fractions in 96-well plates and analyzed as described above.
2.2.11 Separation in 20 mM Hepes, pH 7.5, 200 mM NaCl following reaction of sT-PhaC
with 5 equiv. HBCoA
In a final volume of 50 ptL at 30 'C, the reaction contained: 200 pM PhaCcc (3.75 nmol)
and 500 pM [3H]-sTCoA (specific activity 1300 cpm/nmol) in 20 mM Hepes pH 7.5, 200 mM
NaCl. The reaction was initiated by addition of enzyme, and after ~10 s was chased with 1 mM
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HBCoA, then loaded onto a 10 mL Sephadex G50 column (7 mm x 300 mm, 10 mL) and eluted
with 20 mM Hepes pH 7.5, 200 mM NaCl at 0.6 mL/min. The eluent was collected in 190 x 100
pL fractions in 96-well plates and analyzed as described above.
2.3.12 Analysis of small molecule products of the reaction of sTCoA with PhaCcc by HPLC
In a final volume of 500 pL at 30 *C, the reaction contained: 50 pM PhaCcc and 500 pM
[3H]-sTCoA (specific activity = 147 cpm/nmol) in 20 mM Hepes pH 7.5, 20 mM NaCl. Aliquots
(50 pL) were withdrawn from 5 s to 5 min and quenched in 20 ptL ice-cold 10% TCA. The
samples were centrifuged at 4 C for 10 min at 20,000 xg to pellet the precipitated protein. The
supernatant was removed and the pellets were washed with 50 pL ice cold H20, and the wash
combined with the supernatant. The combined wash and supernatant were adjusted to pH ~5 by
addition of 12 pL 1 M NaOH. One hundred pL of each sample was injected onto a nucleoside-
nucleotide column (Alltech, 7 pm, 4.6 mm x 250 mm) attached to a Waters HPLC equipped with
a diode array detector. The elution protocol used 20 mM KPi pH 4.7 (solvent A) and methanol
(solvent B) and a linear gradient from 5% to 70% solvent B from 0-60 min. Fractions (1 mL)
were collected, and 900 pL from each fraction was combined with 9 mL scintillation fluid
(Perkin Ellmer) and counted for 10 min. The rate of sTCoA consumption and new product
formation were fit to Equations 2.5 and 2.6.
Equation 2.5 y = yo + Ae x/
where 1/t is the rate constant of sTCoA consumption. To calculate the rate of sDCoA formation,
the total nmol of sDCoA present in the reaction was determined by the total radioactivity in the
peak. To determine the rate constant k, the data were fit to Equation 2.6.
Equation 2.6 y = A1 -A 2 xe-
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2.2.13 Identification of small molecule products of the reaction of sTCoA with PhaCcc by
matrix assisted laser desorption mass spectrometry time of flight analysis (MALDI-TOF)
In a final volume of 50 pl, the reaction contained: 50 ptM PhaCc, and 500 [LM sTCoA in
20 mM Hepes pH 7.5, 20 mM NaCl. The sample was then treated and analyzed by HPLC
identically to the time points described above. The peaks were collected from the HPLC, shell
frozen in liquid N 2 and lyophilized. The samples were solubilized in 100 pL H20 and submitted
for MALDI-TOF analysis at MIT Biopolymers. Ten pL of each sample was desalted using a
Zip-tip (C18, Millipore, Billerica, MA) and eluted with 50% acetonitrile, 0.1% trifluoroacetic
acid (TFA) and then combined 1:1 with matrix (a-cyano-4-hydroxycynammic acid) and
analyzed.
To quantitate products containing no radioactivity, a standard curve using known
amounts of HBCoA was prepared. Samples (100 pL containing 10-250 nmol) were injected onto
the HPLC and analyzed by A2 60. The peaks were integrated and peak areas were plotted against
nmol HBCoA to generate a standard curve. The amount of sTCoA was quantitated by A2 60 as
well because the peak overlapped with a peak containing radioactivity but no A260.
2.2.14 Gel permeation chromatography (GPC) analysis of the M, of PHB produced by
reaction of PhaCcc and sT-PhaCcc reacted with HBCoA
The M, and PDI of PHB produced by PhaCcc in vitro under three different reaction
conditions was determined.
PHB in a typical assay (reaction 1). The reaction contained in a final volume of 100 pL:
50 nM PhaCcc and 1 mM [1-4C]-HBCoA (specific activity 175 cpm/nmol (R)-HBCoA), 20 mM
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Hepes pH 7.5, 20 mM NaCl. The reaction was carried out 30 min at 30 'C, at which time all the
substrate was consumed.
PHB produced by reaction of [3H]-sT-PhaC with HBCoA to determine whether sTCoA is
chemically competent for polymerization (reaction 2). In a final volume of 12.5 pL at 30 C,
PhaCcc (50 pM) was reacted with 500 pM [3H]-sTCoA (specific activity = 5700 cpm/nmol) for
10 s at room temperature (RT) in 20 mM Hepes pH 7.5, 20 mM NaCl. Ten pLL of this reaction
was then added to 990 pl 20 mM Hepes pH 7.5, 20 mM NaCl to dilute PhaCcc and unreacted
[3 H]-sTCoA, and 100 [tL was diluted into 1 mM HBCoA in 1 mL 20 mM Hepes pH 7.5, 20 mM
NaCl to give a final concentration of 50 nM PhaCcc. The reaction was carried out for 30 min at
30 0C.
PHB produced by reaction of sT-PhaC with [1-"C]-HBCoA (reaction 3). This reaction
was identical to reaction 2, except that unlabeled sTCoA and [1-14C]-HBCoA (specific activity
175 cpm/nmol (R)-HBCoA) were used.
GPC analysis of PHB produced. The three reaction mixtures were transferred to
borosilicate tubes (16 x 125 mm), shell frozen and lyophilized to dryness. A magnetic stir-bar
was added to each tube, the tubes were capped with rubber septa, and each septum was pierced
with a glass Pasteur pipette, which functioned as a make-shift reflux condensor. CHCl3 (2 mL)
was added to each tube, which were refluxed for 48 h at 70 C. The tubes were then cooled,
centrifuged at 4 C for 10 min at 3,000 xg to pellet the insoluble material, and the chloroform
was carefully removed with a Pasteur pipette and stored at -20 C until analysis. The insoluble
material was refluxed an additional 48 h in 2 mL fresh chloroform at 70 0C, after which the
insoluble material was once again pelleted by centrifugation. This chloroform extract was
combined with the material from the first extraction. The samples were then filtered to remove
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remaining insoluble material using a glass syringe (0.5 mL) fitted with a 0.4 pm PTFE filter (13
mm). The filters were washed with 3 mL fresh chloroform, which was added to the filtrate.
Reactions 1 and 3 were concentrated to 500 p.L and reaction 2 was concentrated to 250 p.L by
evaporating excess chloroform under a stream of air. To determine recovery, 25 pL of the
extracted material was placed in a scintillation vial and the chloroform was evaporated under a
stream of air. The radioactivity in each sample was analyzed by liquid scintillation counting.
Each sample (100 p.L) was then injected onto a 2 x 300 x 7.5 mm Plgel Olexis column
(Varian, Palo Alto, CA) connected to a Waters 515/2487 HPLC and eluted at a flow rate of 1
mL/min with chloroform at 30 'C. Fractions (1 mL) were collected, and each fraction was placed
in a scintillation vial and the chloroform was evaporated under a stream of air. Fractions were
mixed with 9 mL of scintillation fluid, vigorously vortexed, and analyzed by scintillation
counting. Isopropanol (retention time, 21 min) was added to each sample as an internal standard
(at 1 pL per 120 pL of sample) to normalize product retention times. Molecular weights were
determined by comparison to a set of polystyrene standards (Varian) of the M, (retention time):
3.1 kDa (17.8 min), 10 kDa (17 min), 73 kDa (15.4 min), 205 kDa (14.8 min), 490 kDa (13.9
min), 1800 kDa (12.9 min), 5000 kDa (12.4 min). The M, and PDI of each sample were
determined using the standard curve polynomial generated by PSS WinGPC Unity software with
the above standards. The preparation of the standard curve is described in detail in section 3.2.11
of Chapter 3. Retention volumes were plotted against radioactivity and M., Mn and PDI were
determined using Equations 3.6, 3.7 and 3.8, and the adjusted calibration curve in section 3.2.11.
Radioactivity was substituted for refractive index intensity (lv).
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2.2.15 Activity of PhaCcc following acylation with sTCoA
In a final volume of 10 ptL at 30 'C, PhaCc, (50 tM) was reacted with 500 PM sTCoA.
After ~10 s, the reaction was diluted with 590 pL 20 mM Hepes pH 7.5, 20 mM NaCl, and 10
ptL was withdrawn and added to an assay mixture. The assay mixture contained, in a final
volume of 170 pL: 50 nM PhaCc, (some portion of which is acylated with sT), ~0.5 IM sTCoA
and 1 mM HBCoA. At various time points, 20 pl aliquots were withdrawn, quenched in 50 pL
ice cold 10% TCA and analyzed by the discontinuous DTNB assay as described above.
2.2.16 Examination of the uniformity of loading of reaction of PhaCc, with HBCoA
2.2.16.1 SDS-PA GE and autoradiography analysis
In a final volume of 22 pL, PhaCcc (4 ptM) was reacted with 5 and 50 equiv. of [1-1 4C]-
HBCoA (88,000 cpm total per reaction) at 30 C. At 10 and 30 s, 10 pL aliquots were withdrawn
and quenched in 10 pL Laemmli buffer (without reducing agent) and the samples were not
boiled. A PhaCcc standard and the 20 iL samples were quickly loaded onto a 10% SDS-PAGE
gel and run at 150 V for 1 h on ice. The gel was stained for 15 min in fresh Coomassie stain, then
destained for 15 min in fast destain. The gel was rinsed 3 x 5 min in H20, then immediately
dried. The gel was then exposed to a low energy phosphor screen (Molecular Dynamics) for 12
h. The phosphor screen was scanned using the Storm Imaging System and analyzed using
ImageQuant TL software (Amersham Biosciences). Densitometry analysis was performed using
ImageJ Software (30).
2.2.16.2 GPC analysis
In a final volume of 100 ptL the reaction contained: 4 pM PhaCcc and 200 pM [1-14C]-
HBCoA (specific activity 175 cpm/nmol (R)-HBCoA) in 20 mM Hepes pH 7.5, 20 mM NaCl.
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The reaction was carried out for 5 min at 30 0C to allow for complete substrate consumption.
Proteinase K (50 pg) (Sigma-Aldrich) was added to the reaction and incubated 30 min at 37 C
to digest PhaCcc. The reaction was transferred to a borosilicate tube (16 mm x 125 mm), flash
frozen and lyophilized to dryness. PHB was extracted as described in section 2.2.13. The
extracted PHB was concentrated to 250 ptL by evaporating chloroform under a stream of air. A
sample (100 pL) was analyzed by GPC as described in section 2.2.13.
2.2.17 Examination of the uniformity of loading of reaction of PhaCcc primed with sTCoA
and then reacted with HBCoA
In a final volume of 22 pL, PhaCcc (4 pM) was reacted with 500 jIM sTCoA for ~10 s at
30 C and the reaction was chased with 5 or 50 equiv. [1- 1 4C]-HBCoA (85,000 cpm total per
reaction) for 30 s. The reactions were quenched by the addition of 22 pL Laemmli buffer without
reducing agent and the samples were not boiled. Twenty pL of each sample was loaded
immediately onto one half of a 10% SDS-PAGE gel for Coomassie staining and onto the other
half for autoradiography. PhaCcc standards were also loaded to each half of the gel and the gel
was run on ice for 1 h at 150 V. The gel was then carefully cut in half. One half was stained for
15 min in fresh Coomassie stain, then destained for 15 min in fast destain. The gel was rinsed 3 x
5 min in H20, then imaged. The other half was immediately dried and exposed to a low energy
phosphor screen for 12 h and scanned as above. A standard curve of the log(Mw) of four protein
standards and the PhaCcc control was prepared by measuring (in mm) the distance traveled by
each protein standard from the top of the separating gel.
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2.2.18 Analysis of PhaCcc migrating with ["C]-PHB by SDS-PAGE, Western blot and
silver stain analysis
In a final volume of 22 pL, PhaCcc (4 pM) was pre-incubated 30 s at RT with 0 or 500
iM sTCoA, then 50 equiv. of [1- 14C]-HBCoA (85,000 cpm) was added for a final volume of 22
ptL. The reactions were quenched after 10 s with an equal volume of Laemmli buffer without
reducing agent and the reactions were not boiled. Each sample was split into two 10 pL
fractions, which were loaded onto two separate 10% SDS-PAGE gels. The gels were run on ice
for 1 h at 150 V. One gel was stained for 15 min in fresh Coomassie stain, and destained for 15
min in fast destain. The gel was rinsed 3 x 5 min in H20, then imaged. The second gel was rinsed
in for 30 min in 25 mM Tris base pH 8.3, 192 mM glycine, 0.01% SDS (w/v), 15% methanol
(v/v) (Western blot transfer buffer). The protein samples were then wet transferred onto a PVDF
membrane (Immun-Blot, Bio-Rad) in Western transfer buffer for 80 min at 100 V on ice. The
membranes were then blocked in blocking buffer containing 3% milk (w/v) in Tris-acetate-
EDTA (TAE) buffer with 0.1% Tween-20 (v/v). The primary rabbit antibodies for PhaC were
used without further purification. Blots were incubated with anti-PhaC antibody (1:2000 diluted)
in blocking buffer for 1 h at RT, then rinsed 3x for 5 min in 50 mL phosphate buffered saline
(PBS). For the secondary antibody, goat anti-rabbit antibody conjugated with horseradish
peroxidase (Thermo Scientific, Rockford, Ill.) was used at a 1:2000 dilution in blocking buffer.
The blots were incubated in secondary antibody for 1 h at RT, then rinsed 3x for 5 min in 50 mL
PBS. The blots were developed using SuperSignal® West Femto Maximum Sensitivity Substrate
(Thermo Scientific) and imaged using a BioRadChemiDoc XRS imager.
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2.2.19 Cloning, expression and purification of PhaP
For construction of the plasmid pRBhis6phaP, phaP was amplified from -200 ng of
genomic DNA using Taq polymerase and the primers phaPfw/phaPrev (Table 2.1) to introduce a
5' NdeI restriction site and a 3' HindIl restriction site, respectively. The amplified PCR product
was digested with NdeI and HindIll and ligated overnight at RT with pET28a vector digested
with the same restriction enzymes at an insert to vector ratio of 5:1. The ligation reaction was
transformed into E. coli XL10 Gold cells, and colonies were screened by colony PCR using
GoTaq polymerase and the primers phaPfw/phaPrev (Table 2.1). One colony containing insert
was sent for sequencing at the MIT Biopolymers Laboratory.
pRBPhaP was transformed into E coli BL21 (DE3) cells. Cultures (2 L LB supplemented
with 50 tg/mL Km in 6 L flasks) were inoculated with 5 mL saturated overnight culture and
grown at 37 'C to OD6 00 = 0.6. The cultures were then cooled on ice to ~18 'C and expression
was induced by addition of 0.4 mM IPTG. The cells were grown 3-4 h at 18 'C and harvested by
centrifugation. Cells (typically 2 g per L of culture) were flash frozen in liquid nitrogen and
stored at -80 'C until use.
All purification steps were carried out at 4 'C. Cells were resuspended in 3-5 mL/g of wet
cell paste in lysis buffer containing: 50 mM NaH2PO 4, 300 mM NaCl, 10 mM imidazole, pH 8.0.
The cells were lysed by two passes through a French pressure cell at 14,000 psi. The insoluble
cell debris was removed by centrifugation at 17,000 xg for 20 min. The soluble fraction was
equilibrated with 1 mL of Ni-NTA resin (Qiagen) per 5 mL of soluble extract for 30 min by
gentle stirring. The slurry was loaded into a column and the resin allowed to settle, then the
flowthrough was collected by gravity flow. The column was washed with 20 cv of lysis buffer
followed by 10 cv of lysis buffer with 50 mM imidazole. PhaP was eluted with 5 cvs lysis buffer
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containing 250 mM imidazole. The fractions containing PhaP (determined by A280) were
combined and exchanged into 50 mM Tris pH 7.6, 10 mM NaCl and combined with 0.25 mL Q
Sepharose resin per mg of protein. Under these conditions, PhaP does not bind to the column.
The flowthrough containing PhaP was thus collected and concentrated to 200 pM (3 mg/mL).
Subsequent to purification, the His6 affinity tag was removed by treatment with three units of
thrombin (Roche) per mg of PhaP for 12 h at 4 'C. A typical yield was 5 mg PhaP per g of cells.
2.2.20 Determination of oligomeric state of PhaP by SEC
PhaP (100 iL of 180 p.M) was injected onto a Superdex 200 10/300 GL column (M,
range = 10,000-600,000 Da, GE Healthcare, Piscataway, NJ) attached to an Akta Purifier FPLC
(GE Healthcare, Piscataway, NJ) at 4 'C. The eluent was 20 mM Hepes pH 7.5, 200 mM NaCl
and the flow rate was 0.25 mL/min. A280 and A260 was monitored. Retention times were
compared with the retention times of the M, standards described in section 2.2.9.
2.2.21 Effect of PhaP, BSA and hecameg on PhaCcc activity
In a final volume of 170 ptL, the reaction mixture contained: 20 mM Hepes pH 7.5, 20
mM NaCl, 0.76 mM HBCoA, 25 nM PhaCcc and 25 nM to 12.5 piM PhaP or 25 nM BSA. PhaP
or BSA and HBCoA were preincubated at 30 'C for 5 min, then reaction was initiated by
addition of PhaCcc. At various time points, 20 tL aliquots were withdrawn and quenched in 50
ptL 10% TCA. Time points were analyzed as described above using the discontinuous DTNB
assay. A similar reaction was carried out with PhaCccAN. In a final volume of 170 pL, the
reaction mixture contained: 20 mM Hepes pH 7.5, 20 mM NaCl, 500 nM PhaCccAN, 500 nM
untagged-PhaP and 0.76 mM HBCoA.
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2.2.22 Pull-down of PhaP with PhaCcAN and PhaCcc
A final volume of 1 mL contained 20 mM Hepes pH 7.5, 20 mM NaCl, 10 p.M
PhaCccAN or PhaCcc and 10 pM untagged-PhaP and was incubated for 10 min at 4 'C. The
mixture was then incubated with 0.2 mL Ni-NTA agarose resin, loaded into a column (0.5 x 1.2
cm) and the flow through collected. The column was washed with 4 x 1 mL fractions of 20 mM
Hepes pH 7.5, 20 mM NaCl, 10 mM imidazole and the washes collected. The protein was eluted
with four 1 mL fractions of 20 mM Hepes pH 7.5, 20 mM NaCl, 250 mM imidazole. Fifteen pL
of each fraction was combined with 10 pL Laemmli buffer and analyzed by 15% SDS-PAGE. A
control reaction containing only 10 pM untagged-PhaP was carried out identically to assess non-
specific binding to the Ni-NTA resin.
2.2.23 Examination of the effect of PhaP on the uniformity of loading of PhaCcc by SDS-
PAGE and autoradiography
A final volume of 22 p.L contained: PhaCcc (4 pM) pre-incubated 5 min at RT with 4 p.M
PhaP, and the reaction was chased with 5 or 50 equiv. of [1- 1 4C]-HBCoA (85,000 cpm total per
reaction). The reactions were quenched by the addition of 22 p.L Laemmli buffer without
reducing agent and the samples were not boiled. The samples were then processed as described
in section 2.2.16.1.
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2.3 Results
2.3.1 Expression and purification of PhaCcc and PhaCccAN
PhaC from C. crescentus is annotated in the NCBI database as a 65 kDa synthase
(accession number NP_420193) with the start methionine indicated with an arrow in Figure 2.4.
In 2001, however, Qi and coworkers suggested that the start codon had been misassigned and
that PhaC was actually a 73 kDa synthase containing an unusual N-terminal domain rich in
proline, alanine and lysine residues that contains no homology to any protein in the database
(31). This proposal was based on cross-reactivity between antibodies raised to PhaCRe and a 73
kDa band with which it reacted in C. crescentus crude extracts. Alignment of PhaCRe with the
longer PhaC from C. crescentus shows that the two share 37% sequence identity, and that the
majority of the putative N-terminal domain does not align with PhaCRe (Figure 2.4). Secondary
structure prediction programs such as Jpred and CFSSP (Chou and Fassman Secondary Structure
Prediction Server) gave no insight about the N-terminal domain.
To investigate which annotation was correct, we cloned, expressed and purified both
constructs of PhaC. The portion of phaC that encodes the truncated 65 kDa PhaCcc construct
(phaCAN) was cloned into pET28a to encode an N-terminal His6 -tag with no linker, and with
(G4 S)n linkers where n = 1, 2 and 3. Expression and small-scale purification of these proteins
revealed no benefit to having (G4 S)n linkers, and we therefore proceeded with the construct with
no additional linker between the His 6-tag and the N-terminus of PhaC. The full length phaC was
cloned into pET28a to encode a His6-tag with a spacer between the tag and the start of phaC that
encodes the following amino acid sequence: SSGLVPRGSHMAS. The underlined portion of the
linker is a thrombin cleavage site.
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PhaCCc matakaapkarkkaatkadeaataekvaakpkaaaksgkpkakpediqpppqsdsaraap
PhaCRe ------------------------------------------------------------
PhaCCc ppppppgdappfppfesmlspdqlkmvetlsanlaraavtaqgaiaeaalrqadrpaalt
PhaCRe -------------------------------------matgkgaa-astqegksqpfkvt
* ** * *
PhaCCc pdpfhvapaln-----------------------evmtrlaaqpdrlmraqadlfgqymel
PhaCRe pgpfdpatwlewsrqwqgtegnghaaasgipgldalagvkiapaqlgdiqqrymkdfsal
* ** * * * * * *
PhaCCc wqtaarraagedvapvvapaagdkrfndpdwasnpmfdlmkqsyllssnwlngliaevdg
PhaCRe wqamaegkae------atgplhdrrfagdawrtnlpyrfaaafyllnaralteladav-e
** * * * ** * * * * * *
PhaCCc vdpatkrrvefftkmltdafspsnflisnpaalrevvqtqgqslvrgmenfaadlerggg
PhaCRe adaktrqrirfaisqwvdamspanflatnpeaqrlliesggeslragvrnmmedltrgk-
* * * * ** ** *** ** * * * ** * * ** **
PhaCCc qlaisqtdlakfkvgenvatapgkvvyqndilqllqfdpttdtvceipllifppwinkfy
PhaCRe --- isqtdesafevgrnvavtegavvfeneyfqllqykpltdkvharpllmvppcinkyy
***** * ** *** * ** * **** * ** * *** ** *** *
PhaCCc imdlrpensmirwltaqgftvfvaswvnpdqtlaaktfedymvegiydaaqqvmtqcgvd
PhaCRe ildlqpesslvrhvveqghtvflvswrnpdasmagstwddyiehaairaievardisgqd
* ** ** * * ** *** ** *** * * ** * * *
PhaCCc rvnt gycigg :llsvalahmaargdkrinsatffaaqqdf aeagdlllftneewlqsie
PhaCRe kinv gfcvgg :ivs talavlaargehpaasvtllttlldfadtgildvfvdeghvqlre
*** * *** **** * * *** * * * * * *
PhaCCc qqmdqa----ggflpsqsmadtfnalrgndliwsffvsnylmgkeprpfdllfwnadqtr
PhaCRe atlgggagapcallrglelantfsflrpndlvwnyvvdnylkgntpvpfdllfwngdatn
* * ** ** *** * * *** * * ******** * *
PhaCCc mpkalhlfylrnfykdnal-ttgklslggerldlskvkipiyvqsskddhLapyrsvyrg
PhaCRe lpgpwycwylrhtylqnelkvpgkltvcgvpvdlasidvptyiygsredh vpwtaayas
* *** * * * * ** * * * ** ***' *
PhaCCc arafggpvtftmag ghiagvinhpdarkyqhwtnselpadvsewiagahehpgswwphw
PhaCRe tallanklrfvlga ghiagvinppaknkrshwtndalpespqqwlagaiehhgswwpdw
* vI ******* * * **** ** * *** ** ***** *
PhaCCc aawlkarsgdqvpar-dpakgklkpledapgsfvlvksqp
PhaCRe tawlagqagakraapanygnaryraiepapgryvkaka--
** * * * *** * *
Figure 2.4 Alignment of PhaCRe with PhaCcc. The arrow indicates the start Met as annotated
in the database used for PhaCcAN. Red boxes highlight the active site residues. The synthases
share 37% identity.
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Expression of both full-length PhaCcc and PhaCccAN at 37 C resulted in little protein in
the soluble fraction, thus expression of both proteins was carried out at 18 C. Typical growths of
PhaCcc and PhaCccAN yielded 2 g cells per L of culture and typical purifications yielded about
10 mg protein per g of cells in the case of PhaCccAN and 3 mg protein per g cells in the case of
PhaCcc. During purification, a large fraction of both PhaCccAN and PhaCcc was lost in the 50
mM imidazole wash (Figure 2.5A, lane 6 and Figure 2.5B, lane 8); however, in both cases the
specific activity of this fraction was considerably lower than that of the final protein (0.09 vs. 1
U/mg in Table 2.3, 8.5 vs. 50 U/mg in Table 2.4) despite the proteins being comparably pure by
SDS-PAGE. It is possible that the protein that elutes in the 50 mM imidazole wash is aggregated
protein. Furthermore when the 50 mM imidazole wash is assayed, it is diluted into buffer so the
assay contains -2 mM imidazole, which may negatively affect activity. In a single step, both
proteins can be purified to 95% homogeneity as judged by 10% SDS-PAGE (Figure 2.5A, lane 7
and Figure 2.5B, lane 9) and the pure protein is free of DNA contamination. Unlike PhaCRe,
successful purification of both PhaCcc constructs does not require additives such as the detergent
hecameg.
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Figure 2.5 Typical 10% SDS-PAGE purification gel of PhaCccAN and PhaCcc. A)
Purification gel of PhaCcAN. Lane 1, M, standards. Lane 2, soluble cell-free extract. Lane 3,
insoluble cell-free extract. Lane 4, Ni-NTA agarose flowthrough. Lane 5, 10 mM imidazole
wash. Lane 6, 50 mM imidazole wash. Lane 7, final purified PhaCcAN, eluted with 250 mM
imidazole. B) Purification gel of PhaCcc. Lane 1, M. standards. Lane 2, whole cell pre-induction
sample. Lane 3, whole cell post-induction sample. Lane 4, soluble cell-free extract. Lane 5,
insoluble cell-free extract. Lane 6, Ni-NTA agarose flowthrough. Lane 7, 10 mM imidazole
wash. Lane 8, 50 mM imidazole wash. Lane 9, final purified PhaCcc, eluted with 250 mM
imidazole.
Table 2.3 Purification of truncated PhaCccAN.
Purification step Volume Protein Activity
(mL) (mg) (Ua/mg) Total units % yield
Crude soluble extract 8 87 0.3 24 100
Crude insoluble extract 6.5 93 0.09 8.1 n/a
Ni-NTA flowthrough 14 63 0.1 6.3 26
10 mM imidazole wash 42.5 6.7 0.04 0.3 1.2
50 mM imidazole wash 25 5.6 0.09 0.5 2.1
Pure sample 0.75 14 1 14 60
aOne unit of activity is one p.mol CoA released per min.
b% yield is calculated based on total units in crude soluble extract.
155
75 kDa
36 kDa
B)
Table 2.4 Purification of full length PhaCcc.
Purification step Volume Protein Activity
(mL) (mg) (Ua/mg) Total units % yield"
Crude soluble extract 11 180 4.9 880 100
Crude insoluble extract 30 18 14 250 n/a
Ni-NTA flowthrough 10 120 1.4 170 20
10 mM imidazole wash 40 28 0.9 25 2.8
50 mM imidazole wash 24 12 8.5 100 11
Pure sample 1.0 11 50 550 63
aOne unit of activity is one pmol CoA released per min.
b% yield is calculated based on total units in crude soluble extract.
2.3.2 PhaCc, has 50-fold higher activity than PhaCccAN
A DTNB assay is used to measure the activity of all PhaCs by monitoring CoA release.
Incubation of PhaCccAN (500 nM) with HBCoA gives the results shown in Figure 2.6A. These
studies reveal sigmoidal kinetics, with a lag phase in CoA release followed by a roughly linear
phase in CoA release. The time points from 2.5 to 10 min in Figure 2.6A were used to measure
the specific activity of 0.5-1.5 U/mg at 30 *C. A similar lag phase has been reported for PhaCRe
(3, 6). Full length PhaCcc was assayed using the same protocol and the results are shown in
Figure 2.6B. The specific activity is -50 U/mg. As can be seen in the inset in Figure 2.6B, there
is no clear linear portion of the curve, so specific activities are determined by fitting the assay
data at < 2 min to a linear function. The difference in activity between the 73 kDa and 65 kDa
PhaC suggests that the gene has been misannotated and that the full length protein is 73 kDa.
Support for this conclusion is provided by Western blots using antibodies to his-tagged
PhaCccAN, which identified a band in crude extracts of C. crescentus that migrates at -75 kDa
(section 3.3.4 of Chapter 3).
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Figure 2.6 Time course of CoA release catalyzed by PhaCccAN and PhaCcc. A) The assay
was carried out at 30 'C and contained 0.76 mM HBCoA and 500 nM PhaCcAN. The inset is an
expansion of the first 5 min. Data are fit to Equation 2.1 in section 2.2.5. B) The reaction mixture
contained 25 nM PhaCcc and 0.76 mM HBCoA. The inset is an expansion of the first 4 min. The
data are fit to Equation 2.1. Assays were done in triplicate and the error bars are standard
deviation from the mean.
Notably, full-length PhaCcc has no lag phase in activity. The origin of the lag phase in
PhaCccAN is not understood, although we have previously proposed with PhaCRe that it might be
associated with a requirement for dimerization and/or priming of the synthase for
polymerization. Consistent with the lack of requirement for hecameg or another detergent in
purification buffers, the presence of 0.05% hecameg in the assay buffer had no effect on the
activity of PhaCcc (Figure 2.7).
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Figure 2.7 Effect of 0.05% hecameg on PhaCcc activity. A) Time course of CoA release from
assays containing 25 nM PhaCcc and 0% (e, blue) or 0.05% (o, red) hecameg. The data are fit to
Equation 2.1.
2.3.3 Full length PhaCcc is stable during storage at 4 C and -80 C
Because the full length PhaCcc appears to be the relevant synthase in vivo, we went on to
further characterize its kinetics. In order to assess the stability of PhaCcc activity upon storage,
aliquots were stored with and without 20% glycerol at 4 C and -80 C, and assayed after one
week. Even after one week at 4 *C, the activity remained the same as the freshly purified sample
(Figure 2.8A). The presence of glycerol did not have an appreciable effect on the activity upon
storage at 4 C or -80 C (Figure 2.8B). Therefore, PhaCcc was stored in 20 mM Hepes pH 7.5,
200 mM NaCl at -80 C for prolonged storage.
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Figure 2.8 Time course of CoA release from PhaCc, stored at 4 'C and -80 'C. The reactions
were carried out at 30 'C and contained 0.76 mM HBCoA. A) Assays of PhaCc (25 nM) that
was freshly purified (o, blue), or stored at 4 'C for 6 days in the absence (E, red) and presence (A,
green) of 20% glycerol. B) Assays of PhaCcc (25 nM) that was freshly purified (0, blue), or stored
for 6 days at -80 'C in the absence (o, cyan) and presence (x, magenta) of 20% glycerol. All
assays are fit to Equation 2.3. The insets show the first 2 min of CoA release fit to a linear
function, from which the specific activity is calculated.
2.3.4 Kinetic parameters of full-length PhaCcc
The kinetic parameters for full-length PhaCcc (designated PhaCcc subsequently) were
next determined in 20 mM Hepes buffer, pH 7.5, and the results shown in Figure 2.9A fit to the
Michaelis-Menten equation, and in Figure 2.9B fit to the Hill equation. Though both equations
provide good fits, the Hill equation provides a slightly better fit (R2 = 0.96 for the Michaelis-
Menten equation vs. R2 = 0.99 for the Hill equation), suggesting that the kinetics of full-length
PhaCc, exhibit some cooperativity. The Michaelis-Menten equation gives a kcat of 84 s- , a Km of
0.35 mM and a kcat/KM 2.6 x 10' M~'s~1. The Hill equation gives a kcat of 75 s~1, a KM of 0.29 mM
and a kcat/KM of 2.6 x 105 M~'s~1. The Hill coefficient n is 1.5. Cooperativity as a function of
substrate concentration has also recently been reported with the class I synthase from Aeromonas
caviae (PhaCAC), and similar analysis gave a Hill coefficient of 2.6 (12). At HBCoA
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concentrations of 0.75-1 mM PhaCcc has nearly maximum activity, and subsequent assays were
performed at these concentrations.
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Figure 2.9 Specific activity of PhaCcc as a function of [HBCoAj. The reactions were carried
out at 30 'C and contained 50 nM PhaCcc and 0.05-6 mM HBCoA. The data were fit to A) the
Michaelis-Menten equation (Equation 2.2) and B) the Hill equation (Equation 2.3). The error
bars represent the standard deviation from the mean of at least three assays.
2.3.5 Characterization of active site mutants of PhaCcc reveals C406, D562 and H590 are
involved in catalysis
Previous work from our lab identified the active site residues C319, D480 and H508 in
PhaCRe and their involvement in catalysis (3, 4, 6). C319 is located within the "lipase box" motif
(G-X-C-X-G) and has been shown in PhaCRe to be involved in covalent catalysis (3, 6). H508 is
proposed to generate the active thiolate by deprotonating C319, and D480 is thought to be
involved in activating the hydroxyl group of the incoming HBCoA monomer for nucleophilic
attack on the acylated enzyme (4). The sequence alignment of PhaCRe with PhaCcc shows the
corresponding residues to be C406, D562 and H590 in PhaCcc (Figure 2.4, red boxes). The
active site mutants PhaCcc-C406A, -C406S and -D562N were therefore prepared to determine
whether these residues were also important to PhaCcc activity. The mutants were expressed and
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purified identically to wt PhaCcc and assayed for activity (Figure 2.10 and Table 2.5). PhaCc,-
C406S and -D562N have specific activities of 0.002 and 0.006 U/mg, respectively. PhaCcc-
C406A and PhaCcc-H590Q had activities of 0.0002 U/mg, which is the lower limit of detection
for the assay. As expected, the C406A mutant is inactive, consistent with its involvement in
covalent catalysis.
1.0-
0.8-
0.6-
0.4-
0.2-
0.0-
0 5 10 15 20 25 30
Time (min)
Figure 2.10 Time course of CoA release catalyzed by mutant PhaCces. The reactions were
carried out at 30 'C and contained 1 mM HBCoA and 100 pM PhaCcc-D562N (9), 100 pM
PhaCcc-C406S (o), 50 p.M PhaCc,-C406A (A), and 50 pM PhaCcc-H590Q (K).The data for
PhaCcc-D562N and PhaCc,-C406S are fit to Equation 2.3. Error bars represent the standard
deviation from the mean of three experiments.
Table 2.5 Activities of mutants of full length PhaCc, and PhaCRe.
PhaCcc PhaCRe a
Construct SA (U/mg) % of wt SA (U/mg) % of wt
wt 50 100 20 100
C406Ab 0.0002 0.0004 <0.0001 <0.0005
C406S 0.002 0.004 n/ac n/a
D562N 0.006 0.012 0.0008 0.004
H590Q 0.0002 0.0004 n/a n/a
aValues taken from reference (4), in which the relative specific activities were measured.
bNumbering is from PhaCc,
Cnot available in reference
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2.3.6 Size exclusion chromatography (SEC) suggests that PhaCcc resides in predominantly
a single oligomeric state
PhaCRe is a mixture of monomeric and dimeric forms in solution with a KD of ~4 pM.
The active form is predominantly the dimer of PhaCs, which synthesizes a single PHB chain (3,
10). In the case of PhaCAc the equilibrium shifts towards dimeric state upon incubation with
HBCoA (12). The class III synthase PhaECA, is a mixture of dimers and tetramers of PhaEC,
both of which are active. In this system as well the PhaC appears to make a single PHB chain
per dimer of PhaECs (5). The unusual stoichiometry of PHB chains/PhaC has important
mechanistic implications. We therefore wanted to determine if the oligomeric state of PhaCcc
and the number of PHB chains per PhaCcc fit this model. SEC as 4 'C was used to examine its
MW, and the elution profile and resulting standard curve are shown in Figure 2.11.
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Figure 2.11 Size exclusion chromatography standards. A) A 2 80 trace of protein standards. Vo,
void volume. T, thyroglobulin. F, ferritin. A, aldolase. C, conalbumin. 0, ovalbumin. B)
Standard curve prepared plotting the gel phase distribution coefficient (Kav) of each standard vs.
its logM,.
To examine the quaternary structure of PhaCcc, (100 p.L of 1, 25 or 100 jM) was
analyzed and the retention time of the major peak at each concentration is ~43.8 min (Figure
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2.12). Using the standard curve, the molecular weight is 240 kDa based on the standard curve.
The subunit molecular weight of PhaCc, is 75 kDa, and if the protein is assumed to be globular it
may be a trimeric. At 1 p.M and 25 tM, a second shoulder peak is observed that elutes with a
retention time of between 49-50 min. The M, of this peak according to the standard curve is
-130 kDa, which would be consistent with a dimer of PhaCs.
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Figure 2.12 Representative SEC traces of PhaCcc. Samples (100 pL) were injected onto a GE
Healthcare Superdex 200 10/300 GL column at 4 'C and eluted at 0.25 mL/min with 50 mM
KH2PO 4 , pH 7.5, 150 mM NaCl. A) A2 80 trace of 1 pM (blue, right Y-axis) and 25 piM (red, left
Y-axis) PhaCcc. B) A2 80 trace of 25 pM (red) (right Y-axis) and 100 pM (green) (left Y-axis)
PhaCcc. In both panels, the traces at each [PhaC] are plotted on two Y-axes that are adjusted for
scale.
We also analyzed the quaternary structure of PhaCccAN to determine whether the N-
terminal domain has an effect on oligomerization. At a concentration of 50 pM, PhaCccAN
elutes as three peaks (Figure 2.13A, black trace). The predominant peak elutes with a retention
time of ~49 min and has a M, of 165 kDa based on the standard curve. A dimer has a calculated
M, of 134 kDa. A smaller feature (53 min) has a M, of 90 kDa and is likely a monomer of
PhaccAN, which has a calculated M, of 67 kDa. Finally a third small feature elutes at ~40.6 min
and has a M, of 370 kDa. This peak could correspond to either a pentamer (P) of PhaCs (M, of
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335 kDa) or a hexamer (H) of PhaCs (M, = 400 kDa). The distribution of oligomeric species
from 1-25 pM was also examined (Figure 2.13B). Analysis of peak heights suggests that the
dimer to monomer ratio does not change with concentration. Together the results suggest that
PhaCceAN exists predominantly as a dimer in solution. Taking into account structural modeling
efforts with PhaCcc presented in Chapter 4 that model the N-terminal 8 kDa as a separate domain
from the rest of the protein, it is possible that like PhaCccAN, PhaCcc is also a mixture of dimeric
and monomeric PhaCs, but has an unusual shape due to the N-terminal domain.
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Figure 2.13 Representative SEC traces of PhaCcAN. Samples (100 pL) were injected onto a
GE Healthcare Superdex 200 10/300 GL column at 4 'C and eluted at 0.25 mL/min with 20 mM
Hepes, pH 7.5, 200 mM NaCl. A280 was monitored. A) A280 traces of 50 pM (black), 25 pM
(red), and 10 pM (blue) PhaCccAN. B) A280 traces ofl0 pM (blue), 5 ptM (magenta) and 1 pM
(green) PhaCccAN.
Because the peak areas were lower than expected given the concentrations of PhaCcc
injected onto the column, the recovery of PhaCcc from the column was measured. A second
sample (100 piL of 100 pM, 0.75 mg) was injected and the protein peak was collected,
concentrated and the amount of PhaCcc recovered was measured by A280. Of the 0.75 mg of
PhaCcc injected onto the column, ~0.3 mg was recovered, suggesting that more than half of the
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PhaCc, was precipitating. We do not observe aggregate protein eluting in the void volume (28-29
min). With prolonged use the column back pressure increased, suggesting that the protein was
precipitated on the filter at the top of the column.
2.3.7 Reaction of PhaCcc with sTCoA: analysis of CoA release suggests one sT per PhaC
monomer
SEC suggested that the oligomeric state of PhaCcc was distinct from that of PhaCRe,
which is a mixture of monomer and dimer species in solution. Furthermore, PhaCc, does not
require hecameg for purification and does not have a lag phase in activity. The stoichiometry of
PHB synthesis was previously shown to be one PHB chain per dimer for both PhaCRe and
PhaECAv (3-5, 32). In the case of PhaCRe, incubation with sTCoA prior to addition of HBCoA
shortened the lag phase and increased the specific activity of the enzyme (3). Furthermore the
acylated enzyme is stable to hydrolysis, allowing its isolation and quantitation of sT bound.
To examine the similarities and differences with other PhaCs, we quantitated CoA release
by incubation of PhaCcc with 10 equiv. sTCoA. The results are shown in Figure 2.14. These
experiments showed a burst of CoA release corresponding to ~1 per monomer of PhaCcc. This
stoichiometry is distinct from previous observations, and suggested that PhaCcc can be uniformly
loaded, which could facilitate studies of polymer elongation. The burst of CoA release is
followed by continued slow CoA release at a rate of 0.2 min~1, which proceeds at 1/24,000 of the
turnover rate (Figure 2.14).
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Figure 2.14 Reaction of PhaCcc with sTCoA monitored by DTNB assay. The reaction
contained 50 ptM PhaCcc and 500 ptM sTCoA and was carried out at 30 'C. Error bars represent
the standard deviation from the mean of three experiments. Equivalents of CoA released are
given per PhaC monomer. CoA release occurs from 10 s to 5 min at 0.2 min- .
2.3.8 Sephadex G50 analysis of PhaCcc reacted with [3H]-sTCoA reveals 0.2 equiv. of [3HJ-
sT per PhaC
We next determined the amount of acylated enzyme that could be isolated by gel
filtration at 4 'C. If the rate of CoA release measured in the previous experiment is indicative of
the rate of hydrolysis of the acylated enzyme, then we would predict that the acylated enzyme
has a half-life of 3.5 min at 30 'C. Assuming that a decrease in temperature of 10 'C results in a
2-fold decrease in the rate of hydrolysis, we would predict that the half-life would be ~15 min at
4 'C. This analysis suggests that PhaCcc acylated with one equiv. of sT could be readily isolated.
To investigate whether this was the case, PhaCcc (50 ptM) was incubated with 10 equiv. [3H]-
sTCoA for 30 s at 30 'C, then placed on a Sephadex G50 column at 4 'C to separate [3 H]-sT-
PhaCc, from unreacted [3H]-sTCoA. The eluent was collected in fractions and analyzed for
radioactivity to examine the stoichiometry of labeling (Figure 2.15). The recovery of
radioactivity was 95%. PhaCcc eluted at 6.3 min and was associated with only 0.19 equiv. of
[3H]-sT. The remaining radioactivity was associated with the peak that eluted after ~10 min,
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which includes unreacted [3H]-sTCoA, [3H]-sT acid and other small molecule products. An
identical control reaction containing PhaCcc-C406A was carried out to determine whether the
active site Cys was essential for observing association of [3H]-sT with the synthase. The
recovery of radioactivity was 94% and no radioactivity was associated with the synthase (data
not shown), suggesting that wt PhaCcc is covalently labeled with [3H]-sT.
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Figure 2.15 Acylation of PhaCcc with [3H]-sTCoA followed by separation by Sephadex G50
chromatography. The reaction contained 50 pM PhaCcc and 500 pLM [3H]-sTCoA (specific
activity = 1300 cpm/nmol). A) Elution profile showing A2 8 0 (e) and A2 60 (c), indicating PhaCcc
(fractions 65-100) and unreacted sTCoA and free CoA (fractions 100-200). B) Expansion of A280
elution profile (*) between fractions 40-120, overlaid with cpm measured for each fraction (A).
In an effort to stabilize the acylated enzyme, the same experiment was carried out except
that sT-PhaCcc was eluted from the Sephadex G50 column equilibrated in 20 mM KH 2PO 4 , pH
4.7, 2 M urea. This buffer was chosen because thioester linkages are susceptible to hydrolysis
under basic conditions, but moderately stable to hydrolysis between pH 2-6 (33). The urea was
added to partially denature PhaCcc to limit enzyme-catalyzed hydrolysis. The recovery of
radioactivity was 90%. PhaCcc eluted after ~8.3 min and the fractions that contained synthase
were analyzed by scintillation counting, revealing only 0.11 equiv. [3H]-sT associated with
PhaCcc (Figure 2.16). This result was unanticipated given that the thioester should be more
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stable to hydrolysis under mildly acidic conditions. The remaining radioactivity was found in
small molecules and eluted after 17 min.
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Figure 2.16 Reaction of PhaCc, with [3H]-sTCoA followed by separation by Sephadex G50
chromatography. The reaction was carried out at 30 'C and contained 50 p.M PhaCcc and 500
p.M [3H]-sTCoA. The specific activity of the [3H]-sTCoA was 1300 cpm/nmol. After -10 s of
incubation the reaction was placed on a Sephadex G50 column at 4 'C and eluted with 20 mM
KH2PO 4, pH 4.7, 2 M urea. A) The elution profile showing A2 8 0 (e) and A2 60 (o), indicating
PhaCcc (fractions 20-40) and [3H]-sTCoA (fractions 45-100). B) Expansion of the peak
containing PhaCcc, with A280 (e) and cpm (A) overlaid.
Finally, we investigated whether reaction of [3H]-sT-PhaCcc with 5 equiv. HBCoA would
stabilize the acylation by extending the PHB chain. The hypothesis was that a longer chain could
potentially close the active site, slowing the rate of hydrolysis. For these experiments, the
concentration of PhaCcc was higher than in previous experiments to ensure that the enzyme was
saturated with HBCoA. PhaCcc (200 pM) was reacted with 500 pM [3H]-sTCoA for -10 s at 30
0C, followed by addition of 5 equiv. HBCoA and the mixture was placed on a Sephadex G50
column at 4 'C after ~10 s of reaction. The column was eluted in 20 mM Hepes pH 7.5, 200 mM
NaCl (Figure 2.17). The recovery of radioactivity from the column was 92%. PhaCcc eluted at
7.5 min and the protein-containing fractions were analyzed by scintillation counting. Only 0.04
equiv. [3H]-sT per monomer of PhaCcc were associated with the synthase, ~5-fold less than when
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HBCoA is omitted. Again, this result was unexpected and suggested that the reaction of PhaCcc
with [3H]-sTCoA might be more complicated than anticipated, and that rapid hydrolysis of the
acylated enzyme is not the reason for our inability to isolate PhaCcc labeled with 1 equiv. [3H]-
sT.
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Figure 2.17 Elution profile of [3H]-sT-PhaCcc reacted with 5 equiv. of HBCoA. PhaCcc (200
pM) was reacted with 500 pM sTCoA, and chased with 1 mM HBCoA. A) Elution profile
showing A2 8 0 (e) and A2 60 (0), indicating PhaCc, (fractions 40-60) and [3H]-sTCoA or [3H]-
small molecules (fractions 70-150). B) A2 80 elution profile (0) overlaid with cpm measured for
each fraction (A).
2.3.9 sTCoA undergoes chemistry subsequent to acylation of PhaCc,
Our inability to isolate uniformly acylated [3H]-PhaCcc in spite of attempts to stabilize
the acylated enzyme by reducing the temperature and pH, and by extending the acylated chain,
suggested that another factor besides instability of the acylated enzyme was thwarting our
efforts. To determine whether additional reaction(s) besides acylation to produce CoA and sT-
PhaCcc occurred, the small molecule products of this reaction were isolated and examined by
HPLC and their retention times compared to a set of authentic standards, which included CoA,
HBCoA, sTCoA and the terminally-saturated tetramer CoA, sT 4CoA. PhaCcc (25 nmol) was
incubated with [3H]-sTCoA (250 nmol, specific activity = 146 cpm/nmol) and aliquots of the
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reaction were quenched with 10% TCA at time points from 10 s to 5 min. Each aliquot was
centrifuged to pellet the precipitated protein and the supernatant was removed. The protein pellet
was washed once with H20 and the wash was added to the supernatant. The radioactivity
associated with the precipitated protein was analyzed by scintillation counting from 10 s to 5
min, revealing changes with time, with a maximum of 0.9 equiv. [3H]-sT-PhaCcc at 0.75 min
(Table 2.6).
Table 2.6 Equivalents of [3H]-sT associated with PhaCcc following incubation for the
indicated lengths of time.
Time (min) Equiv. [3H]-sT per PhaC
0.16 0.73
0.5 0.70
0.75 0.88
1 0.69
2 0.81
3 0.61
5 0.56
To examine the small molecule products, the pH of the supernatant/wash was adjusted to
pH ~5 by addition of 1 M ice-cold NaOH with rapid mixing to avoid local high concentrations of
base. The samples were analyzed by HPLC and fractions were collected. The recovery of
radioactivity for each time point was 95-100%. As a control, [3H]-sTCoA was injected onto the
HPLC and fractions were collected and analyzed by scintillation counting to detect additional
radioactive species present as breakdown products due to storage of the starting material (Figure
2.18A). The results show that a radioactive species lacking A260 that migrates with a retention
time of 37 min is present in the starting material.
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Figure 2.18 HPLC traces of PhaCcc incubated with [3H]-sTCoA. A) Control of [3H]-sTCoA
prior to reaction with PhaCc. The peak with an elution time of 47 min is [3H]-sTCoA. An
additional radioactive peak containing no A260 elutes at -37 min. B) Small molecule products of
PhaCcc incubated with [3H]-sTCoA. The reaction was carried out at 30 C and contained 50 pM
PhaCc, and 500 pM [3H]-sTCoA (specific activity 146 cpm/nmol). Aliquots of the reaction were
analyzed after 10 s (red), 45 s (green) and 5 min (blue) incubation. C) Expansion of small peaks
with later elution times from panel B. The species in panels B and C are labeled as they are
referred to in the text.
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Table 2.7 Amounts (nmol) of small molecule species produced by the reaction of PhaCcc
with [3Hj-sTCoA from 10 s to 5 mina.
Time CoAb sDCoAb,c sTCoAb sT 4CoAb,c 56-65
point 15 min' 18 min 31 min' 43 min 47 min 52 minb 54 min min'
0 0 0 0 0 250 0 0 0
0.16 13 25 40 7 179 7 6 0
0.5 17 - - 18 - 10 14 4
0.75 22 35 25 26 105 11 13 8
1 25 38 47 28 75 11 14 8
2 25 63 31 54 49 15 12 20
3 30 74 28 57 29 18 7 26
5 27 99 17 55 16 17 4 32
aThe amounts were determined on individual aliquots, but are reported normalized to the entire
reaction. The A2 60 trace for the 0.5 min time point was not obtained due to a malfunction with
(likely a bubble inside of) the diode array detector. Therefore the amounts of CoA, the species at
31 min, sTCoA and sT 4CoA (all determined from A260) are not given.
bAmount was determined by A2 60.
cAmount was determined by radioactivity.
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Figure 2.19 Changes in the amounts of the species in Table 2.7 as the reaction progresses.
A) Changes in the amounts of the species at 15 min (A), 54 min (sT 4 CoA) (0) and 56-65 min
(X). B) Changes in the amounts of the species at 31 min (v), 37 min (o) and 52 min (o).
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Figure 2.18B shows overlays of the A260 trace and radioactivity of the time points taken
after 10 s, 45 s and 5 min incubation of [3H]-sTCoA with PhaCc, with the major products
labeled as they will be referred to in this section. The amounts of each species, shown in Table
2.7, were determined by radioactivity and/or A260 using a standard curve prepared from HBCoA
(5-250 nmol, 50 jiM-2.5 mM). Figure 2.19 shows the changes in concentration of some of these
species. After 10 s, the amount of CoA (elution time 18 min), determined by A2 60, was 24.8
nmol, equal to one equiv. per PhaC. This result suggests PhaCcc reacts with [3H]-sTCoA to
produce a burst of CoA and [3H]-sT-PhaC, and is consistent with the DTNB assays of PhaCcc
reacted with sTCoA, which also indicate a burst of one equiv. CoA release after 10 s (section
2.3.8). Additional CoA release occurs from 10 s to 5 min with a kosb of 0.6 min-' (Figure 2.20A),
similar to the rate constant measured by the DTNB assay (0.2 min'). The peak with a retention
time of 47 min is [3H]-sTCoA. The amount of [3H]-sTCoA decreases from 10 s to 5 min at a rate
of 1.4 min-' (Figure 2.20B). It should be noted that after the 45 s time point, the amount of [3H]-
sTCoA determined by radioactivity no longer correlated with that calculated by A260, as the
former consistently indicated higher amounts of [3H]-sTCoA than the latter. This result was
interpreted to indicate that one or more species (possibly [3H]-HBn acid) was formed that co-
eluted with [3H]-sTCoA. Therefore, the concentration of [3H]-sTCoA was determined by A2 60,
providing the results shown in Figure 2.20B.
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Figure 2.20 Changes in the amount of A) CoA and B) [3H-sTCoA during incubation of
PhaCcc with [3H]-sTCoA. In a final volume of 500 ptL, the reaction contained 50 pM PhaCcc
(25 nmol) and 500 IM [3H]-sTCoA (250 nmol). The amount of CoA and [3H]-sTCoA was
determined by comparison of the A260 peak area to a standard curve prepared from HBCoA. The
data for [3H]-sTCoA consumption were fit to Equation 2.5 to give a rate of disappearance of 1.4
min-.
After 10 s, quantitation of [3H]-sTCoA by A260 and radioactivity indicates that -180 nmol
unreacted [3H]-sTCoA remains of the initial 250 nmol. Considering that only 25 nmol CoA was
released in the burst, this result suggested that an additional -45 nmol [3H]-sTCoA has been
consumed in reactions other than the acylation reaction that produces CoA and [3H]-sT-PhaCcc.
One species that migrates with a retention time of 31 min has A260 but contains no radioactivity,
and changes little in the course of the reaction (Figure 2.19B). Radioactive species migrating
with retention times of 15 min, 37 min, 43 min, 52 min and 54 min are also formed. The peak at
37 min is present in the control. The peak at 43 min represents the major small molecule product
and increases over the course of the reaction.
To identify this major product (43 min), the identical reaction was carried out in which
PhaCcc and unlabeled sTCoA were incubated 5 min at 30 'C. The small molecules were
analyzed by HPLC and the peak at 43 min was collected, lyophilized to dryness and analyzed by
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MALDI-TOF. The MALDI-TOF (positive mode) data revealed that the sample had a m/z of
924.8, consistent with the expected m/z of a singly protonated saturated dimer CoA (sDCoA)
(Figure 2.21A and B). Analysis of the amount of sDCoA by radioactivity and A2 60 yields the
same results and revealed that sDCoA is produced with a rate constant of 1 min~1 and that its
production stops after 2 min (Figure 2.21C). The rate constant measured is considerably slower
than the turnover number of the enzyme of 4800 min-'; howeve, it is similar to the rate constant
for the consumption of sTCoA.
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Figure 2.21 MALDI-TOF analysis and rate of formation of sTCoA. A) MALDI-TOF of
sDCoA (elution time 43 min) in positive mode. The calculated M, of is 923.71, and the major
peak has a m/z of 924.75, consistent with [M+H]+. B) Structure of sDCoA. C) Rate of formation
of sDCoA. The amount of sDCoA present in the reaction was determined by both A260 and
radioactivity, giving consistent results. The data were fit to Equation 2.6, giving kobs of 1 min-1
for the formation of sDCoA. This reaction was carried out once.
One mechanism that could account for the formation of sDCoA and for the slow rate of
CoA release is shown in Scheme 2.1. In this mechanism, PhaCcc is acylated with [3H]-sT and
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CoA remains non-covalently bound. This species is referred to as [3H]-sT-PhaC-CoA. CoA can
dissociate from this species, leaving [3H]-sT-PhaC. The rate constant measured for this process is
0.2-0.6 min~1, a range provided by the results of the DTNB assays discussed in section 2.3.8 and
the experiments described in this section. Alternatively, [3H]-sT-PhaC-CoA can undergo a
reaction in which the thiolate of CoA attacks the indicated ester of sT to generate HB-PhaC and
sDCoA. This reaction occurs with a rate constant of 1 min, measured from the rate of formation
of sDCoA. It should be noted that, in order for the measured rates to be indicative of CoA release
and sDCoA formation, the rates of hydrolysis of HB-PhaC and [3H]-sT-PhaC would have to be
faster than 1 min-1 , as these steps would be necessary to free up the enzyme active site for
reaction with additional [3H]-sTCoA.
The fact that PhaCcc can catalyze thiolysis via CoA to generate sDCoA and putative HB-
PhaC may be suggestive of a possible mechanism of termination. While it must be cautioned that
sTCoA is not the natural substrate and that the reactions observed could be off pathway, previous
studies have suggested that the thiol N-acetylcysteamine can serve as chain transfer (or chain
termination) agent in vitro (25). Thus the kobs for the formation of sDCoA of 1 min may be
indicative of the rate constant for chain termination. Taking into account the rate of
polymerization of 4800 min-1, then one would expect that a PhaCcc molecule would on average
synthesize a PHB chain of -5000 HB units before a termination event would occur. This would
correspond to PHB of a M, of 400-450 kDa. This M, is similar to that of PHB extracted from C.
crescentus, which has a M, of 350-400 kDa (Chapter 3).
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Scheme 2.1 Proposed mechanism for formation of [3H]-sDCoA. PhaCc, first reacts with [3H]-
sTCoA to form [3H]-sT-PhaC*CoA, where CoA remains bound to the enzyme active site. This
species can then either lose CoA (red pathway), or CoA can attack the indicated ester bond to
form [3H]-sDCoA and HB-PhaC (blue pathway).
We next wished to conclusively identify the radioactive species that has a retention time
of 54 min, as its migration was consistent with an sT4CoA standard. A very small peak with the
same elution time is present in the control (Figure 2.18A), but contains no radioactivity. This
peak was collected and submitted for MALDI-TOF analysis, which confirmed that it contains
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1 min 1
sT 4CoA, in addition to two other peaks which we could not identify based on their m/z values. In
negative mode analysis, sT4CoA has a predicted m/z of 1094.89 for the singly deprotonated
species (Figure 2.22). It accumulates to ~13 nmol, then declines as the reaction progresses.
sT 4CoA is likely yet another product of a side reaction of PhaCc, with sTCoA. A mechanism
which could account for this product is shown in Scheme 2.2, which involves attack by PhaCcc
at an internal oxoester rather than the thioester of sTCoA to form HBCoA and sD-PhaCcc. The
formation of HBCoA in this model is necessary to account for the amount of sT 4CoA formed, as
there is not sufficient contaminating HBCoA in the [3H]-sTCoA stock to account for sT 4 CoA
formed via chain elongation. HBCoA could dissociate from the enzyme and attack the thioester
of sT-PhaCcc to elongate the chain by one unit. Several additional species form as the reaction
progresses. These species have later elution times (after 54 min) and appear in small amounts,
and most contain radioactivity but have no detectable A260. These species may be [3H]-HBn
acids. In summary, the reaction of PhaCcc is more complicated than originally anticipated and
involves the formation of several products in addition to the predicted sT-PhaCcc species.
178
809.161
1250
1000
U~750-
500 1095.344
944682
250
0-
600 700 800 900 1000 1100
m/z
Figure 2.22 Negative mode MALDI-TOF spectrum of the peak with an elution time of -54
min. sT 4CoA has a predicted Mw of 1095.9. The sample contained a peak with a m/z of 1095.3,
consistent with the predicted m/z of the [M-H]~ species of sT 4CoA (1094.9).
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Step 1
0 0 0 3H
CoAS
0 OH
CoASJ<
O 0 3H
Step 2
O 0 0 3 H
O OH
CoAS
0 0 0 0 3 H
-- S- + CoAS 0 O O
Scheme 2.2 Possible mechanism for the formation of [3H]-sT 4CoA. In the first step, HBCoA
is formed from the reaction of PhaCcc with [3H]-sTCoA in which the Cys attacks at the indicated
oxoester rather than the CoA thioester. HBCoA then dissociates from the active site. In the
second step, HBCoA formed from Step 1 attacks the thioester of [3H]-sT-PhaCcc as indicated to
form [3H]-sT4CoA.
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2.3.10 GPC analysis of the reaction products of PhaCcc and sT-PhaCcc incubated with [1-
'
4C]-HBCoA: sTCoA is chemically competent for polymerization
To investigate the Mw of PHB produced in vitro and determine whether it is consistent
with the M, predicted by a rate of chain termination of 1 min-1, PHB produced in vitro was
extracted into chloroform for analysis by GPC. Given the low refractive index of PHB and the
experimental limitations on the amount of polymer that can be generated in vitro, it is necessary
to prepare PHB from radiolabeled substrates in order to monitor its elution. These experiments
also allowed us to examine the chemical competence of [3H]-sT to produce [3H]-PHB.
Three types of reactions were carried out. In the first reaction, unprimed PhaCcc (50 nM)
was reacted 30 min with 1 mM [1- 14C]-HBCoA and the PHB was extracted into chloroform for
GPC analysis. [1- 14C]-HBCoA is typically prepared by diluting [1-1 4 C]-(R/S)-HBCoA with
unlabeled (R)-HBCoA. As a result, 50% of the radioactivity in a given sample is (S)-HBCoA.
Therefore, 50% of the total radioactivity present in an experiment should not be incorporated
into PHB due to very low concentrations and that (S)-HBCoA has previously been shown not to
be a substrate for PhaCs. The PHB eluted from the GPC column with a retention time of 12.7
min (Figure 2.23). Using the adjusted calibration curve prepared as described in section 3.2.11
(Chapter 3), the Mw and PDI of the polymer were calculated to be 680 kDa (~8,000 HBs) with a
PDI of 12 (Table 2.8). Small molecules eluted between 21 and 23 min. For this reaction, the total
recovery of [1- 4 C]-(R)-HBCoA was ~100% (Table A2.1 in the Appendix to this Chapter). A
small amount of [1-1 4 C]-(S)-HBCoA was apparently also incorporated into polymer (~40 pmol)
(Table A2.2). However, assays of PhaCcc with racemic (R/S)-HBCoA suggested that (S)-HBCoA
is not a substrate for PhaCcc (not shown). One possible explanation for the incorporation of (S)-
HBCoA into polymer is that it undergoes non-enzymatic transesterification with the polymer
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during the extraction of polymer into chloroform. Alternatively, in our assays, we may not have
been able to measure the consumption of a small amount of (S)-HBCoA because of the limit of
detection by the DTNB assay.
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Figure 2.23 GPC trace of PHB extracted from polymerization of [1-14C]-HBCoA by
PhaCc. The reaction contained 50 nM PhaCcc and 1 mM [1-14C]-HBCoA (specific activity =
175 cpm/nmol [1- 14C]-(R)-HBCoA). The polymer elutes with a retention time of 12.9 min. The
small molecules elute with retention times between 21-23 min. The experiment was performed
once.
Table 2.8 M, and PDI of PHB extracted from in
PhaCc, with HBCoA.
vitro reactions of unprimed and primed
Reaction [PhaCc,] (pM) [HBCoA] (pM) sTCoAa Mw (kDa) PDIb
1 0.05 1000* no 680 12
2 0.05 1000 yes* 440 35
3 0.05 1000* yes 530 9.8
4 4 20* no 28 15
5 4 200* no 64 4.5
denotes the species containing the radiolabel
athe concentration of sTCoA in the final reaction is not provided because it is diluted 1000-fold
from the initial reaction and is present in the assay as a mixture of free sTCoA and acylated sT-
PhaCc,.
bthe PDls measured in these experiments are considerably higher than that of PHB extracted
from C. crescentus. This is likely due to the fact that because fractions are collected to make the
measurements. Smaller fractions afford more precise measurements, but for practical purposes
the fractions are not extremely small.
182
S
0
S
S'~gS *SSS@ee
In the second reaction, PhaCc, was first primed with [3H]-sTCoA then diluted 1000-fold
(to a final concentration of 50 nM) into an assay mixture containing 1 mM HBCoA, and
incubated for 30 min. The PHB was then extracted into chloroform and analyzed by GPC as
above (Figure 2.24). The total recovery of radioactivity was 78%, which includes the
radioactivity extracted into chloroform and the radioactivity that remained associated with the
chloroform-insoluble material (Table A2.1). PHB eluted with a retention time of 13.7 min, and
the radioactivity associated with the PHB peak (210 cpm in the entire sample) corresponded to
0.036 nmol of [3H]-sT incorporated into polymer (Table A2.2). The reaction contained 0.05
nmol of PhaCcc, so the stoichiometry of incorporation of [3H]-sT into polymer was 0.73 per
PhaC. The M, of the polymer was ~440 kDa (~5,000 HBs) and the PDI was 35 (Table 2.8). The
small molecules eluted as a large peak after 19 min and likely include unreacted [3H]-sTCoA and
the additional species observed in the previous section.
The PDI of the polymer peak is extremely high because the radioactivity of the peak is
very low and the peak is broad. The Mn of the sample, which is the sum of the M, of each chain
divided by the total number of chains, is much lower than the M., because the calculation for M,
takes into account the M, of a chain in determining the M, of the entire sample (that is, high M,
chains are weighted more heavily in the calculation), whereas M, is simply the numerical
average. Therefore PDI, which is M,/Mn, is much higher when Mn is considerably smaller than
MW.
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Figure 2.24 GPC trace of PHB extracted from polymerization of HBCoA by PhaCcc
primed with [3HJ-sTCoA. The final reaction contained 50 nM PhaCce, some portion of which
was acylated with [3H]-sTCoA, and 1 mM HBCoA. A) Full elution profile of extracted material.
Polymer (the low, broad peak) elutes with a retention time of -13.7 min, and small molecules
elute after 19 min. B) Expansion of the polymer peak from A. The experiment was carried out
once. The error of each measured fraction in the polymer peak is ~8%.
In order to confirm the results of the reaction of [3H]-sT-PhaCcc with HBCoA, a third
reaction was carried out in which PhaCcc was primed with sTCoA, then the mixture was diluted
1000-fold into 1 mM [1- 14C]-HBCoA (specific activity = 175 cpm/nmol [1-1 4C]-(R)-HBCoA). In
this reaction, [1-1 4C]-HBCoA instead of [3H]-sTCoA (available at low specific activity)
facilitated PHB quantitation and analysis. The resulting polymer was extracted into chloroform
and analyzed by GPC (Figure 2.25). The reaction contained a total of 35,000 cpm [1-1 4C]-(R/S)-
HBCoA, of which 29,200 cpm (85%) was extracted into chloroform, while 4,400 cpm remained
with the material that was insoluble in chloroform. The total recovery of radioactivity was
therefore 98% (Table A2.1). Of the chloroform extracted material, ~85% was in large polymer
that eluted at 12.7 min, whereas the remaining radioactivity was associated with small molecules
that eluted in two peaks after 19 min (Table A2.2). We again see incorporation of more than 50%
of the total radioactivity in polymer, analysis of which indicates that -40 pmol of [1-14C]-(S)-
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HBCoA was incorporated into polymer. The M, of the polymer was 530 kDa (~6,000 HBs) with
a PDI of 9.8. The M, measured in this experiment was slightly higher than that measured in the
previous reaction and the PDI was considerably lower, likely because of the higher radioactivity
in the polymer peak.
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Figure 2.25 GPC trace of PHB extracted from polymerization of [1- 4C]-HBCoA by PhaCcc
primed with sTCoA. The final reaction contained 50 nM PhaCce, some portion of which was
acylated with sTCoA, and 1 mM [1- 14C]-HBCoA (specific activity = 175 cpm/nmol [1-C]-(R)-
HBCoA. The polymer peak eluted with a retention time of 12.7 min, and the small molecules
eluted in two peaks after 19 min. The experiment was done once.
The reactions described in this section contained 20,000 equiv. of HBCoA relative to
PhaCc,. Therefore the observed Mws are lower than would be expected for uniform loading (i.e.
one chain per monomer) if no termination occurred, as this would result in polymer of Mw ~1.7
MDa. These results thus suggest that termination occurs in vitro in the absence of factors other
than PhaCcc. Previous studies of PhaECAv also suggested the class III synthase was capable of
catalyzing termination in vitro, suggesting this is a common feature of PHB synthases (11).
Furthermore, the Mws measured that correspond to PHB chains of 5,000-8,000 HB units are
consistent with the rate constant of thiolysis by CoA (measured in the previous section by
sDCoA formation) being 1 min-.
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2.2.11 Priming with sTCoA increases the specific activity of PhaCcc ~2-fold
The results discussed in the preceding sections suggest that the reaction between sTCoA
and PhaCcc produces at least two species of acylated PhaCcc, namely sT-PhaC and HB-PhaC.
We therefore further explored sTCoA as a primer for polymerization by measuring the activity of
PhaCcc following acylation with sTCoA. PhaCcc was reacted with 10 equiv. sTCoA for ~10 s at
30 OC, and the reaction was diluted 70-fold by the addition of buffer. An aliquot of the diluted
reaction was added to an assay mixture containing 1 mM HBCoA and the CoA release was
monitored by DTNB assay (Figure 2.26). In the final assay, the concentrations of PhaCcc was 50
nM and sTCoA at 0.5 pM as a mixture of sTCoA and sT-PhaCcc. The results indicated that
priming has only a small effect on activity, increasing it about 2-fold relative to the unprimed
enzyme, from 42 U/mg to 72 U/mg. Together with the results demonstrating the chemical
competence of sTCoA, these studies demonstrate that sTCoA can serve as a primer for PhaCcc,
and that priming has a small but measurable effect on the activity of PhaCcc. In the case of
PhaCRe, which has a lag phase in CoA release that precedes the linear phase, priming with
sTCoA decreases the length of the lag phase and increases the activity 3-fold (3).
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Figure 2.26 Effect of priming with sTCoA on the activity of PhaCcc. A) The reactions
contained 50 nM PhaCcc reacted with either 1 mM HBCoA (e, blue), or PhaCcc reacted first
with 500 pM sTCoA then diluted to a final concentration of 50 nM PhaCc, and 0.5 pM sTCoA
in 1 mM HBCoA (o, red). The data are fit to Equation 2.3. B) Expansion of the early time points.
The data are fit with a linear function to calculate specific activity. Error bars represent standard
deviation from the mean of three experiments.
2.3.12 Reaction of PhaCcc and sT-PhaCc, incubated with [1-"CJ-HBCoA analyzed by SDS-
PAGE/autoradiography
2.3.12.1 Reaction of PhaCcc with 5 or 50 equiv. [1- 4 CJ-HBCoA: the rate of initiation is slower
than the rate of elongation
The observation that PhaCcc can at least initially be uniformly loaded by reaction with
sTCoA led us to consider whether the same is true when HBCoA is present in only a small
excess over PhaCcc. A difficulty we have previously encountered in studying the elongation
process of polymerization is that, because the rate of elongation in PhaCRe and PhaECAv is much
faster than the rate of initiation, even in the presence of just a few equivalents of HBCoA, high
M, polymer is generated (6, 10). This phenomenon has been shown by SDS-PAGE and
autoradiography analysis of the polymerization products of PhaCs incubated with [1- 4 C]-
HBCoA. While this is not an ideal method for examination of PHB products, as we do not fully
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understand the migratory properties of different chain lengths of PHB in the denaturing gel, it
does provide a sense of the distribution of oligomeric and polymeric products. To investigate the
uniformity of loading with a small excess of HBCoA, PhaCc, (4 pAM) was reacted with 5 or 50
equiv. [1-14C]-HBCoA, and the products were examined by SDS-PAGE and autoradiography
(Figure 2.27). These experiments required a higher concentration of PhaCc, than in previous
experiments to allow detection of PhaCc, by SDS-PAGE and Coomassie staining. This method
allows visualization of changes in the migration of PhaCcc relative to the control with no
HBCoA, and potentially the detection of small [14C]-HB oligomers associated with synthase.
If PhaCcc were uniformly loaded with 5 equiv. HBCoA, one might expect to observe
radioactivity associated with the synthase by autoradiography, but little or no shift in the
migration of PhaCcc. If PhaCcc were uniformly loaded with 50 equiv. HBCoA, then one might
expect to see by SDS-PAGE that PhaCcc migrates more slowly than the control, as a chain of 50
HBs would increase the Mw by -4.3 kDa. Autoradiography would further demonstrate that the
radioactivity is associated with PhaCcc. Again, however, it must be noted that the migratory
properties of such species in SDS-PAGE are difficult to predict.
SDS-PAGE with Coomassie staining shows that the majority of the synthase is
unmodified when reacted with both 5 and 50 equiv. HBCoA (Figure 2.27A). By
autoradiography, a single predominant species (species II) is observed in the reactions of PhaCc,
with both 5 and 50 equiv. HBCoA (Figure 2.27B). Species II migrates through the stacking gel
to the interface of the stacking and separating gels. We interpret this species to be high M, PHB
that does not enter the gel due to its M., hydrophobicity, shape, precipitation, or all of the above.
A small amount of radioactivity is also associated with species I, which remains in the well. In
all lanes there is no detectable radioactivity associated with the synthase, even after exposure for
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2 days (not shown). Together these results suggest that PhaCcc is not uniformly loaded when
reacted with 5 or 50 equiv. [1- 14C]-HBCoA.
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Figure 2.27 SDS-PAGE (10%) monitoring PHB formation from 5 or 50 equivalents of [1-
14C]-HBCoA incubated with PhaCcc. Both reactions contain ~85,000 cpm total. Lanes 1-5 are
the same in both panels. A) Lanes 1-5, Coomassie stain of PhaCcc with indicated equiv. of [1-
14C]-HBCoA and reaction times. B) Autoradiography of the gel in panel A. Lane 1, 3 pg of
PhaCc,. Lanes 2 and 3, PhaCcc (3 pg per lane) with indicated equiv. of [11 4 C]-HBCoA (specific
activity = 2 x 105 cpm/nmol) and reaction times. Lanes 4 and 5, PhaCc, (3 pg per lane) with
indicated equiv. of [1-"C]-HBCoA (specific activity = 2 x 104 cpm/nmol). W, wells. GF, gel
front. The 30 kDa markers near the bottom of the gels do not line up because after imaging of the
Coomassie stain and prior to autoradiography, the gel was dried, causing it to crack and contract
slightly at the bottom.
In order to confirm that species II is high M, polymer, and to determine its M, and PDI,
PhaCc, (4 pM) was reacted with 5 or 50 equiv. [1-' 4C]-HBCoA, and the resulting polymer was
extracted into chloroform for GPC analysis (Figure 2.28). For both reactions, the total extraction
efficiency was -100% (Table A2.1). PHB produced from incubation of PhaCcc with 5 equiv.
HBCoA had a M, of 28 kDa (325 HB monomers) and a PDI of 15, and that produced from
incubation of PhaCcc with 50 equiv. had a M, of 64 kDa (750 HB monomers) and a PDI of 4.5
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(Table 2.8). These results indicate that the rate of elongation is faster than the rate of initiation
and the synthase is not uniformly loaded when reacted with 5 or 50 equiv. HBCoA. Furthermore,
our interpretation of species II as high M, PHB is correct.
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Figure 2.28 GPC trace of PHB produced by reaction of PhaCcc with 50 equivalents of [1-
1C]-HBCoA. The reaction contained 4 pM PhaCcc and 200 pM [1 -14C]-HBCoA. The specific
activity of the [1- 4 C]-HBCoA was 175 cpm/nmol (R)-HBCoA. PHB was extracted into
chloroform by two rounds of refluxing at 70 C for 48 h. The reaction was carried out once.
2.3.12.2 Reaction of sT-PhaCcc with 5 or 50 equiv. [1- 1 4CJ-HBCoA: priming with sTCoA
increases the distribution of radioactive species
We next investigated whether priming with sTCoA affected the uniformity of loading in
the presence of 5 and 50 equiv. [1- 1 4C]-HBCoA. We have previously established that incubation
of wt PhaECAV with sTCoA resulted in enzyme labeled with 0.5 equiv. sT (5). When the enzyme
was rapidly denatured, digested with trypsin and examined by mass spectrometry, three peptides
were isolated containing the active site Cys covalently labeled with sT and a sT chain that had
been extended by one and two HB units. PhaECAV was thus caught in the act of elongation due to
the presence of a small amount of HBCoA in the sTCoA as the result of breakdown during
storage. This observation suggested that priming bypassed the slow rate of initiation to allow
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more uniform elongation by just a few HB units. To investigate the effect of sTCoA on our
ability to observe small [1 4C]-HB oligomer species associated with synthase that might suggest
uniform loading, PhaCc, (4 pM) was incubated with 10 equiv. sTCoA for ~10 s, then chased
with 5 or 50 equiv. of [1- 14C]-HBCoA. The products of the reaction were analyzed by SDS-
PAGE and autoradiography (Figure 2.29). Again SDS-PAGE with Coomassie staining reveals
no difference in the migration of PhaCcc compared to the control (Figure 2.29A). However,
autoradiography revealed that priming with sTCoA prior to reaction with [1 -14C]-HBCoA
changed the distribution of radioactive species. Figure 2.29B shows four distinct radioactive
species, species I-IV, and two broad regions of "smeared" radioactivity, regions i and ii.
Species I (in the wells) and species II (at the gel front) are present with and without
priming with sTCoA. Species III is present only when PhaCcc is acylated with sTCoA and
migrates just above the unmodified synthase. In lane 2 of Figure 2.29B, species III migrates with
an apparent M, of 89 kDa, 14 kDa larger than unmodified PhaCc,. This species could
correspond to PhaCcc modified with a 160mer of PHB, but represents only a small fraction of
total synthase as we detect no PhaCcc by Coomassie staining. Finally, species IV, present in lane
2 migrates at the position of PhaCcc, and is likely PhaCcc associated with small PHB oligomers.
We have previously interpreted such a species to be (HB), where n = 3-10 (11). This species is
only detectable when PhaCcc is reacted with 50 equiv. of [1-1 4C]-HBCoA, even though the
reaction contains the same total cpm as the reaction with just 5 equiv. of [1 - 14C]-HBCoA.
Together, the results suggest that acylation with sTCoA affects the distribution of radioactive
species in vitro. To quantitate the distribution of radioactivity, we performed densitometry
analysis to determine what percentage of total radioactivity each species accounted for. This
analysis revealed that the radioactivity present in species III and IV accounts for 15-20% of the
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total radioactivity in the reactions containing both 5 and 50 equiv. [1-C]-HBCoA. In contrast,
when PhaCcc is not primed with sTCoA, there is no detectable radioactivity associated with
species III and IV. This suggests that priming with sTCoA increases the uniformity of loading,
allowing for the detection of small (HB)n species associated with synthase. The distribution of
radioactivity is provided in Figure A2.1 in the appendix to this Chapter.
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Figure 2.29 SDS-PAGE (10%) analysis of the polymerization of [1-'C]-HBCoA by PhaCcc.
A) Coomassie stained gel. M, molecular weight standards. Lanes 1-3 are as described for panel
B. B) Autoradiography of gel in panel A. Lane 1, control reaction containing 3 ptg of PhaCcc.
Lane 2, PhaCcc (3 pg) reacted with 10 equiv. of sTCoA for 1 min, then chased with 50 equiv. of
[1- 4C]-HBCoA (specific activity = 2 x 104 cpm/nmol). Lane 3, PhaCcc (3 pg) reacted with 10
equiv. of sTCoA for 1 min, then chased with 5 equiv. of [1- 4C]-HBCoA (specific activity = 2 x
105 cpm/nmol). M, molecular weight standards. C) Standard curve prepared from migration (in
mm) of the indicated M, standards and PhaCcc standard in the gel. This standard curve was used
to estimate the M, of species III. W, wells. GF, gel front.
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2.3.13 SDS-PAGE and Western blot analysis indicates that small amounts of PhaCcc are
associated with [14C]-PHB species
PhaCc, cannot be detected associated with the radioactive species in the experiments
above in Figure 2.29, presumably because of non-uniform loading of PhaCcc and the
insensitivity of Coomassie staining methods. In order to determine whether the radioactive
species observed in Figures 2.25 and 2.27 contain PhaCc, two reactions were carried out and
analyzed by the more sensitive methods of Western blot analysis using antibodies raised to
PhaCcAN and silver staining. In the first reaction, PhaCcc was reacted with 50 equiv. of [1 -14C]-
HBCoA, and in the second reaction PhaCcc was first acylated with sTCoA, then chased with 50
equiv. of [1-1 4C]-HBCoA. Both reactions were carried out at RT then quenched by addition of
Laemmli buffer, and immediately loaded onto two SDS-PAGE gels and run on ice. One gel was
stained with Coomassie stain and the second was transferred to a PVDF membrane for Western
blot analysis. Furthermore, the material that did not transfer from the SDS-PAGE gel to the
Western blot membrane was analyzed by silver staining of the gel, which can detect as little as
0.25 ng of protein.
These experiments indicate that, although the majority of the synthase remains
unmodified, the radioactive species observed in Figure 2.29B are in fact associated with small
amounts of PhaCcc. The amount of PhaCcc associated with the radioactive species II increases
substantially when the enzyme is first acylated with sTCoA (Figure 2.30A-C, lanes 3 and 4).
Even the relatively insensitive Coomassie stain detects a small amount of protein, which does not
enter the separating gel, migrating at the position of radioactive species 1I (Figure 2.30A, lane 4).
This species is only observed when the enzyme is acylated with sTCoA prior to reaction,
suggesting that priming increases the population of PhaCcc that generates high M, polymer. By
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Western blot, a more sensitive method of detection, two distinct PhaCcc bands can be seen at this
position (Figure 2.30B, lane 4). The samples in lanes 3 and 4 in Figure 2.30 are extremely
overloaded for Western blot detection; thus, many non-specific bands not visible by SDS-PAGE
nevertheless cross-react with the anti-PhaCc, antibodies. However, comparison of lanes 3 and 4
in panel B again confirms that the two distinct bands in species II are only observed when the
synthase is first acylated with sTCoA prior to reaction with [1- 4C] -HBCoA.
A silver stain of the SDS-PAGE gel following blotting to a PVDF membrane for Western
blot analysis reveals that the transfer of protein species is not complete (Figure 2.30C). The
transfer appears quite poor in regions of the gel where we expect PHB to be migrating, based on
experiments in the previous section. Interestingly, a sharp band in lane 4 of panel C migrates at
the position of radioactive species II. This band is likely the same band observed in lane 4 of
panel A, which does not transfer completely to the PVDF membrane, potentially due to its
association with PHB. Additionally, the radioactive smear in region ii contains protein that also
does not transfer to the PVDF membrane (Figure 2.30C, lane 4). This could be PhaCcc
associated with varying sizes of polymer, or with polymer of varying structures. It should be
noted that part of the gel containing the smear in region ii broke during imaging. A large portion
of the radioactivity in both the reactions with and without pre-acylation with sTCoA is associated
with what we interpret to be large polymer that does not enter the gel (species I). These
experiments demonstrate that acylation of PhaCcc with sTCoA prior to the polymerization
reaction results in a broader distribution of PhaCcc species associated with polymer than without
priming. This distribution is distinct from what is observed when the enzyme is not pre-acylated
with sTCoA, suggesting that sTCoA increases the uniformity of loading of PhaCc,.
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Figure 2.30 SDS-PAGE (10%), Western blot and silver stain analysis of PhaCcc species
from in vitro polymerizations. A) Coomassie stain and B) anti-PhaC Western blot of 10% SDS-
PAGE analysis of reaction species. C) Silver stain of SDS-PAGE gel following transfer of
proteins to PVDF membrane for Western blot analysis. Lanes 1-4 in panels A, B and C are the
same. Lane 1, molecular weight standards. Lane 2, PhaCcc standard (3 pg). Lanes 3, 4 pM
PhaCcc (3 pg) reacted with 200 pM HBCoA. Lane 4, 4 p.M PhaCc, (3 [ig) reacted with 500 pM
sTCoA, then chased with 200 p.M HBCoA. D) Autoradiograph of reaction containing 4 p.M
PhaCcc (3 pg) reacted with 500 p.M sTCoA then chased with 200 pM HBCoA. Panel D is taken
from Figure 2.29 and included for comparison. The arrows indicate the gel front and the position
of Species II.
2.3.14 Expression and purification of His6-PhaP
In Chapter 4, we present studies in which we identified the major granule associated
protein in C. crescentus, the phasin PhaP, and in which the in vivo role of PhaP was investigated
in cultures of C. crescentus grown in nitrogen-limited medium. These experiments indicated that
PhaP is a 15 kDa protein that is the predominant granule-associated protein under our growth
conditions. Furthermore, PhaP plays an important role in promoting PHB accumulation, as the
AphaP mutant strain of C. crescentus (harboring a clean deletion of phaP) accumulates PHB to
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only 10% that of the levels in the wt strain. We were therefore interested in studying the effect of
PhaP in vitro on the activity of PhaC to determine whether reduced PHB accumulation in the
AphaP mutant could be explained in terms of an effect on the activity of PhaCcc. Toward this
end, the phaP gene was cloned into pET28a and expressed as an N-terminally His 6-tagged
construct containing the sequence SSGLVPRGSHMA between the His 6 tag and PhaP, where the
underlined portion is a thrombin cleavage site. Growth of E. coli harboring the plasmid encoding
phaP yielded 2 g of cell paste per L of culture. PhaP was purified to >95% homogeneity as
judged by SDS-PAGE by Ni-NTA affinity purification (Figure 2.31). However, anion exchange
chromatography using Q Sepharose resin was necessary to remove contaminating DNA. PhaP
has an isoelectric point of 7.8, thus at pH 7.6 did not bind to the Q Sepharose resin. This pI
facilitated separation from contaminating DNA, which binds strongly to the resin. The
purification yield was 5 mg PhaP per g of cells. Incubation with thrombin cleaved the His6 tag
completely, as judged by 15% SDS-PAGE (Figure 2.31, compare lanes 10 and 11) and Western
blot analysis using antibodies to his-tagged PhaP (not shown).
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Figure 2.31 SDS-PAGE (15%) purification gel of His6-PhaP. Lanes 1, 7 and 9, M, standards.
Lane 2, whole-cell pre-induction sample. Lane 3, soluble cell-free extract. Lane 4, insoluble cell-
free extract. Lane 5, Ni-NTA agarose flowthrough. Lane 6, Ni-NTA agarose 10 mM imidazole
wash. Lane 8, post Ni-NTA column, eluted with 250 mM imidazole. Lane 10, Q Sepharose
flowthrough (final purified His6-PhaP). Lane 11, PhaP after cleavage of His6 tag with thrombin.
The asterisk indicates the position of thrombin.
2.3.15 SEC of PhaP indicates that it is a tetramer or pentamer in solution
As discussed in Chapters 1 and 4, the nucleating granule species in vivo (i.e., the PHB
granule precursor) is proposed, on the basis of observations made in R. eutropha, to consist of a
dimer of PhaCs covalently attached to a high M, PHB chain, with 4-9 PhaPs associated (19, 34).
Small angle X-ray scattering studies of PhaP 1 from R. eutropha indicated that it is a homotrimer,
with the subunits arranged in a flat triangular shape (15). Atomic force microscopy studies of
granules isolated from R. eutropha have been interpreted to suggest that PhaP1 forms a semi-
regular network of PhaP 1 molecules arranged to form pores, or sites of ingress from the surface
of the granule to the PHB core (35). The oligomeric state of phasins can likely provide insight
into its role in vivo in promoting PHB accumulation.
To determine the oligomeric state of PhaP, PhaP (100 ptL of 180 pM) was examined by
SEC at 4 'C in 20 mM Hepes pH 7.5, 200 mM NaCl, using a Superdex 10/300 GL size exclusion
column with an elution flow rate of 0.25 mL/min (Figure 2.32). A peak eluting in the void
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volume (Vo) is likely aggregated protein. The predominant peak has a M, consistent with a
tetramer (T) or pentamer (P) of PhaPs and the calculated M, of this peak based on the standard
curve was 68 kDa. A tetramer of PhaPs would have a M, of 60 kDa and a pentamer would have
a M, of 75 kDa. A smaller peak eluting after the tetramer/pentamer peak has a calculated Mw of
35 kDa, which may correspond to a dimer of PhaPs (predicted M, = 30 kDa). Thus, PhaP from
C. crescentus appears to be predominantly a tetramer or pentamer of PhaPs, if it is assumed to be
globular.
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Figure 2.32 Representative SEC trace of PhaP. Samples (100 pLL of 180 pM) were injected
onto a GE Healthcare Superdex 200 10/300 GL column at 4 'C and eluted at 0.25 mL/min with
20 mM Hepes pH 7.5, 200 mM NaCl.
2.3.16 PhaP and BSA increase HBCoA turnover in assays of PhaCc,
Given that the deletion of phaP in C. crescentus dramatically reduces its PHB
accumulation capability, we were interested in understanding what effect PhaP has on the
activity of PhaCcc in vitro. In a preliminary set of experiments, assays were carried out in the
presence of one mole equivalent of PhaP to PhaCcc (on a per monomer basis). In these assays the
concentration of PhaCcc was 25 nM, as at higher concentrations of PhaCcc, the effect observed
by including PhaP in the assay was less pronounced. Under these conditions, the inclusion of one
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equivalent of PhaP facilitates complete turnover of HBCoA by PhaCc, in 15 min, whereas
PhaCc, alone only turns over ~60% of the HBCoA (Figure 2.33).
1.0-
0.8-
0.6-
0.4 -
0.0-
0 4 8 12 16
Time (min)
Figure 2.33 Effect of PhaP and BSA on full length PhaCcc activity. The assays contained
0.76 mM HBCoA, 25 nM PhaCcc alone (e, blue) or in the presence of 1 mole equivalent of PhaP
(o, red) or BSA (A, green). The data are fit to Equation 2.1. Error bars represent the standard
deviation from the mean of three experiments.
Bovine serum albumin (BSA) has been shown to bind to PHB granules in vitro (36).
Niamsiri and coworkers demonstrated that BSA can promote the formation of PHB granules on a
surface to which PhaCRe has been immobilized via an N-terminal His6 tag (37). Addition of BSA
to the reaction resulted in larger granules and higher total substrate turnover. The authors
proposed these observations are the result of BSA interacting with the hydrophobic polymer to
prevent hydrophobic collapse. They proposed that this interaction would allow greater substrate
access to PhaC, by preventing the growing chain from blocking the active site. Jossek et al. have
also observed an increase in turnover of HBCoA in assays of PhaECAV as a result of the inclusion
of BSA and PhaPl from R. eutropha (38). We therefore investigated the effect of BSA on
PhaCcc turnover, to determine whether it mediated a similar effect as PhaP, as this could give us
insight into how PhaP enhances turnover. PhaCcc was assayed in the presence of one equivalent
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of BSA and the results demonstrated that its inclusion affords more extensive turnover of
HBCoA in the slow phase, allowing for consumption of ~80% of the HBCoA. As discussed
above, high M, polymer is produced in vitro, therefore PhaP and BSA could be playing a similar
role to that proposed by Niamsiri et al. in stabilizing the nascent PHB granule.
Interestingly, the opposite effect is seen in assays of PhaCRe in the presence of PhaPl.
Previous studies by Mimi Cho showed that increasing amounts of PhaP1 increased the length of
the lag phase and decreased the specific activity of PhaCRe (19). The PHB produced in the
presence of PhaP1 migrated faster through an SDS-agarose gel than PHB produced in the
absence of PhaP 1. However, analysis of the PHB by GPC demonstrated that PhaP 1 did not affect
the M,. These results together were interpreted to suggest that PhaP 1 increased the lag phase and
slowed the overall reaction rate in order to promote folding of the nascent polymer as it emerged
from PhaCRe. Thus, while the observed effects on the activity of phasins on PhaCcc and PhaCRe
are opposite, they may still be serving the same role in packaging of the polymer and assisting in
in vitro granule assembly.
In Chapter 3, we demonstrate that the ratio of PhaP/PhaC increases during PHB
accumulation from 35 to 500. To determine the effect of increasing equivalents of PhaP on
HBCoA consumption and specific activity in vitro, assays were carried out in the presence of 0-
500 equivalents of PhaP (Figure 2.34). From zero to 50 equivalents of PhaP the specific activity
of PhaCc, increases from 43 U/mg to 125 U/mg. Increasing the equivalents of PhaP to 500 gives
no further increase in specific activity (Table 2.9).
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Figure 2.34 Effect of increasing ratio of PhaP to PhaCcc on HBCoA consumption in vitro.
The data are fit to a sigmoidal function. A) The assays contained 0.76 mM HBCoA, 25 nM
PhaCcc alone (., blue) or in the presence of 1 (o, red), 2 (A, green), or 5 (0, cyan) equivalents of
PhaP. B) The assays contained 0.76 mM HBCoA, 25 nM PhaCcc alone (e, blue) or in the
presence of 10 (x, dark green), 50 (o, magenta) or 500 (E, dark red) equivalents of PhaP. The
data are fit to Equation 2.1.
Table 2.9 Rate of CoA release
equivalents of PhaP.
and specific activity of PhaCcc in the presence of varying
Equivalents PhaP Rate (pmol/min) Specific Activity (U/mg)
0 0.0125 43
1 0.0187 65
2 0.217 75
5 0.215 74
10 0.251 87
50 0.361 125
100 0.385 133
500 0.377 130
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We next compared the effects of PhaP on turnover at two concentrations of HBCoA (300
ptM and 750 pM) and two concentrations of PhaCcc (25 nM and 50 nM) to determine whether
either of these parameters influenced the observed effect of PhaP. The Km for HBCoA is -300
pM, hence this concentration was selected for comparison. For these experiments, we selected
50 equiv. of PhaP relative to PhaCc, (on a monomer basis) because the results of the previous
section indicated that, under the reaction conditions, at this ratio the maximum specific activity
of PhaCcc was achieved (Table 2.9). As shown in Figure 2.35A, when the concentration of
HBCoA is 300 jiM, doubling the concentration of PhaCcc from 25 nM (red) to 50 nM (blue) has
the same effect as including 50 equiv. of PhaP (green), in that under both conditions the HBCoA
is completely turned over. However, increasing the concentration of HBCoA to 750 pM lessens
the effect of doubling the concentration of PhaCcc on the total fraction of substrate consumed
(Figure 2.35B). When the assay contains 50 nM (blue) instead of 25 nM PhaCcc (red), the
fraction of total CoA consumed only increased from 50 to 75% in the experimental time frame.
However, inclusion of PhaP to an assay containing 25 nM PhaCcc (green) facilitated complete
turnover of the substrate. Therefore, the effect of PhaP becomes more pronounced at higher
concentrations of HBCoA, an important factor in understanding the role of PhaP in enhancing
turnover, as will be discussed below. The fact that all of the substrate is consumed in the assays
containing 300 jiM HBCoA also suggests that the slowing of turnover in assays containing
higher [HBCoA] is due to accumulation of PHB rather than the [HBCoA] dropping far below its
Km.
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Figure 2.35 Effect of varying the concentration of PhaCcc and HBCoA on turnover in the
presence of PhaP. A) Assays carried out at an HBCoA concentration of 300 pM. The assays
contained 25 nM PhaCcc (o, red), 25 nM PhaCcc and 25 nM PhaP (o, green), or 50 nM PhaCcc
(A, blue). B) Assays carried out at an HBCoA concentration of 750 p.M. The assays contained
25 nM PhaCcc (9, red), 25 nM PhaCcc and 25 nM PhaP (o, green), or 50 nM PhaCcc (A, blue).
2.3.17 PhaP also increases HBCoA consumption in assays of PhaCcAN
The observation that the corresponding PhaPs have opposite effects on the activities of
PhaCRe and PhaCcc raises the possibility that the unusual N-terminal domain of PhaCcc mediates
the effect of PhaP. We therefore tested the effect of PhaP on PhaCccAN activity. The presence of
one equiv. of PhaP in the assay mixture of PhaCceAN led to the same effect as with PhaCcc
(Figure 2.36). The substrate is turned over completely in the presence of one equiv. of PhaP
whereas in its absence, only ~60% of the substrate is consumed within the same timescale. This
result suggests that the N-terminal domain of PhaCcc is not necessary to mediate the effect of
PhaP on PhaC activity.
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Figure 2.36 Time course of CoA release from PhaCcAN in the presence of one equivalent
of untagged-PhaP. The assays contained 0.75 mM HBCoA, 500 nM PhaCcAN and 0 nM PhaP
(e, blue) or 500 nM PhaP (o, red). Error bars are standard deviation from the mean of three
experiments. The data are fit to Equation 2.1.
2.3.18 Full length PhaCcc and PhaP interact in solution
The observation that the addition of PhaP to the assay mixture increased the consumption
of HBCoA led us to investigate whether PhaCccAN and PhaCcc interact with PhaP in vitro.
Taking advantage of the affinity tag on PhaCce, PhaP was incubated for 10 min at 4 *C with
either PhaCccAN or PhaCc, in a 1:1 ratio (at 10 p.M each protein), and the mixture was
equilibrated with Ni-NTA resin and loaded onto a column. When PhaP was incubated with
PhaCcc, neither the flowthrough nor the washes contained either protein (Figure 2.37A, lanes 2-
6). When the column was eluted with 250 mM imidazole, PhaP and PhaCcc both elute (Figure
2.3 7A, lanes 7-10). In contrast, when PhaCceAN was incubated with PhaP and the proteins added
to 250 p.L of Ni-NTA resin, PhaP came out in the flowthrough and wash fractions (Figure 2.37B,
lanes 2-4). The control reaction containing only PhaP demonstrates that PhaP itself does not bind
the column and in the absence of PhaCcc comes out in the wash fractions (Figure 2.37C, lanes 2-
6). These results suggest that PhaCcc and PhaP form a complex in vitro, but PhaCceAN and PhaP
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either do not or interact more weakly; thus, the N-terminal domain of PhaC may mediate
interaction with PhaP. However, the observation that PhaP has the same effect on the turnover of
substrate by both proteins indicates that the interaction between the proteins is not necessary, and
therefore PhaP is likely interacting with the nascent PHB chain to facilitate polymerization.
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Figure 2.37 SDS-PAGE (15%) analysis of pull-down assay of PhaP with PhaCcc. A) Pull-
down of PhaP with PhaCcc (10 p.M each). Lane 1, Mw markers. Lane 2, flowthrough. Lanes 3-6,
10 mM imidazole wash fractions. Lanes 7-10, 250 mM imidazole elution fractions. B) Pull-down
of PhaP with PhaCccAN (10 pM each). Lane 1, Mw markers. Lane 2, flowthrough. Lanes 3-6, 10
mM imidazole wash fractions. Lanes 7-10, 250 mM imidazole elution fractions. C) Control
containing 10 pM PhaP. Lane 1, M, markers. Lane 2, flowthrough. Lanes 3-6, 10 mM imidazole
wash fractions. Lanes 7-10, 250 mM imidazole elution fractions.
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2.3.19 Including PhaP in assays of PhaCcc results in a small amount of [1 4C]-HB. associated
with PhaCcc
Finally, we examined the effect of PhaP on the uniformity of loading of PhaCcc by
HBCoA using SDS-PAGE and autoradiography assay. PhaP and PhaCc, were incubated at RT
for 5 min, then the reaction was initiated by the addition of 20 or 200 p.M [1-"C]-HBCoA. The
predominant radioactive polymer species is species II, which migrates through the stacking gel to
the separating gel front, but does not enter the gel (Figure 2.38). This is also the predominant
species in the absence of PhaP, as seen in Figure 2.27. Interestingly, we see radioactivity in
species IV, which migrates at the position of the synthase. Densitometry analysis indicates that
this species accounts for 3% of the total radioactivity in lane 2 (Figure 2.38). As demonstrated in
experiments discussed above, this species is not observed in the absence of PhaP, but is observed
when PhaCcc is first primed with sTCoA. It is possible that including PhaP in the assay stabilizes
this species sufficiently under the assay conditions such that it is detectable by SDS-
PAGE/autoradiography. Figure A2.1 in the appendix to this Chapter provides the distribution of
radioactive species in Figure 2.38.
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Figure 2.38 SDS-PAGE (10%) analysis of the polymerization of [1- 14 C]-HBCoA by PhaCcc
in the presence of PhaP. A) Coomassie stained gel. M, molecular weight standards. Lanes 1-3
are as described for panel B. B) Autoradiography of gel in panel A. Lane 1, control reaction
containing 3 pg of PhaCcc. Lane 2, PhaCcc (3 ptg) incubated with one equiv. PhaP for 1 min,
then reacted with 50 equiv. of [1-' 4C]-HBCoA (specific activity = 2 x 104 cpm/nmol). Lane 3,
PhaCc, (3 ig) incubated with one equivalent PhaP for 1 min, then reacted with 5 equiv. of [1-
1C]-HBCoA (specific activity = 2 x 105 cpm/nmol). M, molecular weight standards. Molecular
weights were estimated using the standard curve in Figure 2.29C.
2.3.20 PhaP does not change the M, of PHB produced by PhaCcc in vitro
Analysis of the M, and PDI of PHB produced by wt R. eutropha and the mutant strains
AphaP1 and AphaR (which overexpresses PhaP1) demonstrated that the PHB in both mutant
strains has a lower M, than in wt, and the PDI is higher in AphaP1 (19). These results suggested
that PhaP 1 plays a role in triggering termination, and therefore in part dictates M, and PDI of the
polymer. Studies presented in Chapter 3 of this thesis suggest that the same is not true in C.
crescentus: PHB extracted from the wt strain and the two mutant strains AphaP and AphaR has
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nearly the same M, and PDI. In order to confirm that PhaP does not affect the M, and PDI of
PHB produced by PhaCcc in vitro, reactions were carried out in which PhaCcc was reacted with
20,000 equiv. HBCoA in the presence of 1 and 10 equiv. PhaP. The resulting PHB was extracted
into chloroform for analysis by GPC and compared to PHB produced in the absence of PhaP
(Figure 2.39). The extraction efficiencies of these reactions varied between 90-95% and the Mw
of the PHB produced was between 250-400 kDa, whereas the Mw of PHB produced when PhaP
is omitted is -660 kDa. Due to the inherent error in these measurements, the Mws are likely the
same or very similar. Again, the Mw of the PHB suggests that termination has occurred in vitro.
Furthermore, the PDI remains between 7-12 regardless of the reaction conditions. Together these
results suggest that PhaC alone catalyzes termination and controls the Mw and PDI of the
polymer. It should be noted that the PDI values of PHB extracted from C. crescentus are
typically ~2, considerably lower than the PDI of PHB produced in vitro. This difference could be
due to the fact that measurements of in vitro produced PHB are made by collecting and analyzing
fractions for radioactivity. The smaller the fraction, the more precise the measurements are,
particularly at the beginning and end of a peak. However, for practical purposes, extremely small
fractions were not collected. Alternatively, PHB produced in vivo could inherently have a lower
PDI as a result of conditions in vivo that cannot be mimicked in vitro, such as the concentration
of HBCoA, the presence of other protein factors, or perhaps even the quaternary structure of
PhaC and PhaP on the surface of granules.
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Figure 2.39 GPC trace of PHB extracted from reactions containing PhaCce, PhaP and
HBCoA. The reactions contained 50 nM PhaCce, I mM HBCoA and 0 nM (0), 50 nM (0) or
500 nM PhaP (A) and were carried out for 30 min at 30 C.
2.4 Discussion
In this Chapter we demonstrate that full length PhaCc, is 73 kDa and has an activity that
is 50-fold higher than PhaCc,.AN. Kinetic studies on PhaCcc revealed that it does not exhibit a
lag phase in CoA release and is very soluble in comparison with the prototypical class I synthase
PhaCRe-We therefore pursued in vitro studies into the mechanism of polymerization in the hopes
that it might provide new insight.
We first examined the priming process by acylation of PhaCcc with sTCoA, which
demonstrated that, in contrast to PhaCRe and PhaECAv, PhaCcc generates one PHB chain per
monomer. This observation initially led us to investigate whether the elongation process could be
monitored with this synthase. However, as is the case with PhaCRe and PhaECAv, the rate of
initiation with PhaCcc is much slower than the rate of elongation, preventing us from studying
the early steps in the elongation process. When PhaCcc is incubated with 5 equiv. of HBCoA,
high M, PHB is produced and most of the PhaCcc is unmodified. Thus, non-uniformity of
loading appears to be a common feature of PHB synthases examined in detail to date (6, 10).
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Affinity purification of a StrepIl-tagged PhaCRe from an engineered mutant strain of R.
eutropha revealed that a fraction of the total synthase in vivo is associated with high M, PHB,
while the rest is unmodified (34). This result suggests that the synthase in vivo is non-uniformly
loaded as well, raising the possibility that non-uniform loading is an inherent and necessary
feature of PhaCs. One possibility is that non-uniform loading ensures that high M, polymer is
synthesized in vivo regardless of the concentration of HBCoA. In both R. eutropha and C.
crescentus, even when the cells contain very little PHB, the Mw of the PHB is high (19). This
feature of PHB biosynthesis may be necessary to ensure that the PHB is properly packaged into
granules or contained within granule precursors (discussed in Chapter 3), which may require that
the PHB is full length. Our SDS-PAGE/autoradiography experiments investigating the products
of the reactions of PhaCcc and sT-PhaCcc with [1- 14C]-HBCoA suggested that priming with
sTCoA increases the uniformity of loading, such that 20% of the radioactivity was associated
with smaller (HB)n species. However, the relevance of the artificial primers to the in vivo
reaction is still unclear.
While we cannot study the mechanism of elongation due to the issue of non-uniform
loading, we have studied the role of PhaP from C. crescentus in the physical process of
elongation and granule assembly. Our results have led us to propose the model shown in Figure
2.40 for the involvement of PhaP in in vitro granule assembly. In this model, PhaP associates
with PhaCcc in the absence of HBCoA (species 1). Next, HBCoA is added at a large excess over
PhaCcc and PHB synthesis begins. PhaP acts as a chaperone, interacting with the growing PHB
chain as it emerges from the PhaCcc active site (species 2). As the polymer forms in vitro, if
there is sufficient PhaP present, PhaP can also coat the growing granule (species 3) to further
prevent non-specific "sticking" of PhaCcc to the hydrophobic surface, which could disrupt its
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activity. In the absence of PhaP, we propose the growing PHB granule collapses onto PhaCcc,
shown as species 3 in Figure 2.40B, hindering further turnover by blocking access of HBCoA to
the active site. As more substrate is consumed, a phase or structural transition occurs, and
granules may fuse as they grow larger (species 4). PhaCcc catalyzes termination and reinitiation
in vitro in both the presence and absence of PhaP, and termination may occur via thiolysis at an
oxoester of the PHB chain, rather than at the HBn-PhaC thioester, leaving a primed synthase. The
evidence for this model, presented in the following paragraphs, comes from experiments
described in this Chapter and in Chapter 3, as well as what we and others have observed for in
vitro reactions with PhaCRe and PhaECAV.
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Figure 2.40 Working models for the role of PhaP in promoting in vitro granule assembly.
A) Formation of granules in the presence of PhaP. Prior to addition of HBCoA, PhaC and PhaP
interact in solution (species 1). The stoichiometry of this interaction is not known, but because
PhaP is thought to be a tetramer or pentamer at physiological concentrations, it is depicted as
such. When HBCoA is added, PhaC starts to synthesize a PHB chain, and PhaP acts as a
chaperone to facilitate the egress of the growing chain from the active site (species 2). As more
HBCoA is added to the growing polymer, excess PhaP in the assay mixture can associate with
the surface of a nascent granule (species 3). We propose that this species is ~170 HB units long,
and still soluble. The association of PhaP allows access of HBCoA to the active site of PhaC.
Finally, when the PHB reaches ~22 kDa in M, a phase change occurs to produce the insoluble
granule, which can potentially fuse with other granules in the assay mixture (species 4). B)
Formation of granules in the absence of PhaP. The main distinction between this model and the
model in panel A is that when the polymer reaches a certain M., it collapses back onto PhaC (as
shown in species 3), hindering further turnover.
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The model begins with PhaCc, and PhaP in the absence of HBCoA. SEC experiments
suggest that PhaCc, is a mixture of two oligomeric species at low concentrations. These species
have Mw that are most consistent with a trimer of PhaCcc. However, SEC experiments examining
the quaternary structure of PhaCcAN demonstrated that the truncated synthase is a mixture of
two species, with the major species having a M, consistent with a dimer. Thus, we believe that
PhaCcc may be a dimer with an unusual shape that could come from the N-terminal domain. This
domain likely has an extended or unusual structure due to the presence of a proline rich region,
including six consecutive Pro residues that are immediately followed by the sequence PPFPPF.
Unfortunately, attempts to model this domain using secondary structure prediction software
provided no structural insight. Because material is lost during our SEC experiments, additional
experiments are required to fully understand the quaternary structure of PhaCc,, including for
example analytical ultracentrifugation studies. Regardless of its quaternary structure, our studies
of the acylation of PhaCcc with sTCoA suggest that a dimer of synthases makes two PHB chains.
For clarity, only a single chain is depicted in Figure 2.40. We furthermore propose that in the
absence of HBCoA, PhaP associates with PhaCcc. This proposal is based on pull-down assays,
which demonstrated this association in vitro. It should be noted that we do not have evidence for
the stoichiometry of the interaction depicted in Figure 2.40; however, based on SEC of PhaP, at
the concentrations used in our pull-down assays, PhaP is a tetramer or pentamer.
Our model next depicts an early stage in the polymerization process, after a short PHB
chain of 3-10 units has been synthesized. PhaP associates with this chain, facilitating its egress
from the active site of PhaCcc. We predict that this species is an intermediate in polymerization
based on a variety of experiments. First, SDS-PAGE/autoradiography experiments of PhaCcc
primed with sTCoA then reacted with [1- 14C] -HBCoA reveal a [14C]-HBn species migrating at
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the position of PhaCc. Because the association of [ 14C]-HBn does not alter the apparent
migration properties of PhaCc, in the SDS gel, n is likely small. In similar experiments carried
out with the mutant enzyme D302A-PhaECAV, [14C]-HBn species observed by SDS-
PAGE/autoradiography with migratory properties similar to those observed in the experiments in
the present work were analyzed by trypsin digest of the enzyme followed by ESI-MS (26). These
experiments revealed peptides containing C149 that had been modified with (HB)n, where n =3-
10. It is by analogy to these experiments that we propose that (HB)3.1o-PhaCcc is an intermediate
in polymerization. This species was not observed without priming of PhaCcc with sTCoA prior
to incubation with [1-1 4C]-HBCoA, which could be due to the fact that under these experimental
conditions, most of the substrate is converted into large polymer due to the rapid elongation
process. Alternatively, [14C]-HB3.io-PhaCcc species may be present only in very small amounts
and therefore not detectable due to the specific activity of the [1-1 4C]-HBCoA. Interestingly,
inclusion of PhaP in the assay mixture results in an increase in the amount of the (HB) 3.10-
PhaCcc species, which may suggest that interaction of PhaP with this species stabilizes it
sufficiently to hydrolysis to allow its accumulation and thus detection by SDS-PAGE.
Evidence that PhaP interacts with the growing PHB chain comes from assays carried out
with PhaCcc and PhaCccAN. Including PhaP in the assay mixture increases the extent of HBCoA
turnover catalyzed by both synthases. The significance of this observation will be addressed
further below. Pull-down assays indicate, however, that under our reaction conditions,
PhaCccAN and PhaP do not interact, whereas PhaCcc and PhaP do. This could mean either that
the N-terminal domain of PhaCcc mediates this interaction, or that the KD of the interaction
between PhaP and PhaCccAN is higher than that of PhaCcc. Thus, the effect mediated by
including PhaP in the assay mixtures of both synthases is likely due to interaction of PhaP with
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the PHB chain rather than with the synthase. The proposal that PhaPs carry out their various
roles in polymerization via interaction with the PHB chain rather than with the synthase is also
consistent with observations made with PhaP 1 from R. eutropha. In wt R. eutropha, a ratio of 1-2
PHB chains per PhaPI in vivo is maintained throughout cell growth and PHB accumulation (19,
39) (He and Stubbe, unpublished data). When phaCRe is replaced with phaECV in an engineered
mutant strain of R. eutropha, the same molecular ratio is maintained (19), indicating that the ratio
is not "synthase-specific" and suggesting that it is maintained by an interaction between PHB
and PhaPl. Furthermore, pull-down assays between PhaP1 and PhaCRe indicate that the two
proteins do not interact in solution, yet including PhaP1 in assays of PhaCRe increases the length
of the lag phase, decreases the specific activity of the synthase, and alters the structure of the
resulting polymer (judged based on its migratory properties through an SDS-agarose gel matrix)
(19). Though the effects on the activities of PhaCRe and PhaCcc are opposite with their respective
phasins, in both cases the phasins appear to exert their effects via interaction with the PHB.
As polymerization continues in our model, the PHB chain begins to fold over on itself,
forming a small amorphous granule. We propose that an additional intermediate in the
polymerization process is HB,-PhaC where n = -170. This species was also observed by SDS-
PAGE/autoradiography experiments examining the reaction of sT-PhaCcc with [1- 14C]-HBCoA
(Figure 2.29). Its identity was inferred based on the fact that a [14C]-HB-containing species was
observed to migrate slower than unmodified PhaCcc with a predicted Mw of ~14 kDa larger than
PhaCcc, which would correspond to PhaCcc modified with -170 HB units. A few things are
interesting about this observation. The first is that this species migrates into the separating gel
rather than precipitating at the top of the gel, suggesting that it is sufficiently soluble to migrate
through SDS-PAGE, though, as noted above, we do not fully understand how various HBa
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species migrate in SDS-PAGE. GPC analysis of the M, of the PHB formed from the reaction of
unprimed PhaCc, with [1- 4 C]-HBCoA that does not enter the separating gel but precipitates at
the top reveals that it is ~22 kDa. Together, these results suggest that within the 14 kDa and 22
kDa range in Mws, the PHB undergoes some sort of structural and/or phase change that prevents
it from migrating into the SDS-PAGE separating gel. The observation of the HB170-PhaCcc
species is also interesting because when C149S-PhaECAv is reacted with HBCoA and analyzed
by ESI-MS, similar species including HB75-C149S-PhaC, HB 105-C149S-PhaC and HB 238-
C149S-PhaC have been observed (Li and Stubbe, unpublished data). Thus similar intermediates
are observed with these two enzymes, suggesting that some feature of its structure facilitates its
detection by our methods of analysis.
Our model proposes that PhaP associates with this species to package it in such a way as
to prevent it from collapsing onto PhaCcc and hindering access of HBCoA and thus further
turnover. As briefly mentioned above, when HBCoA is present at a sufficiently high
concentration (0.75-1 mM) in our assays, the rate of the reaction slows as the substrate is turned
over, and appears to stop before complete substrate consumption. This effect can be alleviated by
reducing the concentration of HBCoA, which facilitates complete turnover of substrate. This
result suggests that the decrease in turnover is due to accumulation of PHB in the assay mixture
rather than the concentration of HBCoA falling below its Km as is it consumed. The slowing of
turnover can also be alleviated by including PhaP, suggesting that PhaP associates with the
forming PHB granules to prevent non-specific aggregation that hinders turnover. The species
that form in the presence and absence of PhaP are illustrated as species 3 in Figure 2.40A and B.
This feature of our model is similar to the model proposed by Niamsiri and coworkers, who
studied the role of BSA in promoting the formation of PHB granules by PhaCRe that was
215
immobilized to a gold surface (37). They convincingly demonstrated by AFM that BSA
promotes the formation of larger granules and more complete substrate consumption than occurs
in its absence. Niamsiri et al. furthermore presented fluorescence confocal microscopy images,
which they interpret as demonstrating that BSA is found throughout the granule, rather than just
on its surface (37). Unfortunately, from the images provided, it is difficult to critically evaluate
the data, and we have no evidence that PhaP is found inside the granule rather than just on its
surface. In fact, our electron microscopy studies using immunogold labeling of antibodies to
PhaPI suggest that it is only on the surface of granules in R. eutropha (1, 2).
The role of PhaP in preventing granule collapse to maintain the activity of PhaCcc and
access of HBCoA to the active site is consistent with observations we have made in vivo as well,
as described in Chapter 3. Our in vivo studies demonstrate that the AphaP mutant strain of C.
crescentus only accumulates PHB to -1% of its cdw, whereas the wt strain accumulates PHB to
~12% of its cdw. Analysis of the activity of PhaCcc in crude cell extracts of wt and AphaP
demonstrates that in the wt strain, PhaCcc has higher activity and catalyzes more extensive
turnover of exogenous HBCoA than PhaCcc in AphaP. Furthermore, in AphaP the expression
levels of PhaCcc decrease as a function of growth time. We have interpreted these results to
suggest that in the absence of PhaP in vivo, the PHB aggregates in such a way as to hinder
further turnover, and that PhaCc, may be degraded as a result of unfolding or precipitating on the
exposed surface of the hydrophobic granule. Thus, we have observed PhaP playing a similar
function in promoting granule assembly both in vivo and in vitro.
We finally propose in our model that PhaCcc catalyzes termination, and unexpected
results with the artificial primer sTCoA suggest that termination might occur by thiolysis to leave
a primed synthase. It has been previously demonstrated that synthases are capable of catalyzing
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termination (11, 40). Our GPC experiments examining the M, of PHB produced by PhaCc,
demonstrate that the M, is lower than would be expected assuming each PhaC makes one PHB
chain. This result suggests that termination and reinitiation of polymerization are occurring in the
presence of just PhaCc, and HBCoA. The working model for termination is that the synthase
either activates a water molecule for hydrolysis of the PHB chain, or that a nucleophilic amino
acid residue on PhaC first attacks the chain to catalyze transfer from the active site Cys, followed
by rapid hydrolysis (11). In both cases, the enzyme is proposed to terminate the chain at 3-10 HB
units removed from the Cys residue, leaving a primed synthase.
In the present studies, we unexpectedly found that when PhaCc, is incubated with
sTCoA, it catalyzes side reactions in addition to the expected acylation reaction. The major side
reaction is the formation of sDCoA, which we propose happens by the thiolysis mechanism
shown in Scheme 2.1, in which CoA from the most recently added HB unit reattacks at an
internal oxoester. sDCoA forms at a rate of 1 min-, whereas the rate of polymerization is ~5,000
min'. Given the differences in these rates, one would expect that if the rate of thiolysis is in fact
indicative of termination, then the typical PHB chain length would be -5,000 HB units long.
Consistent with this expectation, both in vitro and in vivo, we see PHB that is 3,000-6,000 HB
units long. Thus, a mechanism for controlling chain termination might be the relative rates of
polymerization versus thiolysis by CoA.
It is becoming clear from our studies that synthases catalyze unusual chemistry in
addition to the chemistry of polymerization. As described in the introduction, incubation of wt
PhaCRe and PhaECAV with sTCoA followed by addition of the chain terminator HBCH 2CoA
results in the formation of a major product that is one HB unit shorter than the product predicted
by the mechanisms in Figure 2.1 (Li and Stubbe, unpublished data). Because these and the
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present observations have been made with artificial primers, it is not yet clear whether they are
relevant to the normal reaction pathway. However, the fact that PhaCcc is capable of catalyzing
thiolysis to leave PhaC primed with an HB unit is attractive in terms of our working model for
termination. We have also re-examined the reaction of PhaECAv with sTCoA and found that this
reaction also results in the formation of a small amount of sDCoA (Figure A2.2, in the Appendix
to this Chapter), suggesting that this chemistry might be general to synthases. Therefore, we
propose a modification to the model for termination that PhaCs catalyze chain termination by
thiolysis using CoA, leaving a primed synthase that is ready to synthesize the next PHB chain.
The results presented in this Chapter demonstrate that some of the peculiarities that make
PHB synthases difficult to study, such as the issue of non-uniform loading, are likely general
features of PHB synthases. However, in our studies of the new class I synthase from PhaCce, we
have gained insight into the role of PhaP in promoting granule assembly, as well as into a
possible mechanism for termination by thiolysis. The issue of initiation of PHB formation
remains unresolved, largely because of the challenge of non-uniform loading. Recent studies
suggest that PhaC from Aeromonas caviae may be useful for examining the mechanism of
priming, as this synthase appears to uniformly load when incubated with just a few equiv. of
HBCoA (12). However a more thorough and careful examination of this synthase than what has
thus far been carried out is necessary. In summary, PhaCs are difficult to study mechanistically
due to the issues described in this Chapter, and ultimately our understanding of PHB
polymerization may come from studies carried out on synthases isolated from a variety of
sources. The studies presented in this Chapter add a few more insights into the puzzle of PHB
biosynthesis.
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2.6 Appendix
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Figure A2.1 Distribution of radioactivity in species observed by SDS-
PAGE/autoradiography analysis of PhaCcc reacted with [1-' 4C]-HBCoA. Analysis was
performed using ImageJ Software (30). A) Distribution of radioactivity from Figure 2.29B. B)
Distribution of radioactivity from Figure 2.38B.
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Table A2.1 Inventory of radioactivity.
Initial radioactivity Radioactivity after extraction into Radioactivity analyzed
chloroform by GPC
cpm cpm
Reaction Total Total cpm in cpm % injected recovered
cpm cpm washesa extracted extraction onto from
(RIS) (R) (R)b column column (%)
1 13,700 6,850 2,480 11,600 1OOC 5,800 5,480 (95)
2 2,85 -- 120 2,110 78 1050 920 (88)
3 35,000 17,500 7,300 24,700 1OOC 4,950 5,000 (100C)
4 35,000 17,500 4,400 29,200 1OOC 11,700 10,200 (87)
5 13,700 6,850 2,400 6,100 90 2,440 2,590 (100c)
awash fractions were collected from the material that remained associated with the tube in which
samples were refluxed
bthe % extraction is determined on the basis of the total nmol of [1- 14C]-(R)-HBCoA extracted
into chloroform; in reactions 1 and 3, in which the cpm extracted is greater than the total cpm of
[1- 14C]-(R)-HBCoA in the reaction, the assumption is made that 100% of the [1-14C]-(R)-
HBCoA was extracted in addition to some portion of the [1 -14C]-(S)-HBCoA.
'in some cases, recoveries were >100%, which is likely due to error associated with the
difficulties of pipetting exact amounts of chloroform
dthe RIS distinction does not apply to [3H]-sTCoA
Table A2.2 Distribution of extracted radioactivity between polymer and small molecules.
Distribution of extracted radioactivity
cpm in PHB (% of
cpm in small
molecules
Reactiona Total cpm extracted total) (% of total)
1 11,600 1 2 6 0 0 ( 10 0 b) 0(0)
2 2,110 210(10) 1,900(90)
3 24,700 21,600 (87) 3,100 (13)
4 29,200 25,100 (85) 4,500 (15)
5 6,100 6,420 ( 1 0 0 b) 0 (0)
220
athe reaction numbering used is the same as in Table 2.8
bin some cases, recoveries were >100%, which is likely due to error associated with the difficulties of
pipetting exact amounts of chloroform
A) B)
0.015-
0.20 sTCoA sDCoA
0.15 0.010-
00
S0.10-
CoA"
0.05- s~A005
0.00 , , , , , 0.000
30 35 40 45 50 55 40 41 42 43 44 45
Elution time (min) Elution time (min)
Figure A2.2 Small molecule products of the reaction of PhaECA, and sTCoA. The reaction
contained 50 p.M PhaECAV and 500 p.M sTCoA, and was carried out for 10 min (red) and 60 min
(blue) at 30 'C. The samples were worked up as described in section 2.3.12. A) A2 60 trace,
showing a peak at 31 min (also observed in the reaction with sTCoA and PhaCcc), the increase in
the peak at 43 min (sDCoA) and a decrease in the peak at 47 min (sTCoA). B) Expansion of the
region around the peak corresponding to sDCoA.
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Chapter 3:
The role of PhaP in promoting PHB accumulation in Caulobacter crescentus in
nitrogen-limited medium
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3 The role of PhaP in promoting PHB accumulation in Caulobacter crescentus
in nitrogen-limited medium
3.1 Introduction
In Chapter 2, we reported the isolation and characterization of PhaC from Caulobacter
crescentus (PhaCcc) as well as its phasin, PhaP. In vitro assays revealed that the kinetics of
PhaCc, are biphasic and have an initial burst phase followed by a slower phase. Under certain
reaction conditions, the inclusion of PhaP can increase the length of the burst phase and increase
the total consumption of substrate from -70% (in the absence of PhaP) to 100%. The observation
that PhaP increases the extent of HBCoA turnover in vitro suggests that it may play a key role in
PHB biosynthesis in vivo as well. The goal of the current work was to investigate the role of
PhaP in PHB biosynthesis in C. crescentus. To that end, growth conditions that promote PHB
accumulation have been developed and PhaP expression levels under these conditions measured
as a function of PHB accumulation. The effect of deletion of phaP on the PHB content of cells,
the molecular weight (Mw) and polydispersity (PDI) of the PHB, and the granule size and shape
has been examined. The role of a putative regulator of PhaP expression, PhaR, is also
investigated.
Phasins are the major PHA-granule associated proteins. They share little sequence
similarity, but have the general features that they are typically small (13-25 kDa), amphiphilic
proteins that are associated with the PHA granule surface and can constitute a high fraction of
the total cellular protein during PHA accumulation (1). Phasins can be identified in sequence
searches by the phasin2 motif, which is not a particular amino acid sequence but instead a region
enriched in hydrophobic residues. Phasins are thought to play an important role in PHA granule
biogenesis, yet only the role of PhaP1 from R. eutropha has been thoroughly studied. When
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limited in nitrogen but with an abundance of fructose available (referred to as PHBhigh growth
conditions), R. eutropha accumulates PHB up to 80% of its cell dry weight (cdw). Under these
conditions PhaPi constitutes up to 5% of the total protein content of the cell (2, 3). PhaPi
expression is strictly correlated with PHB accumulation and the ratio of PHB chains to PhaP is 1-
2 throughout growth. Its deletion results in accumulation of only 40% PHB cdw, and that PHB is
packaged in a single irregularly shaped granule, as opposed to the 5-15 spherical granules
accumulated in the wt strain (3-6). PhaP is also thought to dictate polymer termination and
thereby its M, and PDI. If PhaP is absent or if it is overexpressed during PHB accumulation the
polymer M, is lower, suggesting uncontrolled termination. The PDI also increases in the absence
of PhaP (7).
Dozens of organisms have putative transcriptional regulators of phasin expression,
collectively referred to as PhaRs. The functional assignments are made primarily based upon i)
homology to known PhaRs, such as that from R. eutropha, ii) association with PHB granules,
and iii) their locations within the genome relative to other PHB biosynthetic genes. The role of
PhaR in PHB biosynthesis has been convincingly demonstrated in R. eutropha and to a lesser
extent in Paracoccus denitrificans (5, 8, 9). In R. eutropha, deletion of phaR results in a strain
that constitutively overexpresses PhaP 1 and accumulates PHB in more and smaller granules than
the wt strain (5, 8). This result, in combination with the results from deletion of phaP1, suggests
that PhaP 1 determines the size and number of PHB granules in R. eutropha. PhaR homologs in
some a-proteobacteria (a group that includes C. crescentus) such as Rhizobium etli and
Sinorhizobium meliloti contain a PhaR homolog called AniA. Studies have suggested that AniA
plays a role in regulation of the expression of many genes involved in directing carbon flux
through various biosynthetic pathways, including PHB biosynthesis (10, 11). Pseudomonas
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oleovorans expresses PhaF, which is a granule-associated protein thought to be involved in
regulation of the PHA synthase PhaCI and Phal, a phasin-type protein (12, 13). Thus, regulation
of PHB accumulation appears to vary by organism (14).
A great deal has been learned from studying the role of PhaP 1 in PHB accumulation in R.
eutropha and its regulation by PhaR. However, the generality of these functions in PHB
accumulating organisms has not been thoroughly studied. Furthermore, when an essential
nutrient (nitrogen, phosphate, 02, etc.) is limiting, R. eutropha accumulates PHB to -80% cdw,
which is likely much higher than the levels to which it is accumulated in the "natural"
environment. We have investigated PHB accumulation in C. crescentus in nitrogen-limited
conditions to determine if the roles of PhaPl and PhaR in R. eutropha are general to PHB
accumulating organisms. C. crescentus has long been known to accumulate PHB (15), but the
first characterization of its accumulation as a function of growth was not reported until 2001
(16). In that study, Qi and Rehm grew C. crescentus in rich medium lacking Ca2+ and
supplemented with 1% glucose. Under these conditions, C. crescentus accumulated PHB to
-18% of its cdw. They showed that antibodies to PhaCRe cross-reacted with PhaC from C.
crescentus (PhaCcc), and in Western blots using these antibodies PhaCcc appeared to be 73 kDa,
8 kDa larger than PhaCRe (65 kDa) (16). Since that study, there have been no additional
publications reporting the investigation of PHB biosynthesis in C. crescentus.
Our efforts have been to characterize the PHB biosynthetic proteins of C. crescentus. As
a starting point, a protocol for growth on nitrogen-limited defined minimal medium
supplemented with 1% glucose (PHB production, or PHBp, medium) was developed. We have
identified putative biosynthetic proteins PhaP and PhaR as granule-associated, and constructed
the precise deletion strains of C. crescentus, AphaP and AphaR. Antibodies to recombinantly
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purified PhaCc, and PhaP were generated. The levels of PHB, PhaP and PhaCc, were measured
in the two mutant strains and the wt strain during a growth in nitrogen-limited medium
supplemented with glucose, in order to develop a model for the role of PhaP in promoting PHB
accumulation in C. crescentus. The results show that while PhaCcc is constitutively expressed,
the expression levels of PhaP are correlated with PHB accumulation. Quantitative analysis
demonstrated that the ratio of PHB chains to PhaP remains between 1-2 throughout growth,
similar to the ratio measured in R. eutropha (He and Stubbe, unpublished data)(7, 17). Deletion
of phaP results in severe attenuation of PHB accumulation. We have examined the role of PhaR
in regulating PhaP expression and find that in the mutant strain AphaR, PhaP levels are
upregulated but still correlated with PHB levels, suggesting that the mechanism of regulation of
PhaP expression in C. crescentus is distinct from that in R. eutropha. Finally, transmission
electron microscopy (TEM) is a tool we and others have previously used to examine biogenesis
of granules in R. eutropha. TEMs of wt C. crescentus and the two mutant strains provided some
insight into the role of PhaP, suggesting that PhaP helps to control the size and number of PHB
granules in C. crescentus. This role is similar to what has been proposed for R. eutropha (3).
In summary, our results suggest that some of the observations made in R. eutropha, such
as the molar ratio of PhaP to PHB and the correlation of PhaP expression with PHB levels, are
common features of PHB producing organisms regardless of the extent to which PHB is
accumulated. However, the mode of regulation of the expression of PHB biosynthetic proteins
and their correlation with PHB levels are distinct in C. crescentus, reinforcing the notion that
regulation mechanisms are organism specific.
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3.2 Materials and Methods
3.2.1 Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) at the highest purity
available, unless otherwise noted, and used without further purification. Restriction enzymes
were purchased from New England Biolabs (Beverly, MA) and Taq DNA polymerase was
purchased from Promega (Fitchburg, WI). Oligonucleotide primers were purchased from
Integrated DNA Technologies (Coralville, IA) and are listed in Table 3.1. Strains and plasmids
are listed in Table 3.2. The relative concentrations of vectors and inserts used for ligation
reactions were determined by densitometry analysis of ethidium bromide stained 1% agarose
gels. Glutaraldehyde (15% solution), Os04, uranyl acetate, propylene oxide, low viscosity
embedding resin (LVER, containing vinyl-4-cyclohexene dioxide, diglycidyl ether
polypropylene glycol, nonenyl succinic anhydride, and dimethylamino ethanol combined in
proportions as per the manufacturer's protocol), flat silicone embedding molds and 200-mesh
nickel grids coated with carbon Formvar were purchased from Electron Microscopy Sciences
(Hattfield, PA).
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Table 3.1 Primers and oligonucleotides used in this study.
Name Sequencea
phaPURfw 5'-GATATAGGATCCGAGGTAAGCCTGGCGAACATGAAGCGACGTC
CGTCATTTGAACTGG-3'
phaPURrev 5'-GATATACATATGCAGCTCGACCTTCCGCCCCGCCTCCTTTCCTCC
CCAGGAGACTCCCC-3'
phaPDRfw 5'-GATATACATATGGGCCTGCTCCAGGCGCGCTCACCGGCGCGTCT
GTGACATCAGAACTTGAAGG-3'
phaPDRrev 5'-GATATAGGATCCGATCGAGATCTGGCCCGAGATGTGGACCAGG
CTTCCGGAGCGTACG-3'
phaRURfw 5'-GATATAGGATCCCGGCGGCTTCGATGACGGCCTTGCCCAGTTC-3'
phaRURrev 5'-GATATACATATGTTCGTTCCCTAGAAGCGGTTACGTCCGCTTTTC
GCATCGCACTATCGCG-3'
phaRDRfw 5'-GATATACATATGCCAAGCCGATCCAGCCGTTCTTAACCGTCCTG
GCCCTAGG-3'
phaRDRrev 5'-GATATGGGATCCCCGTGCCAAGATAGGTCGATCTGGCCGTGTCC
AGCAC-3'
phaCfw 5'-GATATAGCTAGCATGGCCACGGCGAA-3'
phaCrev 5'-GATATAGGATCCTCAGGGTTGTGACTTTACCAGCAC-3'
phaCIntfw 5'-GATATAGGATCCCCGCTGCTGATCTTCCCGCCGTGGATCAACGT
GG-3'
phaCIntrev 5'-GATATAGGATCCCTGACGAAGAACGACCAGATCAGGTCGTTAC
CGCGCAGGGCG-3'
phaRIntfwb 5'-GCCAACCGCCGCCTCTACAACACGGCATCCTCTTCGTACGTCAC
CC-3'
phaRIntrevb 5'-CGCATCCTCGGGACGGACATAGGCGAAGGGCGAGAACATCTTC
ATCGCC-3'
phaRExtfwb 5'-CGACCACCACCTTGGCCGAGCCGTCGGCAATCTGCTGG-3'
phaRExtrevb 5'-CGTCGCGTGGAACCAGGGCGTCGAAGGGGATCGATCGGACC-3'
phaZfwb 5'-GATATACATATGCTCTACGCCCTGCACGAGGCGGCCTATTAC-3'
phaZrev b 5'-GATATAAAGCTTTCAGACTTCCTCGCCGAAGTTCGGGTCGC-3'
aRestriction sites underlined.
bUsed only for sequencing purposes.
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Table 3.2 Plasmids used in this study.
Strain Genotype Reference
Caulobacter crescentus
CB15N Wild type
CB1002 CB15N, AphaP This study
CB1003 CB15N, AphaR This study
CB 1005 CB 1 5N, phaCkm; phaC is disrupted by insertion of This study
pJQ200mpl8Km encoding kmR in the middle of
phaC
Plasmid Description Reference
pJQ200mp 18Km (18)
pRB02 pJQ200mp18Km containing phaP deletion allele; This study
deletion allele consists of 300 bp 5' upstream and 3'
downstream region fragments flanking phaP joined
by an NdeI site, and is inserted into a BamHI site in
the multiple cloning region
pRB03 pJQ200mpl8Km containing phaR deletion allele; This study
deletion allele consists of 300 bp 5' upstream and 3'
downstream region fragments flanking phaR joined
by an NdeI site, and is inserted into a BamHI site in
the multiple cloning region
pRB05 pJQ200mp18Km containing phaC insertion allele; This study
insertion allele consists of an internal 500 bp
fragment of phaC, and is inserted into the BamHI
site in the multiple cloning region
3.2.2 Media and growth conditions
C. crescentus (a gift of Prof. Michael Laub) and three mutant strains (AphaP, AphaR,
phaC:km) were cultivated in PYE (peptone-yeast extract, 0.2% Bacto peptone [Difco], 0.1%
yeast extract [Difco], 1 mM MgSO 4 , and 0.5 mM CaCl2) or in modified M2 minimal salts (6.1
mM Na2HPO 4, 3.9 mM KH2 PO4 , 4.7 mM NH 4Cl, 0.5 mM CaCl2, 10 pM FeSO 4) with 1%
glucose. Modified M2 minimal medium supplemented with 1% glucose will be referred to as the
PHBp (PHB production) growth medium. All growths were carried out at 30 'C with shaking at
220 rpm. A single colony from a PYE/agar plate was grown 15-18 h (to saturation, OD 600 = 1.4)
in 50 mL PYE in a 500 mL baffled flask. This culture is the "saturated overnight culture." A
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second 50 mL PYE culture in a 500 mL flask, the "starter culture," was inoculated with 2.5 mL
of the saturated overnight culture. This starter culture was grown 4-5 h until OD600 = 0.15 (early
log phase), then 25 mL was used to inoculate 500 mL PHBp cultures in 4 L baffled flasks.
3.2.3 Isolation and purification of PHB granules by ultracentrifugation
PHB granules were isolated from 500 mL wt C. crescentus grown 24 h in PHBp by a
modification of a previously reported protocol (19). Cells (-I g wet weight) were harvested by
centrifugation for 20 min at 10,000 xg and the cell pellet was resuspended in 3 mL granule
isolation buffer (50 mM Tris, 1 mM EDTA, pH 8.0). The cells were lysed by two passes through
the French pressure cell at 14,000 psi. The insoluble fraction (containing PHB granules) was
pelleted by centrifugation for 20 min at 4 'C and 20,000 xg. The soluble supernatant was
decanted and the insoluble fraction was resuspended in 3 mL of granule isolation buffer.
Resuspended PHB granules (3 mL per glycerol gradient) were purified from other insoluble
material by ultracentrifugation over a glycerol density gradient at 21,000 rpm for 2 h at 4 'C in a
Beckman L8-70M Ultracentrifuge equipped with an SW 41 rotor. The glycerol gradient was
composed of the following: 2 mL each of 90% glycerol, 80% glycerol, 70% glycerol and 40%
glycerol prepared in granule isolation buffer. The glycerol solutions were prepared using
volumetric flasks. The gradient was prepared in Ultra-Clear Centrifuge Tubes (14 x 89 mm)
(Beckman Instruments, Palo Alto, CA). The 40% glycerol layer was added first to the centrifuge
tube. Using a syringe equipped with a blunt-ended cannula needle, the layers were added one at a
time in order of increasing density by slowly dispensing each layer below the less dense layers.
The layers were of sufficiently different density such that mixing of layers could be prevented by
slow and careful dispensing. The density gradients were prepared immediately before use.
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Following centrifugation, a syringe equipped with an 18%2 gauge needle was used to
pierce the side of the centrifuge tube to extract the materials that sedimented at the density layer
interfaces. The extracted samples were pelleted by centrifugation for 10 min at 14,000 xg at
room temperature (RT), and the glycerol supernatant was discarded. Each sample was
resuspended in 100 ptL Laemmli buffer (20) to give a final concentration of -2-5 mg/mL protein.
For identification of granule-associated proteins, samples were resolved by 15% SDS-PAGE and
blotted to PVDF membranes (Immun-Blot, Bio-Rad) for 80 min at 100 V on ice in a Criterion
wet blotting apparatus (Bio-Rad). The blotting buffer contained 25 mM Tris base, 192 mM
glycine, 0.01% SDS (w/v) and 15% methanol (v/v). The blots were stained with Coomassie
stain, and select protein bands of interest were carefully excised with clean razor blades and
submitted to the Tufts Proteomics Core Facility for N-terminal sequencing by Edman
degradation.
3.2.4 Protein purification and generation of antibodies
Expression and purification of the N-terminally (His)6-tagged proteins PhaCccAN,
PhaCcc and PhaP were carried out as described in section 2.2.4 of this thesis. PhaCccAN is a
truncated construct of PhaCc, in which the N-terminal 8 kDa domain (85 amino acids) is deleted.
PhaCccAN and PhaP (~I mg each) were sent for preparation of antibodies by Covance
(Princeton, NJ).
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3.2.5 Homologous recombination to construct the phaC disruption strain phaC:km
IF
5- aMH
BamHI BamHH
Bamifi BamHI
+ IF
BamHI BamHI ieatoB pRBO5
pJQ200mp18Km kmR sacB
kmR
sacB
Figure 3.1 Cloning of pRB05. A 0.5 kb internal fragment (IF) of phaC was amplified using
primers that inserted BamHI restriction sites on both ends of the fragment. The IF and parent
plasmid pJQ200mpl8km were digested with BamHI then ligated together to generate the
plasmid pRB05.
Construction of the homologous recombination plasmid pRB05. For reasons that are
unclear, the clean deletion strain AphaC could not be prepared by the precise deletion methods
described below that were used to prepare AphaP and AphaR. Therefore a disruption mutant
strain was constructed in which the homologous recombination plasmid pRB05 was inserted in
the middle of phaC, conferring kanamycin (21) resistance. pRB05 was prepared from
pJQ200mp 18Km, which encodes km resistance (kmR) as a marker for successful gene disruption
(Table 3.2) (Figure 3.1) (18). pRB05 contains a 0.5 kb internal fragment of phaC which
undergoes recombination with phaC in the genome to insert pRB05. The resulting mutant strain
is referred to as phaC:km. To construct pRB05, a 0.5 kb internal fragment ofphaC (consisting of
bp 976-1474 of phaC) was amplified using GoTaq polymerase and the primers
phaCIntfw/phaCIntrev (Table 3.1), which insert BamHI sites to the 5' and 3' ends of the
amplified product. The phaC internal fragment and parent plasmid pJQ200mpl8Km were
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digested with BamHI and the ligation was carried out overnight with T4 DNA ligase at RT at an
insert to vector ratio of 5:1 to generate pRB05. The ligation reaction was transformed into E. coli
XL1O Gold cells and plated on LB/agar containing 50 ptg/mL km. Twenty-four colonies were
screened by colony PCR using the primers phaCIntfw/phaCIntrev (Table 3.1). Six colonies
containing the insert were grown overnight in 5 mL LB containing 50 pg/mL kin, and the
plasmids were isolated and submitted for sequencing at the MIT Biopolymers Laboratory.
Homologous recombination to prepare the phaC:km strain. pRB05 was introduced into
wt C. crescentus (250 l cells of OD 60 0 = 20 in PYE) by electroporation at RT for 1 s at 1.5 V (T
= 5 msec) using a Bio-Rad E. coli Pulser. Following electroporation, 1 mL of PYE was added to
the reaction and it was incubated for 2 h at 30 C with gentle rotation. The transformation
reaction was centrifuged at 4 C for 10 min at 10,000 xg to pellet the cells and the supernantant
was decanted. The cells were resuspended in 100 ptL fresh PYE and plated on PYE/agar
supplemented with 25 pg/mL km to select for incorporation of pRB05 into the genome. Eleven
km resistant colonies were screened by colony PCR using two reactions. The first reaction was a
positive control using the primers phaZfw/phaZrev to amplify the putative phaZ, with an
expected size of 1.3 kb. The second reaction used the primers phaCfw/phaCrev, with an expected
product size of 2 kb (if phaC is intact) or no product if phaC is disrupted, because the inserted
sequence would be >10 kb and likely not successfully amplified. All eleven km resistant colonies
screened contained the phaC disruption. The disruption was further confirmed by Western blot
analysis, which failed to detect PhaCc. The cells also did not produce PHB when grown 24 h in
PHBP medium.
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3.2.6 Homologous recombination to construct the AphaP and AphaR mutant strains
UR DR
5,- - -3, 5---| -=3, NdelBamHI Ndel NdeI BamHI
BamHI amHI
+ UR DR
BamHI BamHI 3-wayligati n* pRB02
or
pRB03
kmR
sacB
Figure 3.2 Cloning of pRB02 and pRB03. Upstream region (UR) and downstream region (DR)
fragments (0.3 kb each) of sequence flanking phaP or phaR were amplified using primers to
insert the indicated restriction sites. The UR and DR fragments of phaP or phaR were digested
with NdeI and BamHI and parent plasmid pJQ200mp I8km was digested with BamHI. The UR
and DR of phaP and the UR and DR of phaR were ligated into pJQ200mp I8km to generate
pRB02 and pRB03, respectively.
Construction of homologous recombination plasmids pRB02 and pRB03. pRB02 and
pRB03, derivatives of the parent plasmid pJQ200mp I8Km, were used to construct the precise
deletion strains AphaP and AphaR, respectively. pJQ200mp 18Km encodes kanamycin resistance
(kMR) and sucrose sensitivity (sacB) selection markers for homologous recombination. pRB02
contains a 0.3 kb region located immediately upstream of phaP ligated adjacent to a 0.3 kb
region located immediately downstream of phaP. Similarly, pRB03 contains a 0.3 kb region
located immediately upstream of phaR ligated adjacent to a 0.3 kb region located immediately
downstream ofphaR. These plasmids are diagrammed in Figure 3.2.
For construction of pRB02, 0.3 kb fragments of the upstream region (UR) and
downstream region (DR) immediately adjacent to the phaP open reading frame were amplified
separately from C. crescentus by colony PCR. To amplify the UR and insert BamHI and NdeI
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restriction sites on the 5' and 3' ends, respectively, the primers phaPURfw/phaPURrev and
GoTaq polymerase were used (Table 3.1). To amplify the DR and insert NdeI and BamHI
restriction sites on the 5' and 3' ends, respectively, the primers phaPDRfw/phaPDRrev and
GoTaq polymerase were used. The UR and DR PCR products were purified and digested with
NdeI and BamHI. The digested UR and DR fragments were then combined with BamHI-digested
pJQ200mpl 8Km in a ratio of 5:5:1 (UR:DR:pJQ200mpl 8Km) and ligated using T4 DNA ligase.
For construction of pRB03, 0.3 kb UR and DR fragments of the putative phaR open
reading frame were amplified and inserted into pJQ200mp 18Km by a method identical to that
used for pRB02, except that the primers used were phaRURfw/phaRURrev (Table 3.1).
The ligation reactions to generate pRB02 and pRB03 were transformed into E. coli XL 10
Gold cells and plated on LB/agar containing 50 pig/mL km. Twenty-four colonies of each
transformation were screened by colony PCR using the primers phaPURfw/phaPDRrev (for
pRB02) and phaRURfw/phaRDRrev (for pRB03). Six colonies containing insert were grown
overnight in 5 mL LB containing 50 pg/mL km, and the plasmids were isolated and submitted
for sequencing at the MIT Biopolymers Laboratory.
Homologous recombination to prepare the AphaP and AphaR strains. pRB02 and pRB03
(500 ng) were introduced into wt C. crescentus (250 p.L cells of OD 60 0 = -20 in PYE) by
electroporation at RT 1.5 V for 1 s (,r = 5 msec) using a Bio-Rad E. coli Pulser. Immediately
following electroporation, 1 mL of PYE was added and the cells were grown 2 h at 30 *C with
gentle rotation. The transformation reactions were centrifuged at 4 'C for 10 min at 10,000 xg,
the supernatant was decanted and the cells were resuspended in 100 p.L PYE and plated on
PYE/agar supplemented with 25 ptg/mL km to select for the first recombination event (insertion
of the plasmid into the genome). After two days growth at 30 'C, the km resistant colonies were
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grown overnight at 30 *C in 5 mL PYE in 125 mL flasks with shaking at 220 rpm to allow
excision of the plasmid from the genome (with or without the gene of interest). Five pL of the
overnight cultures was plated on PYE/agar supplemented with 3% w/v sucrose to select for
excision of the plasmid. The plates were incubated for two days at 30 'C. Each sucrose
insensitive colony was then streaked out twice, once onto PYE/agar containing 25 pg/mL km
and once onto PYE/agar containing 3% sucrose. The colonies that were sucrose insensitive and
km sensitive had successfully excised the plasmid from their genome.
Screening of km sensitive/sucrose insensitive colonies to identify mutant strains. Colonies
that were both km sensitive and sucrose insensitive were then screened by PCR to confirm the
mutations. Eight AphaP transconjugants were screened to confirm excision of phaP from the
genome. A wt C. crescentus colony was also included as a control. Each colony was screened by
three different PCR reactions. The first reaction was a positive control using the primers
phaCfw/phaCrev, which amplified phaC (expected product size 2 kb). The second reaction used
the primers phaPfw/phaPrev to amplify phaP, with expected product sizes of 0.42 kb if phaP is
present, or no product if phaP is excised. The third reaction used the primers
phaPURfw/phaPDRrev, which anneal 0.3 kb upstream and 0.3 kb downstream of phaP and
amplify the sequence between. In this reaction, if phaP is present the expected product size is 1
kb, whereas if phaP is deleted, the expected product size is 0.6 kb. One colony of the eight
screened contained the products of the expected sizes for a AphaP transconjugant.
Eleven AphaR transconjugants were screened to confirm excision of phaR from the
genome. A wt C. crescentus colony was also included as a control. Each colony was screened by
three different PCR reactions to confirm excision of phaR. The first reaction was a positive
control using the primers phaCfw/phaCrev, which amplified phaC (expected product size 2 kb).
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The second reaction used the primers phaRIntfw/phaRIntrev, which anneal to internal portions of
phaR. If phaR is intact, the expected product size is 0.4 kb (an internal fragment of phaR), and if
phaR is excised no product is expected. The third reaction used the primers
phaRExtfw/phaRExtrev, which anneal 0.3 kb upstream and 0.3 kb downstream of phaR. If phaR
is intact, the expected product size is 1.2 kb. If phaR is excised, the expected product size is 0.6
kb. The reaction containing the primers phaRExtfw and phaRExtrev produced inconclusive
results in wt C. crescentus as the reaction failed to amplify a band. However, in a single AphaR
transconjugant of the eleven screened, a 0.6 kb fragment was amplified using primers
phaRExtfw/phaRExtrev, and no product resulted from the reaction using the primers
phaRIntfw/phaRIntrev. These observations suggested that phaR had been excised in this colony.
To confirm this expectation, the 0.6 kb PCR product amplified using the primers
phaRExtfw/phaRExtrev was ligated into pCR-TOPO 2.1 (Invitrogen) following the
manufacturer's protocols. The ligation product was transformed into E. coli TOP10 cells for
amplification, and the sequencing analysis at MIT Biopolymers confirmed the excision ofphaR.
3.2.7 Preparation of samples for PHB quantitation and Western blot analysis
Aliquots of cells were withdrawn from PHBP cultures of wt, AphaP and AphaR at various
time points for preparation of Western blot and crotonate analysis. For the 0 h time points, 40
mL of PYE "starter" culture (grown 4-5 h to OD 600 =0.15) was withdrawn. For the 7.5 and 10 h
time points, 30 mL of PHBP culture was withdrawn. For the remaining time points, 25 mL of
PHBP culture was withdrawn. Aliquots were centrifuged at 4 'C for 10 min at 5,000 xg to pellet
the cells. Cell pellets were rinsed by resuspension in 15 mL ice cold ddH20 and pelleted again by
centrifugation at 4 'C for 10 min at 5,000 xg. The pellets were then resuspended in 0.75-1 mL of
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ddH20 and the OD 600 of the suspension was determined from a 1:50 dilution in ddH20. The
number of cells in the suspension was calculated using the conversion factor that an OD 600 of 1
corresponds to 1.1 x 106 cells/ptL. This conversion factor was determined by preparing 106-, 107-
and 10 8-fold dilutions of a saturated overnight PYE culture, plating 100 pL of each concentration
in triplicate on PYE/agar, and counting the colonies after 2 days of growth at 30 'C. The cell
suspensions were then lysed by sonication using a VirSonic100 Sonicator (SP Industries,
Warminster, PA) set to a power setting of 3-4. Each sample was sonicated on ice by 30 x 1 s
pulses separated by 1 s pauses to prevent overheating.
For Western samples, 150 tL of the lysed suspension was combined with 150 p1L
Laemmli buffer (20) and the samples were frozen in liquid nitrogen and stored at -80 'C until use
(within two weeks). For crotonate samples, the remaining lysate was added to pre-weighed
borosilicate vials (16 x 125 mm) (Corning, Corning, NY) then dried overnight in a 120 'C oven.
3.2.8 Crotonate assay analysis of PHB content in cell samples
Following overnight drying, the dry weight of each crotonate sample (typically 10-20
mg) was determined and the samples were boiled in 1 mL concentrated H2 SO 4 for 30 min for
analysis of PHB content by the crotonic acid assay (22). Samples or dilutions of samples (25
pL), containing 2.5-250 pg of PHB, were injected onto a Bio-Rad Aminex HPX-87H organic
acid column connected to a Waters 515/2487 HPLC and eluted with 5 mM H2 S0 4 at a flow rate
of 0.5 mL/min at 50 'C with monitoring of absorption at 210 nm. The temperature was
controlled by a Waters Column Heater. The retention time for crotonic acid was 33 min. A
standard curve of PHB (2.5-250 pg) versus peak area was generated from commercially
available PHB (Fluka).
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3.2.9 Quantitative Western blot analysis to measure PhaP and PhaC expression levels
For PhaP Western blots, gels were loaded such that each lane contained approximately
~7.5 x 107 cells. To prepare samples for the standard curve, 7.5 x 107 AphaP cells were spiked
with recombinant PhaP (25-300 ng). Each time point was measured in triplicate from three
different cultures. For PhaC Western blots, gels were loaded such that each lane contained ~7 x
107 cells and the standard curve (1-10 ng) was prepared from recombinant His6-PhaC. The
standard curve was not spiked with the phaC:km mutant strain.
Samples were resolved by 10% (for PhaC Western blots) or 15% (for PhaP Western
blots) Criterion precast SDS-PAGE gels (Bio-Rad). Samples were blotted onto PVDF
membranes (Immun-Blot, Bio-Rad) for 80 min at 100 V on ice in a Criterion wet blotting
apparatus (Bio-Rad). The blotting buffer contained 25 mM Tris base, 192 mM glycine, 0.01%
SDS (w/v) and 15% methanol (v/v). The blots were then blocked in blocking buffer containing
3% milk (w/v) in Tris-acetate-EDTA (TAE) buffer with 0.1% Tween-20 (v/v). The primary
rabbit antibodies for PhaP and PhaC were used without further purification. Blots were incubated
with anti-PhaP antibody (1:5000 diluted) or anti-PhaC antibody (1:2000 diluted) in blocking
buffer for 1 h at RT, then rinsed 3 x 5 min in 50 mL phosphate buffered saline (PBS).
For PhaP Westerns, the secondary antibody was goat anti-rabbit antibody conjugated
with horseradish peroxidase (Thermo Scientific, Rockford, Ill.), used at a 1:2000 dilution in
blocking buffer. For PhaC Western blots the secondary antibody was also goat anti-rabbit
conjugated with horseradish peroxidase, but from a different supplier (Santa Cruz
Biotechnology, Santa Cruz, CA). The blots were incubated in secondary antibody for 1 h at RT,
then rinsed 3 x 5 min in 50 mL PBS. The blots were developed using SuperSignal@ West Femto
Maximum Sensitivity Substrate (Thermo Scientific) and imaged using a BioRadChemiDoc XRS
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imager. Signals were analyzed using the Quantity-One® software and quantitated by comparison
to the standard curves.
The rationale for using two different antibodies was based on the observation from
preliminary Western blots that the secondary antibody from Santa Cruz Biotechnology was more
sensitive than the secondary antibody from Thermo Scientific. While the secondary antibody
from Thermo Scientific was sufficiently sensitive to detect PhaP, PhaC was more difficult to
detect and required the higher sensitivity secondary antibody from Santa Cruz Biotechnology.
3.2.10 Gel permeation chromatography (GPC) analysis of PHB molecular weight.
Preparation of samples for extraction of PHB into chloroform. Samples of varying
volumes were withdrawn from PHBP cultures at various time points. The volume was dependent
on the predicted PHB content as determined by crotonic acid analysis. For a given time point,
measurements were made from three samples taken from three individual cultures. For wt cells
at 0 h, 500 mL PYE "starter" cultures were centrifuged at 10,000 xg for 20 min at 4 'C to pellet
the cells. To accumulate enough cell mass, nine separate 500 mL cultures were grown in three
separate growths. The three cultures in each growth were combined into one GPC sample. For wt
cells at 10 h, 500 mL PHBP culture was centrifuged to pellet the cells. For wt 20 h and 40 h
samples, 200 mL PHBp culture was centrifuged at 4 'C for 20 min at 10,000 xg to pellet the cells.
The cell pellets were resuspended in 5-10 mL ddH20 and transferred to 50 mL Falcon tubes. The
samples were frozen in liquid nitrogen and lyophilized to dryness. For the 0 h and 10 h samples,
the lyophilized cells (70 mg) were divided into ~20 mg portions, which were placed into
borosilicate tubes (16 mm x 125 mm) for extraction into chloroform. For the 20 h and 40 h time
245
points, 20 mg cells was removed and placed into a borosilicate tube for extraction into
chloroform.
For AphaP cells, 500 mL PHBP culture grown 24 h was centrifuged at 10,000 xg for 20
min at 4 'C to pellet the cells. The supernatant was decanted and the samples were resuspended
in 5 mL ice cold ddH20, transferred to 50 mL Falcon tubes and frozen in liquid nitrogen and
lyophilized to dryness. The resulting lyophilized cell masses (~200 mg) were divided into 20 mg
portions, which were transferred to borosilicate tubes (16 mm x 125 mm) for extraction into
chloroform. For AphaR cells, 200 mL PHBP culture grown 24 h was centrifuged at 10,000 xg for
20 min at 4 'C to pellet the cells. The cell pellets were resuspended in ~10 mL ice cold ddH20
and transferred to 50 mL Falcon tubes. The samples were frozen in liquid nitrogen and
lyophilized to dryness. From the lyophilized cell mass, a single 20 mg portion was transferred
into a borosilicate tube for extraction into chloroform.
Extraction of PHB by refluxing in chloroform. One magnetic stir bar was added to each
sample, the tubes were capped with rubber septa and each septum was pierced with a glass
Pasteur pipette. This set-up was designed to function as a makeshift condenser such that upwards
of 30 individual samples could be prepared at a time. PHB was extracted by refluxing in
chloroform at 70 'C for 48 h with stirring. Care was taken to thoroughly resuspend the
lyophilized material in the chloroform by disrupting clumps with a spatula and vigorous stirring.
After extraction, the cell debris was removed by filtration using a glass syringe fitted with a 13
mm syringe filter with a 0.45 ptm PTFE membrane (Perkin Elmer, Hopkinton, MA). Each filter
was washed with 3-5 mL fresh chloroform, which was added to the filtrate. Excess chloroform
was evaporated under a stream of air to bring the samples to a final concentration of ~3 mg/mL
as determined by crotonic acid assay. The volume of the final sample varied between 200 [tL and
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2 mL. The extraction efficiency was determined by crotonic acid assay of 25-100 pL of the
extracted material. Typical efficiencies were 30-40%.
Analysis of PHB M, and PDI by GPC. Samples (100 pL) were injected onto a 2 x 300 x
7.5 mm Plgel Olexis column (VWR, Rador, PA) connected to an HPLC with a refractive index
detector (Waters, Milford, MA) and eluted at a flow rate of 1 mL/min with chloroform at 30 'C.
The temperature was controlled with a Waters Column Heater. Isopropanol (retention time, 21
min) was used as an internal standard at 1% v/v in each sample to adjust sample peak retention
times. The retention times of the eluted material were compared to a set of polystyrene standards
(Varian) of molecular weights (retention time): 3.1 kDa (17.8 min), 10 kDa (17 min), 73 kDa
(15.4 min), 205 kDa (14.8 min), 490 kDa (13.9 min), 1800 kDa (12.9 min), 5000 kDa (12.4
min). The Mw and PDI of each sample was determined using the PSS WinGPC Unity software
(Polymer Standards Service, GmbH, Mainz, Germany) and a standard curve prepared as
described in section 3.2.11 from the polystyrene standards.
Calculation of the M, and PDI of a sample using the adjusted calibration curve. For a
given sample, the data are exported as a .cdf file, which is the file format supported by the PSS
WinGPC Unity software. For data analysis, the first step is to adjust the retention time of
isopropanol to 21 min. The retention time of isopropanol can vary between 21 - 21.5 min. The
second step is to import the adjusted calibration curve, prepared as described below. The third
step is to manually select the peak of interest using the cursor, and the software automatically
applies the adjusted calibration curve to generate the M., Mn, PDI and other values of interest.
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3.2.11 Preparation of an accurate calibration curve to calculate the M, and PDI of PHB
extracted from C. crescentus
Determination of the absolute M, of PHB by static light scattering (SLS). SLS
experiments were carried out by Dr. Mimi Cho in order to determine the M, of a PHB standard.
This M, was used to adjust the calibration curve prepared using polystyrene standards as
described below, in order to account for differences in peak broadening and migration between
PHB and polystyrene. In SLS, the M, of a polymer is determined using the Rayleigh equation
(Equation 3.1).
KC IEquation 3.1 = +22C)PR9  MW
The Rayleigh equation relates the ratio of scattered light to incident light (Ro) of a sample to its
M,. K is the optical constant, C is the sample concentration, A2 is the 2nd virial coefficient
related to solute/solvent interaction, and Po is the angular dependence of the scattering intensity
(23, 24). For the purposes of SLS, the particle size is assumed to be smaller than the wavelength
of incident light and the concentration of sample is sufficiently dilute to prevent multiple photon
scattering. These assumptions allow Po to be approximated as one, simplifying the Rayleigh
equation to Equation 3.2.
Equation 3.2 KC 1 +2,2C
R9  MW
A Debye plot of KC/Ro versus C is generated by measuring R at various sample concentrations.
Equation 3.2 is the linear function that describes the Debye plot, in which the y-intercept is the
M, of the polymer sample and the slope is A2. R0 values are determined in the SLS experiment
using Equation 3.3.
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In 2
Equation 3.3 R =A 2 RT
In Equation 3.3, IA is the scattering intensity of the solute, IT is the scattering intensity of toluene
(the reference standard), n, is the refractive index of the solvent, nT is the refractive index of
toluene (1.50), and RT is the Rayleigh ratio of toluene (1.35 x 10-) (23).
K in Equation 3.2 is the optical constant and is determined using Equation 3.4, where k is
the wavelength of incident light, NA is Avogadro's number, n0 is the refractive index of the
solvent, and dn/dC is the differential refractive index of the solute.
2n 2 dn 2
Equation 3.4 K = (n )
,VNA dC
For SLS experiments, PHB was extracted into chloroform from R. eutropha grown 24 h
in PHBhigh, then 100 pL of a 3 mg/mL solution of extracted PHB was injected onto the GPC
column as described in the previous section. The peak containing PHB (retention time 10-15
min) was collected and the sample was dried under a stream of air. The residue was then
dissolved in 2,2,2,-trifluoroethanol (TFE) to -2 mg/mL and the solution was filtered through a 4
mm glass syringe fitted with a 0.2 pm PTFE membrane (VWR). To determine the exact
concentration of the sample, an aliquot was removed for crotonate analysis. Dilutions of the PHB
solution (0.05-0.2 mg/mL) were prepared in TFE for analysis by SLS. SLS experiments were
carried out on a Malvern Zetasizer ZS instrument (Malvern, Worcestershire, UK) with a 633 nm
laser. The refractive index of the solvent TFE (n0) is 1.291 (25). The differential refractive index
of PHB was previously determined to be 0.150 mL/g (26, 27). Two different SLS experiments
were carried out from two different GPC purifications of PHB and the M, was 990 kDa ± 50
kDa.
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Generation of the calibration curve. The calibration curve correlates retention times with
the known peak molecular weight (28) of the polystyrene standards described in section 3.2.10.
The logMp of the standards were plotted against their retention times using the PSS WinGPC
Unity software. The data were fit to a 2 "d degree polynomial (logMp = AV2 + BV + C), where A,
B and C are constants and V is the retention volume. The absolute Mw of PHB determined by
SLS was then used to adjust the calibration curve to account for differences in peak broadening
and migration between PHB and polystyrene. This adjustment was done using Equations 3.5 and
3.6.
1 1 1
Equation 3.5 1g MPHB = (log-)+ logMpoystrer5+a K 1+a
L[(MPHB) *I,
Equation 3.6 M = N
~IV
V=1
Equation 3.5 is the Mark-Houwink relation, which relates the molecular masses of two different
polymers (PHB and polystyrene in our experiments). K and a are relative intrinsic viscosity
parameters (29) and logMpoystyrene is the 2nd degree polynomial described above. Equation 3.6 is
the mathematical definition of M, and Iv is the differential refractive index signal from GPC and
(MPHB)V is the molecular mass of PHB at a given retention volume (V).
The PSS WinGPC Unity software finds values for K and a that satisfy both equations.
The values Iv and V come from the SLS experiments with the PHB standard and the GPC trace
of the PHB standard, respectively. When satisfactory values for K and a have been obtained, the
software reports a function of logMPHB versus V, also a 2nd degree polynomial. This function is
the adjusted calibration curve that was used to obtain the M, and PDI values for all GPC
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samples described in this chapter. Equations 3.7 and 3.8 are applied by the program to calculate
the number average molecular weight (MN) and PDI, respectively.
N
Equation 3.7 Mn = N "I
I v (MPHB )v
V=I
Equation 3.8 PDI = w
Mn
3.2.12 Quantitation of PHB and PhaP in the soluble fractions of wt C. crescentus grown in
PYE
Two 500 mL PYE cultures in 4 L baffled flasks were inoculated by the same protocol as
described in section 3.2.2. The cultures were grown at 30 'C for 15 h with shaking at 220 rpm.
The cells were then pelleted by centrifugation for 10 min at 10,000 xg at 4 'C. The supernatant
was decanted and the cells were resuspended in ~40 mL of cold 20 mM Hepes pH 7.5, 20 mM
NaCl. The cells were lysed by two passes at 4 'C through the French pressure cell at 14,000 psi.
For one culture, the lysate was transferred to a 50 mL pear-shaped flask, shell frozen in liquid
nitrogen and lyophilized. The resulting cell material was refluxed in 20 mL chloroform with
stirring for 48 h at 70 *C for GPC analysis. The sample was prepared and analyzed as described
above. For the other culture, Western blot and crotonate samples were prepared from the whole
cell lysate and analyzed as described above. The soluble and insoluble fractions were then
separated by centrifugation at 4 'C for 20 min at 30,000 xg. The soluble fraction was decanted
and set aside. The insoluble fraction was resuspended in 20 mM Hepes pH 7.5, 20 mM NaCl to a
volume equal to that of the soluble fraction. Samples for crotonate and Western blot analysis
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were prepared and analyzed as described above. The remaining soluble and insoluble fractions
were transferred to individual 50 mL pear-shaped flasks and refluxed in ~20 mL chloroform for
48 h at 70 'C for GPC analysis. The samples were then prepared and analyzed as described
above.
3.2.13 Error propagation in calculation of mole ratios of PhaP, PhaC and PHB
The errors (standard deviation from the mean) of measurements of PhaP and PHB levels
were propagated to calculate the error for mole ratios of PHB to PhaP. The following equation
for error propagation for uncertainties in products and quotients was used:
Equation 3.9 Sq = q ( )2 + ( 2 )2
x y
The uncertainty in the ratio q (Sq) is equal to the square root of the sum of the squares of the
fractional uncertainties in x and y (PhaP and PHB concentrations, respectively) times the ratio q
(30).
Because multiple measurements are made in order to calculate the mole ratios, there are
several sources of error. These include cell counting, PHB measurement (which can be a
significant source of error when the cells contain very little PHB), quantitation of protein levels
by Western blot, and M, determination of PHB by GPC. In particular for measurement of PHB
MW, extraction efficiencies were often quite low due to the samples containing very small
amounts of PHB. However, it should be noted that mole ratios are independent of cell counting
and thus have inherently lower error.
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3.2.14 Activity assays to compare PhaC activity in wt and AphaP crude cell lysates
The specific activity of PhaC was measured in crude cell lysates of wt or AphaP cells
grown in PYE medium. The inoculation protocol was as described in section 3.2.2, except that
200 mL PYE cultures (instead of PHBP cultures) in 2 L baffled flasks were inoculated at a
dilution of 1:25. The PYE cultures were grown at 30 C with shaking at 220 rpm until OD 60 0 =
~0.75, at which point the cells were pelleted by centrifugation at 10,000 xg for 15 min at 4 C.
The cell pellets (-0.5 g) were resuspended in 10 mL of 20 mM Hepes pH 7.5, 200 mM NaCl
then lysed by passage twice through the French pressure cell at 14,000 psi. The crude lysates
were immediately assayed in triplicate at 30 C. The crude lysates were not subject to
centrifugation; thus, assays measured the activity in both the soluble and insoluble fractions. It
should be noted that the final assays were not cloudy and did not appear to contain particulate
matter from the insoluble fraction. The assays contained in a final volume of 210 [L: 40 ptL
lysate (A 10 ptg total protein) and 1 mM HBCoA in 20 mM Hepes pH 7.5, 20 mM NaCl. At
various time points 20 ptL aliquots were withdrawn and quenched in 50 piL ice cold 10%
trichloroacetic acid (TCA). Each sample was centrifuged to pellet precipitated protein, and 68 p.L
was withdrawn and added to 262 ptL 0.25 mM 5-5'-dithiobis-(2-nitrobenzoic acid) (DTNB) in
0.5 M K2HPO4 , pH 7.8. The A4 12 of each sample was measured. To calculate specific activity,
the amount of PhaC in each sample was determined to be 14 ng by Western blot analysis carried
out as described in section 3.2.8. The samples for Western blots were prepared by combining
crude lysate with one volume of Laemmli buffer, then boiling for 15 min at 100 C.
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3.2.15 Transmission electron microscopy (TEM)
3.2.15.1 Fixation
The methods for preparation of TEM samples were adapted from (31). To prepare a
typical sample, 25 mL of cell culture grown in PHBP medium was combined 1:1 with 25 mL
fixative containing 2% (v/v) glutaraldehyde, 3% (w/v) paraformaldehyde, 5% (w/v) sucrose in
0.1 M sodium cacodylate, pH 7.4. Samples were mixed with gentle rocking for 1 min, then
centrifuged for 10 min at 7000 xg at 4 'C. The cell pellets were resuspended in 10 mL fresh
fixative and incubated for 1 h at 4 'C with gentle rocking. After fixation, the cell pellets were
washed three times in 1 mL of 0.1 M sodium cacodylate pH 7.4 by centrifugation at 7000 xg at 4
'C. After fixation and for the rest of the sample preparation, the cell pellets were hard and did not
readily dissociate into individual cells or clumps of cells. The pellets were therefore "dislodged"
with a toothpick from the bottom of the sample tube into the various solutions and broken apart.
The cell pellets were then dislodged into 1 mL of 1% OsO4 solution in Veronal-acetate buffer
(0.24% (w/v) sodium acetate, 0.58% (w/v) sodium barbitol, 0.02 N HCl) and incubated for 1 h at
RT with gentle rotation. Samples were centrifuged for 5 min at 14,000 xg, and the supernatant
was removed. One mL Kellenberger uranyl acetate stain (0.5% uranyl acetate in Veronal acetate
buffer) was then added to each sample, and the pellets were dislodged and broken apart, then
incubated overnight for additional staining.
3.2.15.2 Dehydration
Following uranyl acetate staining, the uranyl acetate was removed and the pellets were
dehydrated by incubation in increasing concentrations of ethanol. The pellets were dislodged into
1.5 mL 50% (v/v) ethanol in ddH20 and rotated gently on a nutating mixer at RT for 10 min,
then centrifuged 1 min at 14,000 xg and the supernatant decanted. This process was repeated
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with 70%, 90% and 95% ethanol, and repeated three times with 100% ethanol. The pellets were
then dislodged into 1 mL of a mixture of 50% (v/v) ethanol, 50% (v/v) propylene oxide for 5
min, then 100% propylene oxide for 5 min. Finally the pellets were dislodged into 1 mL of a
mixture of 50% (v/v) propylene oxide, 50% (v/v) low viscosity embedding resin (23) and
incubated overnight at RT.
3.2.15.3 Embedding
The pellets were transferred into 1.5 mL 100% LVER, placed under vacuum at RT for 4
h, then exchanged into fresh 100% LVER. This process was repeated three times. After the final
incubation in LVER the samples were centrifuged 1 min at 14,000 xg and then LVER was
removed. The pellets were then placed on a clear surface (typically a plastic petri dish) and cut
into smaller pieces (~1-2 mm) using a toothpick. Several pieces of each sample were then
embedded in flat silicone molds in ~250 [tL fresh 100% LVER. The samples were cured for 48 h
at 60 0C.
3.2.15.4 Sectioning and microscopy
Sectioning and imaging were carried out at the W.M. Keck Microscopy Facility at the
Whitehead Institute (Cambridge, MA). Sectioning was performed by Dr. Mimi Cho. Sections
(70-80 nm thick) were cut from each beam capsule using a Reichert Ultracut E Ultramicrotome
equipped with a Diatome diamond knife. Sections were scooped up by 200-mesh Formvar coated
nickel grids. Samples were then imaged using an FEI Technai Spirit Transmission Electron
Microscope at 80 kV at the W.M. Keck Microscopy Facility at the Whitehead Institute for
Biomedical Research. To estimate the bias of granules in 9 h wt cultures towards the perimeter
of the cells, a total of 322 granules from 220 cells were examined. The cells were selected from
18 micrographs collected from three separate growths and had a long axis of >1 gm parallel to
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the plane of the micrograph, which accounted for 25-30% of the total cells in each micrograph. A
line was drawn carefully down the center of the cell, and the distance of each granule from this
line was measured to determine whether the granules were located closer to the edge of the cell
or the center. To determine the distribution in numbers of granules per cell in 9 h wt cultures, the
same cells with an axis of >1 ptm were examined. The same analysis of numbers of granules per
cell was carried out on selected cells in 24 h wt cultures (177 cells from 10 micrographs), 24 h
AphaP cultures (276 cells from 13 micrographs) and 24 h AphaR cultures (182 cells from 10
micrographs). The diameter of granules was measured in mm and converted into nm using the
scale bar. While measuring an accurate diameter of granules requires serial slicing and
tomography, measuring the range of diameters of hundreds of granules can provide a range in
which the typical granule falls.
3.3 Results
3.3.1 Growth of wt C. crescentus in nitrogen-limited medium
In order to characterize PHB accumulation in C. crescentus, it was first necessary to
identify suitable and reproducible growth conditions. Several media have been reported in the
literature for growth of C. crescentus (32). The most common rich medium used in the
laboratory is PYE, which contains 0.2% peptone, 0.1% yeast extract, 0.5 mM CaCl2 and 1 mM
MgSO 4. At peptone concentrations higher than 0.5%, cells become unusually elongated, thus
PYE is suitable for growth of C. crescentus because it is low in nutrients compared to typical
rich media (15). Several minimal media have also been reported for growth of C. crescentus
(32). Growth in M2 minimal medium was first reported by Johnson and Ely in 1976 and is now
the most common medium for growth of cultures on defined minimal medium (33). C.
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crescentus can utilize a variety of compounds as its sole carbon source, the most common of
which in laboratory cultures is glucose. These guidelines as well as previous studies discussed
below informed our preliminary examinations of growth conditions.
Two preliminary growths were carried out. The first growth reproduced the results of Qi
and coworkers, who reported PHB accumulation in C. crescentus to -18% cdw after 60 h growth
at 30 C in PYE medium lacking Ca2+ and supplemented with 1% glucose, referred to as PYE(-)
medium (16). Their rationale for choosing PYE(-) was not clear from the paper; however' earlier
studies suggested a role for Ca 2+ in phosphate uptake into the cell. Therefore, Ca2+ starvation
may indirectly cause phosphate limitation (34). To reproduce their results, 50 mL PYE cultures
in 500 mL baffled flasks were grown to saturation (15 h, OD6 00 = 1.4) and the cells pelleted and
washed with 0.85% saline. PYE(-) cultures (grown in duplicate in 2.8 L baffled flasks) were
inoculated with the washed cells and grown 24 h. The two cultures reached a final OD 600 = 4.3
and contained 18 and 24% PHB cdw.
The second set of preliminary growth conditions reproduced the results of Dr. Chris
Brigham (Sinskey lab at MIT), who reported PHB accumulation to -19% cdw in a modified M2
salts minimal medium supplemented with 1% glucose, referred to as modified M2G (Brigham,
unpublished data). In this media the concentration of NH4 Cl was reduced to 2.3 mM, 25% of the
concentration in the standard growth conditions. Modified M2G medium was adapted from
growth conditions previously used to study gene expression in C. crescentus during nitrogen
limitation (35). To reproduce Brigham's results, 50 mL PYE cultures in 500 mL baffled flasks
were grown to saturation, pelleted and washed in 0.85% saline. The washed cells were then used
to inoculate 2 x 1 L modified M2G cultures in 2.8 L flasks. The cultures were grown 24 h and at
this time were saturated at an OD 60 0 = 0.7. The two cultures contained 6.5 and 16% PHB cdw.
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These preliminary studies suggested that while Brigham's results in M2G could be
reproduced to induce PHB accumulation, the growth protocol did not produce consistent results
between two cultures. Furthermore, while Qi and Rehm's PYE(-) protocol afforded greater cell
masses for a given culture volume, the exact nature of nutrient limitation was not clear in this
medium. Therefore, even though modified M2G medium resulted in lower cell masses, it was
pursued in our studies, and will henceforth be referred to as PHBp (PHB production) medium.
Initial attempts to conduct time course studies of growth and PHB production in wt cells
grown in PHBP medium were complicated by the fact that the cultures had long and variable lag
phases of 4-12 h preceding logarithmic growth. It was therefore necessary to develop an
inoculation protocol in which reproducible lag phases in growth could be achieved. In this
protocol, which is outlined in Figure 3.3, single colonies grown on PYE/agar plates were used to
inoculate 50 mL PYE cultures in 500 mL baffled flasks, which were grown overnight to
saturation. A second set of 50 mL PYE "starter cultures" was then inoculated with 2 mL of the
saturated overnight culture, and grown to early log phase (0D600 = 0.15, 4-5 h post inoculation).
Finally, 500 mL PHBP cultures in 4 L baffled flasks were inoculated directly with 25 mL of
starter culture (without first rinsing cells in saline to remove PYE).
Several aspects of this protocol contribute to the reproducibility of growth. First, oxygen
limitation can lead to filamentous cells and irregularities in cell division (32), therefore cultures
were always grown in baffled flasks with 7-10x volume in head space relative to the culture
volume. Second, inoculation of minimal medium with saturated cultures in stationary phase can
lead to the long and variable lag phases observed in preliminary growths, thus PHB, cultures
were always inoculated with PYE starter cultures in early log phase. And finally, 500 mL PHBP
cultures were inoculated with 25 mL of PYE culture directly (i.e. without first washing the cells
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with saline) to provide a small amount of "carryover" nutrients in the minimal medium. As a
result of these modifications to the growth protocol, a reproducible lag phase of -5 h and
subsequent growth were achieved.
Single
1. PYE plate colony 2. Overnight culture grownto saturation (15 h)
1:25 dilution
1:25
4. PHB, culture < dilution 3. Starter culture grown to
4.PButure OD600 = 0. 15 (4-5 h)
Figure 3.3 Schematic of growth protocol. All growth in liquid media was carried out at 30 'C
with shaking at 220 rpm. Individual colonies grown 2 days at 30 'C on PYE/agar plates were
used to inoculate 50 mL liquid PYE cultures in 500 mL baffled flasks. These cultures were then
grown overnight to saturation. Two mL of overnight culture was then used to inoculate 50 mL
liquid PYE starter cultures in 500 mL baffled flasks. These starter cultures were grown 4-5 h
until they reached an OD 600 = 0.15. The starter cultures were then diluted 1:25 into 500 mL of
PHBp growth medium in 4 L baffled flasks for growth and PHB accumulation.
Having optimized the growth conditions, the growth and PHB levels in wt C. crescentus
grown in PHBP medium were measured in three separate cultures. Following a 5 h lag phase, the
cultures grew with a doubling time of 3 h until OD 60 0 = 0.6 (after 15 h), then continued to grow
more slowly (Figure 3.4). After prolonged growth in minimal medium, nutrients are depleted and
C. crescentus growth slows and the duration of the swarmer stage increases (35). This is
reflected in the slowed growth from 15 h to 36 h. By 36 h the cultures reach an OD6 0 0 = 1.0, and
little to no additional growth is observed to 72 h.
Samples were taken between 0-72 h to analyze PHB content of the cells by the crotonic
acid assay. PHB accumulates during both the log phase (5-15 h) and the later slow growth phase
(15-36 h). The amount of PHB in the cells increases from 1 ± 0.2% cdw at 0 h to 11 ± 1.8% after
36 h (Figure 3.4). Interestingly, at the early time points the cells contained at least 5x less PHB
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than R. eutropha contains at its minimum, allowing us in this system to monitor PHB production
at the granule initiation phase. From 36 h to 72 h, the cells did not accumulate additional PHB. In
these growths the cells accumulated less PHB than in the preliminary growths reproducing
Brigham's results. The discrepancy between PHB levels might reflect the fact that the flasks
used in the preliminary growths had a smaller head space. Thus, the cultures were likely
inadvertently 0 2-limited in addition to being limited in nitrogen, which may have resulted in
higher PHB levels.
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Figure 3.4 Growth and analysis of PHB levels in wt C. crescentus grown in PHBp growth
conditions. The OD60 0 (e) and amount of PHB (% cdw) (o) were measured at the indicated
growth times. Error bars are standard deviation from the mean of samples from three different
cultures.
3.3.2 Isolation of granules allowed identification of granule-associated proteins
Granules from the above growth conditions were isolated by glycerol density gradient
ultracentrifugation to determine if proteins involved in granule biogenesis could be identified.
Identification of proteins associated with PHB granules can be problematic and the method of
granule isolation must be carefully considered. Isolation methods that are too harsh might
promote dissociation of important factors, precluding their identification. On the other hand,
gentler isolation methods can result in the non-specific co-purification of proteins that are not
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involved in granule biosynthesis. This problem is especially an issue when considering the
hydrophobic nature of PHB granules, which tends to promote non-specific adsorption of
proteins. Therefore, granule-association alone does not necessarily indicate a protein is involved
in PHB biosynthesis.
In spite of these complications, granule association of proteins that are homologs to
known PHB biosynthetic proteins can be informative. A putative phasin (PhaP), intracellular
depolymerase (PhaZ), and homolog of PhaR from R. eutropha are annotated in the C. crescentus
genome. This annotation is based on their sequence similarity to homologs in other organisms.
However, these proteins have not been previously characterized. Phasins, PhaRs and
depolymerases have been shown to be granule associated in several organisms (1, 3, 36-38).
Therefore, to determine whether any or all of these proteins are present on granules in C.
crescentus, they were isolated from wt cultures grown in both PYE(-) and PHBP medium. The
results from a culture grown 24 h in PHBP medium are shown in Figure 3.5, but they are
representative of results achieved in both growth conditions. All purification steps were carried
out at 4 C. The cells were first lysed by French pressure cell, then the granules were purified
from the insoluble lysate fraction by ultracentrifugation over a glycerol density gradient. Three
bands, at the interfaces of the 40% and 70% glycerol layers, the 70% and 80% glycerol layers,
and the 80% and 90% glycerol layers (Figure 3.5A), were collected individually with syringes.
The proteins were resolved by 15% SDS-PAGE then transferred to a PVDF membrane, which
was stained with Coomassie to visualize the proteins (Figure 3.5B). Several protein bands in the
material from the 40%/70% glycerol interface (Figure 3.5B, lane 3) were excised and sent for
sequencing by N-terminal Edman degradation. These bands are indicated with asterisks in Figure
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3.5B. The results were compared to sequences found in the Caulobacter crescentus CB 15
genome (39).
A)
400/o/70A
70%/800A
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B)
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Figure 3.5 Granule isolation by glycerol density gradient ultracentrifugation and SDS-
PAGE (15%) analysis of proteins associated with isolated PHB granules. Granules were
isolated from cultures following 24 h growth in PHBP medium. A) Glycerol density gradient
ultracentrifugation to isolate PHB granules from insoluble cell material. The gradient of 40%,
70%, 80% and 90% glycerol was prepared in 100 mM Tris, 1 mM EDTA, pH 8.0. The interfaces
of these layers are represented next to the gradient as 40%/70%, for example. B) SDS PAGE
(15%) analysis of granule-associated proteins isolated from the different interfaces of the
gradient in A. Lane 1, protein content of band 1. Lane 2, protein content of band 2. Lane 3,
protein content of band 3. The asterisks indicate the bands sent for sequencing. Lane 4, soluble
cell-free extract. Lane 5, molecular weight standards.
The protein migrating just below the 15 kDa protein marker present in all three samples
was noticeably enriched in the topmost, whitest band (Band 3) that sedimented at the interface of
the 40% to 70% glycerol layers (Lane 3, Figure 3.5B). The band was excised and sent for
sequencing, and the 5 N-terminal amino acids of the protein were AAAEN. This sequence is
present in the database in CC_2160 (accession number NP_490263), annotated as "PHB-granule
associated protein, phasin." The sequence AAAEN is found at position 49 of CC_2160, which is
annotated as a 20 kDa protein of 191 amino acids. However the protein as isolated attached to
PHB granules migrates as a ~15 kDa protein (Figure 3.5B). Furthermore, Western blot analysis
of this protein, discussed below, confirms that it is ~15 kDa in whole cells. The annotation
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appears to be incorrect in the database with methionine 48 being the correct translational start
site for the protein. This protein will be referred to as PhaP in the remainder of this thesis. A
BLAST search using the PhaP amino acid sequence does not identify additional phasin-like
proteins in the C. crescentus genome. Furthermore, BLAST searches using the sequences of
PhaP1, 2, 3, 4 and 5 from R. eutropha neither identifies PhaP nor any additional phasin
candidates (3, 40, 41). This is perhaps not surprising, because PhaP1 and PhaP share only 22%
sequence identity and differ in M, by 5 kDa. The phasins from Azospirillum sp. B510 and
Sinorhizobium meliloti are both -15 kDa in M, and share 37% and 39% sequence identity with
PhaP from C. crescentus, respectively. A BLAST search using the sequence of these phasins
identifies PhaP but no additional phasin candidates. Thus, it is likely that C. crescentus has only
a single phasin, which we have identified by its granule association. Recently, an additional PHB
granule-associated protein, PhaM, was identified in R. eutropha (42). The authors proposed that
PhaM is responsible for associating PHB granules with the nucleoid in order to promote even
segregation of granules between daughter cells during division. Neither SDS-PAGE analysis nor
BLAST using PhaM from R. eutropha identified a homologous protein in C. crescentus. In fact,
homologs of PhaM are absent from all sequenced a-proteobacteria genomes (including C.
crescentus) and seem to be exclusive to the P-proteobacteria.
The faint band at ~25 kDa was also analyzed and contained the sequence SENPE. This
sequence is found in the listing CC_0509 (accession number NP_419328), annotated as a 23.8
kDa "hypothetical protein" containing a "PHB/PHA accumulation regulator DNA-binding
domain." This protein has 29% sequence identity to PhaR from R. eutropha and will be referred
to as PhaR in the rest of this thesis. The corresponding gene phaR is located in the C. crescentus
genome immediately upstream of genes whose products are annotated as PhaA and PhaB, the
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putative f-ketothiolase and NADPH-dependent reductase, respectively, required to make (R)-
HBCoA, in the PHB biosynthetic pathway. The association of PhaR with PHB granules and its
homology to PhaR from R. eutropha suggests a role in PHB biosynthesis, which we have
explored in these studies.
The strong band at ~37 kDa contained the sequence MVSFLT and was identified as an
uncharacterized, conserved protein. This protein has 23% homology to a protein from
Oceanicola batsensis annotated as NADH:ubiquinone oxidoreductase 41 kDa complex I subunit.
The observation that it co-purifies with granules may be due to its membrane association rather
than specific granule association. This band is a major granule-associated protein in granule
isolations from PYE(-) cultures as well (data not shown). This finding illustrates the caution that
must be taken when interpreting results from granule isolation experiments.
A band at -50 kDa was excised and submitted for Edman sequencing revealing the amino
acids MLYAL. This sequence is found starting at position 8 in the listing CC_0250 (accession
number NP_419069), which is annotated as a 48 kDa "polyhydroxyalkanoate depolymerase,
intracellular." As is the case with the PhaP sequence, the listing in the database may have
identified the incorrect start methionine in CC_0250. The observation that this protein is
associated with the PHB granule supports the annotation as a PHB depolymerase, as it is known
in several other systems that depolymerases are constitutively expressed and associated with
PHB granules (14). Furthermore CC_0250 shares 45% homology with PhaZal from R. eutropha.
A BLAST search using the CC_0250 sequence does not retrieve other putative PHB
depolymerases, nor does use of any of the R. eutropha depolymerases (PhaZal, PhaZa2, PhaZa3,
PhaZd) as search vehicles in BLAST reveal any additional depolymerases. Using the 78 kDa R.
eutropha oligomer hydrolase PhaZb as a BLAST template does not reveal a homolog in C.
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crescentus. However, using the oligomer hydrolase PhaZc for BLAST reveals that C. crescentus
contains several proteins containing a/n hydrolase domains that are 30-40 kDa in M,. None of
these has been characterized so their involvement in PHB biosynthesis is unknown. Finally, an
additional putative depolymerase, CC_0847 (accession number NP_419664.1), was identified
using the sequence of a protein annotated as an extracellular depolymerase in Pseudomonas
stutzeri (accession number ACG63775) as a search vehicle in BLAST. CC_0847 is annotated as
a 35 kDa "hypothetical protein" containing an esterase lipase domain and an LqpC domain,
which contains the lipase box (GxSxG) that is characteristic of intracellular PHB depolymerases.
Sequencing of the band that migrates at -75 kDa gave DDQKA, which is found
beginning at position 23 in a protein annotated as a 70 kDa outer membrane cobalamin receptor
protein. As with the 37 kDa protein described above, this protein is likely present in the granule-
containing fraction resulting from contamination with membrane material.
Compared to R. eutropha, which has at least five phasins, up to seven intracellular
depolymerases, and two 3-hydroxybutyrate oligomer hydrolases, C. crescentus appears to use a
"simpler" set of PHB biosynthetic proteins, having only a single phasin and one intracellular
depolymerase as well as an additional putative depolymerase.
3.3.3 Construction of phaC:km, AphaP, AphaR strains
In order to investigate the role of PhaP in PHB accumulation, three mutant strains were
constructed. The strain phaC:km, a disruption strain in which a km resistance marker is inserted
in the middle of phaC, was constructed because several attempts to generate the clean deletion
strain of phaC were unsuccessful. The clean deletion strains AphaP and AphaR were
successfully prepared. The mutations of all strains were confirmed by PCR screening and/or
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sequencing, and Western blot analysis of phaC:km and AphaP with anti-PhaC and anti-PhaP
antibodies, respectively, further confirmed the deletions.
3.3.4 Generation and characterization of antibodies against PhaC and PhaP
Antibodies to PhaP and PhaCc, were generated from purified recombinant PhaP and
PhaCc, and used for Western blot analysis of expression levels of PhaP and PhaC during PHB
accumulation. (His)6-tagged PhaCccAN and PhaP were expressed recombinantly in E. coli,
purified by Ni-affinity chromatography as described in Chapter 2, and sent for generation of
rabbit polyclonal antibodies. Antibodies were used without further purification.
We first characterized the antibodies to PhaCcc to determine the M, of PhaCcc in vivo.
As discussed above, studies by Qi and coworkers led them to conclude that C. crescentus
expresses a 73 kDa class I synthase based on cross-reactivity between anti-PhaCRe antibodies and
a band migrating at ~75 kDa in C. crescentus crude extracts (16). However, the cross-reactivity
between their PhaCRe antibodies and PhaCc, was poor and it is difficult to draw a strong
conclusion from their data (see section 1.5.3). Our antibodies to PhaCcc were not very sensitive
and PhaC is present at low amounts in the cells (discussed below). At a dilution of 1:2000, the
PhaC antibody cross-reacted with several bands. Western blot analysis of wt cells in comparison
with phaC:km cells however, identified a strong band that migrated at the position of a His 6-
PhaC standard (75 kDa) that was not present in phaC:km (Figure 3.6). Its position relative to the
75 kDa His 6-PhaC standard suggests that the synthase is in fact the longer 73 kDa protein. This
conclusion is supported by in vitro assays of PhaCcc and His6-PhaCccAN in Chapter 2, in which
the former was shown to have 50-fold higher activity than the latter.
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Figure 3.6 Anti-PhaC Western blots of wt and phaC:km. Each lane contains 3 x 108 cells.
Samples (two of each) were taken from a single culture of each strain grown 24 h in PHBp. The
standard curve was prepared from recombinantly purified His 6-PhaC.
Preliminary PhaP Western blots revealed that antibodies to PhaP were highly specific and
did not cross-react with other bands in whole cell samples of C. crescentus. They were used
without further purification at a dilution of 1:5000.
3.3.5 The M, of PHB is high throughout growth in PHB,
We next wished to quantitatively characterize levels and changes in levels of PHB, PhaP
and PhaC during growth in PHBP. The M, and PDI of PHB in wt cells at various points in PHB
accumulation were first examined. PHB from cells grown 5 h in PYE (starter culture, 0 h time
point in Figure 3.4) and 10 h, 20 h and 40 h in PHBp medium was extracted into chloroform for
GPC analysis. The extraction efficiencies varied from 20-55% (Table 3.3). Several issues affect
the extraction efficiency. Cells grown 0 h or 10 h in PHBp contain only ~1% PHB cdw, and
extraction of very small amounts of material from large cell mass typically results in low
recovery. To increase yield, each of the lyophilized cell samples from 0 h and 10 h time points
(~70 mg per sample) were split into 20 mg fractions, which were individually refluxed in
chloroform. The PHB extracted from all fractions of a given sample was then combined for GPC
analysis. This approach improved the extraction efficiency considerably: when PHB was
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extracted from 70 mg lyophilized cells, the recovery was typically ~10% (data not shown), while
in 20 mg fractions the recovery increased to 30-50% (Table 3.3).
The M, and PDI were determined by comparison to a standard curve generated from
polystyrene standards. Each time point was measured in triplicate from three individual cultures.
The GPC analysis indicates that the M, of PHB is ~325 kDa throughout growth. Even at very
early time points in PHB, growth conditions, when PHB is only ~-% cdw, the M, of the PHB is
high and the PDI is ~2 (Figure 3.7). This result is similar to what was previously reported in R.
eutropha in cells that contain only 5% PHB: its M, is -700 kDa, compared to ~1,000 kDa when
the cells contain 80% PHB cdw (7). As observed with R. eutropha, the elongation rate in vivo
appears to be much faster than the initiation rate, giving rise to full length polymer even at the
earliest time points. Furthermore, the similarities of the M, of PHB throughout the time course
suggest a built in mechanism for chain termination. The PDI remains ~2 from 0-20 h, but PHB
extracted from cells grown 40 h has a higher PDI of ~4.5.
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Figure 3.7 Gel permeation chromatography of PHB extracted from wt C. crescentus grown
in PHB, conditions. A) Overlay of representative GPC traces of PHB extracted from
C. crescentus grown in PHBp medium at the following time points: 0 h (green), 10 h (red), 20 h
(blue), 40 h (magenta), B) Mw (striped) and PDI (gray) of PHB from 0-40 h. Error bars are the
standard deviation from the mean of three separate samples, each taken from a different culture.
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Table 3.3 Percent PHB extracted from lyophilized C. crescentus.
Strain Growth time (h) %PHB extracteda MW PDI
wt 0 53 11 310 ±44 2.0 ±0.3
10 31 7 330 ±27 2.0 ±0.4
20 55 10 310 ±21 2.0 ±0.4
40 36 6 360 ±22 4.4 ±0.4
AphaP 24 26 6 430 ±28 2.1 ±0.6
AphaR 24 21 3 270 ±21 1.8 ±0.2
aExtraction efficiency was determined by crotonic acid assay.
Error bars are the standard deviation from the mean of extraction from three samples, each taken
from a different culture. The values for the individual samples are provided in Table A3.1 in the
Appendix.
3.3.6 Molecules per cell of PHB, PhaC and PhaP in wt C. crescentus as a function of growth
Comparison of the concentrations of PHB, PhaC and PhaP per cell can provide insight
into the roles of PhaC and PhaP in PHB accumulation. To determine concentrations per cell, it
was first necessary to establish a method for determining the number of cells in a given sample.
This was done by normalization of cell concentrations based on OD 600 . Typically, cells of a
known OD 600 were serially diluted and the cells counted by plating on PYE/agar. Subsequently,
an OD 60 0 = 1 was assumed to be 1.1 x 106 cells/pL. Because the maximum concentration of PHB
accumulated was ~10% cdw, it was assumed that it does not contribute to OD 60 0 (43). Knowing
the concentration of cells and the concentrations of PHB, PhaC and PhaP during growth on PHBP
medium from 0-72 h, the number of molecules of each species per cell was calculated.
From the mass of PHB per cdw and its M., the number of molecules of PHB per cell was
calculated and was found to increase ~10-fold from 14,000 ± 160 PHB chains per cell at 0 h to
150,000 ± 25,000 chains per cell at 72 h post inoculation (Figure 3.8). The Mw of PHB in R.
eutropha is ~700 kDa when the cells contain 5% cdw of PHB, which corresponds to ~14,000
molecules per cell (7).
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Figure 3.8 Concentrations of PhaC (A), PhaP (o) and PHB (9) in wt PHB, cultures. The
numbers were calculated from quantitative Western blot analysis of PhaP and PhaC levels and
from GPC analysis of PHB molecular weight. The Mw of PHB used to calculate the ratios was
325 kDa. Each measurement was made in triplicate. The error bars reflect the standard deviation
from the mean of these measurements. The data for the individual replicates are included in
Table A3.2 as an appendix to this Chapter.
Regardless of growth conditions or PHB content, PhaC in R. eutropha is constitutively
expressed at 2,000-6,000 molecules per cell (7, 44). To investigate whether the same is true in C.
crescentus, the expression levels of PhaCc, in the wt strain were examined by Western blot
analysis (Figure 3.9). The results indicate that throughout growth, PhaC levels remain between
200-400 molecules/cell (Figure 3.8). Thus, while the levels of PhaC in C. crescentus are about
one order of magnitude lower than in R. eutropha, they also remain constant through PHB
accumulation.
In order to investigate whether PhaP expression levels correlate with PHB levels in C.
crescentus, as is the case in R. eutropha, Western blot analysis of PhaP levels was carried out
(Figure 3.10). From 0-72 h PhaP levels increase from 7,000 ± 1,500 molecules per cell at 0 h to
103,000 ± 25,000 molecules/cell at 72 h, about a 15-fold change (Figure 3.8A). In R. eutropha,
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PhaP levels increase 1 6-fold from 11,000 to 180,000 molecules per cell (7). In contrast with
PhaC levels, absolute PhaP concentrations in the two organisms are very similar.
Standard curve Oh 7 h 10h
PhaC (ng) 1 2 3 4
........................
Standard curve
PhaC (ng) 1 2 3 4
PhaC (ng)
Standard curve 30 h 36 h
1 2 1 4
Standard curve 50h 72 h
PhaC (ng) 1 2 3 4
Figure 3.9 Anti-PhaC Western blot of wt C. crescentus grown in PHB, medium. All sample
lanes contain 1.9 x 108 cells. It should be noted that the standard curve in this figure is prepared
from His6-PhaC (75 kDa), thus it migrates at a slightly higher M, than PhaC (73 kDa) in the
samples. Furthermore the standards are not spiked with an equal number of phaC:km cells.
Samples were taken at each time point from three individual cultures.
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Standard curve 0 h 7 h 10h
PhaP (ng) 25 50 100 200 300
Standard curve 15 h 20 h 25 h
PhaP (ng) 25 50 100 200 300
Standard curve 30 h 36 h
PhaP (ng) 25 50 100 200 300
Standard curve 50 h 72 h
PhaP (ng) 25 50 100 200 300
Figure 3.10 Anti-PhaP Western blots of wt C. crescentus grown in PHBp. The standard curve
was prepared from recombinantly purified PhaP and each lane of the standard curve contains 7.5
x 10 cells of AphaP. Each sample lane contains -7.5 x 107 cells. Samples were taken at each
time point from three individual cultures.
3.3.7 Mole ratios of PhaC and PhaP to moles of PHB in PHB,
Having determined the molecules of PHB, PhaCc, and PhaP per cell, the mole ratios of
PHB/PhaP and PHB/PhaC throughout growth were calculated. The mole ratio of PHB to PhaP
provides insight into the in vivo role of PhaP in granule biogenesis in C. crescentus. This ratio
remains between 1-2 throughout growth in PHBp, indicating that PhaP plays an important
mechanistic role in PHB production (Figure 3.11). This striking ratio has also been observed in
R. eutropha grown in both rich and nitrogen-limited media, further strengthening the argument
that this stoichiometry is mechanistically important to understanding the role of PhaP in granule
formation (7, 17) (He and Stubbe, unpublished data). This role will be addressed in more detail
in the Discussion section. Because there are -300 PhaCs per cell throughout PHB accumulation,
the moles of PHB/PhaC increases -10-fold from 50 to 500, indicating that multiple termination
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and reinitiation events occur throughout growth (Figure 3.11). This is similar to what we have
observed in R. eutropha, in which the mole ratio of PHB/PhaC increases -1 5-fold from 6-87 (7).
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Figure 3.11 Mole ratios of PHB/PhaP and PHB/PhaC in wt C. crescentus grown in PHBp.
Error bars are propagated from the uncertainties in Figure 3.10.
3.3.8 PHB and PhaP are present in the soluble cell fraction in wt C. crescentus starter
cultures
The modified micelle model for granule formation, currently our favored model,
proposes that the species that nucleates granule formation is a soluble, cytoplasmic species
containing PhaC, PhaP and full length PHB. We therefore wished to determine whether a portion
of the PHB in starter cultures of wt C. crescentus is in the soluble cell fraction. To obtain
sufficient cell mass, two cultures were grown 15 h until early stationary phase, and the cells were
pelleted and resuspended in buffer. One culture was lysed, shell frozen and lyophilized, then the
PHB was extracted into chloroform to prepare a sample for GPC analysis. The second culture
was lysed, and whole cell samples for crotonate and Western blot were taken from the lysate.
The soluble and insoluble fractions were subsequently separated by centrifugation, the insoluble
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fraction was resuspended in buffer to a volume equal that of the soluble fraction, and samples
were analyzed from each fraction by crotonate assay and Western blot using PhaP antibodies.
Additionally, to determine the M, of the PHB in both fractions, the remaining soluble and
insoluble material was shell frozen and lyophilized, and the PHB was extracted into chloroform
for GPC analysis. Scheme 2.1 shows a flow chart for the analysis of samples from the second
culture.
Cell suspension (41.5 mL)
Lysis
Western <0.3 mL ICel lysate (41.5 mL) 0.5 mL > Crotonate
Sample sample
Centrifugation
Resuspension in buffer
Soluble lysate (40.7 mL) Insoluble lysate (40.7 mL)
0.3 mL 39.4 mL 1 mL 0.3 mL 39.1 mL 0.5 mL
Western Crotonate Western Crotonate
Sample sample sample sample
GPC sample GPC sample
(445 mg dry) (240 mg dry)
Scheme 3.1 Flow chart for crotonate, Western blot and GPC analysis of samples from
whole cell, soluble and insoluble fractions of wt C. crescentus. Cells were grown 15 h in PYE
then pelleted and lysed. Samples were taken for crotonate, Western blot and GPC analysis from
the whole cell, soluble and insoluble cell fractions.
GPC analysis of the PHB in the whole cell sample from the first culture revealed that its
Mw was 180 kDa with a PDI of 2.2 (Figure 3.12) (Table 3.4), slightly lower than the Mw of PHB
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from the time point taken 9 h after inoculation into PHB, medium. Crotonate analysis of PHB
content of the whole cell lysate of the second culture revealed that whole cells contained 2%
PHB cdw. Analysis of the soluble and insoluble fractions individually indicated that they
contained 0.2% and 3.4% PHB by dry weight. As a percentage of the total PHB (by mass) in the
cells, the soluble fraction contained ~7%, compared to ~90% in the insoluble fraction (Table
3.5). This result is similar to the percentage of total PHB present in the soluble fraction of the R.
eutropha strain from which soluble PHB was isolated, which accounts for 10% of the total PHB
in the cells by mass (38).
Table 3.4 M, and PDI of PHB extracted from whole cell, soluble and insoluble fractions of
wt C. crescentus grown 15 h in PYE. The measurements were made once from a single sample.
Cell fraction %PHB extracted MW PDI
Whole cell 40 180 2.2
soluble 33 196 2.0
insoluble 63 190 2.3
To compare the M, of PHB in the soluble and insoluble fractions, and determine whether
the soluble PHB was full length, it was extracted into chloroform for GPC and compared to the
M, of PHB in whole cells. The Mw of the PHB in the soluble and insoluble fraction were 196
kDa with a PDI of 2.0, and 180 kDa with a PDI of 2.2, respectively. Again, due to low quantities
of PHB in all samples, extraction efficiencies were low (Table 3.4). However, the data suggest
that the M, of PHB in PYE starter cultures is lower than that in cultures accumulating PHB, and
furthermore that the soluble fraction of cells at this time point contains PHB.
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Figure 3.12 Gel permeation chromatography of PHB extracted from the whole cell (red),
soluble (blue) and insoluble (green) fractions of C. crescentus. PHB was extracted from cells
grown 15 h in PYE then lysed by French press.
Table 3.5 Summary of PhaP and PHB content of the whole cell, soluble and insoluble
fractions of C. crescentus grown in PYE.
Volume PhaP % total PHB % total Ratio of
(nmol) PhaP (nmol) PHB PHB:PhaP
Whole cell 41.5 40+/-3.8 100 63 100 1.6:1
Soluble 41.5 4.8+/-0.7 12 4.1 6.5 0.9:1
fraction
Insoluble 41.5 32+/- 1.3 80 62 89 1.9:1
fraction
The soluble nucleating species isolated from R. eutropha contained an enrichment of
PhaP molecules per PHB chain compared to the whole cell and insoluble fraction (38). We
therefore examined the PhaP content in whole cell, soluble, and insoluble fractions by
quantitative Western blot analysis (Figure 3.13). Using these data in combination with the mass
of PHB in the cells and its M,, the molar ratio of PHB to PhaP was calculated. The molar ratio
of PHB to PhaP was 1.7:1 in whole cells, 0.8:1 in the soluble fraction, and 2:1 in the insoluble
fraction (Table 3.5). While we have been able to isolate C. crescentus from growth conditions in
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which it contains very little PHB, we are unable to measure an increase in PhaP relative to PHB
chains at this early time point, as is suggested by observations in R. eutropha (38).
Standard curve WS I
PhaP(ng) 10 20 30 40 50
Figure 3.13 Quantitative Western blot analysis of PhaP content of whole cell (W), soluble
(S) and insoluble (I) cell fractions of 15 h PYE starter cultures. The standard curve was
pre ared from recombinantly purified PhaP and each lane of the standard curve contains 7.5 x
10 cells of AphaP. Samples were taken in triplicate from one culture.
3.3.9 Deletion of phaP results in decreased PHB production compared to the wt strain
Growth and PHB accumulation in AphaP cultures was examined in triplicate to gain
further insight into the role of PhaP in PHB biosynthesis in C. crescentus (Figure 3.14). In PHBp
medium AphaP accumulates PHB from 0.5 to 1.5% cdw, 10- to 20-fold lower than the wt strain
under the same growth conditions. The cultures saturate at an OD600 = -0.75, slightly lower than
wt cells. In R. eutropha, deletion of phaP1 results in decreased accumulation of PHB by 50%
relative to the wt strain. In addition the PHB had lower Mw and higher PDI, 740 kDa with a PDI
of 3.3, than in the wt strain. In order to determine whether deletion of phaP in C. crescentus
affected the Mw and PDI of the PHB, AphaP was grown 24 h and the PHB was extracted into
chloroform for GPC analysis. The Mw from three different cultures was 430 ± 28 kDa and the
PDI was 2.1 ± 0.6 (Table 3.3). These values are very similar to those for the wt strain, indicating
that the behavior of PhaP from C. crescentus has some distinct features relative to that of PhaPi
in R. eutropha.
Due to the fact that AphaP makes very low levels of PHB, it was necessary to isolate
PHB from large masses of cells. Extraction efficiency decreases as the mass of cells increases,
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thus the samples were divided into 20 mg portions of cells for extraction. The efficiency was still
quite low, 20-30% of the expected quantity of PHB as predicted by crotonate assay analysis of
whole cells (Table 3.3). It is possible that PHB of a particular Mw and PDI is preferentially
extracted, a caveat that must be considered when interpreting the data. However, if the extracted
material is indicative of all PHB chains, then the role of PhaP in chain termination is minimal in
C. crescentus.
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Figure 3.14 Growth and analysis of PHB levels in C. crescentus AphaP grown in PHB,
growth conditions. The OD600 (9) and amount of PHB (% cdw) (0) were measured at the
indicated growth times. Error bars represent the standard deviation from the average of three
growths.
3.3.10 Molecules of PHB and PhaC per cell in the AphaP mutant strain
If we make the assumption that the M, of PHB in AphaP remains the same throughout
growth, as is the case with the wt strain, then we can calculate the molecules of PHB per cell in
AphaP as a function of growth. At 0 h in PHBP medium the cells contain 5,100 ± 300 PHB
chains per cell, and the concentration of PHB increases -3-fold to 14,600 ± 1,300 after 72 h
growth (Figure 3.15A) (Table A3.4).
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Figure 3.15 Quantitative analysis of PHB and PhaC levels in AphaP PHB, cultures. A)
Concentrations of PHB (e) and PhaC (A) per cell. Values were calculated from quantitative
Western blot analysis of PhaC levels and crotonate analysis of PHB levels from 0-72 h. The M,
of PHB used to calculate PHB molecules/cell (430 kDa) was determined by GPC from the
average M, of PHB extracted from three cultures grown 24 h in PHBp. B) Mole ratio of
PHB/PhaC. The error bars are propagated from the uncertainties in A. The data for the individual
replicates are provided in Table A3.4 as an appendix to this Chapter.
To investigate whether reduced PHB accumulation in AphaP is the result of lower PhaC
expression, PhaC levels during growth in PHBp were determined by Western blot (Figure 3.16).
The amount of PhaC per cell from 0-15 h was 200-300 molecules. However, after 15 h the
amount of PhaC per cell steadily declined to ~60 molecules per cell at 72 h. Thus, while PhaC
levels were initially similar to those in the wt strain, PhaC levels appeared to decrease with time.
This observation raised the possibility that PhaC might be degraded in AphaP because it is
inactivated as a function of polymerization due to the formation of unfolded hydrophobic
polymer, as is suggested in assays presented in Chapter 2.
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Standard curve 0 h 7 h 10h
PhaC(ng) 1 2 3 4
Standard curve 15 h 20 h 25 h
PhaC(ng) 1 2 3 4
Standard curve 30 h 36 h
PhaC (ng)- 1 2 3 4
Standard curve 50 h 72 h
PhaC (ng) 1 2 3 4
Figure 3.16 Western blot of PhaCcc in AphaP cells grown 0-72 h in PHBP. The standard
curve is prepared from recombinant PhaCcc and is not spiked with the disruption mutant
phaC:km. Each lane contains -7.5 x 10 7 cells. Samples were taken at each time point from three
individual cultures.
3.3.11 In vitro assays of crude cell lysates of wt and AphaP cultures suggest that presence of
PhaP enhances consumption of HBCoA
To investigate whether reduced accumulation of PHB by the strain AphaP is a result of
inactivation of PhaC due to the presence of PHB that is not associated with PhaP, the activity of
PhaC was measured in crude cell lysates of wt and AphaP grown to OD 600 = 0.75 PYE. PYE
growth conditions were selected over PHBP medium because PHB levels are low and cell density
is comparably high in PYE. In this experiment, wt cells contained 0.2% cdw and AphaP
contained 0.1% PHB cdw, within error of one another. To achieve comparable cell density in
cultures grown in PHB, medium, the wt strain would contain -10% PHB cdw whereas AphaP
would contain only 0.5-1.5% PHB. This 10- to 20-fold difference in PHB levels might interfere
with PhaC activity measurements by increasing the activity of PhaC in wt due to association with
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PHB granules (or priming with PHB) instead of the presence of PhaP, thus PYE growth
conditions were selected for this experiment.
To prepare assay samples, wt and AphaP cells were pelleted, resuspended in buffer and
lysed by passage through the French pressure cell at 4 'C. The amount of PhaC in each strain
was determined by quantitative Western blot analysis (Figure 3.17A). The wt strain and AphaP
both contained ~200 molecules of PhaC/cell, consistent with the above findings that PhaC levels
in the two strains are initially similar, but that levels in AphaP decrease during growth in PHBp.
CoA release by PhaC in samples of wt and AphaP lysate containing 14 ng PhaC was measured
using the discontinuous DTNB assay (Figure 3.17B). Both the biphasic kinetics and the effect of
PhaP seen in experiments on the recombinant proteins (Chapter 2) are observed with the native
proteins as well. In vitro experiments using recombinant proteins have demonstrated that the
presence of PhaP increases both the specific activity of PhaC and the overall turnover of
HBCoA. This effect is clear in the crude cell extract assays of native PhaC in the wt and AphaP
strains as well. PhaC in wt cell lysate turns over 50% more HBCoA than in AphaP cells under
these experimental conditions, despite both containing the same amount of PhaC. This result
suggests that lower PHB accumulation in AphaP may also be the result of the positive effect that
PhaP has on the extent of the polymerization reaction by PhaC. Furthermore, we have interpreted
the results of the in vitro assays with PhaP to suggest that PhaP promotes folding of the PHB
chain that allows access of the soluble HBCoA to the active site of PhaC as the insoluble
polymer grows. Therefore, one explanation for the decrease in PhaC levels is that in the absence
of PhaP, PhaC might unfold due to association with the hydrophobic polymer, leading to its
degradation by proteolytic machinery.
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Figure 3.17 Specific activity of PhaCcc in crude lysates of wt and AphaP cells. A) Anti-PhaC
Western blot to measure amount of PhaC in wt and AphaP cell lysate samples. B) CoA release
by PhaC in wt (o, red trace) and AphaP (o, blue trace) lysates. The reactions contained 40 IL
lysate (- 110 pg total protein, 14 ng PhaCcc) and 1 mM HBCoA. Data are fit to the sigmoidal
function given in section 3.2.13. C) Expansion of early time points in B. Error bars represent the
standard deviation from the average of three assays.
3.3.12 Deletion of phaR results in decreased PHB accumulation relative to wt
C. crescentus contains a putative homolog of PhaR, which was identified in this work
as a granule-associated protein. To examine whether deletion of phaR has an effect on growth
and PHB accumulation, AphaR was grown 0-72 h in PHBp medium. The growth of AphaR was
very similar to the wt strain, showing a logarithmic growth phase between 5-15 h with a
doubling time of ~3 h, followed by a period of slower growth. After 30 h, AphaR accumulated
-7% PHB cdw, slightly less than wt grown in the same conditions (Figure 3.18). The amount of
PHB did not increase significantly from 30-72 h. After 24 h growth in PHBhigh medium, wt R.
eutropha accumulates 66% PHB cdw, whereas AphaR accumulates just 45% PHB cdw. Thus, in
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both organisms, deletion of phaR results in accumulation of PHB to 70% that of wt levels. To
determine the Mw and PDI of the PHB, cultures were grown 24 h in PHBP and the PHB was
extracted into chloroform for GPC analysis. The Mw was 270 21 kDa, slightly lower than wt,
but the PDI was 2.2 ± 0.6, similar to wt.
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Time (h)
Figure 3.18 Growth and analysis of PHB levels in C. crescentus AphaR grown in PHB,
growth conditions. The OD600 (9) and amount of PHB per cell (c) were measured at the
indicated growth times. The error bars represent the standard deviation from the mean of three
different cultures.
3.3.13 Molecules of PHB, PhaP and PhaC per cell in the AphaR mutant strain
Again, if we make the assumption that the Mv of PHB in AphaR remains the same
throughout growth, then we can calculate the molecules of PHB per cell. At 0 h in PHBp medium
AphaR cells contain 4,300 ± 1,100 PHB chains per cell (Figure 3.19). The amount of PHB
increases to 246,000 ± 18,000 chains per cell after 72 h growth (Table A3.6).
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Figure 3.19 Quantitative analysis of PhaP and PHB levels in C. crescentus AphaR grown in
PHB, conditions. A) Molecules of PhaC (A), PHB (o) and PhaP (o) per cell. B) The molar ratio
of PHB to PhaP and PHB/PhaC as a function of growth time. The error bars in A represent
standard deviation from the mean of three samples from three different cultures. The error bars in
B are propagated from the uncertainties in A. The Mw of PHB used to calculate molecules per
cell and the PHB:PhaP ratio above was 270 kDa, determined from a single measurement of PHB
produced by AphaR after 24 h in PHBp. The data are given in Table A3.6 as an appendix to this
Chapter.
In R. eutropha, PhaR acts as a negative regulator of phaP expression, and its deletion
results in constitutive overexpression of PhaP and reduced PHB accumulation (70% that of wt).
Qualitative Northern blot studies suggest that PhaF, a regulatory protein involved in PHA
biosynthesis in P. oleovorans, controls transcription of phaC] in addition to the gene for the
phasin phal (12, 13). To understand the role of PhaR in C. crescentus, PhaP and PhaC levels
were investigated in the AphaR strain. Western blots of PhaC expression levels in AphaR show a
difference from the wt strain (Figure 3.20). In AphaR, the expression of PhaC was higher than in
the wt strain and varied between 400 ± 80 and 880 ± 40 molecules per cell (Figure 3.19). This
feature is distinct from what is seen in the AphaR strain of R. eutropha, in which PhaC levels are
constitutive but lower than in wt, and is instead similar to the role of PhaF in P. oleovorans.
Analysis of PhaP levels show that the concentration of PhaP in AphaR is -6-fold higher than in
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A) B)
the wt strain at 0 h, and -2-fold higher at later time points (36-72 h) (Figures 3.19 and 3.21). In
the AphaR mutant of R. eutropha, PhaP1 is constitutively overexpressed and its levels do not
change with increasing PHB. However, in the AphaR strain of C. crescentus, PhaP is
overexpressed but its levels still increase 4-fold with increasing PHB, from 44,000 ± 5,000
molecules per cell at 0 h to 185,000 ± 35,000 molecules per cell at 72 h post inoculation (Figure
3.19). The results suggest that PhaR plays a role in controlling PhaP expression level but not in
coupling it to PHB accumulation, and that it also plays a role in controlling PhaC expression
levels.
Standard curve 0 h 7 h 10h
PhaC (ng) 1 3 5 10
Standard curve 15 h 20 h 25 h
PhaC (ng) 1 3 5 10
Standard curve 30 h 36 h
PhaC (ng) 1 3 5 10
Standard curve 50h 72 h
PhaC (ng) 1 3 5 10
Figure 3.20 Western blot analysis of PhaC levels in AphaR grown in PHB, medium. The
standard curve is prepared from recombinant PhaCcc and is not spiked with the disruption mutant
phaC:km. Each sample lane contains -7.5 x 107 cells. Samples were taken at each time point
from three individual cultures. All samples intensities were within the standard curve.
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Standard curve 0 h 7 h 10h
PhaP(ng) 25 50 100 200 300
Standard curve 15 h 20 h 25 h
PhaP(ng) 25 50 100 200 300
Standard curve 30 h 36 h
PhaP (ng) 25 50 100 200 300
Standard curve 50 h 72 h
PhaP (ng) 25 50 100 200 300
Figure 3.21 Western blot analysis of PhaP levels in AphaR grown in PHB, medium. The
standard curve was prepared from recombinantly purified PhaP and each lane of the standard
curve contains 7.5 x 107 cells of AphaP. Each sample lane contains -7.5 x 107 cells. Samples
were taken at each time point from three individual cultures.
At early time points, the ratio of PHB to PhaP is 1:10. At later time points, this ratio
decreases to 1-2, similar to the ratio observed in the wt strain (Figure 3.19B). The observation
that, despite the differences in concentrations of PhaP and PHB in AphaR compared to wt, the
ratio of PHB to PhaP is ultimately 1-2 further underscores the significance of this ratio to
understanding the role of PhaP in PHB accumulation.
3.3.14 Electron microscopy visualization of granule formation in wt, AphaP and AphaR
strains
To examine early granule localization and further explore the role of PhaP in PHB
biogenesis in C. crescentus, wt, AphaP and AphaR cells were grown in PHB, medium and
samples were prepared for TEM analysis. R. eutropha, contains at minimum 5-10% PHB cdw at
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early time points in PHB biogenesis in the growth conditions employed (7, 17, 44). TEMs of R.
eutropha cells containing 5% PHB cdw revealed that tiny granules were localized adjacent to the
nucleoid along the long axis of the cell (17, 31). C. crescentus offers a unique opportunity to
examine very early granules when PHB is present at only 1% cdw. TEMs at 9 h of C. crescentus
grown in PHBp containing ~1% PHB cdw reveal that early putative granules are small, with
diameters between 50-100 nm (Figure 3.22A). It should be noted that serial slices would be
necessary to quantitate and statistically analyze the size and number of granules. However, the
fact that only small granules are seen in all randomly sectioned slices suggests that there are no
larger granules present in the cell. The number of granules per cell was determined by counting
granules from 220 cells in 18 micrographs (from three separate growths). Of these cells, 50%
contained 0-1 granules, 30% contained 2 granules, and 20% contained 3-6 granules (Table 3.6).
Figure 3.22 shows representative cells containing 3-6 granules in order to emphasize the
localization of early granules to the perimeter of the cell. In the 220 cells whose granules were
counted, ~85% of the granules are located closer to the membrane than to the center of the cell.
A "dark-stained feature" like that observed by Tian et al. that is now believed to be nucleoid is
not evident in these samples (17). However, there are no nucleoid-free regions in the cytoplasm
of C. crescentus (45). Thus, is it likely that nucleoid exclusion of early granules is the cause of
their localization near the cell membrane. From these data we cannot determine whether the
granules are nucleoid associated. After 12 h growth in PHBp the PHB content increased to -3%
cdw. At this stage the cells contain a mixture of large (200-250 nm in diameter) and small (50-
100 nm in diameter) granules (Figure 3.22B).
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A)
B)
Figure 3.22 Representative electron micrographs of granules at A) 9 h and B) 12 h growth
in PHBP. The cells from this growth contain 1% PHB at 9 h and 3% PHB at 12 h growth. The
bar represents 1 pm.
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Table 3.6 Granule counting in wt, AphaP and AphaR cultures grown in PHB,.
% of cells containing a given number of granulesa
Number of
granules wt (9 h)b wt (24 h)c AphaP AphaR
0 20 10 27 4
1 24 31 54 12
2 28 32 17 27
3 18 17 1.5 29
4 6 6 0.5 14
5 3 3 0 10
6 1 1 0 3
7+ 0 0 0 1
aThe number of cells containing a particular number of granules is given as a percentage of the
total number of cells that were counted.
bFor the 9 h wt culture, granules in 220 cells were counted.
'For 24 h cultures, granules in 177 wt cells, 276 AphaP cells and 182 AphaR cells were counted.
Cultures of the wt strain grown 24 h in PHBP medium were also examined by TEM
(Figure 3.22). Cells whose long axis was parallel to the plane of the micrographs (>1 im in
length in the micrographs) were examined to determine the average number of granules per cell.
Of 177 cells from ten micrographs, 90% contained 0-3 visible granules, while the remaining 10%
contained 4-6 granules. This distribution is summarized in Table 3.4. The granules vary in size
from 100-300 nm in diameter. At this stage, the cells appear elongated relative to those in early
PHBP cultures (Figure 3.23). The outer layer of the cells is wavier than in the cells in Figure
3.16, which may be caused by the dehydration and embedding process being more disruptive to
cells grown for extended periods on nitrogen-limited medium, as has been proposed in aged
nitrogen-limited cultures of R. eutropha (46). The irregular looking morphology compared to the
younger cultures in Figure 3.17 may also be due to extended growth in nutrient limited medium
(32, 47).
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Figure 3.23 Electron micrographs of wt grown 24 h in PHB, medium. The cells accumulate
PHB to 10-12% cdw under these growth conditions. The above panels are representative images,
and additional micrographs can be found in the appendix of this thesis. The bar represents 1 im.
TEMs of AphaP cultures grown 24 h in PHBp medium reveal that these cells contain
PHB in a single granule that is similar in shape to those found in wt after 24 h growth. The
granules in AphaP at this time are 50-150 mm in diameter, smaller than in the wt strain after 24 h
(Figure 3.24). The AphaP cultures contain 1% PHB cdw, thus a more informative comparison
might be with the 9 h wt cultures in Figure 3.20A, which also contain ~I% PHB cdw. In contrast
to AphaP, a majority of wt cells contain many small granules at this stage. Of 276 AphaP cells
from 13 different micrographs, 80% contained 0-1 visible granules per cell. The morphology of
AphaP cells at this stage resembles the younger cultures in Figure 3.20 rather than the irregular
morphology of the cells in Figure 3.23.
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Figure 3.24 Electron micrographs of AphaP grown 24 h in PHB, medium. The cells
accumulate PHB to -% cdw under these growth conditions. The above panels are representative
images, and additional micrographs can be found in the Appendix of this thesis. The bar
represents 1 ptm.
Finally, TEM of AphaR cultures grown 24 h in PHB, medium suggests that deletion of
phaR results in the production of more granules per cell, despite lower overall PHB content
compared to wt. The granules of 182 cells in ten micrographs whose long axes were parallel to
the plane of the micrograph were counted. Of these cells, 30% contained 3 granules and another
-30% contained 4-7 granules. In comparison, micrographs of the wt strain discussed above
indicated that only -10% of wt cells contained 4-6 granules, and none contained 7 or more
granules. It should be noted that Figure 3.25 shows AphaR cells that are representative of the
population of cells containing 3-7 granules (which accounted for 60% of the cells), however 15%
of the cells contained 0-1 granule (Table 3.6).
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Together the analysis of the wt strain and the two mutant strains by TEM suggests that
PhaP plays a role in determining the number and size of granules in C. crescentus, as has been
proposed for PhaP 1 in R. eutropha.
Figure 3.25 Electron micrographs of AphaR grown 24 h in PHB, medium. The cells
accumulate PHB to 7-8% cdw under these growth conditions. The above panels are
representative images, and additional micrographs can be found in the appendix of this thesis.
The bar represents 1 im.
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3.4 Discussion
The studies presented in this Chapter outline our efforts to understand the mechanism of
PHB granule formation in C. crescentus, as well as the role of the predominant granule-
associated protein PhaP in promoting PHB accumulation. Most of our understanding of PHB
biosynthesis has come from studies carried out in R. eutropha, which accumulates PHB to 80%
of its cdw when the cells are limited in nitrogen but in the presence of an abundant carbon
source. These studies have been extremely informative; however, most organisms do not
accumulate PHB to such extreme levels. We were therefore interested in investigating whether
paradigms of granule formation and the roles of the PHB biosynthetic proteins that were
established based on studies in R. eutropha were also true for an organism that accumulates far
less PHB. We have investigated PHB accumulation in C. crescentus, which we have shown
accumulates PHB to just 12% of its cdw when nitrogen is a limiting nutrient but a carbon source
is abundant. PhaC and the granule-associated proteins, PhaP, PhaR and PhaZ were identified. To
examine the roles of PhaP and PhaC in granule biogenesis, antibodies were generated and their
expression levels throughout growth were examined by Western blot analysis. The deletion
mutants AphaP and AphaR were generated to determine the effect on the amount of PHB and its
Mw and PDI, and on PhaP and PhaC expression levels. Together, these studies provided a
quantitative picture of the concentrations of PHB, PhaC and PhaP during PHB accumulation in
C. crescentus. The results are discussed in the context of what is known in R. eutropha, and a
model for granule initiation and growth in C. crescentus is proposed.
PhaC synthesizes PHB from the soluble, monomeric substrate HBCoA to generate high
Mw polymer. As the polymer grows, a phase transition occurs from soluble precursors to
insoluble, amorphous polymer. During the process of granule growth, several additional proteins
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including phasins (PhaPs), depolymerases (PhaZs), and the transcription factor PhaR, become
associated with the granule. The proteins are found on the surface of the granule, suggesting they
associate after the granule is formed. Of these proteins, phasins are the predominant component,
while the other proteins are thought to be present at much lower levels. A key question in
probing the mechanism of granule formation is how the transition from soluble monomeric
precursors to insoluble polymer occurs without subjecting the cell to the stress of large regions of
exposed hydrophobic PHB. Understanding the structure of the mature granule is key to
understanding how granule formation occurs.
Several studies have been undertaken to examine the composition of mature granules. In
R. eutropha, mature PHB granules are typically 200-500 nm in diameter and at maximum PHB
accumulation, the cells contain 5-15 granules (6). The phasin PhaP1 is the predominant granule-
associated protein (3, 4). Based on studies examining the surface area of granules, and the size
and number of PhaP1 molecules per cell, PhaP1 has been calculated to cover 22-54% of the
surface of granules (7, 17). Dennis and coworkers examined the surface of isolated granules by
atomic force microscopy (AFM) and observed a lattice-like network covering the granules,
which they interpreted as being composed of PhaP1 (48). In their studies the lattice covered the
entire granule. However, the calculations of surface coverage by PhaP1 as well as recent cryoET
data discussed below, suggest that the granules have only partial or "patchy" surface coverage.
Importantly, cryoET is a non-perturbative method, whereas AFM has many drawbacks including
sample preparation that involves lysing cells, drying of isolated granules, and the potential for
mechanical deformation from the AFM tip. Thus the AFM observation of full surface coverage
by Dennis et al. may be the result of an artifact from sample preparation and imaging.
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Early studies of PHB granules isolated from Bacillus megaterium revealed that they are
97-98% PHB, 2% protein and 0.5% lipid (19). This observation led to speculation that granules
could be partly coated with a lipid bilayer or monolayer. EM evidence from various groups
rovided conflicting results as to the thickness of the putative surface layer, which some claimed
was consistent with a monolayer and others with a bilayer (49-52). Thus, no concrete evidence
for a lipid coating has been obtained, and in fact more recent data suggests that lipid coating is
unlikely. First, use of cryoET to examine the surface of granules in R. eutropha revealed that
they contain a "patchy," discontinuous surface that is ~2 nm thick and less dense than the inner
and outer membrane bilayers (6). A thickness of 2 nm is too thin to be a lipid monolayer and is
instead consistent with a proteinaceous layer. Given relative abundances of proteins on the
surface of granules in R. eutropha, this is likely composed predominantly of PhaPl. Second,
microarray studies of mRNA transcripts in R. eutropha grown under PHB accumulation
conditions revealed that the expression of enzymes involved in the biosynthesis of cardiolipin
and phosphatidylethanolamine (the major cell membrane phospholipids in R. eutropha)
decreases (53). This finding is inconsistent with a model in which the cells would need to
synthesize large amounts of lipids to coat growing PHB granules. Together the results suggest
that in R. eutropha the surface of the granules is composed of "patches" of proteinaceous rafts
composed of PhaP1 and likely other PHB biosynthetic proteins including PhaC, PhaZs and
PhaR, and that no continuous lipid monolayer is present, and a bilayer is clearly ruled out due to
size.
CryoET data, in addition to providing information about the surface composition of
mature granules as discussed above, have also given insight into the localization of early
granules and their growth and fusion throughout PHB accumulation (6). The localization of
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granules has implications on their mechanism of formation, and cryoET has conclusively
demonstrated that early granules form in the cytoplasm, and do not bud from the cell membrane
and/or poles, as has been previously reported. Early EM experiments carried out in our lab
suggested that early granules formed around a dark-stained scaffolding structure, whose identity
was at the time unknown. CryoET suggests that this structure was in fact nucleoid, rather than
for example a scaffolding protein (6). Furthermore, cryoET revealed that throughout PHB
accumulation, there is continual granule nucleation and growth, as well as fusion of mature
granules into larger ones. The observation that granules fuse lends further support to the idea that
the surface of granules is patchy rather than continuous, with hydrophobic surfaces allowing
fusion.
Conditions have not been identified in which R. eutropha contains no PHB. Thus our
understanding of how mature granules form from soluble precursors is based on fortuitous
observations made in an engineered mutant strain of R. eutropha containing a StreplI-tagged
PhaC in place of the wt PhaC (38). In this strain, when the cells contain 5% PHB cdw, affinity
purification of the synthase reveals that a fraction is associated with high M, PHB and PhaP1,
and that this species is soluble. The stoichiometry in this fraction is 2 PhaCs, 1 PHB chain and 4-
9 PhaPls, which is proposed to be indicative of a soluble nucleating species (a granule
precursor). Whereas whole cell measurements of the ratio of molecules of PHB to PhaP reveal
that it is 1-2 throughout PHB accumulation, PhaP 1 appears to be enriched relative to PHB in the
nucleating species, which led to the proposal that PhaPI plays a role in maintaining the solubility
of the nucleating species. Furthermore, this species did not contain PhaR or PhaZs, suggesting
that they become associated at a later point in granule formation. From these data, a model for
PHB granule formation was proposed in which the soluble nucleating species contain just PhaC,
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PhaP1 and HBCoA. These species then fuse as PHB accumulation continues, and following
fusion of the nucleating species, a phase transition occurs from soluble to insoluble polymer and
other granule-associated proteins bind the mature granules (38).
Based on our studies of PHB accumulation in C. crescentus, we propose a model for
granule formation that is very similar to that in R. eutropha, with a few distinctions (Figure
3.26). In this model, at early time points in granule formation, the cells contain mostly insoluble
PHB with a small population of soluble PHB. Both the soluble and insoluble fractions contain
PHB with a M, of -200 kDa, and 1-2 PHB chains per PhaP. The insoluble species arise from the
fusion of these soluble species. PhaP plays a role in maintaining the structure and solubility of
these species. When the cells find themselves limited in an essential nutrient but with an
abundant carbon source, PHB begins to accumulate and the soluble species fuse and grow. PhaC
alone dictates termination and reinitiation, controlling the M, and PDI of the PHB. As the
amount of PHB in the cells increases, the ratio of PHB chains to PhaP remains between 1-2. The
model proposes that the ratio is maintained because each terminated chain remains with a PHB
chain to maintain its structure and to prevent it from occluding the PhaC active site, thereby
allowing further turnover. PhaP serves to "fold" each PHB chain as it is being synthesized to
prevent it from collapsing onto PhaC, thereby obscuring the active site and preventing turnover.
The mature granule comprises PHB, PhaP, PhaC as well as PhaZ and PhaR. The evidence for
this model, as well as the features that are distinct from what is proposed in R. eutropha, are
discussed below.
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Figure 3.26 Model for granule initiation and formation in C. crescentus. The initial
nucleating species is composed of PhaC (green spheres), PHB and PhaP (red spheres), where
PhaP and PHB are present in a 1:1 ratio. As PHB accumulation begins, the soluble species fuse
and undergo a phase transition to form early granules. As PHB synthesis progresses, PhaC
catalyzes termination and reinitiation. Each terminated chain remains associated with one PhaP,
which is replaced by a newly synthesized PhaP (purple spheres) to maintain the ratio of 1-2 PHB
chains per PhaP.
PhaC is depicted as a dimer with each monomer synthesizing a PHB chain. This species
is proposed on the basis of experiments described in Chapter 2 in which acylation with the
artificial primer sTCoA (a terminally saturated trimer of HBCoA) suggests a stoichiometry of
one chain per monomer. Furthermore, size exclusion chromatography experiments suggest that
PhaC may be a dimer with an unusual shape. In Figure 3.26 the second monomer and its
respective PHB chain and PhaP are depicted in a lighter shade for clarity.
The identity of the soluble nucleating granule species is supported by a number of
observations in this Chapter and in Chapter 2, and also by comparison to the putative nucleating
species in R. eutropha. In nutrient rich PYE broth, C. crescentus contains 0.5-2% PHB cdw, and
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~10% of this PHB is soluble, while the remaining PHB is in insoluble granules. PHB granules
are nearly always present in C. crescentus cells grown in PYE imaged by a variety of methods
including cryoET (54), whole cell TEM (55), and thin section TEM (15, 55). The soluble species
contains high M, PHB and 1 PHB chain per PhaP, and the insoluble species contains high Mw
PHB and 1-2 PHB chains per PhaP. We propose that the granules arise from the fusion of these
soluble species. The observation that the nucleating species contains high M, PHB that is
soluble is similar to the model proposed for R. eutropha. However, in R. eutropha the nucleating
species is proposed to contain 4-9 PhaPs per PHB chain, enriched relative to the 1-2 PHBs per
PhaP present in the bulk whole cell measurement. There are several possible explanations for
this difference. First, the soluble species in R. eutropha was isolated from a mutant strain in
which the wt phaC gene was replaced with a gene encoding a StrepIl-tagged PhaC (56). In this
strain, StreplI-PhaC was upregulated 30-fold relative to PhaC in the wt strain despite being under
control of the endogenous promoter, and the M, of the PHB was ~1/3 that of PHB in the wt
strain. Thus the enrichment of PhaP1 in the soluble species could be an artifact of the strain.
Alternatively, if the nucleating species in wt R. eutropha is the same as that in the StrepIl-PhaC
strain, then the nucleating species in R. eutropha and C. crescentus could simply have different
compositions due to differences in the properties of the PHB. In wt R. eutropha the PHB is
between 700-1000 kDa throughout growth, -3-fold higher than that in C. crescentus. The
enrichment of PhaP1 in the nucleating species in R. eutropha is proposed to play a role in
maintaining the solubility and structure of the PHB (38). The fact that the soluble PHB species in
C. crescentus contains just one PhaP per PHB chain may reflect the fact that fewer PhaPs are
required to maintain the structure and solubility of PHB of a lower M,. Finally, measurements
made at very early time points in PHB accumulation in C. crescentus have inherently higher
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error due to the fact that we are measuring very small amounts of PHB and PhaP. Therefore, we
cannot rule out that PhaP levels are enriched relative to PHB at early time points, but that we
simply cannot make this measurement accurately given the error.
Several experiments have given insight into the function of PhaP in the synthesis of
granules. In Chapter 2, we present results suggesting that just one equivalent of PhaP relative to
PhaC in in vitro assays facilitates an increase in specific activity of PhaC and in overall turnover
of HBCoA. Under these assay conditions (high ratio of HBCoA to PhaC), PhaC is assumed to be
relatively uniformly loaded, thus at least at early stages in polymerization, the ratio of PHB
chains to PhaP is - 1:1. Additionally, pull-down assays of PhaC and the N-terminally truncated
PhaCccAN with PhaP indicate that only full length PhaC and PhaP interact in vitro, yet PhaP
mediates the same effect on activity and substrate consumption with both synthases. This
suggests that PhaP interacts with the growing PHB chain rather than with PhaC. Finally, in this
Chapter we demonstrated in activity assays of crude cell lysates from both wt and AphaP C.
crescentus grown in PYE that the specific activity of PhaC and its overall turnover of
exogenously added HBCoA are increased in the wt strain relative to AphaP. We interpret these
results together to suggest that PhaP associates with the PHB chain to package it in such a way as
to maintain its solubility, at least in the region around the PhaC active site, so as to prevent
collapse of hydrophobic polymer onto PhaC and thereby allow access of soluble HBCoA.
A "folding" or "packing" function of PhaP is consistent with what has been proposed in
several systems. Steinbuchel and coworkers noted, by phase contrast and scanning electron
microscopy, that granules produced in vitro by PhaEC from Allochromatium vinosum were
smaller in the presence of PhaPi from R. eutropha than in its absence (57). Niamsiri et al.
demonstrated that addition of BSA to a reaction containing HBCoA and PhaC from R. eutropha
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immobilized on a surface resulted in the formation of larger granules and more complete
substrate turnover (58). BSA has long been known to bind PHB (3, 5, 8), and they suggested that
in their experiments, BSA was playing a role in folding the nascent granule to prevent it from
obscuring the PhaC active site, similar to what we have proposed for PhaP in C. crescentus. A
folding function is also consistent with our TEM results, which suggest that PhaP plays a role in
C. crescentus in determining the number and size of granules. While we have not performed
stereology or tomography to examine the exact size, volume and number of granules, generally
we see that AphaR contains more and smaller granules than wt. In AphaP, which contains 1%
PHB cdw, a comparison of the sizes of granules to those in wt cells also containing 1% PHB
reveals that AphaP contains fewer and larger granules than wt. In R. eutropha wt, AphaP1 and
AphaR strains, the same trends in granule size and number are observed (45, 59). Finally, our
finding that AphaP cannot accumulate more than 1% PHB cdw can be explained by a model in
which PHB misfolds and/or crystallizes in the absence of PhaP, which could lead to the active
site of PhaC being obscured, or simply to the precipitation of PhaC on the exposed hydrophobic
granule. Precipitation or unfolding of PhaC could lead to its degradation by the proteolytic
machinery in the cell, which would be consistent with our observation that PhaC levels decrease
as a function of growth time in AphaP.
Our observation that early granules form near the perimeter of the cell in C. crescentus
seems to suggest they might bud from the membrane, as has alternatively been proposed as a
mechanism for granule formation. This result would contradict a model in which the nucleating
species is soluble; however, we think the membrane budding model is still not supported, for
three reasons. First, the nucleoid of C. crescentus has previously been shown to occupy the
majority of the cytosol (Figure 3.27) (54, 60). Thus, the appearance of early granules near the
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cell membrane may be due to nucleoid exclusion. Second, investigation of cryoET images of C.
crescentus from the Jensen lab have fortuitously provided high resolution images of PHB
granules that are ~100 nm in diameter, similar to what we see in wt cells after 9 h growth in
PHBP medium (Figure 2.22A). In their micrographs the granules are near the membrane but are
very clearly not budding from it (59). Finally, if granules were budding from the membrane, one
would expect that lipids derived from the membrane would associate with the granule surface
and cause the PHB granules to be insoluble. Our observation that 10% of the PHB is in the
soluble fraction at early time points suggests that lipids are not associated.
A) B) C)
Figure 3.27 Phase contrast and fluorescence microscopy images of C. crescentus. A) Phase
contrast image. B) Fluorescent image of FM4-64 cytoplasmic membrane dye signal. C)
Fluorescent image of DAPI nucleoid dye signal. The DAPI signal overlays with the phase
contrast image in panel A, suggesting that there are no nucleoid-free regions in C. crescentus.
Furthermore the DAPI stain is even throughout the cell. The scale bar is 2 pm. Figure is adapted
from (7).
Our model continues with the fusion of soluble species, which occurs as more PHB is
accumulated, leading to the formation of granules. After each PHB chain is completed, PhaC
catalyzes termination. In Chapter 2, we propose this is controlled by the relative rates of
polymerization and termination by thiolysis. In C. crescentus, our observation that PHB in the wt
strain, in AphaP and in AphaR are similar in M, and PDI suggests that PhaP does not play a role
in "triggering" termination, as is thought to be the case in R. eutropha (7). Extraction efficiencies
in preparing GPC samples are low, however, therefore we are making the assumption that the
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extracted material is representative of the total PHB content of the cells. It has long been
proposed that PhaCs alone are capable of catalyzing termination (61, 62). However in the
AphaP1 and AphaR strains of R. eutropha, the M, of PHB is lower and in AphaP1 the PDI is
higher than that in the wt strain. This suggests that PhaP1 plays a role in triggering termination,
and that an increase or decrease in the amount of PhaP1 in the cells leads to uncontrolled
termination and thereby higher PDI (7). This does not appear to be the case in C. crescentus. In
Chapter 2, analysis of the M, and PDI of PHB produced in vitro by PhaC in the presence and
absence of PhaP indicate that 1) PhaC catalyzes termination, as the M, is lower than would be
expected for uniform loading without termination and 2) that the inclusion of PhaP (1-10 equiv.)
does not greatly change the Mw and PDI. Furthermore, the range of Mws of PHB measured in
vitro are very similar to those measured in vivo, 300-600 kDa in the former and 200-400 kDa in
the latter. Together with the results in vivo with mutant strains, these findings suggest that PhaC
catalyzes termination and dictates Mw and PDI in C. crescentus.
The ratio of 1-2 PHB chains per PhaP is maintained throughout PHB biosynthesis, as is
the case in R. eutropha. One way in which this ratio can be maintained is if a PhaP remains
associated with each terminated PHB chain, while a newly synthesized PhaP takes its place to
facilitate folding of the newly initiated PHB chain. This model is identical to what has been
proposed in R. eutropha (6). Such a model would predict that as PHB accumulation occurs,
PhaPs associated with terminated chains would spread outwards from PhaC on the surface of the
granule, which could explain the observation by cryoET of proteinaceous "rafts" on the surface
of granules in R. eutropha (6). However, as we have not yet examined the surface of PHB
granules in C. crescentus, we are speculating for the time being as to the nature of their surface.
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In C. crescentus, the mature granules consist of at least PHB, PhaP, PhaC, PhaZ and
PhaR, as revealed by our analysis of the proteins associated with isolated granules. We have
examined the role of PhaR in C. crescentus, and have demonstrated that deletion of phaR results
in an overall increase in PhaP expression, but that it is still correlated with PHB accumulation.
Deletion of phaR also results in increased expression of PhaC. The role of PhaR in PHB
biosynthesis in C. crescentus remains to be further explored, as is the means of coupling PhaP
expression with PHB accumulation. However, it appears to be distinct from the role of PhaR in
R. eutropha, further suggesting that the regulation of PHB biosynthesis is likely to be distinct in
each organism.
The results presented in this Chapter indicate that some aspects of PHB biosynthesis are
general to organisms such as C. crescentus, which accumulates just 10% PHB cdw in PHBP
medium, and R. eutropha, which can accumulate up to 80% PHB cdw. Our studies in C.
crescentus demonstrate that many of these findings, in particular the striking ratio of one PhaP
per PHB chain in mature granules, are more general features of PHB biosynthesis regardless of
the extent of PHB accumulation. The results also further underscore the importance of PhaP in
granule formation and, in C. crescentus, PhaC activity. While the details of the role of PhaPs in
PHB biosynthesis appear to be distinct, the overall role in promoting PHB biosynthesis by
maintaining the structure of granules appears to be conserved. Finally, aspects of the regulation
of PHB biosynthesis remain poorly understood, and C. crescentus may prove to be an ideal
model for studying regulation because it has a simpler set of PHB biosynthetic genes and
because it already serves as a model for studying signal response and cell cycle regulation.
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3.6 Appendix
Table A3.1 Extraction efficiency, Mw and PDI of PHB extracted from wt cultures. PHB was
extracted from three different wt cultures grown from 0-40 h in PHBp.
Time (h) Extraction efficiency (%)a Mw (kDa) PDI
0 55 347 1.6
62 314 2.2
41 260 2.2
10 25 344 1.7
29 342 1.8
39 297 2.5
20 46 284 2.5
65 325 1.8
53 312 1.8
40 40 330 4.8
29 370 4.1
40 367 4.3
aExtraction efficiency was determined by crotonate analysis.
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Table A3.2 Molecules per cell of PHB, PhaP and PhaC and molar ratios of PHB/PhaP and
PHB/PhaC in wt C. crescentus.
PHB
(molecules/cell)
14,000± 1,160
13,400 ± 520
15,600 ± 640
60,600 ± 7,680
105,000± 15,000
109,100 ± 22,700
121,000 ± 22,700
146,000 ± 9,600
151,000± 1,850
72 151,000 ±25,500
Time
point (h)
0
7
10
15
20
25
30
36
50
306
PhaP
(molecules/cell)
7,200± 1,500
8,200 ± 2,300
23,400 ± 4,700
43,500 ± 7,900
73,600 ± 6,400
64,900 13,600
76,700 8,200
86,700 2,200
80,700 5,500
102,000 25,300
Ratio
PHB/PhaP
1.9 ± 0.4
PhaC
(molecules
per cell)
260 ±10
270 ± 30
300 ± 20
280 ± 20
340 ±10
330 110
220 30
180 40
200 10
260 70
1.6 ±
0.7 ±
1.4 ±
1.4 ±
1.7 ±
1.6±
1.7 ±
1.9 ±
0.5
0.1
0.2
0.2
0.5
0.4
0.1
0.1
Ratio
PHB/PhaC
54 ± 4.9
49± 5.4
53 ± 4.7
220 ± 31
310 ± 44
330± 130
550± 120
800± 170
750 + 30
570 1801.5 ± 0.4
B)
1.0-
0.8-
0.6-
0.4-
0.2-
0.0-
1.0-
0.8-
0.6-
0.4-
0.2-
0.0-
10 12 14 16 1
Volume (mL)
D)
10 12 14 16
1.0-
0.8]
0.6-
0.4-
0.2-
0.0-
18 10 12 14 16
Volume (mL) Volume (mL)
Figure A3.1 Gel permeation chromatography of PHB extracted from wt C. crescentus.
Cultures were grown 0-40 h in PHB, medium, and the PHB was extracted into chloroform by
refluxing at 70 'C for 48 h. PHB was extracted from three separate cultures at A) 0 h, B) 10 h, C)
20 h and D) 40 h post inoculation into PHBp.
Table A3.3 Extraction efficiency, Mw and PDI of PHB extracted from AphaP cultures. PHB
was extracted from three different AphaP cultures grown 24 h in PHBp.
Extraction efficiency (%)a Mw (kDa) PDI
1 20 429 2.7
2 31 407 1.9
3 27 463 1.6
aExtraction efficiency was determined by crotonate analysis.
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10 12 14 16
Volume (mL)
C)
p
18
1.0-
0.8-
0.6-
0.4-
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0.0-
18
A)
8
Table A3.4 Molecules per cell
crescentus.
of PHB and PhaC and molar ratio of PHB/PhaC in AphaP C.
Time
point (h)
0
7
10
15
20
25
30
36
50
72
PhaP
(molecules/cell)
PhaC
(molecules
per cell)
260 10
270 ±30
300 ± 20
280 ± 20
340 ±10
330 110
220 30
180 40
200 10
260 70
Ratio
PHB/PhaP
Table A3.5 Extraction efficiency, M, and PDI of PHB extracted from AphaR cultures. PHB
was extracted from three different AphaP cultures grown 24 h in PHBp.
Extraction efficiency (%)a M, (kDa) PDI
1 19 297 1.8
2 24 260 1.6
3 21 260 1.9
aExtraction efficiency was determined by crotonate analysis.
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PHB
(molecules/cell)
5,080 ± 300
8,000 ± 700
4,180 ± 750
7,670 ± 760
6,470 ± 2,020
7,430 ± 530
8,010± 60
10,200 ± 2,500
10,500± 1,040
14,600± 1,320
Ratio
PHB/PhaC
20± 1.8
26 ± 3.5
15 ± 3.6
39 ± 5.1
59 ± 34
110 ±14
73 ± 4.5
110 ± 28
140 ± 23
240 ± 47
Table A3.6 Molecules per cell of PHB, PhaP and PhaC and molar ratios of PHB/PhaP and
PHB/PhaC in AphaR C. crescentus.
PhaC
Time PHB PhaP (molecules Ratio Ratio
point (h) (molecules/cell) (molecules/cell) per cell) PHB/PhaP PHB/PhaC
0 4,260 ± 1,130 43,500 ± 4,880 410 ± 78 0.1 0.03 10 3.4
7 810 ±590 48,500 ±3,880 700 35 0.02 0.01 1.2 0.9
10 3,430 640 46,500+ 6,520 730± 92 0.07 0.02 4.7 1.0
15 44,500 4,150 78,500 ± 8,000 510 ± 15 0.6 0.08 87 8.6
20 86,300 4,730. 105,000 ±11,100 600 ±80 0.8 0.1 140 21
25 136,000 16,400 133,000 ±33,800 640 ±49 1.0 ±0.3 210 ±30
30 164,000 38,000 130,000 11,600 710 ±28 1.3 ±0.3 230 ±54
36 161,000 34,800 154,000 ± 13,800 670 ± 73 1.0 ± 0.2 240 ± 58
50 184,000 16,100 141,000 ±14,400 400 ±48 1.3 ±0.2 450 ±67
72 246,000 18,000 185,000 ± 34,700 880 ± 43 1.3 ± 0.3 280 ± 25
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Figure A3.2 Gel permeation chromatography of PHB extracted from wt, AphaP and AphaR
strains. A) Overlay of traces of PHB extracted from three AphaP cultures grown 24 h in PHBP
medium. B) Overlay of traces of PHB extracted from three AphaR cultures grown 24 h in PHBP
medium. C) Comparison of M, (striped) and PDI (gray) of PHB extracted from wt, AphaP and
AphaR cultures.
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Chapter 4:
Efforts to crystallize class I and class III PHB synthases
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4 Efforts to crystallize class I and class III PHB synthases
4.1 Introduction
This Chapter describes our efforts to crystallize both class I and class III synthases. These
studies were conducted in collaboration with Prof. Karen Allen in the Boston University
Department of Chemistry. Our lab has collaborated with the Ellenberger and Drennan
laboratories over the past 20 years in ongoing efforts to obtain a crystal structure of the class III
synthase from Allochromatium vinosum, PhaECAv and the class I synthase from Ralstonia
eutropha, PhaCRe- Crystals could be readily obtained in many conditions, but they either did not
diffract or diffracted to poor resolution (7 A or worse). Thus, our efforts to obtain high resolution
structures of PhaECAV and PhaCRe have thus far been unsuccessful.
One possible cause of disorder within a crystal lattice can be thermally labile regions of
proteins, that is, regions that are flexible enough to disrupt the crystal lattice. In an effort to
identify disordered regions of PhaECAv that might prevent tight packing in a crystal lattice,
limited proteolysis experiments were carried out. In these experiments, Geoff Stamper from the
Drennan Lab treated PhaECAv with a small amount of chymotrypsin, and assayed the resulting
protein mixtures for activity. He found that PhaE could be cleaved at two chymotrypsin cleavage
sites, one site 27 residues and a second site 35 residues from the C-terminus of PhaE, with
minimal effect on activity. Paul Hubbard, a former post doc in the Drennan Lab, cloned the
phaEJ27 construct in the pCDF1 vector with an N-terminal His6-tag, and separately cloned
phaC in the pET24a vector. He co-expressed and purified PhaEA27 and PhaC, in a 1:1 ratio (as
judged by SDS-PAGE). We have previously expressed wt PhaECAv from a single vector
containing phaEC and have observed that the two proteins also co-purify in a nearly 1:1 ratio (1,
2). Hubbard identified several conditions in which PhaEA27CAv crystallized. The condition he
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pursued most extensively was condition 59 of the Index Screen from Hampton Research. This
condition contained 0.02 M MgCl2-6H 20, 0.1 M Hepes pH 7.5 and 22% w/v poly(acrylic acid
sodium salt) 5,100. The original crystals only diffracted to >7 A, thus he made several attempts
to improve resolution by grid screening around the initial condition. Unfortunately he was unable
to improve the resolution beyond 7 A.
Hubbard provided us with the PhaEA27CAv construct, and our efforts to crystallize it are
described in this Chapter. We have crystallized it both in the presence and absence of the
inhibitor HBCH 2CoA, which is an analog of HBCoA in which the S of the thioester is replaced
with a methylene group (Figure 4.1). We also prepared a similar PhaEA35CAv construct, in
which PhaE has an N-terminal His6-tag and its 35 C-terminal residues are deleted. PhaEA35CAv
was also extensively screened for crystallization conditions, and like full-length PhaECAv and
PhaEA27CAv, PhaEA35CAv could be readily crystallized but at best diffracted to only 6.3 A.
0 OH
CoA
Figure 4.1 Structure of the HBCoA analog HBCH2CoA.
Another approach was taken to obtain a crystal structure of a class I and/or III PHB
synthase. As discussed in Chapter 1, the database contains hundreds of sequences of class I and
III synthases from various organisms. A common approach, when crystallization of a protein of
interest is not successful, is to investigate homologs. To this end, we cloned class III synthases
from Thiococcus pfennigii, Xanthamonas campestris, Arthrospira maxima, Xanthomonas
oryzaea, and Synechocystis PCC 8603 and class I synthases from Caulobacter crescentus,
Sphingopyxis alaskensis, Leptothrix cholodnii, Magnetospirillum magneticum. In this Chapter,
we focus on the synthase from C. crescentus as well as a truncated construct in which the 85
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N-terminal residues are removed (PhaCcc and PhaCcAN, respectively) and on the PhaCs from L.
cholodnii and S. alaskensis (PhaCLc and PhaCsa, respectively). These synthases are well-behaved
in solution and can readily be purified to >95% homogeneity. Most effort was put into the
crystallization of PhaC from C. crescentus, which is described in detail in this Chapter.
Unfortunately, we were ultimately not successful in our efforts to obtain a crystal
structure. This Chapter is intended to describe our most promising leads and what techniques
were employed in following these leads, and to provide recommendations for future
crystallization efforts.
4.2 Materials and Methods
4.2.1 Materials
All chemicals were obtained at the highest purity available from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified. All crystallography screens, siliconized glass coverslips
and 24-well crystallography trays were purchased from Hampton Research (Aliso Viejo, CA).
(R)-HBCoA was synthesized by Dr. Ping Li following the method of Yuan et al. (3).
Oligonucleotide primers were obtained from Integrated DNA Technologies (Coralville, IA) and
are listed in Table 4.1. Restriction enzymes were purchased from New England Biolabs
(Beverly, MA), GoTaq DNA polymerase and T4 DNA ligase were purchased from Promega
(Fitchburg, WI) and PfuII Ultra polymerase was purchased from Stratagene (La Jolla, CA). The
plasmids used in this study are listed in Table 4.2.
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Table 4.1 Primers and oligonucleotides used in this study.
Name Sequencea
phaEA35fw 5'-CGCGTCGCAGCCCTGTAAAAGCTTGCGGCC-3'
phaEA3 5rev 5'-GGCCGCAAGCTTTTACAGGGCTGCGACGCG-3'
phaCSafw 5'-GCTAGCACCGATATGGGCGAGGACAAGAGCAGCGGCGCGGCGA
ATCC-3'
phaCSarev 5'-GGATCCTTACCGCTGTTTGACGTAGCGGCCGGGGGCGTCCTCG-3'
phaCLcfw 5'-GTACCATATGAGCGCATTCCTCGGGCAGATGCCTGGGTTGGCCG
GCC-3'
phaCLcrev 5'-GTACAAGCTTTCAGACTTTCTGCTTGACGTAACGACCGGGTGCC
GGC-3'
phaCMmfw 5'-GTATAATAAGCTAGCGCCGAGCAGACGGGC-3'
phaCMmrev 5'-CAACTGGGATCCTTACACCGCCTTGAC-3'
phaCAmfw 5'-CATATGATGTTACCTTTCGCCTTACAAATGGGTTTAGAAGACTTA
ACCCAGG
AATATGCAGACCTCACCG-3'
phaCAmrev 5'-GGATCCTCACTCTCGCACTTTTAACCAATCAACAATGGTTGGGGG
TAGGTCTCGCTGTAC-3'
phaEAmfw 5'-CATATGGAAAACGAAACAAATCCGTGGAACGAAATGGCCAATCA
ATGGGTAAACACCTGGACTC-3'
phaEAmrev 5'-GGATCCTCAACTTACTTCTTGAATTGACTCGGGTTTGGGTGAAGAT
GCTGTCATGGTGGATATCTG-3'
phaCSynfw 5'-CATATGATGTTGCCTTTTTTTGCTCAGGTGGGGTTAGAAGAAAAT
CTCCATGAAACCCTAG-3'
phaCSynrev 5'-GGATCCTCACTGTCGTTCCGATAGCCAATGGGCGATC-3'
phaESynfw 5'- GCTAGCAAGTTACTTTATTGGATTTAGTCCC-3'
phaESynrev 5'- GCTAGCTTAGCCTGGGTTTGCTTCTGTTTCTCCC-3'
phaECTpfw 5'-GATATAGGATCCTGGCGGCGGCGGCTCTGGCGGCGGCGGCTCTAA
CGATACGGCCAACAAGAC-3'
phaECTprev 5'-GATATAGCGGCCGCTCAGGCGCG-3'
phaCTpfw 5'-GATATACATATGATGTCCCCATTCCCGATCGACATCCGGCCCGAC
AAG-3'
phaCTprev 5'-GATATAGGATCCTCAGCCGCGTTCGTTCAGCCAGCGGC-3'
phaETpfw 5'-GATATACATATGAACGATACGGCCAACAAGACCAGCGACTGGGT
CGACATCC-3'
phaETprev 5'-GATATAGGATCCTCACTGGCCGGTGGTGGGCTTGGTGGTCTTG-3'
phaECXcfw 5'-GATATACATATGGGCGGCGGCGGCTCTGGCGGCGGCGGCTCTACA
ACCAGCGGTTCGG-3'
phaECXcrev 5'-GATATA-GAGCTC-TCAACCGTTGCCGCCAC-3'
phaCXofw 5'-CATATGAAGGGCCCATTGGGGTTCAGCGCCGAAGACC-3'
phaCXorev 5'-GGATCCTCAGGCATTGCCGCCACGTTCCTGCAGCCAG-3'
phaEXofw 5'-GCTAGCATGGCAAGCAGCGGTTCGGACAACGGCAACTTCGACG-3'
phaEXorev 5'-AAGCTTTCATGCCTGCGCTCCACGTTTTTTACCTGCGGGGGGTG
TG-3'
aRestriction sites are underlined
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Table 4.2 Commercial vectors and plasmids used in this study.
Commercial vec
Plasmid
pPhaEA27Ava pCDF1 containing phaEl27, which is phaE from A.
vinosum truncated on the C-terminus by 27 amino
acids; phaEz27 is inserted between BamHI and
HindIII restriction sites and contains an N-terminal
His 6-tag and the linker VGTGSNDDDDKSP
pPhaEA35Av pCDF1 containing phaEl35, which is phaE from A.
vinosum truncated on the C-terminus by 35 amino
acids; phaEJ35 is inserted between BamHI and
HindII restriction sites and contains an N-terminal
His 6-tag and the linker VGTGSNDDDDKSP
pPhaCsa pET28a containing phaCsa, inserted between NheI
and BamHI restriction sites; encodes N-terminal
His 6-tag with the linker SSGLVPRGDSH
pPhaCLc pET28a containing phaC, inserted between NdeI
and HindIII restriction sites; encodes N-terminal
tor Description
pET24a Expression vector, under control of lac operator, T7
promoter; contains fl origin and encodes kanamycin
(Km) resistance
pCDF1 Expression vector, under control of lac operator, T7
promoter; contains CDF origin and encodes
streptomycin (Sm) resistance; encodes N-terminal
His6-tag and the linker VGTGSNDDDDKSP with
an enterokinase cleavage site underlined
pET28a Expression vector, under control of lac operator, T7
promoter; contains fl origin and encodes kanamycin
resistance; encodes N-terminal (His)6-tag and a
thrombin cleavage site (SSGLVPRGDSH)
pET3a Expression vector, under control of lac operator, T7
promoter; contains fl origin and encodes ampicillin
(Amp) resistance
pTrc99 Expression vector, under control of arabinose
promoter; contains F1 origin and encodes Amp
resistance
pET52b Expression vector, under control of lac operator, T7
promoter; contains F1 origin; encodes N-terminal
StreplI-tag (WSHPQFEK) and the linker
GALEGALEVLFQGPGYQDP, with a rhinovirus
protease cleavage site underlined; encodes Amp
resistance
Description
pPhaCAva pET24a containing phaC, inserted between NdeI
and XhoI restriction sites
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Source
Novagen
Novagen
Novagen
Novagen
Invitrogen
Novagen
Reference
Hubbard,
Drennan,
unpublished
Hubbard,
Drennan,
unpublished
This work
This work
This work
(His)6-tag with the linker SSGLVPRGDSH
pPhaCumb pET28a containing phaCum, inserted between NheI
and BamHI restriction sites; encodes N-terminal
(His)6-tag with the linker SSGLVPRGDSH
pPhaCAm pET3a containing phaCm inserted between NdeI
and BamHI restriction sites
pPhaEAm pET28a containing phaEA, inserted between NdeI
and BamHI restriction sites; encodes N-terminal
(His) 6-tag with the linker SSGLVPRGDSH
pPhaCsyn pET3a containing phaCsyn inserted between NdeI
and BamHI restriction sites
pPhaEsyn pET28a containing phaEsyn, inserted into an NheI
restriction site; encodes N-terminal (His) 6-tag and
the linker SSGLVPRGDSH
pFS91 pTrc99a containing phaECTr; phaE and phaC are
separated by 40 non-coding base pairs
This work
This work
This work
This work
This work
Budde,
Sinskey,
unpublished
pPhaECTp pET52b containing phaECTp inserted between This work
BamHI and Notl restriction sites; encodes N-
terminal StrepIl-tag and contains (G4 S) 2 linker
pPhaCTp pET3a containing phaCTr inserted between NdeI and This work
BamHI restriction sites
pPhaET, pET28a containing phaETp, inserted between NdeI This work
and BamHI restriction sites; encodes N-terminal
(His) 6-tag and the linker SSGLVPRGDSH
pPhaECx, pET52b containing phaECx, inserted between NdeI This work
and BamHI restriction sites; encodes N-terminal
StreplI-tag and contains (G4 S) 2 linker
pPhaCxo pET3a containing phaCx0 inserted between NdeI This work
and BamHI restriction sites
pPhaEx0  pET28a containing phaEx, inserted between NheI This work
and HindlIl restriction sites; encodes N-terminal
(His) 6-tag and the linker SSGLVPRGDSH
aplasmids were a gift of Paul Hubbard
bplasmid was generated by Elizabeth Min
4.2.2 Construction of the expression plasmid pPhaEA35 from pPhaEA27 by mutagenesis
The plasmid pPhaEA35 was generated from the parent plasmid pPhaEA27, which was a
gift of Paul Hubbard from the Drennan Lab. Using pPhaEA27 as a template, eight additional C-
terminal residues were removed in a single mutagenesis step using the primers phaEA35fw and
phaEA35rev (Table 4.1) to generate pPhaEA35. The italicized portions of the primers anneal to
325
the 3' end of phaE immediately upstream of the fragment to be deleted by mutagenesis. The
regular font portions anneal to the region immediately downstream of the fragment to be deleted.
Mutagenesis was carried out using PfuII polymerase and 1 pM each primer; the annealing
temperature was 55 'C and the extension time and temperature were 7 min at 68 *C. The product
was transformed into E. coli XL10Gold cells, which were plated onto LB/agar supplemented
with 50 pg/mL streptomycin (Sm). Plasmid was isolated and the gene was sequenced at MIT
Biopolymers to confirm the desired construct.
4.2.3 Expression and purification of PhaEA27C and PhaEA35C
For expression of PhaEA27CAV and PhaEA35CAv, E. coli BL21(DE3) Gold cells were co-
transformed with pPhaEA27AV/pPhaCAV or pPhaEA3 5AV/pPhaCA,, respectively, for co-expression
of PhaEAv and PhaCAv. In a typical growth, 2 L cultures (LB supplemented with 50 jIg/mL sm
and 50 pg/mL Km) in 6 L flasks were inoculated at a dilution of 1:200 with saturated overnight
cultures harboring pPhaEA27AV/pPhaCAv or pPhaEA35Av/pPhaCAv. The cultures were grown at
37 'C with shaking at 220 rpm until they reached and OD 60 0 = 0.6. The cultures were then cooled
on ice to -25 'C and induced with 0.4 mM IPTG and grown an additional 3-4 h at 25 *C with
shaking at 220 rpm. The cells were then pelleted by centrifugation at 4,000 xg for 10 min at 4 'C.
The cell pellets were flash frozen in liquid nitrogen and stored at -80 C until required. A growth
typically yielded 2-3 g cell paste per L of culture.
PhaEA27CAv or PhaEA35CAV were co-purified using Ni-NTA chromatography. Only
PhaE in each construct contained the His6-tag, and the association between PhaE and PhaC
facilitated co-purification in a 1:1 ratio. The cells (typically -10 g) were resuspended in 3-5 mL
lysis buffer (50 mM NaH 2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by two
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passes through the French pressure cell at 14,000 psi. The insoluble cell debris was removed by
centrifugation at 4 'C for 20 min at 20,000 xg. The soluble supernatant was combined with Ni-
NTA resin (1 mL resin per 10 mg protein) and incubated with gentle stirring for 30 min at 4 C.
The slurry was loaded onto a column and the resin allowed to settle. The flowthrough was
collected by gravity flow. The column was washed with 20 column volumes (cv) lysis buffer,
then the protein was eluted with 5 cv lysis buffer with 250 mM imidazole. The protein
containing fractions were combined and concentrated to 3-5 mL, then exchanged into 50 mM
sodium cacodylate pH 7.5, 20 mM NaCl by two rounds of dialysis for 4 h against 1 L buffer at 4
'C. The typical yield from purification of both PhaEA27CAV and PhaEA35CAv was approximately
10 mg/g of cells. The proteins were concentrated to ~20 mg/mL and aliquots of 30 pL, 50 tL
and 100 pL were flash frozen in liquid nitrogen and stored at -80 'C.
4.2.4 Activity assays of PhaECAv constructs
Activities were measured at 30 C using the 5,5'-dithiobis-(2-nitrobenzoic acid (DTNB)
assay described in Chapter 2, section 2.2.5. In a final volume of 100-200 p1, a typical assay of
PhaEA27CAv or PhaEA35CAv contained 15-20 nM synthase and 0.75 mM HBCoA. At various
time points, 20 ptL aliquots were withdrawn and added to 50 [tL 10% ice cold trichloroacetic
acid (TCA). The samples were centrifuged 5 min at 14,000 xg to remove precipitated protein,
and 68 pL was withdrawn and added to 362 pL 0.25 mM DTNB in 0.5 M KH2PO 4, pH 7.8. A4 12
(s = 13,600 M-cm-) was measured. The assay data are fit to a sigmoidal function whose
equation is given in Equation 4.1.
Equation 4.1 y = A
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4.2.5 Determination of the oligomeric states of PhaEA27CA, and PhaEA35CAv by size
exclusion chromatography (SEC)
The oligomeric states of PhaEA27CAV and PhaEA35CAV were examined by SEC using a
Bio-Sil SEC 400-5 column (Bio-Rad, 300 x 7.8 mm, M, range 20,000-1,000,000 Da) connected
to a Waters 515/2487 HPLC and the elution monitored at 260 and 280 nm. The samples (20 pL
of a 5 mg/mL solution) were injected onto the column and eluted at room temperature (RT) at a
flow rate of 1.0 mL/min with 50 mM sodium cacodylate, pH 7.5, 200 mM NaCl. The M, of each
sample was determined by comparison with a set of standards (Bio-Rad) of retention times (Mw):
thyroglobulin, 9.2 min (670 kDa); 7-globulin, 11.5 min (158 kDa); ovalbumin, 12.2 min (44
kDa); myoglobin, 13.1 min (17 kDa); B12 , 13.9 min (1.35 kDa).
4.2.6 General procedures for setting up crystallization trials
Crystallization conditions are described in greater detail in the Results section. Generally,
for initial screening of crystallization conditions, PhaEA27CAv and PhaEA35CAv were ~20
mg/mL in 50 mM sodium cacodylate pH 7.5, 20 mM NaCl, and PhaCccAN was 30-60 mg/mL in
20 mM Hepes pH 7.5, 20 mM NaCl. Prior to setting up trays, proteins were centrifuged at 4 'C
for 10 min at 14,000 xg to remove insoluble contaminants such as dust or precipitated protein.
Crystallization conditions were screened by the hanging drop method in 24-well trays using
siliconized glass cover slips. The wells contained 500 iL mother liquor and the hanging drop
typically consisted of 1 ptL protein and 1 ptL mother liquor. All proteins were examined in the
following screens (Hampton Research, Aliso Viejo, CA): Crystal Screens I and II (98
conditions); Index Screen (96 conditions); PEG/Ion Screens I and 11 (96 conditions); PEGRX
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Screens I and 11 (96 conditions); SaltRx Screens I and 11 (96 conditions). Trays were incubated at
4 OC, 18 0C, 23 OC and 37 'C, as indicated in the text.
Samples of PhaEA27CA, (20 mg/mL) and PhaCccAN (65 mg/mL) were also submitted to
the Hauptman-Woodward Medical Research Institute (Buffalo, NY) for high throughput
screening using the microbatch-under-oil method of crystallization. In this method, 1536-well
trays are set up such that each well contains 0.2 pLL protein solution and 0.2 ptL crystallization
solution (a different solution in each well) covered by a drop of Parrafin oil (EMD Chemicals,
Inc, Darmstadt, Germany). Slow vapor diffusion from the protein/crystallization solution drop
through the Parrafin oil increases the concentration of protein and precipitant in the drop over
time, which can potentially facilitate crystal formation. The crystallization solutions used in these
experiments can be found at http://www.hwi.buffalo.edu/faculty research/crystallization.html.
4.2.7 In-house screening of crystals for diffraction
Crystals were screened in the Boston University Department of Chemistry using a Bruker
AXS Proteum-R instrument, equipped with a kappa four circle goniometer, MICROSTAR
rotating anode X-ray source and PLATINUM135 CCD area detector for single crystal X-ray
diffraction. Crystals were screened either at RT (wet mounts) or frozen in a stream of nitrogen
(cryo mounts). For wet mounts, single crystals were looped and a small amount of the well
solution (5-10 pL) was pipetted into the tip of a cylindrical plastic sheath with one sealed end,
which was then placed over the loop holding the crystal (Figure 4.2). The sheath was sealed to
the loop using vacuum grease. The well solution in the tip of the plastic sheath prevents the
crystal from drying out during screening. For cryo mounts, single crystals were looped from their
original drop and gently placed in a 5 ptL drop of a cryoprotectant solution (e.g. Paratone-N, PEG
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400, isopropanol). The
cryoprotectant to remove
quickly mounted onto the
A)
crystal was released from the loop and gently agitated in the
excess water from the crystal. The crystal was then looped again and
goniometer head and frozen in a cryostream of nitrogen.
B)
Plastic sheath
Drop of well solution
Crystal
Loop
Mount
Base
Figure 4.2 Diagram of a room temperature (wet) mount for screening crystals for
diffraction. A) Illustration of components for a wet mount set-up. B) Picture of sealed wet
mount. Figure was adapted from (4).
4.2.8 Construction of the expression plasmid pPhaCsa
The gene for the class I synthase from Sphingopyxis alaskensis (phaCsa) was cloned into
the expression vector pET28a for overexpression and purification. A glycerol stock of S.
alaskensis was generously provided by the Sinskey lab in the MIT Department of Biology. The
cells were streaked onto LB/agar without antibiotics and grown overnight at 37 'C. phaCsa (1.8
kb) was amplified by colony PCR on single colonies using GoTaq polymerase and the primers
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phaCSafw/phaCSarev (Table 4.1). phaCSafw inserted an NheI restriction site on the 5' end of
phaCsa, and phaCSarev inserted a BamHI restriction site at the 3' end of phaCsa. The PCR
product was digested with NheI and BamHI and ligated overnight at RT into pET28a digested
with the same restriction enzymes at a vector to insert ratio of 1:5. The ligation product was
transformed into E. coli XL1O Gold cells, which were grown overnight at 37 'C on LB/agar
supplemented with 50 pg/mL Km. Plasmids were isolated and the gene sequenced at the MIT
Biopolymers Facility.
4.2.9 Construction of the expression plasmid pPhaCL,
The gene for the class I synthase from Leptothrix cholodnii (phaCLc) was cloned into
pET28a for expression and purification. Genomic DNA from L. cholodnii was generously
provided from the Emerson lab at the Bigelow Laboratory for Ocean Sciences in East Boothbay,
Maine. phaCLc (1.8 kb) was amplified from 50 ng of genomic DNA using GoTaq polymerase
and the primers phaCLcfw/phaCLcrev (Table 4.1). phaCLcfw inserted an NdeI restriction site on
the 5' end of phaCLc, and phaCLcrev inserted a HindIII restriction site at the 3' end of phaCLc.
The PCR product was digested with NdeI and HindIll and ligated overnight at RT into pET28a
digested with the same restriction enzymes at a vector to insert ratio of 1:5. The ligation product
was transformed into E. coli XL10 Gold cells, which were grown overnight at 37 'C on LB/agar
supplemented with 50 ptg/mL Km. Six colonies were grown to saturation and the plasmids were
isolated and the sequences confirmed by the MIT Biopolymers Facility.
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4.2.10 Expression and purification of PhaCsa and PhaCLc
Expression and purification of PhaCsa and PhaCLc were carried out exactly as described
for PhaCcc and PhaCccAN in Chapter 2. Purification yielded 5 mg PhaCsa per g of cell paste, and
1 mg of PhaCLc per g of cell paste. The proteins were purified to >95% purity as judged by 10%
SDS-PAGE.
4.2.11 Activity assays of PhaCsa and PhaCLc
For PhaCsa, in a final volume of 80 iL, a typical assay contained 53 nM synthase and
0.75 mM HBCoA, and the temperature was varied from 10-40 'C. For PhaCLc, in a final volume
of 90 ptL a typical assay contained 100 nM synthase and 0.75 mM HBCoA and the temperature
was varied from 15-40 'C. Prior to the assay, the enzymes were incubated for 5 min at the assay
temperature. At various time points, 10 ptL aliquots were withdrawn from 0-10 min and added to
25 pL 10% TCA. The samples were centrifuged 5 min at 14,000 xg to remove precipitated
protein, and 33 tL was withdrawn and added to 117 ptL 0.25 mM DTNB in 0.5 M KH2PO 4, pH
7.8. The A4 12 of each sample was measured. The specific activities were calculated from the
linear portion of the assays. The data were fit to a sigmoidal function whose equation is given in
Equation 1.
4.2.12 Construction of the expression plasmid pPhaCum
The gene for the class I synthase from Magnetospirillum magneticum (phaCum) was
cloned into pET28a for expression and purification. Genomic DNA from M magneticum was
generously provided from the Komeili laboratory in the Department of Plant and Microbial
Biology at UC Berkeley. phaCMm (1.8 kb) was amplified from 50 ng of genomic DNA using
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GoTaq polymerase and the primers phaCMmfw/phaCMmrev (Table 4.1). phaCMmfw inserted
an NheI restriction site on the 5' end of phaCum, and phaCMmrev inserted a BamHI restriction
site at the 3' end of phaCm.. The PCR product was digested with NheI and BamHI and ligated
overnight at RT into pET28a digested with the same restriction enzymes at a vector to insert ratio
of 1:5. The ligation product was transformed into E. coli XL1O Gold cells, which were grown
overnight at 37 'C on LB/agar supplemented with 50 jtg/mL Km. Plasmids were isolated and the
sequences confirmed by the MIT Biopolymers Facility.
4.2.13 General strategy for cloning and expression of class III synthases
Cloning of the class III synthases described in this section followed a general strategy in
which phaE and phaC were cloned into separate expression vectors. The phaEs were cloned into
pET28a, which encoded an N-terminal (His)6-tag and Km resistance. The phaCs were cloned
into pET3a, which encoded Amp resistance but no tag. The two plasmids were co-transformed
into E. coli and maintained by Km/Amp selection. Expression, purification and characterization
of the various synthases were successful to varying degrees, but they were generally more poorly
behaved in solution than the class I synthases described above, and were thus not pursued
extensively for crystallization.
4.2.14 Cloning of pPhaEAm and pPhaCAm and expression of PhaECAm
Construction of the expression plasmids pPhaEAm and pPhaCm. Arthrospira maxima (10
mL of liquid culture) was a generous gift of the Dismukes Laboratory from the Department of
Chemistry and Chemical Biology at Princeton. For amplification ofphaE and phaC, the genomic
DNA from A. maxima was first isolated from 1 mL of the liquid culture using the GenElute
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Bacterial Genomic DNA Kit (Sigma-Aldrich) by the manufacturer's protocol. phaE, was
amplified from 50 ng genomic DNA using PfuII Ultra polymerase and the primers
phaEAmfw/phaEAmrev. phaEAmfw inserted an NdeI restriction at the 5' end of phaE and
phaEAmrev inserted a BamHI restriction site at the 3' end of phaE. The amplified PCR product
was digested using NdeI/BamHI and was ligated overnight at RT into pET28a digested with the
same enzymes at an insert to vector ratio of 5:1. phaC was amplified using the primers
phaCAmfw/phaCAmrev. phaCAmfw inserted an NdeL restriction site at the 5' end of phaC and
phaCAmrev inserted a BamHI restriction site at the 3' end of phaC. The amplified PCR product
was then digested with NdeI/BamHI and ligated at RT overnight into pET3a digested with the
same restriction enzymes at an insert to vector ratio of 5:1. The ligation products were
individually transformed into E. coli XL1OGold, which were grown overnight at 37 'C on
LB/agar supplemented with 50 pig/mL Km (for pPhaEAm) or 100 tg/mL Amp (pPhaCAm). Single
colonies were grown to saturation and the plasmids were isolated and sent for sequencing at the
MIT Biopolymers Facility.
Expression of PhaECm. All culture medium was supplemented with 50 pg/mL Km and
100 pig/mL Amp. A single colony of E. coli BL2 1 (DE3) Gold containing pPhaEAm and pPhaCAm
was used to inoculate 5 mL of LB in a 15 mL culture tube. Cells were grown overnight at 37 'C.
The culture was then used to inoculate three separate 500 mL LB cultures in 2 L baffled flasks at
dilutions of 1:200. The cultures were grown at 37 *C with shaking at 220 rpm until OD 60 0 = 0.6.
Of the three cultures, two were cooled to ~18 'C on ice, induced with 0.4 mM IPTG and grown
an additional 4 h at 18 'C. The third culture was induced with 0.4 mM IPTG and grown an
additional 4 h at 37 'C. The cells were harvested by centrifugation at 4,000 xg for 10 min at 4 'C.
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The culture grown at 37 'C following induction yielded ~3 g of cell paste, whereas the cultures
grown at 18 'C following induction yielded - g of cell paste each.
Solubility and activity of PhaECn in crude lysate. To test for the solubility of PhaECAm,
the cell pellets from the culture induced at 37 C and from one culture induced at 18 C were
resuspended in 3 mL per g of cells lysis buffer containing 50 mM NaH2PO4, 300 mM NaCl, 10
mM imidazole pH 8.0. The cell pellet from the third culture that had also been induced at 18 C
was resuspended in lysis buffer containing the detergent 0.1% n-octyl-p-D-glucopyranoside. The
cells were lysed by two passages through the French pressure cell at 14,000 psi. The soluble and
insoluble lysate fractions were separated by centrifugation at 4 C for 20 min at 20,000 xg. The
soluble fractions were decanted into separate tubes and the insoluble fractions were resuspended
in lysis buffer to a volume equal to that of the corresponding soluble fraction. To prepare
samples for SDS-PAGE, soluble and insoluble lysate were combined 1:1 with Laemmli buffer
and boiled for ten min. Samples (10 pL) were analyzed by 12% SDS-PAGE.
Activity assays contained in a final volume of 110 pL: 10 ptL of a 1:25 dilution of soluble
or insoluble lysate and 0.75 mM HBCoA in 20 mM Hepes pH 7.5, 20 mM NaCl. At various time
points, 20 pL aliquots were withdrawn and quenched in 50 piL ice cold 10% TCA. The samples
were briefly centrifuged to remove precipitated protein and 68 [tL was withdrawn and added to
262 pL 0.25 mM DTNB in 0.5 M KH 2PO 4 , pH 7.8. The A4 12 of each sample was measured.
Protein concentration was determined by the Bradford method using a BSA standard.
4.2.15 Cloning of pPhaEsy. and pPhaCsy. and expression and purification of PhaECsy.
Construction of the expression plasmids pPhaEsyn and pPhaCsy. Genomic DNA from
Synechocystis PCC 6803 was a gift from the Stephanopolous Laboratory in the Department of
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Chemical Engineering at MIT. phaEsyn was amplified from 50 ng genomic DNA using PfuII
Ultra polymerase and the primers phaESynfw/phaESynrev. phaESynfw inserted an Nhel
restriction at the 5' end of phaE and phaESynrev inserted an NheI restriction site at the 3' end of
phaE. The amplified PCR product was digested with NheI and was ligated overnight at RT into
pET28a digested with NheI at an insert to vector ratio of 5:1. phaC was amplified using the
primers phaCSynfw/phaCSynrev. phaCSynfw inserted an NdeI restriction site at the 5' end of
phaC and phaCSynrev inserted a BamHI restriction site at the 3' end of phaC. The amplified
PCR product was then digested with NdeI/BamHI and ligated at RT overnight into pET3a
digested with the same restriction enzymes at an insert to vector ratio of 5:1. The ligation
products were individually transformed into E. coli XL 1 OGold, which were grown overnight at
37 'C on LB/agar supplemented with 50 pg/mL Km (for pPhaEsyn) or 100 jtg/mL Amp
(pPhaCsyn). Single colonies were grown to saturation and the plasmids were isolated and sent for
sequencing at the MIT Biopolymers Facility.
Expression andpurification of PhaECsyn. All culture medium was supplemented with 50
pg/mL Km and 100 ptg/mL Amp. A single colony of E coli BL21(DE3)Gold containing
pPhaEsyn and pPhaCsyn was used to inoculate 5 mL of LB in a 15 mL culture tube. Cells were
grown overnight at 37 'C and 0.5 mL was used to inoculate a 100 mL LB culture in a 500 mL
flash, which was grown 16 h to saturation. Four 2 L LB culture in 6 L baffled flasks were
inoculated with the overnight culture at a dilution of 1:200. The cultures were grown until they
reached an OD6 0 0 = 0.6 and were cooled on ice to -18 C. Expression of PhaECsyn was induced
with 0.4 mM IPTG and the culture was grown an additional 4 h at 18 C. The cells were
harvested by centrifugation at 4 'C for 10 min at 4,000 xg. The cell pellet (-17 g) was flash
frozen in liquid nitrogen and stored until use.
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All purification steps were carried out at 4 'C. The cell pellet was resuspended in 3 mL
per g of cells in lysis buffer containing 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole pH
8.0. The cells were lysed by two passes through the French pressure cell at 14,000 psi and the
insoluble debris removed by centrifugation for 20 min at 20,000 xg. The soluble fraction was
combined with Ni-NTA resin (~1 mL per g of cells) and incubated for 30 min with gentle
rocking. The slurry was loaded into a column (3.5 cm x 5.5 cm) and the flowthrough collected.
The column was washed with 20 cv lysis buffer and 10 cv lysis buffer containing 50 mM
imidazole. The protein was eluted with 5 cv lysis buffer containing 250 mM imidazole and
concentrated to ~12 mL. The protein was then exchanged into 50 mM tris pH 7.6, 10 mM NaCl,
5% glycerol by Sephadex G25 (200 mL, 5 cm x 300 cm). The protein was centrifuged for 10 min
at 14,000 xg to remove precipitated protein, and the supernatant was loaded onto a Q Sepharose
anion exchange column (30 mL, 3.5 cm x 7 cm). The column was washed with 2 cv 50 mM Tris
pH 7.6, 10 mM NaCl, 5% glycerol and the protein was eluted with 300 mL of a linear gradient of
0-500 mM NaCl in 50 mM Tris pH 7.6, 5% glycerol. Finally, the protein was exchanged into 20
mM Hepes pH 7.5, 20 mM NaCl by Sephadex G25 chromatography (25 mL, 1 cm x 30 cm). The
final protein was concentrated to 9 mg/mL, centrifuged 10 min at 14,000 xg to remove
precipitated protein, and flash frozen in 50 [tL aliquots and stored at -80 C until use.
Assay of PhaECsyn activity. Protein concentration was determined by A2 8 0 (F = 114,910
M-1cm~1 for PhaEC) or by the Bradford method. Activity was measured by discontinuous DTNB
assay. For crude lysate, the assay contained in a final volume of 110 pL: 10 pL of a 1:100
dilution of soluble extract (0.0015 mg protein total), 0.75 mM HBCoA in 20 mM Hepes pH 7.5,
20 mM NaCl. For the purified protein, the assays contained in a final volume of 130 ptL: 100 nM
PhaECsyn, 0.75 mM HBCoA in 20 mM Hepes pH 7.5, 20 mM NaCl. At time points from 0-10
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min, 20 tL aliquots were withdrawn and quenched in 50 pL ice cold 10% TCA. The samples
were centrifuged 5 min at 14,000 xg to remove precipitated protein and 68 pL aliquots were
withdrawn and added to 262 pL 0.25 mM DTNB in 0.5 M KH 2PO4 , pH 7.8. The A4 12 of each
sample was measured.
4.2.16 Construction of the plasmids pPhaECTp, pPhaETp and pPhaCTp and expression and
purification of PhaECTp
Construction of the expression plasmidpPhaECTr. pFS91 was a gift of the Sinskey lab in
the Department of Biology at MIT. pSF91 contains phaECp, including the 40 non-coding base
pairs between the two coding regions. phaECTr was amplified from 100 ng pFS91 using the
primers phaECTpfw/phaECTprev (Table 4.1). The primer phaECTpfw inserted a BamHI site
and on the 5' end ofphaECTr and encoded a (G4 S) 2 linker (shown in italics in Table 4.1) between
the StreplI-tag and the 5' end of phaECTp. The primer phaECTprev inserted a NotI site at the 3'
end of phaECTr. The PCR product was digested with BamHI and NotI and ligated overnight at
RT at an insert to vector ratio of 5:1 into pET52b digested with BamHI and NotI. The ligation
product was transformed into E. coli XL1OGold cells and grown overnight on LB/agar
supplemented with 100 pg/mL Amp. Plasmid was isolated from individual colonies and the
sequence of pPhaECTp was confirmed by sequencing at MIT Biopolymers Facility.
Construction of the expression plasmids pPhaEp and pPhaCp. phaETr was amplified
from 100 ng pSF91 using PfuII Ultra polymerase and the primers phaETpfw/phaETprev.
phaETpfw inserted an NheI restriction at the 5' end of phaE and phaETprev inserted an NheI
restriction site at the 3' end of phaE. The amplified PCR product was digested NheI and was
ligated overnight at RT into pET28a digested with NheI at an insert to vector ratio of 5:1. phaC
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was amplified using the primers phaCTpfw/phaCTprev. phaCTpfw inserted an NdeI restriction
site at the 5' end of phaC and phaCTprev inserted a BamHI restriction site at the 3' end of phaC.
The amplified PCR product was digested with NdeI/BamHI and ligated at RT overnight into
pET3a digested with the same restriction enzymes at an insert to vector ratio of 5:1. The ligation
products were individually transformed into E. coli XL1OGold cells, which were grown
overnight at 37 'C on LB/agar supplemented with 50 tg/mL Km (for pPhaETp) or 100 Vg/mL
Amp (pPhaCTp). Single colonies were grown to saturation and the plasmids were isolated and
sent for sequencing at the MIT Biopolymers Facility.
Expression of PhaECTrfrom pPhaEC,. All culture medium was supplemented with 100
tg/mL Amp. A single colony of E. coli BL21(DE3) containing pPhaECT, was used to inoculate
a 5 mL culture in a 15 mL culture tube and grown overnight at 37 'C. The entire culture was
used to inoculate a 1 L LB culture in a 2.8 L flask, which was grown at 37 'C until OD 600 = 0.6.
The culture was cooled on ice to ~18 'C then induced with 0.4 mM IPTG. The cells were grown
an additional 4 h at 18 'C, then harvested by centrifugation at 4 *C for 10 min at 4,000 xg. The
cells (~A g) were frozen in liquid nitrogen and stored at -80 'C until use.
Expression from pPhaETr/pPhaCP and purification of PhaECp. All culture medium was
supplemented with 50 ptg/mL Km and 100 tg/mL Amp. Single colonies of E. coli BL21(DE3)
containing pPhaETp and pPhaCT, were used to inoculate 5 mL cultures in 15 mL culture tubes.
The cultures were grown overnight, then used to inoculate 2 L cultures in 6 L flasks at a dilution
of 1:200. The cultures were grown with shaking at 220 rpm at 37 'C until they reached an OD 60 0
= 0.6. The cultures were rapidly cooled on ice to ~18 'C and expression of PhaECTp was induced
with 0.4 mM IPTG. The cells were grown an additional 4 h at 18 'C, then the cells were
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harvested by centrifugation at 4,000 xg at 4 'C for 10 min. The cells were flash frozen in liquid
nitrogen and stored at -80 *C until use. A typical growth yielded 2 g cells per L of culture.
All purification steps were carried out at 4 C. Cells were resuspended in 3 mL lysis
buffer (50 mM NaH2PO 4, 300 mM NaCl, 10 mM imidazole, pH 8.0) per g of cell paste. When
noted in the Results section, the buffers also contained the detergents hecameg or octyl-p-D-
glucopyranoside (0.1% or 1%). The cells were lysed by two passes through the French pressure
cell at 14,000 psi and the insoluble fraction removed by centrifugation for 10 min at 4 'C and
30,000 xg. The soluble fraction was incubated with stirring for 30 min at 4 'C with Ni-NTA
affinity resin pre-equilibrated with lysis buffer (~I mL resin per 3 mL soluble crude extract). The
resin was loaded into a column and the flowthrough was collected. The column was washed with
15 cv lysis buffer then eluted with 5 cv of lysis buffer with 250 mM imidazole. The eluent was
collected in fractions and the fractions containing protein were combined and concentrated and
exchanged into 50 mM Tris pH 7.6, 5% glycerol using Sephadex G25. The protein was then
applied to a Q sepharose column (- mL resin per 3 mL protein). The column was washed with
two cv 50 mM Tris pH 7.6, 5% glycerol, then the protein was eluted with 20 cvs of a linear
gradient from 0-500 mM NaCl. The eluent was collected in 0.5 mL fractions, and the fractions
containing PhaECTp were combined, concentrated, and exchange into 20 mM Hepes pH 7.5, 20
mM NaCl by Sephadex G25. The final protein was concentrated to -5 mg/mL, flash frozen in
liquid N2, and stored in aliquots at -80 'C. A typical yield was about 1 mg PhaECTp per g cells.
Assay of PhaECTr activity. Protein concentration was determined by A2 80 using
E = 118,070 M'1cm-1 for PhaEC. PhaECTp was assayed by the discontinuous DTNB assay. In a
final volume of 110 ptL, a typical assay contained: 10 or 50 nM PhaECTp and 0.75 mM HBCoA
in 20 mM Hepes pH 7.5, 20 mM NaCl. When noted in the Results section, the assays also
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contained the detergents hecameg or octyl-p-D-glucopyranoside (0.1% or 1%). At various time
points, 20 ptL aliquots were withdrawn and quenched in 50 [.L ice cold 10% TCA. The samples
were centrifuged at 4 C for 10 min at 14,000 xg to remove precipitated protein, and 68 pL was
withdrawn and added to 262 p.L 0.25 mM DTNB in 0.5 M KH 2PO4 , pH 7.8. The A4 12 of each
sample was measured.
4.2.17 Cloning of pPhaExe and pPhaCxe and expression and purification of PhaECxe
Construction of the expression plasmid pPhaECxc. Genomic DNA from Xanthomonas
campestris was a gift of the Leach lab in the Department of Bioagricultural Sciences and Pest
Management at Colorado State University. phaECxe was amplified from 50 ng genomic DNA
using PfuII Ultra polymerase and the primers phaECXcfw and phaECXcrev (Table 4.1).
phaECXcfw inserted an NdeI site on the 5' end of phaE and encoded a (G4 S) 2 linker between a
StrepIl-tag and the N-terminus of PhaE. phaECXcrev inserted a BamHI restriction site on the 3'
end of phaC. The amplified PCR product was digested with NdeI/BamHI and ligated at RT
overnight into pET52b digested with the same restriction enzymes at an insert to vector ratio of
5:1. The ligation product was transformed into E. coli XL1OGold cells, which were grown
overnight at 37 C on LB/agar supplemented with 100 pg/mL Amp. Single colonies were grown
to saturation and the plasmids were isolated and sent for sequencing at the MIT Biopolymers
Facility.
Expression and solubility of PhaEC,. All culture medium was supplemented with 100
tg/mL Amp. A single colony of E. coli BL21(DE3) Gold containing pPhaECxc was used to
inoculate 5 mL of LB in a 15 mL culture tube and grown overnight at 37 C. The culture was
then used to inoculate two separate 1 L LB cultures in 2.8 L baffled flasks at dilutions of 1:200.
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The cultures were grown at 37 'C with shaking at 220 rpm until OD 600 = 0.6. One culture was
induced with 0.4 mM IPTG, then grown an additional 4 h at 37 'C. The second culture was
cooled on ice to ~18 'C, induced with 0.4 mM IPTG and grown an additional 4 h at 18 'C. The
cells were harvested by centrifugation at 4,000 xg for 10 min at 4 'C. The culture induced at 37
'C yielded -3 g of cell paste, and the culture induced at 18 'C yielded ~1 g of cell paste. To test
the solubility of PhaECXc, the cell pellets were resuspended in 3 mL 100 mM Tris HCl, pH 8.0,
150 mM NaCl, 1 mM EDTA per g of cells. The cells were lysed by two passes through the
French pressure cell auut 4 *C and 14,000 psi. The insoluble fraction was removed by
centrifugation for 20 min at 20,000 xg, and samples were prepared from each fraction for
analysis by 10% SDS-PAGE.
4.2.18 Cloning of pPhaExo and pPhaCx and expression and purification of PhaECx
Construction of the expression plasmids pPhaEx and pPhaCx. Genomic DNA from X
oryzae pv. oryzae was a gift of the Leach lab in the Department of Bioagricultural Sciences and
Pest Management at Colorado State University. phaEx was amplified from 50 ng genomic DNA
using PfuII Ultra polymerase and the primers phaEXofw/phaEXorev (Table 4.1). phaEXofw
inserted an NdeI restriction at the 5' end of phaE and phaEXorev inserted an BamHI restriction
site at the 3' end ofphaE. The amplified PCR product was digested NdeI and BamHI was ligated
overnight at RT into pET28a digested with the same enzymes at an insert to vector ratio of 5:1.
h - 0 - 5i - 5 
phaCXofw inserted an NheI restriction site at the 5' end of phaC and phaCXorev inserted a
HindlIl restriction site at the 3' end of phaC. The amplified PCR product was digested with
NheI/HindIII and ligated at RT overnight into pET3a digested with the same restriction enzymes
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at an insert to vector ratio of 5:1. The ligation products were individually transformed into E. coli
XL1OGold cells, which were grown overnight at 37 C on LB/agar supplemented with 50 pig/mL
Km (for pPhaExo) or 100 ig/mL amp (pPhaCxo). Single colonies were grown to saturation and
the plasmids were isolated and sent for sequencing at the MIT Biopolymers Facility.
Expression and solubility of PhaECx. All culture medium was supplemented with 50
pg/mL Km and 100 ig/mL Amp. A single colony of E. coli BL21(DE3) Gold containing
pPhaExo and pPhaCxo was used to inoculate 5 mL of LB in a 15 mL culture tube. Cells were
grown overnight at 37 *C. The culture was then used to inoculate three separate 1 L LB cultures
in 2.8 L baffled flasks at dilutions of 1:200. The cultures were grown at 37 C with shaking at
220 rpm until OD6 0 0 = 0.6. Of the three cultures, two were cooled to ~18 C on ice, induced with
0.4 mM IPTG and grown an additional 4 h at 18 C. The third culture was induced with 0.4 mM
IPTG and grown an additional 4 h at 37 *C. The cells were harvested by centrifugation at 4,000
xg for 10 min at 4 C. The culture grown at 37 C following induction yielded ~3 g of cell paste,
whereas the cultures grown at 18 *C following induction yielded -1 g of cell paste each.
4.3 Results
4.3.1 Cloning and purification of PhaEA27CAV and PhaEA35CA,
The full length construct PhaECAv was the focus of crystallization efforts for over a
decade. PhaECA, has a noteworthy tendency to crystallize in many conditions; however, the
diffraction of these crystals was never greater than ~7 A (J. Jia, Year End Report 1999). The
original motivation behind constructing the truncated PhaECAV constructs came from limited
proteolysis experiments carried out by Geoff Stamper that identified the C-terminal end of PhaE
as "floppy" as it could be cleaved with chymotrypsin at two positions 27 and 35 residues from
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the C-terminus. Thermally labile ends of proteins can potentially prevent close packing of
protein molecules within a crystal lattice and therefore limit diffraction. Tian and York prepared
plasmids encoding PhaC and the truncated PhaEs that corresponded to the cleavage sites
identified by limited proteolysis and demonstrated that these proteins retained activity that was
-50-75% of full length PhaECA, (J. Tian, Year End Report 2001).
For crystallography purposes, Paul Hubbard generated the construct PhaEA27CAv, which
encodes PhaEA27 with an N-terminal His6-tag in the plasmid pCDF1 and untagged-PhaCA in
pET24a, so that large quantities of reproducibly pure protein could be obtained rapidly. As with
the full length PhaECAv, PhaEA27CAv crystallized in many conditions, but unfortunately these
crystals also did not diffract to higher than 7 A resolution. In an effort to continue to identify and
refine conditions for the crystallization of PhaEA27CAv we obtained the plasmid constructs for
PhaEA27Av and PhaCAv. We also prepared the plasmid encoding the truncated construct
PhaEA35A, (also containing an N-terminal His 6-tag on PhaE) to mimic the second cleavage site
identified by Geoff Stamper. PhaEA27Av and PhaEA35Av were co-expressed individually with
PhaCA,, and PhaECAvs were purified to >95% homogeneity (as judged by SDS-PAGE) in a
single step (Figure 4.3). The yield was high, typically ~10-15 mg protein per g cell paste.
A) B).
PhaEA27 PhaEA35
PhaC PhaC
Figure 4.3 SDS-PAGE (12%) of purified truncated PhaECAV constructs. A) PhaEA27CAv
and B) PhaEA35CAv-
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4.3.2 PhaEA27CA, and PhaEA35CAV have -66% the specific activity of full length PhaECAv
The specific activity of full length PhaECAv is 150 U/mg at 30 *C (5). PhaEA27CAv and
PhaEA35CAV both have a specific activity of ~100 U/mg at 30 'C, and their kinetics resemble
those of full length PhaECAv, in which a burst phase in CoA release is followed by a slower
phase (Figure 4.4). The specific activity is measured from the burst phase.
0.05-
0.04-
A 0.03
0.02-
0.01-
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Time (nin)
Figure 4.4 Representative assays of PhaEA27CA, and PhaEA35CA,. Assays contained 15 nM
PhaEA27CAv (e, blue) or 20 nM PhaEA35CAv (o, red). Error bars are the standard deviation
from the mean of three experiments. Data are fit Equation 2.1. For PhaEA27CAv, R2 = 0.98 and
X= 1.3 x 106. For PhaEA35CAv, R2= 0.98 and J = 3.4 x 10-7.
4.3.3 PhaEA27CAV and PhaEA35CAv are mixtures of dimers and tetramers of PhaEC in
vitro
In order to further characterize both truncated constructs, the oligomeric state was
examined. Both constructs (20 ptL of 5 mg/mL solutions) were examined by SEC at RT. Their
Mw were determined by comparison to a standard curve prepared using protein standards with
M, of 1.35 kDa to 670 kDa.. PhaEA27CAv is also a mixture of two oligomeric forms (Figure
4.5A). The calculated Mw are 200 kDa and 380 kDa, likely corresponding to a dimer and
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tetramer of PhaEA27CAV, as the predicted M, of the dimer and tetramer are ~160 kDa and 320
kDa, respectively. Full length PhaECAV is a mixture of dimers and tetramers of PhaEC in
solution (6). The predominant form of PhaEA27CAV appears to be the tetramer, similar to full
length PhaECA,. In contrast PhaEA35CAV is predominantly a single species with a calculated M"
of 350 kDa (Figure 4.5B), suggesting that it is a tetramer of PhaEA35C (predicted M, -320
kDa).
A) B)
0.15
010
0.05 D D
0.00
5 7 9 11 13 15 5 7 9 11 13 15
Rdemtam U.(Vn) RnMf Mne (pin)
Figure 4.5 SEC of PhaEA27CA, and PhaEA35CA,. The oligomeric states of A) PhaEA27CAV
(20 ptL of 5 mg/mL) and B) PhaEA35CA, (20 [tL of 5 mg/mL) were examined by SEC at RT
using a Bio-Sil SEC 400-5 column (Bio-Rad). Proteins were eluted at a flow rate of 1 mL/min
with 50 mM sodium cacodylate, pH 7.5, 200 mM NaCl.
4.3.4 PhaEA27CA, crystallizes in many conditions but the crystals only diffract to >7 A
PhaEA27CA, crystallizes in dozens of conditions containing a variety of precipitants
(PEGs of various sizes, salts), additives (salts, small molecules such as ethanol) and buffers.
Some of these conditions will be briefly presented. A few of these conditions will be discussed in
detail in this section and the following, focusing on those that were most thoroughly pursued.
Crystals of PhaEA27C, obtained from the Hauptman-Woodward screen. PhaEA27CAV
(18 mg/mL) was sent to the Hauptman-Woodward Institute for screening of 1536 crystallization
conditions by the microbatch-under-oil method. Crystals of PhaEA27CAV formed in dozens of
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conditions in the Hauptmann-Woodward screen. A selection of these crystallization conditions is
shown in Table 4.3. The diameter of the wells in the images in Table 4.3 is 900 tm.
Table 4.3 Crystals of PhaEA27CAV that formed in the Hauptman-Woodward screen.
Buffer Precipitant Additive
1 0.1 M 24% PEG n/a
ammonium (polyethylene
sulfate, 0.1 M glycol) 20,000
sodium acetate,
pH 5.0
2 0.1 M potassium 20% PEG 1000 n/a
phosphate
dibasic, 0.1 M
CAPS pH 10.0
3 0.1 M potassium 20% PEG 8000 n/a
phosphate-
tribasic, 0.1 M
sodium acetate,
pH 5.0
4 0.1 M bis-Tris 40% PEG 400 0.1 M magnesium
propane, pH 7.0 sulfate heptahydrate
5 0.05 M Hepes pH
6.8
12.5% PEG
3350
0.08% w/v
0.08% w/v
0.08% w/v
0.08% w/v
0.08% w/v
0.08% w/v
Ala-ala
Gly-asp
Gly-gly
Gly-phe
Gly-ser
Ser-tyr
Crystala
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Condition
6 0.1 M MES, pH 40% PEG 400 0.1 M ammonium
6.0 chloride
7 0.2 M Potassium 20% w/v PEG n/a
thiocyanate, pH 3350
7.0
8 3.5 M sodium n/a n/a
formate pH 7.0
9 0.1 M bis-tris pH 20% PEG n/a
6.5 monomethyl
ether (MME)
5000
10 0.1 M Tris pH 1.0 M n/a
8.5 magnesium
sulfate hydrate
0.1 M
ammonium
phosphate-
monobasic, 0.1
M Hepes pH 7.5
12% PEG
20,000
n/a
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12 0.1 M CAPS pH 12% PEG 0.1 M ammonium
10.0 20,000 bromide
13 0.1 M MES pH 40% PEG 4000 0.1 M manganese
6.0 sulfate monohydrate
14 8% tacsimate pH 20% PEG 3350 n/a
5.0
15 0.1 M sodium
citrate tribasic
dihydrate, pH 5.6
1.0 M
ammonium
phosphate
monobasic
athe diameter of the wells in the images is 900 gm.
n/a
The crystals in conditions 2 and 3 are examples of a very common morphology of
PhaEA27CAv crystals produced in a wide variety of conditions. Conditions 2 and 3 in Table 4.3
are buffered at extremes of pH (pH 10 and pH 5, respectively). However, as discussed below,
this crystal morphology forms in a wide range of pHs. In our hands, crystals of the fern/dendrite
morphology (for example, in condition 3) never diffract, and grid screening around the
conditions by varying pH and precipitant concentration does not improve morphology or
diffraction. We attempted to reproduce conditions 1, 3, 9, 14 and 15 from the Hauptman-
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Woodward screen (Table 4.3). Of these, condition 9 was most extensively pursued because the
crystals were reproducible and the pH was near neutral (pH 6.5). Screens were set up using both
the hanging drop and microbatch-under-oil method. In the microbatch-under-oil method, 1-2 iL
of protein (18 mg/mL) was mixed with 1-2 ptL of crystallization solution at the bottom of a well
of a 96-well plate, and the drop was covered with light mineral oil. The ratio of protein to
precipitant and the final volume of the protein drop were varied. The crystals shown in Figure
4.5 were obtained using the hanging drop method with a protein to precipitant ratio of 1:1. The
crystals indicated with arrows in Figure 4.6 were screened for diffraction at RT, but diffracted to
9.5 A at best.
Figure 4.6 Crystals grown in Hauptman-Woodward condition 9. The arrows indicate the
crystals that were screened for diffraction at RT using the wet mount method. The scale bar is
500 ptm.
Crystallization conditions identified by screening by the hanging drop method. Several
conditions from commercially available screens were identified in which PhaEA27CAV
crystallized. These conditions are summarized in Table 4.4.
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Table 4.4 Conditions that promoted crystallization of PhaEA27CAV (20 mg/mL).
Screen (condition Condition Crystal form Diffraction?
number)
Index (73) 0.1 M Tris pH 8.5, 0.2 M Irregular plate, some not screened
NaCl, 25% w/v PEG 3350 dendrite/ferns, 200-300
pim
Index (92) 0.1 M magnesium formate Some diamonds, cuboids, no
dehydrate, 15% w/v 50-100 jim
Polyethylene glycol 3,350
PEG/Ion (1) 0.2 M NaF, 20% PEG Dendrites/ferns, 100-500 no
3350, pH 7.3 pim
PEG/Ion (4)* 0.2 M LiCl, 20% PEG Dendrites/ferns, 100-500 no
3350, pH 6.8 jim
PEG/Ion (6) 0.2 M NaCl, 20% PEG Dendrites/ferns, 100-500 no
3350, pH 6.9 pLm
PEG/Ion (13) 0.2 M sodium thiocyanate, Dendrites/ferns, 100-500 not screened
20% PEG 3350, pH 6.9 pm
PEG/Ion (15) 0.2 M lithium nitrate, 20% Dendrites/ferns, 100-500 not screened
PEG 3350, pH 7.1 pm
PEG/Ion (17) 0.2 M sodium nitrate, 20% Dendrites/ferns, 100-500 not screened
PEG 3350, pH 6.8 pm
PEG/Ion (18)* 0.2 M potassium nitrate, Dendrites/ferns, 100-500 no
20% PEG 3350, pH 6.8 pm
PEG/Ion (21) 0.2 M sodium formate, Dendrites/ferns, 100-500 not screened
20% PEG 3350, pH 7.2 Jim
PEG/Ion (22) 0.2 M potassium formate, Dendrites/ferns, 100-500 not screened
20% PEG 3350, pH 7.3 pm
PEG/Ion (27) 0.2 M sodium acetate, Jagged cuboid, 200 x 300 no
20% PEG 3350, pH 8.0 pim
PEG/Ion (29) 0.2 M potassium acetate, Jagged cuboid, 200 x 300 no
20% PEG 3350, pH 8.1 [tm
PPC Screen (21) 0.1 M sodium cacodylate Long, jagged plate, 750 not screened
pH 6.0, 10% MPEG 5000, pm
10% 2-Propanol
PPC Screen (26) 0.1 M calcium acetate, 0.1 Single irregularly shaped not screened
M HEPES pH 7.5, 10% boulder, 200 pim
PEG 6000
PPC Screen (35) 0.1 M magnesium acetate, Small ferns/dendrites, 50- not screened
0.1 M Tris pH 8.5, 12% 100 pim
PEG 8000
*condition was further grid screened, as described in the text.
Several crystals from the conditions listed in Table 4.4 were screened for diffraction at
RT and at -196 'C using Paratone N and PEG 400 as cryoprotectants. The crystals that formed
with PEG 3350 as a precipitant (conditions 1, 4, 6, 13, 15, 17, 18, 21, and 22 in the PEG/ion
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screen) were all of the fern/dendrite morphology but were never of diffraction quality. The
conditions PEG/ion 4 and 18 (indicated with an asterisk in Table 4.4) were further refined by
grid screening, in which the concentration of additive (lithium chloride or potassium nitrate) and
PEG 3350 were iteratively varied. The crystals that formed in these grid screens were of the
same morphology as the parent conditions (listed in Table 4.4) and also did not diffract.
In an effort to obtain crystals of higher quality, PhaEA27CAv was co-crystallized with the
HBCoA analog HBCH2CoA, in which the S of the thioester in HBCoA is replaced with a
methylene group (Figure 4.1). HBCH 2CoA has previously been shown to be an inhibitor of the
full length PhaECAv (P. Li and J. Stubbe, unpublished data). The strategy was to co-crystalize
PhaEA27CAv with a saturating concentration of HBCH2CoA to potentially "lock" the enzyme
into a tighter conformation that could promote higher quality diffraction. PhaEA27CAv (18
mg/mL, 225 pM) was incubated with 4.5 mM HBCH2CoA and crystal trays were set up by the
standard hanging drop method to screen the commercially available conditions. The conditions
listed in Table 4.5 were identified as promoting crystallization. We decided to focus on condition
26 from the PPC Screen (0.1 M calcium acetate, 0.1 M Hepes, pH 7.5, 10% PEG 6000) because
the crystal forms of PhaEA27CAv in the presence and absence of 4.5 mM HBCH 2CoA were
different from one another (Figure 4.7A and B), suggesting that HBCH 2CoA was bound to
PhaEA27CAv. The initial crystals identified in Table 4.5 did not diffract. Therefore, the condition
was replicated in order to generate many additional crystals that could be screened for diffraction
(Figure 4.7C and D). The crystals were screened for diffraction at RT; however, they diffracted
at best to 7.5 A.
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Table 4.5 Conditions that promoted crystallization of PhaEA27CA, (20 mg/mL) in the
presence of 4.5 mM HBCH2CoA.
Screen (condition Condition Crystal form Diffraction?
number)
Index (46) 0.1 M BIS-TRIS pH 6.5, Small, irregular boulders, not screened
20% w/v PEG MME 5,000 50-150 pm
Index (67) 0.2 M ammonium sulfate, Long thin spears, 150 [um not screened
0.1 M BIS-TRIS pH 6.5, Larger chunks, 200-300
25% w/v PEG 3,350 pm
PPC Screen (1) 0.1 M calcium acetate, 0.1 Irregular dendrites, 50-150 no
M HEPES pH 7.0, 20% pm
PEG 400
PPC Screen (26) 0.1 M calcium acetate, 0.1 Jagged, diamond-shaped, no
M HEPES pH 7.5, 10% 250 gm
PEG 6000
A)
C)
B)
D)
Figure 4.7 Crystals of PhaEA27CA, grown in 0.1 M calcium acetate, 0.1 M Hepes, pH 7.5,
10% PEG 6000. A) PhaEA27CA, (18 mg/mL). The small diamond triangles are likely salt
crystals. The larger irregular boulder is a protein crystal. B) PhaEA27CA, (18 mg/mL) co-
crystallized with 4.5 mM HBCH2CoA obtained from the original screen. C) and D) are also
crystals of PhaEA27CAV (18 mg/mL) co-crystallized with 4.5 mM HBCH 2CoA obtained from
attempts to reproduce the conditions in B. The scale bars are 200 gm.
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4.3.5 Addition of osmolytes improved the diffraction of crystals of PhaEA27CAv co-
crystalized with HBCH 2CoA to 4.5 A
In order to improve diffraction of the crystals described in the preceding section
(condition 26 of the PPC screen), 96 different additives were screened in combination with
condition 26. The additives were part of the commercially available Additive Screen (Hampton-
Research, Aliso Viejo, CA). The results from this screen are shown in Table 4.6. In the majority
of conditions, no crystals formed. However, crystals grew in about -20% of the additives (Table
4.6). Several of these crystals were screened for diffraction.
Table 4.6 Additives that promoted crystallization of PhaEA27CAv with 4.5 mM HBCH 2 CoA
in condition 26 from the PPC Screen.
Additive number Additive Crystal form Diffraction?
3 0.01 M calcium chloride Irregular geometric shapes not screened
dihydrate with flat faces, 150-350
ptm
26 0.01 M L-proline Diamonds, geometric 7 A
shapes with flat faces, 50-
100 pm
27 0.01 M phenol Diamonds, cubes, not screened
geometric shapes with flat
faces shapes, 100-300 pm
29 0.01 M sodium bromide Large boulders, 500 jim, no
smaller diamonds, 100 gm
36 0.01 M taurine Large boulders, 250 jim, A few spots at 5.4 A,
smaller diamonds and most at 6 A
geometric shapes, 50-100
jim
37 0.01 M betaine Diamonds, 50-100 jim, not screened
hydrochloride other geometric shapes,
100 jm
39 0.01 M spermine Single diamond plate, 150 not screened
tetrahydrochloride jim
41 0.01 M sarcosine Diamonds and other A few spots at 4.5 A,
geometric shapes, 100-250 most at 6 A
pm
43 0.1 M guanidine HCl Long, jagged rods, 500 jm 9 A
44 0.01 M urea Larger boulders, 250 pm, 16 A
diamonds and other
geometric shapes, 100-200
jim
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49 0.01 M Flat, connected array of not screened
ethylenediaminetetraacetic jagged diamond plates,
acid disodium salt adhered to coverslip, 1500
dihydrate pim
50 0.5% w/v Diamonds, 50-100 jim 7.5 A
polyvinylpyrrolidone K 15
53 1% w/v PEG 3350 Long, thin slivers, 300 jim no
75 3% v/v (+/-)-2-methyl-2,4- Irregular boulders and not screened
pentanediol diamonds, 150-250 pim
76 5% v/v PEG 400 Diamonds and other 8.2 A
geometric shapes, 100-250
sim
80 4% v/v polypropylene Large irregular boulder, not screened
glycol P 400 600 pim, smaller irregular
shapes, 250 pim
82 3% v/v ethanol Many small diamonds, 30- not screened
50 pm
83 3% v/v 2-propanol Long, thin slivers, 100-300 no
pm
86 4% v/v tert-butanol Small geometric shapes, not screened
100-200 jim
In almost all cases, more crystals formed in the presence of the additives listed in Table
4.6 than in the original condition, and these crystals tended to have sharper faces than those
formed in the original condition. Several of these crystals were screened for diffraction. The
osmolytes taurine and sarcosine, which have been previously shown to improve diffraction
quality of crystals of several proteins (7), produced the most encouraging results. Many crystals
from each additive were screened and these crystals diffracted to -6 A, with one to 4.5 A (Figure
4.8). Though not yet in the range of atomic resolution necessary for structure solving of an
enzyme of unknown structure, these results were promising. Therefore, extensive screening
around these two conditions was carried out. The variables that were iteratively changed
included the concentrations of calcium acetate (0.05 to 0.2 M, PEG 6000 (5 to 20%) and the
buffer pH (from 6.8 to 7.8). The M, of PEG was varied from 400-8,000 and a range of
concentrations of taurine or sarcosine were also examined. However, the resulting conditions
either failed to produce crystals or produced crystals of lesser quality than the original crystals.
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A)
Figure 4.8 Diffraction from a crystal of PhaEA27CAV bound HBCH 2CoA. A) A crystal of
PhaEA27CAV (18 mg/mL) co-crystallized with 4.5 mM HBCH2CoA in 0.1 M calcium acetate,
0.1 M Hepes, pH 7.5, 10% PEG 6000, 0.01 M sarcosine. The scale bar is 200 pm. B) A
diffraction pattern produced from the crystal in A. The highest resolution diffraction obtained
from this crystal was 4.5 A.
4.3.6 PhaEA35CAv crystallizes in many conditions but the crystals also diffract to >7 A
We also explored crystallization of the truncated construct PhaEA35CAv. As discussed
above, this construct was generated based on the results of limited proteolysis experiments
carried out by Geoff Stamper that identified an accessible chymotrypsin cleavage site on the C-
terminus of PhaE. The observation that PhaEA35CAv was primarily a tetramer in solution (as
opposed to a mixture of dimers and tetramers as is the case with PhaEA27CV) suggested that
this construct was homogeneous in solution and therefore might crystallize in a tighter and thus
higher quality form. Several conditions were screened to identify conditions in which
PhaEA35CAv crystallized. PhaEA35CAv (18 mg/mL, 225 pM) was screened with and without 4.5
mM HBCH2CoA. The results are summarized in Tables 4.7 and 4.8.
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B)
Table 4.7 Conditions that promoted crystallization of PhaEA35CAV (18 mg/mL).
Screen (condition Condition Crystal form Diffraction?
number)
Index (46) 0.1 M BIS-TRIS pH 6.5, Irregular, rounded not screened
20% w/v PEG MME 5,000 boulders, 50-200 [im
Index (90) 0.2 M Sodium formate, Irregular, rounded not screened
20% w/v PEG 3350 boulders, 50-200 im
Table 4.8 Conditions that promoted crystallization of PhaEA35CAV (18 mg/mL) in the
presence of 4.5 mM HBCH 2CoA.
Screen (condition Condition Crystal form Diffraction?
number)
Index (80) 0.2 M ammonium acetate, Jagged/dendrite clusters, not screened
0.1 M HEPES pH 7.5, 100-300 pm
25% w/v PEG 3350
Index (87) 0.2 M sodium malonate Cluster of plates, 350 pm not screened
pH 7.0, 20% w/v PEG
3350
Index (95) 0.1 M potassium Several small, rounded not screened
thiocyanate, 30% w/v PEG shapes, 50-100 gm
MME 2000
PPC Screen (18) 0.1 M HEPES pH 7.0, Many thin diamond plates, Dissolved when removed
15% PEG 4000, 10% 2- 100-300 jim from 18 *C room; not
propanol screened
PPC Screen (21) 0.1 M sodium cacodylate Long, thin slivers, 500-700 not screened
pH 6.0, 10% MPEG 5000, pm
10% 2-propanol
PPC Screen (30) 0.1 M sodium chloride, 0.1 A few irregular chunks, not screened
M sodium cacodylate pH 50-100 jim
6.0, 12% PEG 8000
PPC Screen (35) 0.1 M magnesium acetate, Several small, boulders not screened
0.1 M Tris pH 8.5, 12% with irregular surfaces, 50-
PEG 8000 100 pm
Condition 18 from the PPC screen (Table 4.7) was pursued. The original crystals
dissolved upon transferring them from 18 'C to RT. Therefore a screen was carried out at 18 'C
to examine 96 different additives, 8 of which produced crystals. These crystals were stable when
transferred from the 18 'C room to RT for screening and were screened for diffraction. However,
at best the diffraction was ~6.3 A (Table 4.9).
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Table 4.9 Effects of additives on the diffraction of crystals of PhaEA35C, (18 mg/mL) with
HBCH2CoA in 0.1 M Hepes pH 7.0, 15% PEG 4000, 10% 2-propanol.
Additive number Additive Crystal form Diffraction?
2 3% dioxane Thin, triangular no
plates, 200-300 pm
9 4% acetonitrile Thin, triangular 10 A
plates, 200-300 pm
18 4% 1,1,1,3,3,3,- Thin, triangular 7.5 A
heexafluoro-2- plates, 200-300 pm
propanol
27 0.01 M sodium Thin, triangular 6.5 A
bromide plates, 200-300 pim
48 0.01 M urea Thin, triangular 6.25 A
plates, 200-300 ptm
53 0.01 M betaine Thin, triangular 7.5 A
chloride plates, 200-300 pm
77 0.015 mM CYMAL-7 Thin, triangular 7.0 A
plates, 200-300 jim
89 0.033 mM n-tridecyl- Long, jagged spears, 7.5 A
P-D-maltopyranoside 200-300 pm
4.3.7 A single crystal of PhaCccAN that diffracted to 3 A was obtained
In addition to our crystallization efforts with the class III synthases, crystallization of the
class I synthase from C. crescentus was extensively examined. C. crescentus contains an unusual
73 kDa class I synthase, PhaCcc, whose purification and characterization are discussed in depth
in Chapter 2. The synthase differs from the more typical class I synthases (such as PhaCRe) by an
85 amino acid N-terminal domain that is rich in Lys, Ala and Pro residues. This domain has no
homology to any protein in the database. Our original efforts to crystallize the synthase from C.
crescentus, however, focused on a truncated construct of PhaCcc lacking this 85 amino acid N-
terminal domain, PhaCccAN. PhaCccAN has a specific activity that is 50-fold lower than the full
length PhaCcc. This truncated version of PhaCc, is how the synthase is (incorrectly) annotated in
the database.
358
PhaCccAN was readily purified as an N-terminally (His) 6-tagged construct. Despite
sharing 37% identity with PhaCRe, purified PhaCccAN was extremely soluble (up to at least 85
mg/mL, 1.3 mM) and its purification did not require hecameg, as is required for PhaCRe. These
observations led us to believe that PhaCccAN could be a good candidate for crystallization.
Thousands of crystallization conditions were therefore screened using a variety of concentrations
of PhaCceAN (18 mg/mL, 30 mg/mL, 60 mg/mL, 85 mg/mL) and at various temperatures (4 0C,
18 'C, 37 'C). Only a single crystal was obtained, and this crystal formed sometime between 6-
12 months after the tray was initially set up (Figure 4.9A). The original crystallization condition
was from the commercial screen PEGRx (condition 18) and contained 60 mg/mL PhaCcAN in
0.1 M Hepes, pH 7.5 and 30% PEG 1000. However, because the crystal grew after prolonged
incubation, water from the well solution had slowly evaporated and therefore the well solution
was more concentrated than the initial condition. The volume of the well solution was -260 pL,
therefore the concentrations of the components were roughly twice that of the original condition.
This presented a problem in reproducing the crystallization conditions, as discussed below.
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A)
B) C
Figure 4.9 Initial data collection from a crystal of PhaCceAN. A) A single crystal of
PhaCccAN (60 mg/mL) that formed after ~1 year in 0.1 M Hepes, pH 7.5 and 30% PEG 1000.
The scale bar is 200 pm. B) A diffraction image collected at P = 00. B) A diffraction image
collected at p = 90'. The highest resolution was ~2 A.
The crystal from condition 18 was screened for diffraction to confirm that the crystal was
protein and that it diffracted. We decided to screen the whole crystal for diffraction at RT as
opposed to freezing it in a cryoprotectant. Because we had only one crystal, screening
cryoprotectants was too risky as many crystals fall apart or dissolve in the search process.
Furthermore, the crystal was not broken into several smaller pieces for screening of
cryoprotectants because breaking the crystal could potentially disrupt the crystal lattice and
thereby degrade the quality of diffraction. The crystal was initially screened at RT from p = 0
and 90* (where the p angle refers to the rotation of the crystal about its axis in the X-ray beam)
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(Figure 4.9B and C). The initial screens revealed that it diffracted to ~2 A. At RT crystals sustain
radiation damage in the course of data collection that ultimately destroys the crystal. Thus, to
reduce the level of radiation damage and to maximize the amount of data that could be collected
at RT, an 88% complete dataset was collected at 3.1 A resolution by collecting frames
(diffraction patterns) at 1 intervals. The data (108 images) were indexed using the SAINT
software and were 88% complete overall and 95% in the highest resolution shell (3.1-3.3 A) (8).
The dimensions of the unit cell were a = p = 104.2 A, y = 232.7 A and the angles of the vertexes
were a = b = 90', c = 120'. R32 was the lowest symmetry space group that fit the observed
reflections without assuming twinning or non-crystallographic symmetry. Using the SAINT
software, the solvent content was predicted to be ~33% with one full length molecule in the unit
cell. There is most likely one monomer in the asymmetric unit, and the two-fold axis may result
from two monomers forming a dimer interface at the edge of the unit cell. The data were merged
and scaled using the CCP4i software (9).
In order to solve the phases, we attempted molecular replacement using structural models
generated from a variety of structure prediction programs. The input models were chosen either
from i) homologous proteins present in the PDB, or ii) the results of secondary/tertiary structural
prediction software. Table 4.10 lists the programs used to prepare threading models and/or
predicted structures, a description of the general methods used by each program and, where
applicable, the template (a protein of known structure) used for structure prediction. For the
majority of these programs, one simply inputs the sequence of the protein (or region therefore) of
interest, and the software searches the database to find homologous proteins of known structure.
Using these structures, the programs then generate a structural model of the protein of interest
and also provide the xyz coordinates for the positions of every atom modeled. For molecular
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replacement purposes, these coordinates were used as input for the PHASER software along with
the experimental hkl values.
Unfortunately our molecular replacement efforts using the coordinates from models to
search for solutions did not yield acceptable structural models from the experimental data.
Structure prediction programs of PhaCs consistently model the a/s hydrolase core domain as a
P-sheet (4-7 P-strands) surrounded by 3-5 a-helices. However the modeled region (which
contained the a/s hydrolase domain) spans only -50% of the residues of PhaCcAN. Solving the
phases by this method likely failed because the models used for molecular replacement did not
constitute enough of the overall structure.
Table 4.10 Programs used for
replacement.
preparation of structural models for use in molecular
Program Template(s) Method/Notes
LOMETS 1zd4 (human epoxide hydrolase) Models predicted a/P hydrolase folds
lk8q (dog gastric lipase)
1 s8o (human epoxide hydrolase)
EsyPred3D ltah (Bacillus glumae lipase) ltah template was specified; threading model
generated from residues 232-356, containing
pa/ hydrolase fold
EsyPred3D 1 zoi (Pseudomonas putida No template specified; program selected 1 zoi,
esterase) modeled residues 232-505, containing /Phydrolase fold
SWISS-MODEL Itah (Bacillus glumae lipase) Modeled residues 231-505 in PhaC as
containing a/p hydrolase fold
I-Tasser Several Program models fragments of sequence
individually from several templates; modeled
entire sequence as two domains (a/P hydrolase
fold and an a-helical domain)
4.3.8 Attempts to reproduce the crystal of PhaCccAN were unsuccessful
In addition to efforts to solve the structure by molecular replacement, our primary focus
was to reproduce the original crystal using a variety of methods. To first determine whether the
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protein in the crystal was full length or was truncated by proteolysis, 1 tL from a similar
crystallization condition was combined with 60 pL Laemmli buffer and 10 ptL of the sample was
analyzed by 10% SDS-PAGE (Figure 4.10). We analyzed a sample from a similar condition
rather than the drop that contained the crystal to minimize disruption of the original drop.
Furthermore the crystal itself was not analyzed because it was saved for streak seeding and
microseeding experiments, which are described below. The drop analyzed by SDS-PAGE came
from condition 3 of the PEGRx screen, which consisted of 0.1 M Hepes pH 7.5, and 42% PEG
200. The results indicated that condition 3 contained full length protein that migrates the same as
the PhaCccAN standard, and suggests that the single crystal obtained in the similar PEGRx
condition 18 consists of full length PhaCccAN.
M1 2
75 kDa
50 kDa
Figure 4.10 SDS-PAGE (10%) of PhaCccAN. M, molecular weight standards. Lane 1,
PhaCccAN standard. Lane 2, PhaCccAN from -1 year-old drop from a crystallization screen
condition containing 0.1 M Hepes pH 7.5, and 42% PEG 200.
Several factors complicated our attempts to reproduce the crystallization conditions.
Because the crystal was found nearly a year after the original tray was set up, protein from the
same purification was no longer available. Thus, fresh protein from subsequent purifications was
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used. Many trays were set up under conditions identical to the original set-up: 1 pLL of 0.1 M
Hepes pH 7.5, 30% PEG 1000 and 1 pL 60 mg/mL PhaCcAN. Under these conditions, the
protein immediately precipitated, as was observed with the original drop that yielded the crystal.
These results suggested that the crystal formed after slow re-solubilization over the course of the
year. In attempting to reproduce the crystallization conditions, several factors were varied to
mimic the slow increase in concentration of the precipitant and protein over time. Holding the
crystallization conditions constant (0.1 M Hepes pH 7.5, 30% PEG 1000), the concentration of
PhaCccAN was varied from 10-60 mg/mL, and the temperature was varied (4 'C, 18 'C, RT, and
37 C). Alternatively grid screens with PhaCcAN at 10 mg/mL, 30 mg/mL and 60 mg/mL were
carried out in which the pH was varied from 7.0-7.6 in 0.2 unit increments, and PEG was varied
from 5-30% in 5% increments. The ratio of protein to crystallization solution was also varied
from 1:1, 1:2 and 2:1.
To mimic the slow increase in the concentration of PEG 1000, drops were also set up
over wells containing 0.1 M Hepes pH 7.5 and 10% PEG 1000. After one week of equilibration,
the cover slip (on which the drop was mounted) was placed over a well containing 0.1 M Hepes
pH 7.5 and 15% PEG 1000. This process was repeated weekly in 5% increments until the protein
precipitated, typically at 25% PEG 1000. Another method was used to mimic slow drying, in
which drops containing protein and crystallization solution were covered with Parrafin oil, light
mineral oil, or a 50:50 mixture of the two oils. The two oils allow evaporation of water from the
protein drop at different rates, thereby slowly increasing the concentration of the contents of the
drop.
Several attempts were also made to seed crystallization in new drops using the original
crystal and either streak seeding (10) or microseeding (11) methods. For streak seeding, a cat's
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whisker was dragged lightly across the surface of a crystal to capture tiny fragments of crystal
(seeds). The whisker was then dragged lightly through a fresh drop containing protein and
crystallization solution to deposit the seeds, which can serve as sites for the nucleation of new
crystal growth. For microseeding, a small chunk of the crystal was gently broken off, and placed
into 1 mL of "stabilizing solution," consisting of 0.1 M Hepes pH 7.5, 40% PEG 1000. The
crystal was then fragmented by vigorous vortexing with a ceramic bead. From this solution,
serial dilutions of 1:10 to 1:109 were prepared in stabilizing solution. The various dilutions were
used as microseed stock for screening many crystallization conditions. A typical drop contained
1 ptL protein (10-60 mg/mL), 1 piL crystallization solution and ~0.2 [iL microseed stock. Many
of the conditions described in the paragraphs above were also screened by streak seeding and
microseeding. Unfortunately, none of the conditions tested succeeded in reproducing the original
crystal.
4.3.9 The class I synthases from Sphingopyxis alaskensis (PhaCsa) and Leptothrix cholodnii
(PhaCLc) may be good candidates for crystallography
We have also cloned, purified, and characterized the activity of two additional class I
synthases, PhaCsa and PhaCLC, which share 38% and 56% identity with PhaCRe respectively.
Each synthase was expressed as an N-terminally (His)6-tagged protein and could be rapidly
purified to >95% homogeneity (Figure 4.11, lanes 1 and 3). Neither protein required hecameg or
another detergent for successful purification. PhaCsa was readily concentrated to 10 mg/mL for
storage, and PhaCLc was concentrated to -5 mg/mL. PhaCLc was screened at 5 mg/mL in Crystal
Screens I and II (96 conditions), Index Screen (96 conditions), and the PEGRx screen (48
conditions). We have also cloned, expressed and purified the class I synthase from
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Magnetospirillum magneticum (PhaCum) (Figure 4.11, lane 5) but it has not yet been
characterized.
1 1) 1 A4
75 kDa 75 kE
50 kE50 kI
Figure 4.11 Purified class I synthases. Lane 1, 10 pg PhaCL. Lane 2, molecular weight
standards. Lane 3, 5 pg PhaCsa. Lane 4, molecular weight standards. Lane 5, 5 pg PhaCMm.
The specific activities of PhaCsa and PhaCLc at 30 C were determined using the CoA
release assay, and found to be 39 U/mg and 28 U/mg, respectively (Figure 4.12). The kinetics of
both enzymes are similar to PhaCRe, exhibiting lag phases in CoA release, with that for PhaCLc
being more pronounced than that for PhaCsa (Figure 4.12). The specific activity of both enzymes
was therefore determined from the linear phase of CoA release that follows the lag phase.
366
A) B)
0.06- 0.05-
0.05 0.04-
0.04-
_0 0.03-
0.03-3
U . 0.02
0.02.
0.01 0.01-
0.00 0.00 _
0 2 4 6 8 10 0 2 4 6 8 10
Time (min) Time (min)
Figure 4.12 Assays of A) PhaCsa and B) PhaCLC at 30 'C. The assays contained 50 nM PhaCsa
or 100 nM PhaCLC and 0.75 mM HBCoA (0.06 pmol total). The error bars are the standard
deviation from the mean of three measurements. The data are fit to a sigmoidal function.
During an internship required as a member of the Biotechnology Training Grant program,
I worked at Metabolix, Inc. They were interested in identifying PHB synthases that maintain
enzyme activity over the daily temperature fluctuations experienced by crops in the field. To
determine the temperature range over which PhaCsa and PhaCLc are active, assays were carried
out from 10-40 'C in the case of PhaCsa, and 15-40 'C in the case of PhaCLc. The data are
summarized in Table 4.11. PhaCLc achieves maximum activity at 30 'C, then its activity
decreases as the temperature continues to increase.
PhaCsa appears to have a much broader temperature range over which it is active. S.
alaskensis has been isolated from ocean water at 4-8 C, and can also be cultivated in the
laboratory at temperatures of up to 48 'C. These observations are consistent with the thermal
stability of PhaCsa's activity. This characteristic might prove to be an asset for crystallography
purposes, as thermostable proteins, such as those from Thermophiles, are often amenable to
crystallization. Thus far PhaCsa has not been screened in crystallization trials.
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Table 4.11 Specific activities of PhaCsa and PhaCLC from 10-40 'C.
Temperature (*C) Specific activity (pmol/min/mg)
PhaCsa PhaCLC
10 10 ± 0.7 not determined
15 16 1.4 2.3 0.2
20 23+0.2 12 0.7
25 31 ±0.6 23 0.3
30 39 ±2.6 28 0.3
35 48 ±0.6 15 2.6
40 71 ±5.9 3.5 0.6
4.3.10 Cloning of the class III synthases from A. maxima (PhaECAm), Synechocystis sp. PCC
6803 (PhaECsyn), T. pfennigii (PhaECTp), X. campestris (PhaECxe) and X. oryzae (PhaECx)
Five class III synthases were cloned and characterized to varying degrees in order to
determine whether they were suitable candidates for crystallography. In the case of the synthases
from A. maxima, Synechocystis, and X oryzae, phaE and phaC were cloned into two separate
expression vectors encoding different antibiotic resistance markers. The phaEs were inserted into
a vector that encoded an N-terminal (His) 6-tag, whereas phaCs were untagged. In the case of the
synthase from X campestris, phaEC was inserted into a single expression vector. Finally, the
synthase from T. pfennigii was cloned both as phaEC inserted into a single expression vector,
and as phaE and phaC cloned into separate vectors for co-expression.
4.3.10.1 PhaECAm is insoluble and has little/no activity.
Arthrospira maxima is a filamentous cyanobacterium found in tropical and subtropical
lakes. PhaEAm shares 15% identity with PhaEAV, and PhaCAm shares 56% identity with PhaCAV-
phaE, was inserted into pET28a for expression with an N-terminal (His) 6-tag, and phaCm was
inserted into pET3a. The two proteins were successfully co-expressed at a ratio of -1: 1 in E. coli
BL21(DE3)Gold cells at induction temperatures of 37 'C and 18 'C (Figure 4.13). However,
SDS-PAGE analysis of the soluble and insoluble cell fractions following lysis revealed that
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PhaECAm is insoluble in both conditions (Figure 4.13, lanes 3 and 6). Furthermore, lysis of the
cells in the presence of 0.1% n-octyl-p-D-glucopyranoside, a detergent commonly used to
stabilize membrane or otherwise insoluble proteins, did not improve the solubility of PhaECAm
(Figure 4.13, lanes 8 and 9). Finally, the soluble and insoluble fractions were assayed for
polymerization activity, but no activity was detected in either fraction. Thus, PhaECAm was not
pursued further as a crystallography target.
12 3 4 5 6 78 9
37 kD 7 kDa 37
Figure 4.13 Efforts to express soluble PhaECAm. Lanes 1, 4 and 7, molecular weight
standards. Lane 2, soluble fraction, induction at 37 'C. Lane 3, insoluble fraction, induction at 37
C. Lane 5, soluble fraction, induction at 18 'C. Lane 6, insoluble fraction, induction at 18 'C.
Lane 8, soluble fraction, induction at 18 'C, lysis in the presence of 0.1% octyl glucoside. Lane
9, insoluble fraction, induction at 18 C, lysis in the presence of 0.1% octyl glucoside.
4.3.10.2 PhaECsyn was successfully purified but precipitated extensively in crystallization trials
Synechocystis sp. PCC 6803 is a freshwater cyanobacterium. PhaEsyn shares 16% identity
with PhaEA,, and PhaCsy, shares 54% identity with PhaCAV. phaEsyn and phaCsyn were
successfully inserted into the pET28a and pET3a vectors, respectively, and co-expressed in E.
coli BL21(DE3)Gold. Analysis of the protein contents of the soluble and insoluble fractions by
SDS-PAGE following lysis reveals that, while both proteins are present in the soluble fraction,
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there appears to be more PhaEsyn than PhaCsyn (Figure 4.14, lanes 2 and 3). PhaECsyn was
purified from the soluble fraction in two steps by affinity chromatography with Ni-NTA resin,
followed by anion exchange chromatography with Q Sepharose resin. Following the Ni-NTA
step, the protein was exchanged into 50 mM Tris pH 7.6, 10 mM NaCl, 5% glycerol by
Sephadex G25 chromatography. Heavy precipitation was observed following buffer exchange,
and the precipitated protein was removed by centrifugation. Following anion exchange with Q
Sepharose resin, the protein was exchanged into 20 mM Hepes pH 7.5, 20 mM NaCl and
concentrated. During concentration about 50% of the remaining protein was lost to precipitation.
Despite the losses, -3 mg PhaECsyn per g of cells was obtained, with a specific activity of 20
U/mg, and 10% recovery of the total units. The kinetics of PhaECsyn resemble those of PhaCRe,
in which a lag phase precedes the linear phase in CoA release (Figure 4.14). Purified PhaECsyn
was screened for crystallization at 18 'C in 150 conditions (the Index Screen and Crystal Screen
I), but the protein formed dark brown precipitate in almost all of them and was thus not pursued
further.
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Figure 4.14 Expression and purification of PhaECsy.. Lane 1, molecular weight standards.
Lane 2, soluble fraction post induction. Lane 3, insoluble fraction post induction. Lane 4,
molecular weight standards. Lane 5, final purified protein.
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Figure 4.15 CoA release catalyzed by PhaECsy.. The reaction contained 100 nM PhaECsyn and
0.75 mM HBCoA.
4.3.10.3 PhaECTr was successfully purified but precipitated extensively in crystallization trials
Thiococcus pfennigii is a spherical, Gram-negative purple sulfur bacterium. Its class III
synthase has previously been cloned and purified by Liebergesell and coworkers (12). In their
work, the PhaECT, construct was expressed in Pseudomonas putida from a single vector housing
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phaEC that encoded no affinity tag. PhaECTp was purified using Procion Blue H-ERD Sepharose
and hydroxyapatite anion exchange chromatography. The purified protein was a 1:1 complex of
PhaE and PhaC with a specific activity of 20 U/mg at 30 C. We initially cloned phaECTp into a
single expression vector, but found that only one protein (presumably PhaETp) was
overexpressed in E. coli (not shown). We therefore inserted phaEr, and phaCrp separately into
the pET28a and pET3a vectors, respectively, and achieved successful co-expression of both
proteins at 18 C (Figure 4.16). The cells were lysed and the soluble and insoluble fractions were
separated by centrifugation and analyzed by SDS-PAGE. The soluble fraction contained some
PhaECTp, but the majority was insoluble (Figure 4.16, lane 3). The protein was purified by
affinity chromatography using Ni-NTA resin with elution using 250 mM imidazole, followed by
anion exchange using Q Sepharose resin. Following Ni-NTA chromatography, the protein that
eluted from the column was concentrated to 1 mL (5 mg/mL) for buffer exchange. During
concentration PhaECTp precipitated heavily and the precipitated protein was removed by
centrifugation. The supernatant containing soluble protein was exchanged by dialysis at 4 C into
50 mM tris pH 7.6, 10 mM NaCl for Q Sepharose chromatography. A contaminating band
migrating just below the 75 kDa marker could not be removed (Figure 4.16, lane 5). The
resulting protein was concentrated and exchanged into 20 mM Hepes pH 7.5, 20 mM NaCl and
again there was extensive precipitation of PhaECTp, which was removed by centrifugation,
precluding its concentration to higher than ~1 mg/mL. The final protein was ~75% pure due to
the contaminating band migrating just below the 75 kDa marker, which co-eluted with PhaECTp
following each chromatography step. The ratio of PhaE to PhaC appeared to be 1:1 by eyeball
(Figure 4.16, lane 5). PhaECTp was assayed and its specific activity was 20 U/mg, as measured
from the initial linear phase (Figure 4.17). The kinetics resemble those of PhaECAv. PhaECTp was
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screened at 1 mg/mL in Crystal Screens I and 11 (96 conditions), Index Screen (96 conditions),
and PEG/Ion Screens I and 11 (96 conditions). As was the case with PhaECsyn, PhaECTp formed
dark brown precipitate in the majority of conditions, even at very low concentration of enzyme.
Thus it was not extensively pursued in further crystallization trials.
1 2 3 4 5
50 kDa
37 kDa 50 kDa
37 kDa
Figure 4.16 Expression and purification of PhaECTp. Lane 1, molecular weight standards.
Lane 2, soluble fraction with expression at 18 'C. Lane 3, insoluble fraction with expression at
18 *C. Lane 4, molecular weight standards. Lane 5, final purified protein.
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Figure 4.17 CoA release catalyzed by PhaECT,. The reaction was carried out at 30 C and
contained 20 nM PhaECT, and 0.75 mM HBCoA in 20 mM Hepes pH 7.5, 20 mM NaCl.
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4.3.10.4 Expression and purification of PhaECxe and PhaECxO
Xanthomonas campestris and Xanthomonas oryzae are Gram-negative plant pathogens
and are considered select agents by the US government due to their potential for causing
widespread crop destruction. They contain class III synthases with PhaCs that share 57% identity
with PhaCAv, and PhaEs that share 18% identity with PhaEAv- phaECxc was cloned into pET52b,
which encodes an N-terminal StrepII-tag on PhaE for affinity purification. PhaECx, was
expressed in recombinant E. coli harboring the plasmid pPhaECx, at 18 *C; three bands were
apparently over-expressed, one migrating just below the 37 kDa marker and two migrating just
above the 50 kDa marker (Figure 4.18A, lane 3). The sequence of the plasmid was reanalyzed to
confirm it was correct. It was unclear at first whether all three bands were in fact PhaECxc,
because the over-expression was rather weak. To determine whether the three bands co-purified,
cells expressing PhaECxO were lysed and the soluble fraction was combined with Streptactin
affinity resin. When the protein was eluted with desthiobiotin, analysis by SDS-PAGE revealed
three distinct bands (Figure 4.18B, lane 5). To identify these bands, they were transferred to a
PVDF membrane and the fastest migrating band was excised and sent for N-terminal sequencing,
revealing the amino acids MKGPL, which correspond to the first five residues of PhaCx,. It is
likely that the two slower migrating bands are PhaExc and a truncated version of PhaExc. This
construct was not further pursued.
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Figure 4.18 Expression and purification of PhaECxc. Lane 1, molecular weight standard. Lane
2, pre-induction sample. Lane 3, post induction sample. Lane 4, molecular weight standards.
Lane 5, final purified PhaECxc.
PhaECxO was also expressed in recombinant E coli harboring pPhaECx at 37 C and 18
0C, and the cells were lysed to analyze the soluble and insoluble fractions for their protein
content and for activity of PhaECx0 (Figure 4.19). At 37 C, PhaE and PhaC were predominantly
found in the insoluble fraction (Figure 4.19, lane 3). Decreasing the expression temperature to 18
C, however, increased the amount of soluble protein (Figure 4.19, lane 4). Unfortunately, assays
of the soluble and insoluble fractions from both expression temperatures revealed no activity,
thus this protein was not pursued further for crystallography studies.
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Figure 4.19 Expression and solubility of PhaECx,. Lane 1, molecular weight standards. Lane
2, soluble fraction with induction at 37 OC. Lane 3, insoluble fraction with induction at 37 C.
Lane 4, molecular weight standards. Lane 5, soluble fraction with induction at 18 C. Lane 6,
insoluble fraction with induction at 18 *C. Lane 7, soluble fraction with induction at 18 'C and
lysis in the presence of 0.1% octyl glucoside. Lane 8, insoluble fraction with induction at 18 OC
and lysis in the presence of 0.1% octyl glucoside.
4.4 Discussion
Unfortunately we were unable to obtain crystals of a PHB synthase that were of a high
enough quality to solve the X-ray structure. However, some of the observations and progress that
we have made may be helpful for any future attempts to crystallize a synthase.
PhaEA27CAV and PhaEA35CAV crystallize in many conditions. In our experience, the
generalization can be made that crystals of the fern/dendrite morphology, which typically form
with PEG 3350 (or sometimes PEG of a different M,) as a precipitant, never diffract. Grid
screening around a condition that produces crystals of the fern/dendrite morphology has also not
succeeded in producing crystals of diffraction quality. Therefore in future crystallization trials,
we recommend that crystals of other crystal morphologies be given priority in terms of additional
screening for diffraction quality. An additional observation is that co-crystallization with the
inhibitor HBCH 2CoA resulted in the growth of crystals in a few conditions that did not promote
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crystallization in the absence of HBCH2CoA. This result suggests that the crystals were co-
crystals of PhaEA27CAV bound to HBCH2CoA. Refining of these crystallization conditions by
addition of osmolytes such as taurine and sarcosine resulted in the highest diffraction obtained
with a class III synthase construct (4-5 A), though, screening the diffraction of several additional
crystals grown under these conditions revealed that most of the crystals diffracted to >7 A.
However the results suggest that co-crystallization with a non-covalent substrate analog such as
HBCH 2CoA can potentially result in higher quality crystals than those grown in the absence of a
substrate analog.
The most promising result obtained was the discovery of a crystal of PhaCcAN that grew
during an extended incubation (~1 year), as described in section 4.3.7. Our analysis of the
protein from a similar condition in the same crystallization tray suggested that the protein in this
crystal was full-length (rather than a proteolytic fragment). The crystal diffracted to ~2 A, the
highest diffraction yet obtained with any PHB synthase, and a partial data set was collected.
Attempts to solve the structure using molecular replacement with models generated by threading
and structure prediction software were unsuccessful. This is perhaps not surprising considering
the most reliable structure prediction is of the a/P hydrolase fold domain, which comprises only
~200 residues of the 589 residues in PhaCccAN. Attempts to reproduce the crystallization were
also unsuccessful. However, the fact that a crystal of a PHB synthase diffracts to 2 A is
nonetheless a promising result, as previous efforts all resulted in crystals that diffracted no better
than 7 A.
Finally, the class I synthases PhaCsa and PhaCLc are worth exploring further as candidates
for crystallization. They are well-behaved in solution and can be rapidly and highly purified.
Furthermore, PhaCsa seems to be somewhat thermally stable compared to the other synthases.
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Thermal stability is a quality that makes the proteins of thermophiles attractive candidates when
trying to obtain a crystal structure of a homolog to a difficult to crystallize protein of interest, and
suggests that PhaCsa could be amenable to crystallization.
4.5 Acknowledgement
We thank Professor Karen Allen for agreeing to collaborate with us on a difficult project and for
her helpful input. We also thank Drs. Kelly Daughtry, Lorenzo Finci, Nick Denunzio and Nick
Silvaggi for their assistance with screening crystals and for helpful discussions. And finally we
thank Dr. Paul Hubbard for supplying us with pPhaEA27AV and pPhaCAV.
4.6 References
1. Jia, Y., Kappock, T. J., Frick, T., Sinskey, A. J., and Stubbe, J. (2000) Lipases provide a
new mechanistic model for polyhydroxybutyrate (PHB) synthases: characterization of the
functional residues in Chromatium vinosum PHB synthase, Biochemistry 39, 3927-3936.
2. Li, P., Chakraborty, S., and Stubbe, J. (2009) Detection of covalent and noncovalent
intermediates in the polymerization reaction catalyzed by a C149S class III
polyhydroxybutyrate synthase, Biochemistry 48, 9202-9211.
3. Yuan, W., Jia, Y., Tian, J., Snell, K. D., Muh, U., Sinskey, A. J., Lambalot, R. H., Walsh,
C. T., and Stubbe, J. (2001) Class I and III polyhydroxyalkanoate synthases from
Ralstonia eutropha and Allochromatium vinosum: characterization and substrate
specificity studies, Arch. Biochem. Biophys. 394, 87-98.
378
4. Kalinin, Y., Kmetko, J., Bartnik, A., Stewart, A., Gillilan, R., Lobkovsky, E., and Thorne,
R. (2005) A new sample mounting technique for room-temperature macromolecular
crystallography, J Appl. Crystallogr. 38, 333-339.
5. Mfih, U., Sinskey, A.J., Kirby, D.P., Lane, W.S., Stubbe, J. (1999) PHA Synthase from
Chromatium vinosum: cysteine 149 is Involved in covalent catalysis, Biochemistry 38,
826-837.
6. Tian, J. (2005) Mechanistic investigation of polyhydroxybutyrate (PHB) synthases and
elucidation of PHB biosynthesis and degradation process in Wautersia eutropha H6, in
Chemistry, p 345, Massachusetts Institute of Technology, Cambridge.
7. Bolen, D. W. (2004) Effects of naturally occurring osmolytes on protein stability and
solubility: issues important in protein crystallization, Methods (San Diego, Calif 34, 312-
322.
8. Sheldrick, G. M. (2008) A short history of SHELX, Acta Crystallogr. D64, 112-122.
9. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R.,
Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., McNicholas, S. J.,
Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A.,
and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments, Acta
Crystallogr. D Biol. Crystallogr. 67, 23 5-242.
10. Sturo, E. A., and Wilson, I. A. (1991) Applications of the streak seeding technique in
protein crystallization, J. Cryst. Growth 110, 270-282.
11. Luft, J. R., and DeTitta, G. T. (1999) A method to produce microseed stock for use in the
crystallization of biological macromolecules, Acta Cryst. D Biol. Cryst. 55, 988-993.
379
12. Liebergesell, M., Rahalkar, A., and SteinbUchel, A. (2000) Analysis of the Thiocapsa
pfennigii polyhydroxyalkanoate synthase: subcloning, molecular characterization and
generation of hybrid synthases with the corresponding Chromatium vinosum enzyme,
Appl. Microbiol. Biotechnol. 54, 186-194.
380
Chapter 5:
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5 Miscellaneous studies and future outlook
5.1 Introduction
This Chapter presents additional studies carried out during the course of this thesis. These
include electron microscopy studies of the structure of the truncated construct of PhaECAV,
PhaEA27C, additional in vitro studies with PhaCccAN, transmission electron microscopy (TEM)
of stalked and swarmer cells of Caulobacter crescentus, and efforts to prepare mutant
heterodimers of PhaCc. These sections will be presented individually such that each topic has its
own introduction, materials and methods, and results and discussion sections.
5.2 Electron microscopy (EM) investigation of the structure of a truncated mutant
of PhaECAv
5.2.1 Introduction
Our efforts to obtain a crystal structure of class I and III synthases, detailed in Chapter 4,
have not been successful for a variety of reasons. In the case of the truncated and full length
constructs of the class I synthase from C. crescentus, we were unable to obtain crystals. In
contrast, in the case of the truncated mutant of the class III synthase from Allochromatium
vinosum, PhaEA27C, crystals were readily obtained in dozens of conditions, but the crystals
always failed to diffract to under 7 A.
An alternative method for structural analysis of proteins is negative staining electron
microscopy, which has the benefits of not requiring crystallization of a protein of interest and
also allowing the use of much lower concentrations of protein. In this method, a sample of
protein is dispersed on a 70-80 nm thick carbon layer supported on an EM grid. The protein is
stained, typically with uranyl acetate, then imaged with an electron microscope. The protein
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particles disperse randomly across the surface of the grid, so every image captured contains
protein molecules in a variety of orientations and conformational states. Computer software is
then used to assist in the identification of each protein particle followed by the sorting of these
various conformations into groups, which are 2-dimensional representations of the structure of
the protein. The groups can then be used to reconstruct 3-dimensional structures at 10-30 A in
resolution. Thus, while this method does not provide atomic resolution, it can provide
information about the overall conformation of a protein. This section presents our preliminary
efforts to examine the structure of PhaEA27C by EM.
5.2.2 Materials and Methods
5.2.2.1 Materials
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich (St. Louis,
MO) and used without further purification. Copper/rhodium grids and uranyl acetate were
obtained from Electron Microscopy Sciences (Hatfield, PA).
5.2.2.2 Expression and purification of PhaEA27C
Expression and purification of PhaEA27C were carried out as described in section 4.2.3.
5.2.2.3 Preparation and imaging of EM grids and preliminary data analysis
A sheet of freshly cleaved mica was placed into a carbon evaporation chamber, and a thin
(~15 nm) layer of carbon was deposited on it. The carbon film was lifted off of the mica sheets
by floating them in a dish of water. Copper/rhodium grids were grasped with forceps, submerged
in the dish and lifted through the floating carbon film. The grids were then glow-discharged in
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the presence of amylamine in order to briefly activate the surface of the grid, in order to enhance
the adsorption of sample onto the surface.
PhaEA27C was diluted to a final concentration of 20 ig/mL in 150 mM NH4+ acetate, pH
6.8. A sample of protein (5 p.L) was pipetted onto the carbon surface of the grid. After 15 s,
excess sample was removed by touching the corner of a Kim wipe to the edge of the grid. The
grid was then stained with 1% uranyl acetate in ddH20 for 15 s and the excess stain was blotted
with a Kim wipe. Finally the grid was submerged in a dish of water and lifted through a second
thin (~15 nm) carbon film to create a carbon "sandwich." The samples were imaged using an FEI
Technai Spirit Transmission Electron Microscope at 80 keV at the W. M. Keck Microscopy
Facility of the Whitehead Institute.
Using EMAN software for single particle analysis (1), 5505 particles were selected from
10 micrographs and the particles selected by the program were visually inspected to remove false
positives. Selected particles were interpolated to 4.2 A per pixel, and the particles were contained
within 50-pixel boxes, about 50% larger than the particle diameters. The particles were band-
pass filtered in order to retain information between 20 and 220 A. The boxed particle images
were then aligned, in order to bring particles within a particular orientation into common register,
such that the class averages could be prepared. Class averages were then prepared from the
aligned particles.
5.2.3 Results and Discussion
In order to obtain the typical result shown in Figure 5.1, several sample preparation
variables were altered individually, including the sample concentration (5-100 ptg/pL) and the
staining time (5-30 s). Ultimately, the best micrographs were prepared from samples containing
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20 pg/mL PhaEA27C with a staining time of 15 s. In Figure 5.1, the protein complexes are the
bright particles, resembling flowers or coffee beans, surrounded by stain halos. In their original
report of the expression and purification of PhaECA,, Steinbtchel and coworkers also imaged the
synthase by electron microscopy (2). In their micrographs, they see particles that look very
similar to ours, suggesting that truncation of the C-terminal 27 residues of PhaE does not
dramatically change the quaternary structure. This observation is consistent with our
observations that the truncated mutant retains activity. For data analysis, 5505 of these particles
were selected and automatically sorted into 25 class averages (Figure 5.2). Table 5.1 indicates
how many particles are sorted into each of the class averages.
A) B)
Figure 5.1 A typical electron micrograph of PhaEA27C. A) Electron micrograph of
PhaEA27C. The sample was prepared by diluting PhaEA27C to 20 pg/mL in 150 mM NH4 +
acetate, pH 6.8. Five p.L was incubated 15 s on a copper/rhodium grid coated with carbon. The
sample was stained 15 s with 1% uranyl acetate in ddH20. The scale bar is 150 nm B) Expansion
of the boxed region in panel A. The scale bar is 75 nm.
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Figure 5.2 Class averages of PhaEA27C. A) Particles were sorted into 25 class averages. B)
Enlarged class averages and the number of particles in each. The bar represents 15 nm.
Table 5.1 Number of particles sorted into each of the class averages shown in Figure 5.2.
Class average Number of particles Class average Number of particles
Al 122 DI 138
A2 350 D2 125
A3 247 D3 231
A4 279 D4 192
A5 102 D5 129
B1 330 El 300
B2 352 E2 255
B3 515 E3 235
B4 165 E4 110
B5 103 E5 345
Cl 204
C2 250
C3 120
C4 135
C5 171
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Many of the class averages look similar, suggesting that if the software had been
instructed to sort the particles into fewer class averages, these would have been grouped together.
For example, class averages A1, A2 and A5, which contain ~10% of the total particles, represent
apparently very similar structures/orientations of PhaEA27C. The same is true for class averages
C2, D2, D3, E3 and E4, which together contain ~20% of the total particles. The remaining class
averages are similar to one another and depict a globular structure that does not have any
particularly distinctive features.
In Chapter 4, we presented size exclusion chromatography analysis of the quaternary
structure of PhaEA27C, which suggested that it was a mixture of dimers and tetramers of
PhaEA27C. PhaEA27 and PhaC are both ~40 kDa in M., and a typical 40 kDa globular protein
has a diameter of ~4-5 nm. In Figure 5.2B the scale bar is 15 nm, demonstrating that the class
averages tend to have diameters of ~15 nm, which would be consistent with the range of
diameters expected for dimers and tetramers of PhaEA27C. Class average Dl is noticeably
distinct from the other class averages, in particular because it has three-fold symmetry that is
seemingly inconsistent with the observation of dimers and tetramers of PhaEd27Cs being the
predominant quaternary structures. However, the lobes of Dl are approximately the same size as
the larger lobes on class average C2 and other similar class averages (compare the upper right
lobes of Dl with the upper right lobes of C2, D2, D3, E3 and E4). This suggests that D2 may be
either a different orientation of a structure similar to that or C2, or it could represent a partially
disassembled structure that has lost one or more subunits.
These results demonstrate that further examination of the quaternary structure of
PhaECAv could prove fruitful. In particular, it may be interesting to study the mutant D302A-
PhaECAv incubated with 5-100 equiv. of HBCoA. Previous studies carried out in our lab
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demonstrated that the D302A mutant can be relatively uniformly loaded with substrate (3); thus,
we may be able to investigate whether structural changes take place upon initiation of
polymerization.
5.3 In vitro studies of PhaCccAN
5.3.1 Introduction
PhaC from C. crescentus is annotated incorrectly in the database as a 65 kDa protein. In
Chapter 2 we present the cloning and purification of this 65 kDa construct (PhaCccAN) as well as
a 73 kDa construct that was originally proposed by Qi and Rehm to be the relevant form in vivo
(4). In Chapter 2 we demonstrated that the 73 kDa construct has 50-fold higher activity in vitro
than the 65 kDa construct. Studies presented in Chapter 4 demonstrate that the synthase is -75
kDa in vivo by Western blot analysis using antibodies generated to his-tagged PhaCccAN. The 73
kDa construct has an 8 kDa N-terminal domain that is enriched in Ala, Lys and Pro residues.
This domain has no homology to any sequences in the database and furthermore it does not have
any predicted secondary structure.
In this section, we present our additional efforts to characterize PhaCccAN. We have
characterized the quaternary structure of PhaCccAN, the stoichiometry of acylation with sTCoA,
and the effect of priming with sTCoA on the effect of the activity of PhaCccAN.
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5.3.2 Materials and methods
5.3.2.1 Materials
All chemicals were obtained at the highest purity available from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified. The compounds sTCoA was synthesized by Dr. Ping Li
according to the method of Jia et al. (5).
5.3.2.2 Construction of pRBphaCccAN and expression and purification of PhaCcAN
The expression plasmid pRBphaCccAN was constructed as described in section 2.2.2.
PhaCccAN was expressed and purified as described in section 2.2.3.
5.3.2.3 Reaction of PhaCccAN with sTCoA: determination of the stoichiometry of acylation
The stoichiometry of acylation was measured using the DTNB assay to monitor CoA
release. The reaction was carried out at 30 C and contained in a final volume of 110 ptL: 20 mM
Hepes pH 7.5, 20 mM NaCl, 50 pM PhaCccAN and 500 pM sTCoA. At various time points, 20
ptL aliquots were withdrawn and quenched in 50 pL 10% TCA. The samples were analyzed by
the discontinuous DTNB assay described in section 2.2.5.
5.3.2.4 Activity of PhaCcc and PhaCcAN following acylation with sTCoA
The reaction was carried out at 30 C. In a final volume of 110 1, the reaction mixture
contained: 20 mM Hepes pH 7.5, 20 mM NaCl, 100 nM PhaCccAN and 500 pM sTCoA. After
30 s, the assay was initiated by addition of 0.76 mM HBCoA. At various time points, 20 pL
aliquots were withdrawn and quenched in 50 pl ice cold 10% TCA. The samples were
centrifuged 5 min at 14,000 xg to remove precipitated protein, and 68 pL was removed and
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added to 262 pL 0.25 mM 5,5'-dithiobis-(2-nitrobenzoic acid (DTNB) in 0.5 M KH2 PO4 , pH 7.8.
The reactions were incubated for 5 min and A412 of each sample was measured. Specific activity
is calculated from the rate of the linear phase of the kinetic trace and is given in U/mg, where one
unit is one pmol substrate consumed per min. Data were fit to a sigmoidal function using
Equation 5.1.
Equation 5.1 y =- n
5.3.3 Results and Discussion
5.3.3.1 Reaction of PhaCcAN with sTCoA: PhaCcAN is acylated with a stoichiometry of
one per dimer of PhaC
To examine the stoichiometry of acylation with sTCoA, 50 p.M PhaCccAN was incubated
with 500 p.M sTCoA and the reaction was monitored by hand quenching of various time points
followed by DTNB assay to evaluate CoA release. These experiments showed a burst of CoA
release corresponding to 0.5 per monomer of PhaCccAN (Figure 5.3). The stoichiometry of 0.5
per monomer of PhaCcAN is reminiscent of the stoichiometry of PhaCRe, suggestive of half-
sites reactivity. In contrast, however, PhaCRe is predominantly a monomer with a small
population of dimer. As reported in Chapter 2, full length PhaCcc is a single oligomeric species
(dimer or trimer) and its acylation with sTCoA gives a stoichiometry of one per monomer. These
results suggest that the N-terminal domain of PhaCcc plays a role in the stoichiometry of PHB
chain synthesis that requires further study.
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Figure 5.3 Reaction of PhaCccAN with sTCoA. A) CoA release from acylation of PhaCcAN
with sTCoA. The reaction contained 50 ptM PhaCcAN and 500 pM sTCoA and was carried out
at 30 OC. Equivalents of CoA released are given per PhaC monomer. The error bars represent the
standard deviation from the mean of three experiments. B) Expansion of the first 2.5 min.
5.3.3.2 Reaction of sT-PhaCccAN with HBCoA: priming with sTCoA increases the activity
20-fold
We next examined the effect of priming with sTCoA on the activity and on the lag phase
of PhaCccAN. Activity assays following acylation with sTCoA were carried out to determine
whether sT could act as a primer for PhaCcc and increase activity, as is the case with PhaCRe.
PhaCccAN (100 nM) was incubated with 500 ptM sTCoA for 30 s at 30 C, then 1 mM HBCoA
was added to initiate polymerization and the reaction was monitored by hand quenching of
various time points followed by DTNB assay. The results demonstrated that the activity of
PhaCccAN is enhanced nearly 20-fold, from 1 U/mg to 18 U/mg, by priming with sTCoA, and
the lag phase is eliminated or obscured (Figure 5.4). In contrast, as described in section 2.2.12,
acylation with sTCoA prior to reaction with HBCoA increases the activity of full length PhaCcc
by only 2-fold. These results in combination with the size exclusion data that demonstrate
PhaCccAN is a mixture of monomer and dimer in solution are consistent with the proposal that
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sTCoA decreases/eliminates the lag phases of PhaCRe and PhaCccAN by shifting the
monomer/dimer equilibrium in favor of dimer. However, due to the instability of sT-PhacAN
(not shown) this species could not be examined by SEC.
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Figure 5.4 Effect of priming with sTCoA on the activity of PhaCccAN. The reaction
contained 100 nM PhaCccAN reacted with 1 mM HBCoA (e, blue) or pre-acylated with 500 pM
sTCoA then chased with 1 mM HBCoA (o, red).
5.4 TEM analysis of division of granules between stalked and swarmer cells
5.4.1 Introduction
C. crescentus divides asymmetrically, with each round of division producing two distinct
types of daughter cells, the stalked cell and the.swarmer cell (Figure 5.5) (6). The stalked cell is
sessile and has a single polar extension of the cytoplasm, periplasm and cell wall called the
"stalk." The swarmer cell is motile and has a single polar flagellum. Asymmetric division is
thought to play a role in adaptation to nutrient limited growth conditions, because motile
swarmer daughter cells can disperse upon division, thus reducing competition for nutrients
between daughter cells (7). Such nutrient-limited growth conditions, when a carbon source is
abundant, are also conducive to PHB accumulation.
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Figure 5.5 Lifecycle of C. crescentus. The motile swarmer cell remains in the GI phase for a
certain period of time before differentiating into a sessile stalked cell. The stalked cell is capable
of DNA replication and immediately begins a round of cell division. Each stalked cell produces
one stalked cell and one swarmer cell which begin the cycle anew. The different cell types have
different densities, allowing their separation by density gradient centrifugation. GI, lag phase
before DNA replication. S, period of new DNA synthesis. CS, cell separation. Adapted from
reference (8).
The question of how granules are divided between cells during growth is related to the
question of where granules form within the cell and how. Recent studies suggest that granules in
R. eutropha are associated with nucleoid via the recently discovered the protein PhaM (9, 10).
PhaM is thought to non-specifically bind nucleoid and simultaneously PHB. This proposal is
attractive in that it explains how dividing cells, which are necessarily replicating and dividing
nucleoid, could ensure roughly even segregation of granules between daughter cells. PhaM
homologs are found in most members of the P-proteobacteria, a group that includes R. eutropha.
However, a-proteobacteria, including C. crescentus, do not contain an identifiable homolog to
PhaM.
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We were interested in exploring the division of granules between stalked and swarmer
cells in cultures of C. crescentus grown on nitrogen limited medium in the presence of glucose.
Owing to their different densities, stalked and swarmer cells can be separated by density gradient
centrifugation. Separation is most commonly done using Percoll, which is a colloidal mixture of
silica particles (15-30 nm in diameter) that forms a density gradient upon centrifugation. The
method is non-perturbative and is most commonly used as a technique to synchronize cultures of
C. crescentus. Here, we have exploited this technique to separate stalked and swarmer cells at an
early time point in PHB accumulation. The separate cell types were then fixed and embedded for
transmission electron microscopy (TEM) to examine the distribution and localization of
granules. We find that there is no difference between the two populations of cells in terms of
either number or localization of granules. This result suggests that C. crescentus has a
mechanism for dividing granules between daughter cells during division.
5.4.2 Materials and methods
5.4.2.1 Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) at the highest purity
available, unless otherwise noted, and used without further purification. Peptone and yeast
extract were obtained from Difco (Franklin Lakes, NJ). Percoll was purchased from Fluka
(Hannover, Germany). Glutaraldehyde (15% solution), Os04, uranyl acetate, propylene oxide,
low viscosity embedding resing (LVER, containing vinyl-4-cyclohexene dioxide, diglycidyl
ether polypropylene glycol, nonenyl succinic anhydride, and dimethylamino ethanol combined in
proportions as per the manufacturer's protocol), flat silicone embedding molds and 200-mesh
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nickel grids coated with carbon Formvar were purchased from Electron Microscopy Sciences
(Hattfield, PA).
5.4.2.2 Media and growth conditions
Growths were carried out at 30 *C with shaking at 220 rpm, as described in section 3.2.2.
Briefly, 50 mL PYE overnight cultures in 500 mL baffled flasks were inoculated with a single
colony of C. crescentus and grown to saturation (~15 h, OD 60 0 = 1.4). Two mL of overnight
culture was used to inoculate 50 mL PYE "starter" cultures in 500 mL baffled flasks. The starter
cultures were grown 4-5 h until OD 600 = 0.15, then 20 mL was used to inoculate 500 mL PHBp
cultures in 4 L baffled flasks. The PHBP cultures were grown 12 h until OD60 0 = 0.5, and the
cells were pelleted and the stalked and swarmer cells separated be density centrifugation as
described in the following section.
5.4.2.3 Separation of swarmer and stalked cells by centrifugation over a Percoll density
gradient
Stalked and swarmer cells were separated over a Percoll density gradient by an
adaptation from the method of Huguenel and Austin (11). Percoll is a colloidal mixture of silica
particles (15-30 nm in diameter) that spontaneously separate to form a density gradient upon
centrifugation. Stalked and swarmer cells of C. crescentus have densities of 1.01 g/mL and 1.07
g/mL, respectively. PHBp cultures described in section 5.4.2.2 were pelleted by centrifugation at
4 C for 20 min at 10,000 xg and the supernatant was decanted. The cells were washed by
resuspension in 25 mL ice cold sterile 0.85% NaCl, then pelleted again by centrifugation and the
supernatant was discarded.
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The cell pellet was resuspended in 5 mL ice cold 0.85% NaCl and 5 mL ice cold Percoll
and the suspension was placed in an Ultra-Clear Centrifuge Tube (14 x 89 mm) (Beckman
Instruments, Palo Alto, CA). Stalked and swarmer cells were separated by centrifugation at 4 'C
for 30 min at 8,000 xg. Stalked cells remained at the top of the gradient while swarmer cells
sedimented to ~1 cm from the bottom of the tube. The centrifuge tube was carefully pierced
with 3 mL syringes fitted with 18 /2 gauge needles, and the stalked and swarmer cells were
individually withdrawn and placed in 15 mL Falcon tubes. The cell suspensions were diluted
with ice cold 0.85% NaCl to a final volume of 10 mL, and the cells were pelleted by
centrifugation at 4 'C for 20 min at 10,000 xg. The supernatant was decanted from each sample
and EM samples were prepared as described in the following section.
5.4.2.4 Crotonate analysis of the PHB content of each cell type
Samples of each cell type were added to borosilicate tubes (16 mm x 125 mm) and dried
overnight at 120 'C. The samples (~10-15 mg dry weight) were analyzed by the crotonate assay
as described in section 3.2.8.
5.4.2.5 Transmission electron microscopy (TEM)
TEM samples were prepared as described in section 3.2.15 with minor modifications.
5.4.2.5.1 Fixation
The methods for preparation of TEM samples were adapted from (12). To prepare a
typical sample, 25 mL of cell culture grown in PHBP medium was combined 1:1 with 25 mL
fixative containing 2% (v/v) glutaraldehyde, 3% (w/v) paraformaldehyde, 5% (w/v) sucrose in
0.1 M sodium cacodylate, pH 7.4. Samples were mixed with gentle rocking for 1 min, then
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centrifuged for 10 min at 7000 xg at 4 'C. The cell pellets were resuspended in 10 mL fresh
fixative and incubated for 1 h at 4 *C with gentle rocking. After fixation, the cell pellets were
washed three times in 1 mL of 0.1 M sodium cacodylate pH 7.4 by centrifugation at 7000 xg at 4
C. The cell pellets were then dislodged into 1 mL of 1% sO04 solution in Veronal-acetate buffer
(0.24% (w/v) sodium acetate, 0.58% (w/v) sodium barbitol, 0.02 N HCl) and incubated for 1 h at
RT with gentle rotation. Samples were centrifuged for 5 min at 14,000 xg, and the supernatant
was removed. One mL Kellenberger uranyl acetate stain (0.5% uranyl acetate in Veronal acetate
buffer) was then added to each sample, and the pellets were dislodged and broken apart, then
incubated overnight for additional staining.
5.4.2.5.2 Dehydration
Following uranyl acetate staining, the pellets were dehydrated by incubations in
increasing concentrations of ethanol. The pellets were dislodged into 1.5 mL 50% (v/v) ethanol
in ddH20 and rotated gently on a nutating mixer at RT for 10 min, then centrifuged 1 min at
14,000 xg and the supernatant decanted. This process was repeated with 70%, 90% and 95%
ethanol, and repeated three times with 100% ethanol. The pellets were then dislodged into 1 mL
of a mixture of 50% (v/v) ethanol, 50% (v/v) propylene oxide for 5 min, then 100% propylene
oxide for 5 min. Finally the pellets were dislodged into 1 mL of a mixture of 50% (v/v)
propylene oxide, 50% (v/v) LVER and incubated overnight at RT.
5.4.2.5.3 Embedding
The pellets were transferred into 1.5 mL 100% LVER, placed under vacuum at RT for 4
h, then exchanged into fresh 100% LVER. This process was repeated three times. After the final
incubation in LVER the samples were centrifuged 1 min at 14,000 xg and then LVER was
removed. The pellets were then placed on a clear surface (typically a plastic petri dish) and cut
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into smaller pieces (~1-2 mm) using a toothpick. Several pieces of each sample were then
embedded in flat silicone molds in -250 pL fresh 100% LVER. The samples were cured for 48 h
at 60 0C.
5.4.2.5.4 Sectioning and microscopy
Sectioning and imaging were carried out at the W.M. Keck Microscopy Facility at the
Whitehead Institute (Cambridge, MA). Sectioning was performed by Dr. Mimi Cho. Sections
(70-80 nm thick) were cut from each beam capsule using a Reichert Ultracut E Ultramicrotome
equipped with a Diatome diamond knife. Sections were picked up by 200-mesh Formvar coated
nickel grids. Samples were then imaged using an FEI Technai Spirit Transmission Electron
Microscope at 80 kV at the W.M. Keck Microscopy Facility at the Whitehead Institute for
Biomedical Research.
5.4.3 Results and Discussion
In order to examine the division of granules between stalked and swarmer cells, PHBP
cultures grown 12 h were pelleted and the two cells types were separated by density
centrifugation over a Percoll gradient. The stalked and pre-divisional cells remained at the top of
the gradient, while the swarmer cells settled at a band near the bottom of the gradient (Figure
5.6). There appear to be more stalked and pre-divisional cells than swarmer cells, which may be
due to the fact that at the time point the cells were isolated, the cultures were actively growing
and dividing, thus many cells were in the pre-divisional state. Both cell types were analyzed
individually by crotonate assay and were found to contain ~3% PHB cdw, consistent with our
previous measurements of cells isolated at the same time point in growth (Chapter 3). The
isolated cells were then fixed, stained with uranyl acetate and embedded in LVER plastic and
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EM samples were prepared. Comparison of the two cell types reveals little difference between
them in terms of the number and size of granules (Figure 5.7), suggesting that the granules
partition between the two daughter cells during each round of division. Furthermore, the
morphology of the two cell types in Figure 5.7 is very similar. The only morphological
difference between the two cell types is the presence of the flagellum on the swarmer cell and the
stalk on the stalked cell. The flagellum has a diameter of ~20 nm (6), and the stalk has a diameter
of 150-200 nm (7, 13). Considering that the micrographs in Figure 5.7 represent 70-80 nm slices
of samples, it is not surprising that we do not see flagella in Figure 5.7A. In Figure 5.7B portions
of stalks that have been imaged are indicated with black arrows, and a predivisional cell is
indicated with a white arrow.
Stalked cells,
pre-divisional cells
Swarmer cell l
Figure 5.6 Percoll gradient separation of stalked and swarmer cells of C. crescentus. PHBp
cultures were grown 12 h, then the cells were pelleted, washed and applied to the top of the
Percoll gradient. Following centrifugation, the two cell types were carefully pipetted from where
they each had settled, and samples were prepared for electron microscopy.
PhaM homologs are only found in P-proteobacteria such as R. europha, and C. crescentus
belongs to the a-proteobacteria. Because it divides asymmetrically in each round of division, C.
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crescentus has elaborate mechanisms for generating the asymmetry, many of which are well
understood (14). If the a-proteobacteria do in fact contain a distinct dedicated mechanism for
partitioning of granules during growth, C. crescentus may be an ideal candidate for examining
this process.
A) B)
Figure 5.7 TEM of C. crescentus A) swarmer cells and B) stalked and pre-divisional cells
grown 12 h in PHBP medium. Both cell types contain ~3% PHB cdw.
5.5 Preparation and characterization of mutant heterodimers of PhaCc,
5.5.1 Introduction
Two models in Figure 5.8 for the mechanism of polymerization have been proposed
based on studies conducted primarily on PhaCRe and PhaECAV. In both models, a dimer of PhaCs
synthesizes a single PHB chain. This aspect of the models is based on the observations that
acylation with artificial primers such as sTCoA results in a stoichiometry of labeling of 1 per
dimer, and shifts the monomer-dimer equilibrium in favor of a dimer of synthases (15, 16). The
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models differ in whether the Cys residue of both PhaC monomers is involved in catalysis, or
whether the enzymes exhibit half-sites reactivity, with only a single Cys participating in
catalysis. The model shown in Figure 5.8A was based on an analogy to fatty acid synthases and
involves the participation of both Cys residues (17). In this model, there are no non-covalent
intermediates, as the growing chain is passed between the two Cys residues with the addition of
each HB monomer. The model shown in Figure 5.8B was is a variant on the mechanism
proposed for some type III polyketide synthases (18). In this model, a single Cys residue
synthesizes the PHB chain and after each ester bond is formed, the growing chain is transiently
released from the active site Cys. The enzyme is then rapidly reacylated, releasing CoA. This
model predicts that if the rate of reacylation is slowed, transient non-covalent intermediates
could potentially be trapped. We have recently demonstrated the involvement of non-covalent
intermediates with a mutant of the class III synthase from Allochromatium vinosum in which the
active site Cys was mutated to Ser, C149S-PhaECA,. This mutant has a specific activity that is
1/ 2 2 0 0 th that of the wt enzyme. C149S-PhaECAv was reacted with HBCoA and quenched at
various time points, allowing trapping of the intermediates (HB) 2CoA and (HB) 3CoA. While
these findings support the mechanism shown in Figure 5.8B, a caveat remains that the Cys to Ser
mutation could alter the mechanism of polymerization. Non-covalent intermediates in the
reaction of a wt synthase with HBCoA have yet to be observed.
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Figure 5.8 Working models for the mechanism of polymerization by PhaCs. A) Working
model based off of analogy to fatty acid synthase involving the participation of Cys residues
from two PhaCs. B) Working model based off of analogy to some type III polyketide synthases,
involving the participation of only a single Cys residue.
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In elegant experiments carried out by Smith and coworkers on mammalian fatty acid
synthase, preparation of mutant heterodimers demonstrated that a mutation in one domain of one
subunit can be complemented by the wt domain in the second subunit of the dimer (19, 20). In
principle, this is the ideal experiment to distinguish between the mechanisms in Figure 5.8. In the
mechanism in Figure 5.8A, one would predict that a mutant heterodimer composed of a wt
subunit and a mutant subunit in which Cys is replaced with Ala would be inactive if both Cys
residues are required for catalysis. Alternatively if only a single Cys participates in catalysis than
the mutant heterodimer should have the same activity as the wt enzyme. The preparation of such
mutant heterodimers of PhaCRe was reported by Goodwin and coworkers and is described in
detail in Chapter 1 (section 1.3.2.6) (21). In their experiments, wt PhaCRe and mutant C319A-
PhaCRe were combined at a stoichiometry of 1:1 under dilute conditions, which they believed
promote conversion of PhaCRe to monomers. The exact concentration of PhaCRe in the "dilute"
conditions is not provided, but based on the information available in the paper we can estimate
that it is 3 p.M. We have previously examined the dissociation of dimers of PhaCRe isolated by
SEC into monomers, and have measured the KD of the interconversion to be ~4 pM (22). Thus at
3 [tM a portion of PhaCRe is likely still dimeric. To promote conversion to the dimeric form, they
added 70% w/v fructose to the PhaCRe mixture, which they claimed promotes conversion to
dimeric PhaC. They then compared the total units of activity of wt PhaCRe before and after
addition formation of mutant heterodimers, and found that 50% of the total units were lost.
Reassociation of wt and mutant PhaCs should occur at a rate of 1:2:1 of wt-wt to wt-mutant to
mutant-mutant, thus they interpreted their results to indicate that the wt-mutant heterodimers
were inactive, as predicted by the mechanism in Figure 5.8B. However, the authors have failed
to consider the complicated equilibria of the monomer dimer conversion. Furthermore, we have
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attempted to reproduce their studies suggesting fructose promotes dimerization, and have found
that addition of fructose actually decreases the specific activity of PhaCRe. Thus the experiments
of Goodwin and coworkers were not correctly done, and they have likely misinterpreted their
data.
Our observations that PhaCcc is predominantly a single oligomeric state at high
concentrations suggested that stable mutant heterodimers could be obtained given the appropriate
isolation conditions. However, as each PhaCcc is thought to make a single PHB chain on the
basis of acylation studies with sTCoA (Chapter 2), these studies only address whether the active
sites can function independently. We have included these experiments in this Chapter primarily
to provide the experimental details, which may prove useful for future attempts to make mutant
heterodimers.
5.5.2 Materials and Methods
5.5.2.1 Materials
All chemicals were purchased at the highest purity available from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified. Oligonucleotide primers were purchased from Integrated
DNA Technologies (Coralville, IA) and are listed in Table 5.2. Restriction enzymes were
purchased from New England Biolabs (Beverly, MA), GoTaq DNA polymerase and T4 DNA
ligase were purchased from Promega (Fitchburg, WI), and PfuII Ultra and Pfx polymerase were
purchased from Invitrogen (Carlsbad, CA). 3-(R)-hydroxybutyryl-CoA (HBCoA) was
synthesized by Dr. Ping Li by the method of Yuan et al. (23). The plasmids used in this study are
listed in Table 5.3.
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5.5.2.2 Protein quantitation
PhaC concentration was determined by A2 8 0 (c = 103,630 M- cm' for His6-PhaC and
110,330 M- cm' for Strep2-PhaCs) or Bradford assay using BSA as a standard (24). For
heterogeneous mixtures of proteins total concentration was determined by Bradford assay.
5.5.2.3 Construction of N-terminally tagged his6-phaC and strep2-phaCs for expression in E.
cOli
Genomic DNA isolation and construction of the plasmid pRBhis6phaC was carried out as
described in section 3.2.3. For construction of pRBstrep2(HRV)phaC, phaC was amplified from
pRBhis6phaC using GoTaq polymerase and the primers phaCstrep2fw and phaCstrep2rev to
insert a BamHI restriction site at the 5' end of phaC and a NotI restriction site at the 3' end of
phaC. An annealing temperature of 55 *C and an extension temperature of 72 'C for 2 min were
used. The amplified phaC product was digested with BamHI and NotI and inserted into pET52b
(Novagen) that had been digested with the same restriction enzymes, to produce
pRBstrep2(HRV)phaC. pET52b encodes the N-terminal strep2 tag and the sequence
GALEVLFQGPGYQDP. The underlined portion of the sequence is an HRV 3C protease
cleavage site. The portion of pRBstrep2(HRV)PhaC containing strep2-phaC was sequenced by
the MIT Biopolymers Laboratory.
For construction of pRBstrep2phaC, phaC was excised from pRBhis6phaC by digestion
with NheI and BamHI then ligated into pET24a digested with the same restriction enzymes. A
strep2 tag was then inserted by two successive rounds of mutagenesis first using the primers
phaCInsertlfw/phaCInsertlrev to insert the first four amino acids of the strep2 tag (WSHP)
followed by mutagenesis using the primers phaCInsert2fw/phaCInsert2rev to insert the second
405
four amino acids (QFEK). Mutagenesis was performed using PfuII polymerase with 1% DMSO
as an additive. An annealing temperature of 55 'C and an extension temperature of 68 'C for 7
min were used. The plasmid was sequenced at the MIT Biopolymers Laboratory.
5.5.2.4 Construction of his6-phaC-C406A and strep2-phaC-C406A
Attempts to generate the active site C406A mutant synthase by conventional mutagenesis
methods were unsuccessful. Therefore both the His 6-tagged and Strep-tagged mutants were
generated by the primer overlap extension method (25). Construction of pRBhis6phaC-C406A is
described in Chapter 2. For the construction of Strep2-PhaC-C406A, the 5' region of phaC was
amplified using GoTaq polymerase and the primers phaCStrep2fw and phaCC406Arev (product
strepAB) and the 3' region was amplified using GoTaq polymerase and the primers
phaCC406Afw and phaCStreprev (product strepCD) (Table 5.2). phaCStrep2fw introduced a
BamHI restriction site at the 5' end of strepAB and phaCStrep2rev introduced a NotI restriction
site at the 3' end of strepCD.
The amplified PCR products were purified and the relative concentrations estimated by
densitometry analysis by ethidium bromide staining in a 1% agarose gel. Based on this analysis,
strepAB and strepCD were combined in a 1:1 ratio and these products then served as the
templates for a second set of PCR reactions. strepAB and strepCD were amplified using GoTaq
polymerase and the primers phaCStrep2fw and phaCStrep2rev. This PCR reaction "stitched"
together the two template pieces, producing the products strepAD corresponding to strep2-phaC-
C406A. strep2-phaC-C406A was subcloned into pCR2.1 TOPO by the manufacturer's protocol,
then excised using the appropriate restriction enzymes. Using T4 DNA ligase, strep2-phaC-
C406A was ligated into pET52b (Novagen) between BamHI and NotI restriction sites.
406
The resulting plasmid pRBstrep2(HRV)phaC-C406A was sequenced at MIT
Biopolymers Laboratory and was found to contain a single base pair insertion at the site of the
mutation. Therefore a final round of mutagenesis using PfuII polymerase and the primers
phaCC406Afw and phaCC406Afw was carried out to remove the insertion using an annealing
temperature of 55 C and an extension temperature of 68 C. The sequence was confirmed by
sequencing at the MIT Biopolymers Laboratory.
a --- > *
-- b <-d
phaC
\/
AB *
CD
*
AB
* CD
AD
Figure 5.9 Schematic of primer overlap extension method of mutagenesis adapted from
(25). Site-directed mutagenesis is accomplished using primers b and c, which contain the
mutation (*), and primers a and d, which anneal to the 5' and 3' ends of the gene, respectively.
The first PCR reaction produces fragments AB and CD. PCR products AB and CD, which
overlap at the site of the mutation, are then used as template for the second PCR reaction. AB
and CD hybridize at the site of the mutation and PCR using primers a and d generates the full
length product AD.
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Table 5.2 Primers used in Chapter 5.
Name Sequencea
phaCStrep2fw 5' - GGATCCTATGGCCACGGCGAAGGCCGCCCCCAAGGCTCGAA
AGAAAGCCGCGAC -3'
phaCStrep2rev 5' - GATATAGCGGCCGCTCAGGGTTGTGACTTTACCAGCAC - 3'
phaCfw Described in Table 2.1.
phaCrev Described in Table 2.1.
phaCInsertlfw 5' - GGAGATATACATATGGCTAGCTGGAGCCACCCGATGGCC
ACGGCGAAGGCCGCGCCCC - 3'
phaCInsert 1 rev 5' - GGGGCGCGGCCTTCGCCGTGGCCATCGGGTGGCTCCAGCTA
GCCATATGTATATCTCC-3'
phaCInsert2fw 5' - CATATGGCTAGCTGGAGCCACCCGCAGTTCGAAAAGATGG
CCACGGCGAAGGCCGC-3'
phaCInsert2rev 5' - GCGGCCTTCGCCGTGGCCATCTTTTCGAACTGCGGGTGGC
TCCAGCTAGCCATATG-3'
aRestriction sites, insertion sequences, and mutated codons are underlined.
Table 5.3 Plasmids used in Chapter 5.
Plasmid Description Reference
pRBstrep2(HRV)phaC phaC inserted into pET52b between BamHI and This work
NotI restriction sites; encodes N-terminal Strep2
tag (WSHPQFEK) and the linker
GALEVLFQGPGYQDP, containing an HRV 3C
protease site (underlined).
pRBphaCcc Described in Table 2.2. This work
pRBphaCcc-C406A Same as pRBhphaC with point mutation C406A. This work
pRBstrep2(HRV)phaC- Same as pRBstrep2(HRV)phaC with point This work
C406A mutation C406A.
pRBstrep2phaC phaC inserted into pET24a; N-terminal Strep2 tag This work
inserted by mutagenesis, no linker between phaC
and Strep2 tag.
5.5.2.5 Expression and purification of His6-PhaC and His6-PhaC-C406A
His6-PhaC and His 6-PhaC-C406A were expressed and purified as described in section
2.2.3.
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5.5.2.6 Expression and purification of Strep2(HRV)-PhaC, Strep2(HRV)-PhaC-C406A and
Strep2PhaC
All culture medium was supplemented with 100 tg/mL ampicillin (Amp). A single
colony of E. coli BL21(DE3) cells harboring either pRBstrep2(HRV)phaC or
pRBstrep2(HRV)phaC-C406A was used to inoculate 5 mL LB culture broth. The cells were
grown overnight at 37 'C. The entire culture was used to inoculate 1 L of LB in a 2.8 L baffled
flask. The culture was grown to OD 600 = 0.6 at 37 'C then the cultures were rapidly cooled to 25
'C and expression was induced with 0.4 mM IPTG. The cells were grown an additional 3-4 h at
25 'C then pelleted by centrifugation for 10 min at 3,500 x g at 4 'C. The cell pellets were flash
frozen in liquid nitrogen and stored at -80 *C until use. A typical 1 L culture yielded 2.5 g cells.
The cell pellets were resuspended in 5 mL Strep-tactin lysis buffer (100 mM Tris, 150
mM NaCl, 1 mM EDTA pH 8.0) per g cells and lysed by two passes through the French pressure
cell at 14,000 psi. The cell lysate was then centrifuged at 20,000 x g for 20 min to remove the
insoluble cell debris. The resulting clarified extract was combined with Strep-tactin resin (IBA,
GmbH, G6ttingen, Germany; 0.2 mL resin per mL lysate) pre-equilibrated with Strep-tactin lysis
buffer and incubated with gentle rocking for 30 min at 4 'C. The resin was then applied to a
column and the flowthrough collected. The column was washed with 20 column volumes (cvs)
of Buffer A, then the protein was eluted with 10 cvs Strep-tactin lysis buffer containing 1 mM
desthiobiotin and the eluent was collected in fractions. The fractions containing protein were
combined, concentrated and exchanged into 20 mM Hepes pH 7.5, 200 mM NaCl, 10% glycerol.
Typical purifications yielded 2-3 mg of pure protein per g of cells.
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5.5.2.7 Enzyme assays
Enzyme assays were carried out as described in section 2.2.5 with PhaC concentrations
from 0.05 to 1 pM. When indicated, the assay mixture also contained n-octyl-p-D-gluCoside (0.1-
1%). The specific activity is measured from the rate of the first linear phase and is given in
U/mg, where a unit (U) is defined as a pmol of CoA released per min. Data are fit to equation
5.1.
5.5.2.8 Control for binding of Strep2(HRV)-PhaC to Ni-NTA resin and His6-PhaC to Strep-
tactin resin
Purified His6-PhaC (5 p.M) was prepared in 1 mL of Strep-tactin lysis buffer. Purified
Strep2(HRV)-PhaC (5 pM) was prepared in 1 mL Ni-NTA lysis buffer. The solutions were then
combined with the inappropriate affinity resin (0.25 mL) and incubated with gentle rocking at 4
'C for 30 min. The slurries were applied to columns (7 x 10 mm) and the flowthrough collected.
The Strep-tactin resin was washed with 4 x 1 mL Strep-tactin lysis buffer and each wash fraction
was collected. The Strep-tactin resin was then washed with 4 x 1 mL Strep-tactin lysis buffer
containing 1 mM desthiobiotin to elute any His6-PhaC that remained bound to the Strep-tactin
resin and the elution fractions were collected. The Ni-NTA resin was washed with 4 x 1 mL Ni-
NTA lysis buffer and each wash fraction was collected. The Ni-NTA resin was then washed with
4 x 1 mL Ni-NTA lysis buffer containing 250 mM imidazole to elute bound Strep2(HRV)-PhaC
and the elution fractions were collected. Fifteen iL each fraction was combined with 10 pL
Laemmli buffer and the fractions were analyzed by 10% SDS-PAGE.
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5.5.2.9 Testing conditions for formation of His6-PhaC/Strep2(HRV)-PhaC heterodimers by
exchange of homodimers
Several conditions were tested for the dissociation of His6-PhaC and Strep2-PhaC
homodimers and reformation of heterodimers. In a final volume of 1 mL, 5 pM His 6-PhaC and
Strep2-PhaC were combined in 20 mM Hepes, pH 7.5 with the following additives: 0.2-2 M
NaCl; 0.2 M NaCl, 0.3% n-octyl--D-glucoside; 0.2 M NaCl, 1% n-octyl--D-glucOside; 2 M
NaCl, 0.3% n-octyl--D-glucoside; 0.2 M NaCl, 2 M urea; 0.2 M NaCl, 2-4 M guanidinium HCl;
and 0.2 M NaCl, 15% 1,6-hexanediol. The solutions were incubated for 30 min-4 h at room
temperature then exchanged overnight into 4 L 20 mM Hepes pH 7.5, 0.2 M NaCl by dialysis at
4 'C in Slide-a-Lyzer dialysis cassettes (0.5 - 3 mL capacity, 10,000 MWCO) (ThermoFisher
Scientific, Waltham, MA). The dialysis cassettes were then transferred to 4 L Ni-NTA lysis
buffer for 4 h at 4 'C. Following exchange, the solutions were combined individually with 0.25
mL Ni-NTA resin and equilibrated for 30 min at 4 'C. The slurries were then applied to columns
(7 x 10 mm) and the flowthrough was collected. The columns were washed with 4 x 1 mL Ni-
NTA lysis buffer and the washes were collected. The protein was eluted with 4 x 1 mL Ni-NTA
lysis buffer containing 250 mM imidazole, and the elution fractions collected. Fractions (15 ptL)
were combined with 10 ptL Laemmli buffer for analysis by 8% or 10% SDS-PAGE. The elution
fractions (4 mL) were combined with 100 mL Strep-tactin lysis buffer to dilute imidazole, then
concentrated to ~1 mL by filtration through a Centricon (15 mL, 30,000 MWCO) (Millipore,
Billerica, MA). The reactions were again diluted with 20 mL Strep-tactin lysis buffer and
concentrated to 1 mL, then combined with 0.25 mL Strep-tactin resin and incubated for 30 min at
4 'C with gentle rocking. The slurries were loaded to columns (7 x 10 mm) and the flowthrough
collected. The columns were washed with 4 x 1 mL Strep-tactin lysis buffer and the washes were
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collected. The columns were eluted with 4 x 1 mL Strep-tactin lysis buffer with 1 mM
desthiobiotin and the fractions were collected. An aliquot (15 pL) from each fraction was
combined with 10 tL Laemmli buffer and analyzed by 8% SDS-PAGE.
5.5.2.10 Preparation of His6-PhaC/Strep2(HRV)-PhaC heterodimers on a large scale by
exchange in 3 M guanidinium HCl
In a final volume of 5 mL, reaction A contained: 5 pM wt His6-PhaC and 5 pM wt
Strep2(HRV)-PhaC in 20 mM Hepes pH 7.5, 200 mM NaCl and 3 M guanidinium HCl. The
reaction contained 3.5 mg total protein. In a final volume of 10 mL, reaction B contained: 5 pM
wt His6-PhaC and 5 pM Strep2(HRV)-PhaC-C406A in 20 mM Hepes pH 7.5, 200 mM NaCl and
3 M guanidinium HCl. Reaction C was identical to reaction B except that it contained 5 pM
His 6-PhaC-C406A and 5 pM wt Strep2(HRV)-PhaC. The reactions contained 7 mg protein total.
The solutions were incubated for 30 min at room temperature, then dialyzed overnight at 4 'C
against 4 L of 20 mM Hepes pH 7.5, 200 mM NaCl to allow for reformation of dimers. The
reactions were then exchanged by dialysis into Ni-NTA lysis buffer (50 mM NaH2PO 4, 300 mM
NaCl, 10 mM imidazole, pH 8.0) for 4 h at 4 'C. Following dialysis, the reactions were
combined with 2.5 mL Ni-NTA resin (-1 mL for the wt reaction) and equilibrated with gentle
rocking for 30 min at 4 C, then loaded onto columns (7 mm x 30 mm) and the flowthrough
collected. The columns were washed with 20 cvs lysis buffer then 10 cvsNi-NTA lysis buffer
with 50 mM imidazole. The proteins were eluted with five cvs of Ni-NTA lysis buffer with 250
mM imidazole and the elution fractions were combined, concentrated and exchanged into Strep-
tactin lysis buffer. The reactions were combined with 1 mL of Strep-tactin resin and equilibrated
for 30 min at 4 'C with gentle rocking. The slurries were loaded onto columns (7 mm x 10 mm)
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and the flowthrough was collected. The columns were washed with 20 cvs of Strep-tactin lysis
buffer then eluted with five cvs of Strep-tactin lysis buffer with 1 mM desthiobiotin. The
reactions were concentrated to <200 p.L and assayed for activity.
5.5.2.11 Control for loss of activity of His6-PhaC and Strep2(HRV)-PhaC in 3 M
guanidinium HCl
In a final volume of 1 mL, 5 pM His6-PhaC and 5 iM Strep2(HRV)-PhaC were
incubated in two separate reactions for 30 min at room temperature in 20 mM Hepes pH 7.5, 200
mM NaCl, 3 M guanidinium HCl. The reactions were loaded into Slide-a-Lyzer dialysis
cassettes (0.5 - 3 mL capacity, 10,000 MWCO) and dialyzed overnight at 4 'C against 1 L of 20
mM Hepes pH 7.5, 200 mM NaCl, and the activity was assayed and compared to the activities of
fresh protein.
5.5.2.12 Western blot analysis of heterodimers with anti-His6 and anti-Strep2 antibodies
For anti-His6 tag Western blots, samples of reactions B and C (section 5.5.2.10) (10-1000
ng) and a standard of His 6-PhaC (200 ng) were resolved by 8% SDS-PAGE. A sample of
Strep2(HRV)-PhaC (200 ng) was included to test for cross-reactivity with the anti-His6 antibody.
For anti-Strep2 tag Western blots, samples of reactions B and C (10-25 ng) and a standard curve
of Strep2(HRV)-PhaC (5-50 ng) were resolved by 8% SDS-PAGE. The proteins were blotted
onto a PVDF membrane (Immun-Blot, BioRad) at 4 'C for 80 min at 100 V. The blotting buffer
contained 25 mM Tris, 192 mM glycine, 20% (v/v) methanol, and 0.01% SDS. The blots were
blocked in 3% milk, 0.1% Tween-20 in Tris-acetate-EDTA (TAE) buffer (blocking buffer) for
30 min at room temperature. For anti-His 6 Western blots, the blots were incubated for 1 h at
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room temperature with anti-His6 antibody (Roche) conjugated to horse radish peroxidase. For
anti-Strep2 Western blots, the blots were incubated for 1 h at room temperature with anti-Strep2
antibody (Qiagen) diluted 1:1000 in blocking buffer. Anti-Strep2 Western blots were then
incubated 1 h at room temperature in goat anti-mouse secondary antibody conjugated to horse
radish peroxidase (Abcam), used at a dilution of 1:5000. The blots were developed using
SuperSignal@ West Femto chemiluminescent detection reagents (Thermo Scientific) and imaged
using a BioRad ChemiDoc XRS imager. Band intensities were analyzed using Quantity-One® 1-
D software (BioRad).
5.5.3 Results
5.5.3.1 Expression and purification of His6-PhaCs, Strep2(HRV)-PhaCs and Strep2-PhaC
The expression and purification of His6-PhaC and His 6-PhaC-C406A are described in
section 2.2.3. Two strep2-phaC constructs were cloned. Strep2(HRV)-PhaC contains an N-
terminal Strep2 tag that is separated from phaC by a spacer that encodes an HRV 3C protease
cleavage site. Purification of Strep2(HRV)-PhaC and -C406A yielded about 3 mg protein per g
of cells. As with His6-PhaC, a large portion of the synthase is contained within the insoluble
fraction after cell lysis (Figure 5.10, lane 3). Expression at lower temperatures increased the
fraction of synthase in the soluble fraction. The final purified protein was only ~80% pure, as
judged by 10% SDS-PAGE after concentration (Figure 5.10, lane 6), likely due to extensive
precipitation of Strep2(HRV)-PhaC during concentration that consequently enriched
contaminating proteins. Inclusion of 10% glycerol in the storage buffer in subsequent
purifications somewhat mitigated this problem. The specific activity of the preparation shown in
Figure 5.10 was 35 U/mg, compared to ~50 U/mg measured for His6-PhaC. Two additional
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purifications of Strep2(HRV)-PhaC were carried out, and the final proteins had specific activities
of 10 U/mg and 5 U/mg (Table 5.4). The reason for the variability in the specific activities is not
known, but may be due to the tendency of the synthase to precipitate, resulting in impure protein.
75 kD6
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Figure 5.10 SDS-PAGE (10%) gel of Strep2(HRV)-PhaC purification steps. Lane 1,
molecular weight markers. Lane 2, soluble cell-free extract. Lane 3, insoluble cell-free extract.
Lane 4, Strep-tactin column flowthrough. Lane 5, Strep-tactin column wash. Lane 6, final
protein.
Table 5.4 Activity table for the purification of Strep2(HRV)-PhaC.
Volume Protein Activity
Purification step (mL) (mg) (Ua/mg) Total units % yieldb
Crude soluble extract 15 285 11 3140 100
Strep-tactin flowthrough 23 190 7.3 1360 43
Strep-tactin wash 63 38 25 950 30
Final protein 1.7 20 35c 710 23
aOne unit of activity is one ptmol CoA released per min.
b% yield is calculated based on total units in crude soluble extract.
'The purification table gives the results of the purification that yielded synthase with the highest
specific activity.
The second strep2-phaC construct contained phaC with an N-terminal Strep2 tag with no
linker. The tag was inserted by two rounds of mutagenesis and additional mutagenesis was
carried out to insert either a (G4 S) or (G4 S) 2 linker. The purification of Strep2-PhaC with no
linker was robust and yielded synthase with a specific activity of 52 U/mg (Table 5.5). This
specific activity is comparable to the specific activity of His6-PhaC (50 U/mg). Purification of
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Strep2-PhaC also yielded protein that was 95% pure as judged by 8% SDS-PAGE (Figure 5.11,
lane 5), and this protein was used in all subsequent experiments.
75 kDa
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Figure 5.11 SDS-PAGE (8%) analysis of Strep2-PhaC purification steps. Lane 1, molecular
weight standards. Lane 2, soluble cell-free extract. Lane 3, Strep-tactin column flowthrough.
Lane 4, Strep-tactin column wash. Lane 5, final purified protein.
Table 5.5 Activity table for the purification of Strep2-PhaC.
Volume Protein Activity
Purification step (mL) (mg) (Ua/mg)
Crude soluble extract 21 320 8.3
Strep-tactin flowthrough 23 280 4.7
Strep-tactin wash 51 18 14
Final protein 1.5 6 52
aOne unit of activity is one pmol CoA released per min.
b% yield is calculated based on total units in crude soluble extract.
Total units
2660
1320
250
310
% yield"
100
50
9.4
12
5.5.3.2 Control for binding of Strep2(HRV)-PhaC to Ni-NTA resin and His6-PhaC to Strep-
tactin resin
A control was carried out to determine whether non-specific binding of His6-PhaC and
Strep2(HRV)-PhaC to the Streptactin and Ni-NTA affinity resin, respectively, occurred. The
conditions in this experiment mimicked the conditions used for testing various conditions for
exchange of heterodimers, as described below. His6-PhaC mixed with Strep-tactin resin and
loaded into a column is found entirely in the flowthrough and the first two wash fractions (Figure
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5.12A, lanes 2-4). No protein is found in the elution fractions. When Strep2(HRV)-PhaC is
mixed with Ni-NTA resin and loaded onto a column, the protein is almost entirely in the
flowthrough and first two wash fractions (Figure 5.12B, lanes 2-4). A small amount of protein is
present in the first elution fraction (Figure 5.12B, lane 7). Under these conditions the column was
only washed with 10 mM imidazole. In scaled up exchange reactions described below, the Ni-
NTA columns are washed additionally with 50 mM imidazole, which washes out the remainder
of the non-specifically bound Strep2(HRV)-PhaC. These control reactions demonstrate that
under the conditions used subsequently to test conditions for heterodimer formation, there is no
non-specific binding to the affinity resins.
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Figure 5.12 Control to test for non-specific binding of His6-PhaCs and Strep2(HRV)-PhaCs
binding to inappropriate affinity resin. A) His 6-PhaC (50 pM in 1 mL of 20 mM Hepes pH
7.5, 20 mM NaCl) was mixed with 0.2 mL of Strep-tactin resin. Lane 1, molecular weight
standards. Lane 2, flowthrough from Strep-tactin resin. Lanes 3-6, 10 mM imidazole wash
fractions. Lanes 7-10, elution fractions. B) Strep2(HRV)-PhaC (5 pM in 1 mL of 20 mM Hepes
pH 7.5, 20 mM NaCl) was mixed with 0.2 mL of Ni-NTA resin. Lane 1, molecular weight
standards. Lane 2, flowthrough from Ni-NTA column. Lanes 3-6, wash fractions. Lanes 7-10,
elution fractions.
5.5.3.3 Migration of His6-PhaCs and Strep2(HRV)-PhaCs in 8% SDS-PAGE.
His6-PhaC and Strep2(HRV)-PhaC have molecular weights of 76,039 and 76,488 Da,
respectively. We wished to determine whether the two proteins could be resolved by 8% SDS-
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PAGE, as this would be the easiest way to determine whether both were present following
heterodimer preparation and subsequent purification. His6-PhaC, despite having a slightly lower
molecular weight, migrates slightly higher than Strep2(HRV)-PhaC (Figure 5.13A, lanes 2-4
compared to lanes 5-7). When the two proteins are purified separately and then combined for
SDS-PAGE analysis they are clearly distinguishable (Figure 5.13A, lanes 8-10). His6-PhaC-
C406A, Strep2(HRV)-PhaC and Strep2(HRV)-PhaC-C406A migrate at the same position
(Figure 5.13B, lanes 3-5). Strep2-PhaC has a molecular weight of 74,829 Da and migrates more
rapidly than the other PhaC constructs in 8% SDS-PAGE (Figure 5.13B, lane 6).
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Figure 5.13 Relative migrations of His6-PhaCs and Strep2(HRV)-PhaCs in 8% SDS-PAGE.
A) Lane 1, molecular weight standards. Lanes 2-4, His6-PhaC (1-3 ptg). Lanes 5-7,
Strep2(HRV)-PhaC (1-3 pg). Lanes 8-10, His6-PhaC and Strep2(HRV)-PhaC (1-3 pg each
protein). Proteins were purified separately and combined in gel sample. B) Lane 1, molecular
weight standards. Lane 2, His6-PhaC (2 pg). Lane 3, His6-PhaC-C406A (2 pg). Lane 4,
Strep2(HRV)-PhaC (2 pg). Lane 5, Strep2(HRV)-PhaC-C406A (2 jig). Lane 6, Strep2-PhaC (2
ig).
5.5.3.4 Testing conditions for formation of His6-PhaC/Strep2(HRV)-PhaC heterodimers by
exchange of homodimers
In order to find conditions that promote dissociation of PhaC dimers, several small scale
reactions were carried out. His6-PhaC and Strep2(HRV)-PhaC were incubated in 1 mL of
buffered solutions containing a variety of additives.
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5.5.3.4.1 Exchange in 20 mM Hepes pH 7.5, 0.2 M NaCI
His 6-PhaC and Strep2(HRV)-PhaC are stored in 20 mM Hepes pH 7.5, 200 mM NaCl.
An exchange reaction between His6-PhaC and Strep2(HRV)-PhaC was carried out in the storage
buffer in order to confirm that spontaneous exchange doesn't occur, which would complicate
heterodimer isolation. Figure 5.14 shows the results of this control. After purification with both
affinity resins, a small amount of protein elutes from the Strep-tactin column (Figure 5.14B, lane
7). This protein migrates predominantly as a single band, but there appears to have been some
degradation/proteolysis during the course of the experiment. Given that under less strenuous
wash conditions (10 mM imidazole), a small amount of Strep2(HRV)-PhaC sticks to the Ni-NTA
resin (Figure 5.14B), this single band is likely just Strep2-tagged synthase. As the wt PhaCs
migrate at different rates, if both were present we should be able to distinguish them. There does
not appear to be exchange between the His6- and Strep2-tagged synthases in storage buffer.
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Figure 5.14 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC in 0.2 M NaCl. A) Analysis of Ni-NTA affinity purification of
heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column.
Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-
tactin affinity purification of heterodimers following Ni-NTA purification. Lane 1, molecular
weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions.
Lanes 7-10, elution fractions.
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5.5.3.4.2 Exchange in 20 mM Hepes pH 7.5, 0.5-2 M NaCI
Three additional conditions were explored with variable concentrations of NaCl (0.5-2
M) in order to determine whether disruption of electrostatic interactions at the dimer interface
could promote dissociation. In all three conditions only a single band elutes from the Strep-tactin
column, again suggesting that there was no exchange between PhaCs (Figures 5.15-17B, lanes 7
and 8).
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Figure 5.15 SDS-PAGE (8%) analysis of heterodimer exchange of His6 -PhaC and
Strep2(HRV)-PhaC in 0.5 M NaCl. A) Analysis of Ni-NTA affinity purification of
heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column.
Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-
tactin affinity purification of heterodimers following Ni-NTA purification. Lane 1, molecular
weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions.
Lanes 7-10, elution fractions.
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Figure 5.16 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC in 1 M NaCl. A) Analysis of Ni-NTA affinity purification of heterodimers.
Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column. Lanes 3-6, 10
mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-tactin affinity
purification of heterodimers following Ni-NTA purification. Lane 1, molecular weight standards.
Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions. Lanes 7-10, elution
fractions.
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Figure 5.17 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC in 2 M NaCl. A) Analysis of Ni-NTA affinity purification of heterodimers.
Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column. Lanes 3-6, 10
mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-tactin affinity
purification of heterodimers following Ni-NTA purification. Lane 1, molecular weight standards.
Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions. Lanes 7-10, elution
fractions.
5.5.3.4.3 Exchange in 20 mM Hepes pH 7.5, 0.3-1% n-octyl-l-j-glucoside
Previously, we purified the class III PHB synthase from Xanthomonas oryzae. This
synthase, like the prototypical class III synthase from Allochromatium vinosum, is composed of
two subunits, PhaC and PhaE, both ~40 kDa. In this construct, PhaE contained an N-terminal
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His6-tag (His 6-PhaE), whereas PhaC was untagged. In efforts to purify this synthase, n-octyl-p-D-
glucoside was included in the purification buffers at concentrations of 0.1% and 1%. The critical
micelle concentration (cmc) of n-octyl-P-D-glucoside is 0.69%. In the absence or presence of
0.1% n-octyl-p-D-glucoside, His6-PhaE and PhaC copurified by Ni-NTA affinity
chromatography. However, when the purification buffer contained 1% n-octyl-p-D-glucoside,
His 6-PhaE and PhaC did not copurify. Under these conditions there was also no activity in the
soluble cell-free extract. We took this observation to indicate that n-octyl-p-D-glucoside above its
cmc disrupts the interaction between PhaE and PhaC from X oryzae and renders the enzyme
inactive. When the concentration of n-octyl-p-D-glucoside in the assay mixture for (His) 6-PhaC is
increased from 0% to 1%, there is a steady drop in the activity (Figure 5.18). We therefore
explored whether n-octyl-p-D-gluCoside could be used to disrupt the dimeric forms of PhaC,
facilitating heterodimer formation.
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Figure 5.18 Effect of n-octyl-P-D-glucoside on His6-PhaC activity. The assays were carried out
at 30 C and contained 50 nM His6-PhaC and 0% (e), 0.1% (o), 0.3% (A), 0.6% (0), or 1% (x)
n-octyl-p-D-glucoside.
Detergents can disrupt hydrophobic interactions at a dimer interface. We therefore also
tried n-octyl-p-D-glucoside in combination with 0.2 M and 2 M NaCl, the latter condition to
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disrupt both hydrophobic and electrostatic interactions simultaneously. Upon incubation in 0.3%
n-octyl-p-D-glucoside and 2 M NaCl, the proteins precipitated extensively. However, incubation
in 0.3% n-octyl-P-D-glucoside or 2 M NaCl alone did not result in precipitation. In all three
conditions there was no exchange (Figures 5.19-5.21, lanes 7 and 8).
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Figure 5.19 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC-C406A in 0.2 M NaCl, 0.3% n-octyl-P-D-glucoside. A) Analysis of Ni-
NTA affinity purification of heterodimers. Lane 1, molecular weight standards. Lane 2,
flowthrough from Ni-NTA column. Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10,
elution fractions. B) Analysis of Strep-tactin affinity purification of heterodimers following Ni-
NTA purification. Lane 1, molecular weight standards. Lane 2, flowthrough from Strep-tactin
column. Lanes 3-6, wash fractions. Lanes 7-10, elution fractions.
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Figure 5.20 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC-C406A in 0.2 M NaCl, 1% n-octyl-P-D-glucoside. A) Analysis of Ni-
NTA affinity purification of heterodimers. Lane 1, molecular weight standards. Lane 2,
flowthrough from Ni-NTA column. Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10,
elution fractions. B) Analysis of Strep-tactin affinity purification of heterodimers following Ni-
NTA purification. Lane 1, molecular weight standards. Lane 2, flowthrough from Strep-tactin
column. Lanes 3-6, wash fractions. Lanes 7-10, elution fractions.
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Figure 5.21 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC-C406A in 2 M NaCl, 0.3% n-octyl-P-D-gluCoside. A) Analysis of Ni-
NTA affinity purification of heterodimers. Lane 1, molecular weight standards. Lane 2,
flowthrough from Ni-NTA column. Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10,
elution fractions. B) Analysis of Strep-tactin affinity purification of heterodimers following Ni-
NTA purification. Lane 1, molecular weight standards. Lane 2, flowthrough from Strep-tactin
column. Lanes 3-6, wash fractions. Lanes 7-10, elution fractions.
5.5.3.4.4 Exchange in 20 mM Hepes pH 7.5, 0.2 MNaC, 15% 1,6-hexanediol.
Vargo and coworkers reported successful formation of mutant heterodimers of
glutathione-S-transferase by incubation of homodimers in 15-20% 1,6-hexanediol (26).
Therefore, His6-PhaC and Strep2(HRV)-PhaC were incubated in 10-20% 1,6-hexanediol. The
proteins precipitated immediately when incubated in 20% 1,6-hexanediol, but remained soluble
after 2 h in 15% 1,6-hexanediol, so this condition was.pursued. However 1,6-hexanediol did not
promote dissociation of homodimers (Figure 5.22B, lane 7-9).
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Figure 5.22 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC-C406A and
Strep2(HRV)-PhaC in 15% 1,6-hexanediol. A) Analysis of Ni-NTA affinity purification of
heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column.
Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-
tactin affinity purification of heterodimers following Ni-NTA purification. Lane 1, molecular
weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions.
Lanes 7-10, elution fractions.
5.5.3.4.5 Exchange in 20 mM Hepes, pH 7.5, 0.2 M NaC, 2 M urea
Mild denaturation with 2 M urea was explored to dissociate homodimers by partial
unfolding. Though there was no observable precipitation upon refolding, no exchange of
heterodimers occurred (Figure 5.23B, lane 7).
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Figure 5.23 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC in 2 M urea. A) Analysis of Ni-NTA affinity purification of heterodimers.
Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column. Lanes 3-6, 10
mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-tactin affinity
purification of heterodimers following Ni-NTA purification. Lane 1, molecular weight standards.
Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions. Lanes 7-10, elution
fractions.
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5.5.3.4.6 Exchange in 20 mM Hepes, pH 7.5, 0.2 MNaCl, 2-4 Mguanidinium HCI
We also explored denaturation by incubation of His6-PhaC and Strep2(HRV)-PhaC in 2-4
M guanidinium HCl. Incubation in 2 M guanidinium HCl promoted exchange of heterodimers,
identified by two distinct bands in Figure 5.24B, lanes 7 and 8, but with very low yield. We
speculated that the yield could be improve using harsher denaturation conditions, which might
promote more dissociation of dimers into monomers. Thus 3 M and 4 M guanidinium HCl were
tested. Incubation in 3 M guanidinium HCl improved the yield of heterodimers, as judged by
SDS-PAGE (Figure 5.25B, lanes 7 and 8). The proteins precipitated extensively in 4 M
guanidinium HCl, precluding heterodimer formation (Figure 5.26B, lanes 7 and 8). Therefore 3
M guanidinium was selected for scaling up heterodimer exchange.
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Figure 5.24 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC in 2 M guanidinium HCl. A) Analysis of Ni-NTA affinity purification of
heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-NTA column.
Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B) Analysis of Strep-
tactin affinity purification of heterodimers following Ni-NTA purification. Lane 1, molecular
weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6, wash fractions.
Lanes 7-10, elution fractions.
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Figure 5.25 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC-C406A in 3 M guanidinium HCl. A) Analysis of Ni-NTA affinity
purification of heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-
NTA column. Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B)
Analysis of Strep-tactin affinity purification of heterodimers following Ni-NTA purification.
Lane 1, molecular weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6,
wash fractions. Lanes 7-10, elution fractions.
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Figure 5.26 SDS-PAGE (8%) analysis of heterodimer exchange of His6-PhaC and
Strep2(HRV)-PhaC-C406A in 4 M guanidinium HCl. A) Analysis of Ni-NTA affinity
purification of heterodimers. Lane 1, molecular weight standards. Lane 2, flowthrough from Ni-
NTA column. Lanes 3-6, 10 mM imidazole wash fractions. Lanes 7-10, elution fractions. B)
Analysis of Strep-tactin affinity purification of heterodimers following Ni-NTA purification.
Lane 1, molecular weight standards. Lane 2, flowthrough from Strep-tactin column. Lanes 3-6,
wash fractions. Lanes 7-10, elution fractions.
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5.5.3.5 Control for loss of activity of His6 -PhaC and Strep2(HRV)-PhaC in 3 M
guanidinium HCl
To control for activity loss upon incubation in 3 M guanidinium HCl, both His6-PhaC and
Strep2(HRV)-PhaC were incubated in 3 M guanidinium HC1, then dialyzed overnight into 20
mM Hepes pH 7.5, 200 mM NaCl. The enzymes were assayed, revealing that His 6-PhaC activity
dropped from 50 U/mg to 20 U/mg upon incubation in 3 M guanidinium HCl, (Figure 5.27A). In
contrast the activity of Strep2(HRV)-PhaC remained stable at 20 U/mg (Figure 5.27B).
0.6-
2 0.4-
.5 0.2-
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Figure 5.27 Time course of CoA release from wt His6-PhaC and Strep2(HRV)-PhaC
following incubation in 3 M guanidinium HCl. A) His6-PhaC (25 nM) was assayed before (e)
and after (o) incubation for 30 min in 3 M guanidinium HC and overnight dialysis into 20 mM
Hepes pH 7.5, 200 mM NaCl. B) Strep2(HRV)-PhaC (50 nM) was assayed before (A) and after
(0) incubation for 30 min in 3 M guanidinium HCl and overnight dialysis into 20 mM Hepes pH
7.5, 200 mM NaCl.
5.5.3.6 Preparation and characterization of His6-PhaC/Strep2(HRV)-PhaC heterodimers
by exchange in 3 M guanidinium HCl
The encouraging results in 3 M guanidinium HCl prompted us to scale up the reaction so
the specific activities of the resulting heterodimers could be determined. Reaction A, containing
both wt His6-PhaC and Strep2-PhaC, was carried out to assess the activity of wt-wt heterodimers
for comparison with wt-mutant heterodimers, and the results are shown in Figure 5.30. Starting
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from 3.5 mg of protein total, following incubation in 3 M guanidinium and dialysis in refolding
buffer, 2.9 mg of protein were recovered (Table 5.6). The loss is from precipitation upon
refolding as precipitated protein is observed in the dialysis cassettes. In addition, loss of protein
was observed in all three reactions following dialysis. The final yield of heterodimers in reaction
A was very low, only 7 ptg, or 0.2% of starting material. Most of the protein was lost in the
flowthrough and 10 mM imidazole wash fractions from the Ni-NTA column, which we expect to
contain Strep2(HRV)-PhaC homodimers. There was considerably less protein in the flowthrough
from the Strep-tactin resin, which we expect to contain His6-PhaC homodimers. The results
suggest that the protein lost from the 3 M guanidinium unfolding step and dialysis/refolding was
primarily His6-PhaC, which also seems to be true for all three reactions (Tables 5.6, 5.7 and 5.8),
which may in part explain why the yield of heterodimer is so low. The activity of the purified
His 6-PhaC/Strep2(HRV)-PhaC is only 0.93 +/- 0.1 U/mg. By 8% SDS-PAGE two bands can be
clearly distinguished in the final protein sample (Figure 5.28, lane 9). The band that migrates at
an apparent higher molecular weight is His 6-PhaC and the band that migrates at a lower
molecular weight is Strep2(HRV)-PhaC.
75 kDa
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Figure 5.28 SDS-PAGE (8%) analysis of exchange of His6-PhaC and Strep2(HRV)-PhaC in
3 M guanidinium HCl. Lane 1, molecular weight standards. Lane 2, post refolding dialysis step.
Lane 3, Ni-NTA column flowthrough. Lane 4, Ni-NTA column 10 mM imidazole wash. Lane 5,
Ni-NTA column 50 mM imidazole wash. Lane 6, post Ni-NTA column. Lane 7, Strep-tactin
column flowthrough. Lane 8, Strep-tactin column wash. Lane 9, final protein.
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Table 5.6 Activity table of preparation of His6-PhaC/Strep2(HRV)-PhaC heterodimers
(reaction A).
Volume Protein Activity % total
Purification step (mL) (mg) (U/mg) Total units activity
Post-dialysis 5 2.9 4 11 100
Ni-NTA flowthrough 5 1.5 2.9 4.4 38
Post Ni-NTA 14 1.4 2.9 4.1 36
Strep-tactin flowthrough 5 0.25 13 3.3 29
Final protein 0.065 0.007 0.93 +/- 0.1 a 0.007 0.06
aThe specific activity of the final protein was measured in triplicate and the error is standard
deviation from the mean.
Reactions B and C were carried out with twice as much protein as was used in reaction
A, and the yield in both reaction was -10-fold higher than for reaction A (Tables 5.7 and 5.8).
The specific activity of the final purified heterodimers in reaction B was 1.7 +/- 0.1 U/mg. The
results for reactions B and C are shown in Figures 5.29 and 5.30, respectively.
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Figure 5.29 SDS-PAGE (8%) analysis of exchange of wt His6-PhaC and Strep2(HRV)-
PhaC-C406A in 3 M guanidinium HCl. Lane 1, molecular weight standards. Lane 2, post
refolding dialysis step. Lane 3, Ni-NTA column flowthrough. Lane 4, Ni-NTA column 10 mM
imidazole wash. Lane 5, Ni-NTA column 50 mM imidazole wash. Lane 6, post Ni-NTA column.
Lane 7, Strep-tactin column flowthrough. Lane 8, Strep-tactin column wash. Lane 9, final
protein. Lane 10, wt His6-PhaC + Strep2(HRV)-PhaC-C406A standard.
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Table 5.7 Activity table of preparation of His6-PhaC/Strep2(HRV)-PhaC-C406A
heterodimers (reaction B).
Volume Protein Activity % total
Purification step (mL) (mg) (U/mg) Total units activity
Post-dialysis 10 4.6 1.1 5.1 100
Ni-NTA flowthrough 10 1.4 0.2 0.28 5.5
Post Ni-NTA 14 1.8 4 7.2 140
Strep-tactin flowthrough 6.5 0.3 13 3.9 77
Final protein 0.2 0.08 1.7+/- 0.la 0.14 2.7
aThe specific activity of the final protein was measured in triplicate and the error is standard
deviation from the mean.
Finally, His6-PhaC-C406A and Strep2(HRV)-PhaC migrate as one band and cannot be
distinguished by 8% SDS-PAGE. The specific activity of the heterodimers purified from reaction
C is 1.3 +/- 0.1 U/mg. All three heterodimers have specific activities of 1-2 U/mg, considerably
lower than either of the two proteins prior to exchange. The cause of the drop in activity is not
understood but may be in part due to improper re-folding following incubation in guanidinium.
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Figure 5.30 SDS-PAGE (8%) analysis of exchange of His6-PhaC-C406A and wt
Strep2(HRV)-PhaC in 3 M guanidinium. Lane 1, molecular weight standards. Lane 2, post
refolding dialysis step. Lane 3, Ni-NTA column flowthrough. Lane 4, Ni-NTA column 10 mM
imidazole wash. Lane 5, Ni-NTA column 50 mM imidazole wash. Lane 6, post Ni-NTA column.
Lane 7, Strep-tactin column flowthrough. Lane 8, Strep-tactin column wash. Lane 9, final
protein. Lane 10, His6-PhaC-C406A + wt Strep2(HRV)-PhaC standard.
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Table 5.8 Activity table of preparation of His6-PhaC-C406A/Strep2-PhaC heterodimers
(reaction C).
Purification step Volume Protein Activity % total
(mL) (mg) (U/mg) Total units activity
Post-dialysis 10 5.4 7 38 100
Ni-NTA flowthrough 9.5 3.0 7 21 56
Post Ni-NTA 15 2.0 1.1 2.3 6
Strep-tactin flowthrough 10 0.5 1.5 0.75 2.0
Final protein 0.22 0.09 1.3 +/- 0.l a 0.12 0.31
aThe specific activity of the final protein was measured in triplicate and the error is standard
deviation from the mean.
In reactions B and C two bands cannot be as clearly distinguished by 8% SDS-PAGE as
in reaction A. Therefore Western blot analysis using commercially available antibodies against
the His6- and Strep2-tags was carried out. First, two standard curves were generated by Western
blot using anti-Strep2 antibody against 25-200 ng of Strep2-PhaC (Figure 5.3 1A) and 25-200 ng
of a one to one mixture of Strep2(HRV)-PhaC to His6-PhaC (Figure 5.3 1B). The purpose of this
control was to confirm that the standard curves were the same and therefore that the amount of
Strep2(HRV)-PhaC in a mixture of the two proteins could be accurately determined. The
standard are similar, thus the ng of Strep2(HRV)-PhaC present in a sample of Strep2-PhaC/His6 -
PhaC heterodimer was determined using a standard curve containing just Strep2(HRV)-PhaC.
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Figure 5.31 Western blot standard curves of anti-Strep2 antibody. A) Standard curve
generated from 25-200 ng of Strep2(HRV)-PhaC. B) Standard curve generated from 25-200 ng
of a 1:1 mixture of His6-PhaC to Strep2(HRV)-PhaC (12.5-100 ng of each protein). The intensity
in B) is plotted as a function of the ng of Strep2(HRV)-PhaC, rather than of ng of both proteins.
The amount of Strep2(HRV)-PhaC in the heterodimer products of reactions B and C,
His6-PhaC/Strep2(HRV)-PhaC-C406A and His6-PhaC-C406A/Strep2(HRV)-PhaC was then
determined using this method. A sample of reaction B of 10 ng total protein (as judged by
Bradford assay) contains 4.9 ng of Strep2-PhaC, and a sample of 25 ng total protein contains 9.4
+/- 2.3 ng of Strep2-PhaC (Figure 5.32A). A 10 ng sample of reaction C contains 5 ng of Strep2-
PhaC, and a 25 ng sample contains 12 +/- 0.4 ng Strep2(HRV)-PhaC (Figure 5.32B). These
results are consistent with the purified heterodimers containing a nearly 1:1 ratio of His 6-PhaC to
Strep2(HRV)-PhaC.
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Figure 5.32 Anti-Strep2 Western blots of A) His6-PhaC/Strep2(HRV)-PhaC-C406A
(reaction B) and B) His6-PhaC-C406A/Strep2(HRV)-PhaC (reaction C) heterodimers.
A similar analysis was carried out using anti-His6 antibody. Initial attempts to do
quantitative Western blots with anti-His6 antibody failed. The anti-His6 antibody must be used at
a much higher concentration compared to the anti-Strep2 antibody, which led to higher
background. About 10-fold more sample must be loaded to detect the presence of the tag. The
results in Figure 5.33 clearly show that both reactions B and C contain His6-PhaC and His6 -
PhaC-C406A, respectively. His6-PhaC and Strep2(HRV)-PhaC standards were also loaded to
confirm that the antibody does not cross-react with the Strep2-tag or react non-specifically with
PhaC. Taken together, the results from both Westerns confirm that both His6- and Strep2-PhaCs
are present in both reactions, and that Strep2-PhaC comprises about half of the total ng of protein
in each sample. The assay results indicate that both mutant heterodimers have approximately the
same activity as the wild type heterodimer.
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Figure 5.33 Anti-His6 Western blots of A) His6-PhaC/Strep2(HRV)-PhaC-C406A (reaction
B) and B) His6-PhaC-C406A/Strep2(HRV)-PhaC (reaction C) heterodimers. Ten to 1000 ng
each of reactions B and C were loaded, as well as 200 ng of His6-PhaC (H) and Strep2-PhaC (S)
standards.
5.5.3.7 Discussion
This section presents our efforts to prepare and characterize mutant heterodimers of
PhaCcc. We initially speculated that because PhaCcc is entirely dimeric at high concentrations, if
conditions could be identified in which it could be dissociated into monomers, then wt and
mutant monomers could be mixed. To form heterodimers, the protein could then be exchanged
back into conditions that promote dimerization. We thus screened a number of additives to
identify one that would promote exchange of monomers to form heterodimers. However, nearly
all of the additives failed to induce monomerization, with the exception of guanidinium HCl. We
therefore scaled up heterodimer formation in 3 M guanidinium HCl and characterized the
specific activity of the resulting protein. Unfortunately, the specific activity of the heterodimers
was so low, even in the case of the wt heterodimers; thus, it was difficult to draw strong
conclusions. In Chapter 2, we presented SEC studies that showed that decreasing the
concentration of PhaCcc induces the dissociation of dimers into monomers. Hence an alternative
method for the formation of heterodimers might be to simply decrease the concentration, mix wt
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and mutant monomers, and then concentrate the protein to reform dimer. This method could
potentially be less perturbative to the activity of the protein compared to incubation in
guanidinium HCl. Following the reformation of heterodimers, the affinity purification steps
could be carried out as described in this section to remove homodimers.
Finally, it should be noted that if the stoichiometry of acylation of PhaCcc with the
artificial primer sTCoA presented in Chapter 2 is indicative of the stoichiometry of PHB chain
synthesis, then each monomer makes one PHB chain and the mechanism in Figure 5.8A is
necessarily ruled out. Thus, in the case of PhaCc., at least, it seems likely that polymerization
occurs via non-covalent intermediates.
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